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Abstract
Cardiac valve replacement is the second most common heart operation. Currently
available replacement heart valves all have limitations. This study aimed to produce and
characterise a decellularised, biocompatible porcine pulmonary root conduit for use in
the Ross procedure. A process for the decellularisation of porcine pulmonary roots was
developed incorporating trypsin (2.25 × 104 Unit.ml-1) digestion of the adventitial
surface of the scraped pulmonary artery and sequential treatment with: hypotonic Tris
buffer (HTB; 10mM Tris pH 8.0, 0.1% (w/v) EDTA, 10KIU aprotinin), 0.1% (w/v)
SDS in HTB, two cycles of DNase and RNase, and sterilisation with 0.1% (v/v)
peracetic acid.
Histology confirmed an absence of cells and retention of the gross histoarchitecture.
DNA levels were reduced by >90 % throughout the decellularised tissue and functional
genes were not detected using PCR. Immunohistochemistry showed a lack of α-gal 
epitopes and confirmed cell removal but a loss of collagen IV. In vitro biocompatibility
studies indicated the decellularised leaflets were not cytotoxic while the pulmonary wall
was shown to reduce 3T3 cells viability in 3 out of 6 samples.
Uniaxial tensile testing to failure demonstrated no significant difference in the tensile
properties between the fresh and decellularised leaflets and pulmonary walls in the
circumferential and radial directions with the exception of the elastin phase slope of the
pulmonary artery in both directions which showed a significant decrease in the
decellularised tissue. Pulsatile flow testing indicated the decellularised pulmonary roots
had excellent hydrodynamic function and leaflet kinematics in comparison to the fresh
tissue. Initial attempts to culture fresh pulmonary roots in a heart valve bioreactor were
unsuccessful, indicating a need to develop the physiological culture system further.
Overall the decellularised porcine pulmonary roots have excellent potential for
development of a tissue engineered solution for right ventricular out flow tract
reconstruction during the Ross procedure.
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Introduction
From 1998 to 2005, an estimated 288,000 aortic or mitral valve replacement procedures
were performed in the United States with an in-hospital death rate of 4.98 % (Barnett &
Ad, 2009). Although heart valve repair is the gold standard for minor valve disease,
heart valve replacement is the most common and effective treatment for severe valvular
dysfunction. Thus, there is an increasing need for replacement heart valves. Currently,
traditional replacement valves are either mechanical or biological, and each has its
advantages and disadvantages. Mechanical valve replacement carries a risk of
thromboembolism, and thus life-long anticoagulation therapy is required.
Anticoagulation however may cause hemorrhage. Biological valves, including
bioprosthetic and homograft valves, carry a lower risk of thromboembolism, but tend to
fail sooner and more frequently. Homograft valves are associated with limited
availability especially for children. An approach to design an “ideal replacement valve”
would be through tissue engineering. A successful tissue engineered heart valve could
overcome almost all of the drawbacks associated with the currently available valve
replacements. Tissue engineered heart valves would have the potential to remodel and
grow, which are important features especially for children undergoing heart valve
replacement.
1.1 The human heart
The function of the heart is to pump blood to all tissues and organs in the body. It is
thus essential to life. Oxygen, nutrients, waste products and heat are transported with
the aid of the heart around the body at a very high speed (Levick, 2003). It is located
slightly left of the middle of the chest (directly posterior to the sternum). The heart is
protected and supported by the pericardium, which is a double layered membrane.
Normally, the heart weighs 300 to 400 grams in human adults, and measures
approximately 12.5 cm from the base to the apex, which reaches the fifth intercostal
space (Martini, 2006). The heart acts as a strong pump, which is composed of
myocardium, and beats an average of 100，000 times each day, pumping more than
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7,000 litres of blood. A person’s heart may have beaten more than 3 billion times by the
end of his/her life (Martini, 1995).
The heart consists of four chambers, which are the left and right ventricles and the left
and right atria. The four chambers are built around the annulus fibrosus, which is a ring
of fibrous tissue. The heart is supplied by several large blood vessels, by which, blood
can be carried into or away from the heart. The right atrium receives blood through the
superior vena cava and the inferior vena cava. The left and right pulmonary arteries are
connected to the right ventricle and carry blood from the right ventricle to the lungs.
The left atrium receives oxygenated blood from the lungs via the two left and two right
pulmonary veins, which are connected to the posterior wall of the left atrium. The aorta,
which is responsible for carrying oxygenated blood away from the heart and into the
systemic circuit, is connected to the left ventricle. The aorta is the largest vessel
connected to the heart, and has a diameter of about 20 mm in human adults (Martini,
2006; Figure 1.1).
Figure 1.1 Schematic diagram of the structure of the heart. The heart consists of
four chambers: left and right ventricles, and the left and right atria. Several large vessels
are connected to the heart. The superior vena cava and the inferior vena cava are
connected to the right atrium; the left and right pulmonary arteries are connected to the
right ventricle; the left and right pulmonary veins are connected to the left atrium; the
aorta is connected to the left ventricle. (Derived from BiologyDaily, 2005)
The ventricles receive blood from the atria, and are responsible for pumping the blood
out of the heart to different parts of the body. The shape of the left ventricle is
ellipsoidal while the shape of the right ventricle is more irregular. The left ventricle
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appears to wrap around the right ventricle. The ventricle walls consist of cardiac muscle.
Cardiac muscle is strong in order to carry out the pumping work of the ventricles. The
left ventricle, which is responsible for systemic circulation, has to exert four to six times
as much pressure, to push blood around the systemic circuit, as the right ventricle to
push blood around the pulmonary circuit. Thus, the left ventricle has a much thicker
wall than the right ventricle (almost twice as thick) because it requires more muscle and
energy to do its work. The left ventricle also bulges into the right ventricular cavity as it
contracts, improving the efficiency of the right ventricle (Martini, 2006; Levy &
Pappano, 2007).
The atria reside above the ventricles. They are storage chambers for blood returning to
the heart, rather than important pumps for the forward propulsion of blood. They are
formed by a continuum of muscle fibres that originate from the fibrous skeleton at the
base of the heart (Levy & Pappano, 2007). They perform a temporary storage function
and then pump the blood into the corresponding ventricles. The contraction of the atria
contributes to approximately one quarters of the blood that enters the ventricles. The
other three quarters of blood enter the ventricles due to the vacuum force after the
contraction of the ventricles. Since the atria only supply blood to the ventricles, the
contraction force in the atria is much weaker than that in the ventricles. Thus, the walls
of the atria are much thinner compared to that of the ventricles. However, the wall of the
right atrium is slightly thicker than that of the left atrium due to the fact that the right
atrium receives blood from the systemic circulation and experiences higher pressures
(Korossis, 2002; Levick, 2003; Levy & Pappano, 2007).
The blood circulation in the heart is regulated by the cardiac cycle. According to the
contraction of the atria and the ventricles, and the position of the inlet and outlet heart
valves, the ventricular cycle can be divided into four phases: ventricular filling,
isovolumetric contraction, ejection and isovolumetric relaxation (Levy & Pappano,
2007). The blood enters the heart via the left atrium through the pulmonary veins, and is
then pumped into the left ventricle. After the contraction of the left ventricle (ventricular
systole), blood is pumped into the aorta, and the systemic circulation starts. For the right
heart, the right atrium receives blood after systemic circulation through the superior
vena cava and the inferior vena cava. Then, blood enters the right ventricle and is
pumped out of the heart through the pulmonary artery during right ventricular systole.
The pulmonary circulation then starts, and the oxygenated blood returns to the heart
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through the pulmonary veins (pulmonary veins – left atrium – left ventricle – aorta -
systemic circulation – superior vena cava & inferior vena cava – right atrium – right
ventricle – pulmonary artery – lungs – pulmonary veins; Figure 1.2).
Figure 1.2 An illustration of the blood circulation in the human heart.
(http://en.wikipedia.org/wiki/File:Diagram_of_the_human_heart_(cropped).svg)
1.2 Heart valves
The cardiac valves are flexible, tough, endothelium-covered fibrous leaflets (also called
cusps or flaps) present at the exits of the ventricles and atria. The movements of heart
valves are passive, depending on the different transvalvular pressures. The main
function of heart valves is to prevent or minimise backward blood flow, acting as one
way inlets and outlets and allowing the unidirectional flow of blood through the heart
during the cardiac cycle (Rector & Visitors, 2007). There are four valves in the heart
including the tricuspid, mitral, aortic and pulmonary valves (Table 1.1 and Figure 1.3).
The mitral valve has two leaflets whereas the other three have three leaflets. Since the
tricuspid and mitral valves are located between the atria and the ventricles, they are
known as atrioventricular (AV) valves. The aortic and pulmonary valves are classified
as semilunar valves due to the shape of the leaflets, and are located between the
ventricles and the great arteries (the aorta and the pulmonary artery, respectively).
Chapter 1
5
Table 1.1 Heart valves and their locations.
Type Name Location
Atrioventricular
valves
Tricuspid valve Between the right atrium and the right ventricle
Mitral valve Between the left atrium and the left ventricle
Semilunar
valves
Pulmonary valve Between the right ventricle and the pulmonary
artery
Aortic valve Between the left ventricle and the aorta
Figure 1.3 The locations of heart valves. (Lee, 2006)
During ventricular relaxation, the aortic and pulmonary valves close and the mitral and
tricuspid valves open to allow blood from the left and right atria into the left and right
ventricles, respectively. More blood flows into the ventricles as the atria contract.
During ventricular contraction the mitral and tricuspid valves close and the aortic and
pulmonary valves open, allowing blood flow into the aorta and the pulmonary artery,
respectively (Rector & Visitors, 2007).
1.2.1 The atrioventricular valves
The main function of the AV valves is to prevent the back-flow of blood from the
ventricles into the atria. The AV valves are composed of four primary elements: (1) the
valve annulus; (2) the valve leaflets; (3) the papillary muscles; and (4) the chordae
tendineae (Bronzino, 2000). The leaflets of the AV valves are thin and translucent
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fibrous membranes, strong enough to prevent the back-flow of blood (Schoen, 1998).
Similarly to all other tissues in direct contact with the blood, the leaflets of the
atrioventricular valves are covered by endothelial cells. Smooth muscle cells are the
main cell population of the mitral valve interstitium. In addition, non-myelinated nerve
fibres, and blood vessels are also present (Bronzino, 2000). The total leaflet area of the
AV valves is approximately twice that of their respective orifices and, therefore, there is
a considerable coaptation region in the leaflets of the closed AV valves. The AV valve
annulus resides at the base of the leaflets, and is attached to the atrial and ventricular
walls. The chordae tendineae (also known as “heart strings”) are fine, strong
ligamentous tissues attached at the free edge of the leaflets. They insert the leaflets at
multiple locations (about 5 to 60) and extend to the tips of the papillary muscles. The
chordae tendineae play an important role in valve function by preventing eversion of the
leaflets during ventricular systole (Levy & Pappano, 2007). The papillary muscles arise
from the wall of the ventricle and are responsible for generating the tension which is
transferred to the leaflets by the chordae during ventricular contraction. The structures
and arrangement of these valve components are important in providing continuity
between the valve and ventricular wall (Bronzino, 2000).
The mitral valve is the only valve in the heart to have two leaflets; the posterior and
anterior leaflets. These two leaflets are actually one continuous piece of tissue with the
anterior portion being shorter and wider than the posterior. The mitral valve owes its
name to its shape which resembles a mitre (Latin; from the Greek mίtra), or bishop's cap. 
Since the pressure in the left side of the heart is higher than that in the right side, the
mitral valve, together with aortic valve, are the most stressed valves in the heart and are
associated with a high incidence of valvular disease. The tricuspid valve is so named
because it has three leaflets: anterior, inferior and septal (Martini, 1995; Martini, 2006).
1.2.2 The semilunar valves
The semilunar valves (pulmonary and aortic valves) prevent blood from returning back
to the ventricles from the arteries. They consist of three half-moon-shaped cusps, and
thus have been named semilunar. The leaflets of these valves are attached to the artery
wall and are composed of passive, thin fibrous tissue, which is translucent (Schoen,
1999a). At the end of the reduced ejection phase of ventricular systole, the cusps snap
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together due to a brief reversal of the blood flow towards the ventricles, therefore,
preventing blood regurgitation. During ventricular systole, instead of lying back against
the walls of the pulmonary artery and aorta, the leaflets float in the bloodstream
approximately midway between the vessel walls and their closed position (Levy &
Pappano, 2007). Since the arterial walls do not contract, muscular braces are not
required for the semilunar valves. Thus, unlike the atrioventricular valves, semilunar
valves do not have papillary muscles or chordae tendineae.
The pulmonary valve, which is located between the right ventricle and the pulmonary
artery, prevents deoxygenated blood returning to the right ventricle during ventricular
relaxation. It opens during the contraction of the right ventricle, and allows
deoxygenated blood to flow through to the lungs. The aortic valve is the other semilunar
valve. When it opens during the contraction of the left ventricle, the oxygenated blood
flows through the aortic valve to the aorta. It is closed as the ventricle relaxes, and this
prevents blood from returning to the left ventricle.
The aortic valve is the most well-studied heart valve and is prone to valve dysfunction
requiring surgical intervention. It has three leaflets, the left-coronary, right coronary,
and the non-coronary (also named the posterior) leaflets. The left and right coronary
leaflets have coronary arteries, which supply the heart with blood, arising from the
corresponding sinuses. The non-coronary leaflet does not have such an artery. The right
coronary leaflet of the porcine aortic valve has a piece of muscle at its base, which
makes it distinguishable from the left coronary leaflet (Sutton et al., 1995). A cut-open
porcine aortic valve is illustrated in Figure 1.4 A. The orifices of the coronary arteries
can be seen above the left and right coronary leaflets. The position of each leaflet and
the position of the mitral and aortic valves relative to each other are illustrated in Figure
1.4 B. The difference between the human and porcine aortic heart valve is that in pigs
the myocardium is in contact with the right coronary leaflet, forming a muscular shelf.
In humans, however, there is no such shelf. For a single aortic valve leaflet, as
illustrated in Figure 1.4 D, the free edge is along the top of the leaflet. Just in from the
free edge along the superior portion of the leaflet is the coaptation region which is the
portion that contacts the neighbouring cusps. The leaflet is connected to the aortic wall
by the curved inferior portion. The commissure is the region where the free edge meets
the aorta, and the corpus arantii is a large collagenous mass in the coaptation region
which supposedly aids in valve closure and reduces regurgitation (Robarts et al., 1997).
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A histological section of a single aortic leaflet illustrating the different layers stained
with Masson’s trichrome is shown in Figure 1.4 E.
The pulmonary valve has been reported to share similar structural characteristics with
the aortic valve, although some differences have been found (Martini, 2006; Levy &
Pappano, 2007). It also consists of three leaflets, which are attached by convex edges
partly to the infundibular wall of the right ventricle and partly to the origin of the
pulmonary trunk. An image of a cut-open porcine pulmonary valve is presented in
Figure 1.4 F. The pulmonary leaflets are attached to the pulmonary sinuses through
three crescents of infundibular musculature, and there is an incomplete annulus
supporting the leaflets. The three pulmonary leaflets are named the right leaflet
(comparable to the right aortic leaflet), left leaflet (comparable to the left coronary
aortic leaflet), and anterior leaflet (Standring, 2008; Figure 1.4 G). The term
“pulmonary root” refers to the pulmonary valve together with the pulmonary artery
(approximately 5 cm in length) and myocardium (approximately 5 mm in length) that
connects to the valve annulus. The pulmonary root is hardly supported since the
pulmonary annulus inserts into the relatively thin right ventricular myocardium,
whereas the aortic root annulus inserts into the thick left ventricular myocardium.
However, the pulmonary root has myocardium up to the leaflet connections around the
whole circumference. Although thicker, only approximately two thirds of the aortic root
circumference has myocardium (the remaining third is the mitral valve anterior leaflet).
The pulmonary artery wall is thinner than the aorta, and the pulmonary leaflets are
generally thinner than the aortic leaflets. Also, there are no blood vessel associated with
the pulmonary valve leaflets (Fisher & Watterson, 1997). David and colleagues (1994a)
conducted a comparative study in which the thickness of 72 porcine pulmonary leaflets
and 72 porcine aortic leaflets was measured. The mean thickness of pulmonary leaflets
was 0.49 mm whereas the mean thickness of aortic leaflets was 0.67 mm. Porcine
pulmonary valve leaflets exhibited similar tensile properties to aortic valve leaflets in
the circumferential direction, but slight differences existed between the radial directions
(David et al., 1994a; Gerosa et al., 1994). The calcium level in pulmonary walls was on
average less than half of that in the aortic walls, which suggests that pulmonary roots
may exhibit less calcification after implantation. The pulmonary root also has less
elastic tissue than the aortic root (Livi et al., 1987; Hokken et al., 1997).
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1.2.2.1 Structure of the semilunar valve leaflets
The leaflets of the semilunar valves have a total thickness of approximately 300-700μm 
(Martini, 2006). Both collagen and elastin are connective tissue proteins and are the
most abundant extracellular matrix (ECM) proteins in heart valves. Collagen is strong
and stiff while elastin is more flexible. The cross-section of a leaflet shows three distinct
layers; the fibrosa, spongiosa and ventricularis (ordered from the direction of the artery
to the ventricle, Figure 1.4 E). The fibrosa is mainly composed of collagen and elastin,
and has a thickness of about 150-350μm. The collagen in the fibrosa is organised into
large bundles which are oriented predominantly in the circumferential direction of the
leaflets. This directional arrangement of the collagen makes the leaflets highly
compliant in the radial direction and relatively stiff and inextensible in the
circumferential direction. These features are important in accommodating the cyclical
pressure fluctuations during the cardiac cycle since the circumferentially orientated, stiff
collagen bundles are responsible for bearing the diastolic stress. During systole, the
collagen fibres start crimping, and corrugations of the fibrosa produce a visible surface
rippling which disappear during diastole (Figure 1.4 H). When the valve is closed, the
crimping expands in the radial direction, permitting an initial increase in leaflet size
(Figure 1.4 I). The stiffening induced by fully extended collagen crimps during valve
closing contributes to the prevention of leaflet prolapse (Schoen, 1999b). Surrounding
the collagen bundles, there is an elastin matrix which maintains the valve’s
microstructure by restoring the contracted configuration of the leaflets during systole.
The ventricularis is the leaflet layer facing the inflow surface of the valve. It also
consists of collagen and elastin. However, unlike the fibrosa, the collagen is not
organised in any specific direction. Thus, the ventricularis is less stiff than the fibrosa
(Robarts et al., 1997; Schoen, 1999a; Mendelson & Schoen, 2006). The spongiosa is
more of a gap between the fibrosa and ventricularis than a definable structure on its
own. It is primarily composed of water, glycosaminoglycans (GAG`s) and a small
amount of loosely arranged collagen and elastin. GAG`s in this layer are important in
resisting compression, and the loose arrangement of this layer allows it to absorb shock
during the cardiac cycle.
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1.2.2.2 Cells of the semilunar valve leaflets
Heart valve leaflets contain two types of cells: valvular endothelial cells (VEC`s) and
valvular interstitial cells (VIC`s). VEC`s form a single layer on the surface of the leaflet,
and are considered to be morphologically different from aortic endothelial cells
(Butcher et al., 2004; Butcher & Nerem 2004; Sacks & Yoganathan, 2007). For
example, in response to mechanical stress, porcine aortic valve endothelial cells align
perpendicular to flow whereas endothelial cells from the aorta align parallel to flow
(Mendelson & Schoen, 2006). By studying the porcine valvular and vascular endothelial
cells in vitro with 20 dynes.cm-2 steady laminar shear stress for up to 48 hours, Butcher
et al. (2004) reported the vascular endothelial alignment is calpain-, Rho-kinase–, and
PI3K-dependent, whereas valvular endothelial cell alignment is calpain- and Rho-
kinase–dependent, but PI3K-independent. VEC`s are important in regulating vascular
tone, thrombosis, inflammation and remodelling and VEC dysfunction may lead to
multiple disorders including atherosclerosis (Leask et al., 2003). Endothelial cell
dysfunction can be caused by mechanical forces, bacterial infection, autoantibodies and
circulating modulators of endothelial cell function. Common valvular diseases such as
senile degenerative valve disease, myxomatous (or floppy) valves, rheumatic valves,
and infected (endocarditis) valves show changes in the synthetic, morphologic and
metabolic functions of the VEC`s (Leask et al., 2003).
The VIC`s reside within the three layers of the heart valve leaflets, and primarily serve
to maintain the structural integrity of the leaflet tissue by remodelling via protein
synthesis and enzymatic degradation (Bairati & DeBiasi, 1981; Taylor et al., 2003;
Merryman et al., 2006). The VIC`s have characteristics of both fibroblasts and smooth
muscle cells (which range from fibroblast-like to myo-like). The phenotype of VIC`s is
believed to be reversible (Sacks & Yoganathan, 2007). When the phenotype of the
resident VIC population is myo-like, the cells are actively remodelling the ECM, which
indicates that the VIC phenotypic state at any given time is likely related to the current
remodelling demands of the tissue (Rabkin et al., 2002). It is believed that there is a
feedback mechanism between the VEC`s and VIC`s although no direct junctions have
been observed between the two types of cells (Filip et al., 1986; Marron et al, 1996;
Sacks & Yoganathan, 2007; Sacks et al., 2009). In an in vitro study carried out by
Butcher & Nerem (2006), VIC alone or VIC and VEC mixtures were cultured in Type I
collagen hydrogels and exposed to 20 dynes.cm-2 steady shear for up to 96 hours. VIC`s
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proliferated when not in communication with VEC`s. VIC`s secreted matrix in a
valvular endothelial– and flow-dependent manner and VEC`s decreased α-SMA 
expression in VIC`s. Although the exact mechanism was unclear, it was apparent from
the results that the VEC was the key regulator of VIC phenotype and shear flow
enhanced this regulation.
1.2.2.3 Mechanical properties of the semilunar heart valves
The mechanical behaviour of a material refers to its deformation under load. Most
frequently, the mechanical behaviour is expressed as the stress generated in a material
subjected to a particular strain (stress-strain behaviour). The biomechanical testing of
soft tissues such as heart valves is problematic. Soft tissues are non-homogeneic and
their complex nature makes it difficult to obtain fundamental physical parameters.
Generally, in order to characterise the mechanical properties of valvular tissue, uniaxial
tensile tests on strips of tissue (Sauren et al., 1983; Mayne et al., 1989; Korossis et al.,
2002; Stradins et al., 2004; Korossis et al., 2005; Seebacher et al., 2007; Tudorache et
al., 2007) or biaxial mechanical tests on intact valves (Mayne et al., 1989; Billiar &
Sacks, 2000; Vesely et al., 2000) have been frequently used.
Uniaxial tensile testing is more popular since in comparison to biaxial testing it is easier
to perform. However, although important information can be generated, uniaxial tensile
testing is not ideal for determination of the mechanical properties of soft tissue, since
the stress/strain relationship in different directions cannot be obtained at the same time
and on the same point of a tissue specimen. Moreover, the mechanical coupling between
the material axes and the physiological fibre kinematics is not taken into account during
uniaxial tensile testing (Billiar & Sacks, 2000). Uniaxial tensile testing is more
representative of the physiological state of the heart valve tissue although it is a
complex methodology to establish and perform especially on heart valve leaflet tissue,
which has a heterogeneous structure and is small in size (Billiar & Sacks, 2000; Sacks
& Yoganathan, 2007). Both uniaxial and biaxial tensile testing requires flattening of the
tissue, and the force is only applied in 2D. Thus, the true 3D stress-strain behaviour of
the tissue is not achievable using these tests. On the other hand, tensile testing, either
uniaxial or biaxial, can provide quantitative stress-strain information of heart valve
tissue in vitro, which is useful for understanding the mechanical behaviour, as well as
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for comparison of the heart valve replacements to natural tissue. Preconditioning has
been used by many researchers prior to uniaxial tensile testing when determining the
mechanical properties of heart valve tissue in order to generate repeatable results
(Korossis et al., 2002; Fitzpatrick et al., 2010). However, it has been reported that tissue
preconditioning does not contribute to the generation of repeatable stress-strain curves
for heart valve tissue (Carew et al., 2004). Whether there is a need for preconditioning
in the determination of heart valve tissue mechanical properties will be dependent upon
the purpose of the study. For example, for comparative studies, preconditioning can be
omitted as long as the test conditions for each test groups stay the same.
Both uniaxial and biaxial tensile tests (Sauren et al., 1983; Courtman et al., 1994；
Billiar & Sacks, 2000; Korossis et al., 2002; Stradins et al., 2004; Tudorache et al.,
2007) have shown that the stress-strain behaviour of heart valve leaflet tissue has three
distinct phases. The initial phase is linear with a low elastic modulus, during which the
resistance to stretch and force transmission is provided solely by the elastin fibres
(Sauren et al., 1983). The next phase is a transition phase in which the collagenous
crimps of the leaflets is gradually removed (Clarke, 1973; Broom, 1978) and their
contribution to force transmission is increased. The second linear portion represents the
collagen phase and it is characterised by a high modulus. During this phase, the tissue
has a reduced compliance and a small extension of the tissue would produce a high
tension. This reflects the material properties of the strong network of collagen fibres
(Sauren et al., 1983). Of all the tensile parameters that can be acquired from the tensile
testing results, the elastin phase slope, collagen phase slope, and failure stress and strain
give the most information regarding the properties of the tissue such as the extensibility
and the strength. Korossis (2002) reported on the uniaxial tensile properties of the
porcine aortic leaflet. The elastin phase slope, collagen phase slope, failure stress and
failure strain in the circumferential direction were: (7.24 ± 1.95) × 10-5 GPa, (3.79 ±
0.61) × 10-2 GPa, 6.26 ±0.83 MPa and 47.21 ± 5.68 %, and the above parameters in the
radial direction were: (4.01± 0.87) × 10-5 GPa, (2.10 ± 0.30) × 10-3 MPa, 0.93 ± 0.21
MPa and 101.70 ± 9.18 %. Tudorache et al. (2007) reported the failure stress and strain
for porcine pulmonary valve leaflet to be 0.8 ± 0.12 MPa and 80 ± 33 % in the
circumferential and 0.52 ± 0.23 MPa and 70 ± 20 % in the radial direction. The reported
tensile testing results showed a wide range of variability. This was probably due to the
different tensile testing methods that were applied by each research group. Differences
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in the experimental methods including tissue sampling, processing, testing equipment
and experimental settings will all affect the tensile test results. Thus, it is essential in
comparative studies of the tensile properties of tissues that the same methods are
applied. A study carried out by Strandis et al. (2004) reported the failure stress and
strain for human pulmonary valve leaflet to be 2.78 ± 1.05 MPa and 19.40 ± 3.91 % in
the circumferential and 0.29 ± 0.06 MPa and 29.67 ± 4.41 % in the radial direction. The
human pulmonary valve leaflets seemed to be weaker than the porcine tissue. The
results of these studies showed the leaflets to be much more extensible in the radial
direction compared to the circumferential direction, which corresponds to the anisotropy
of the leaflets.
Uniaxial tensile testing has been applied to study the mechanical properties of the aortic
or pulmonary root wall by a number of groups (Sauren et al., 1983; Lokie et al., 1993;
Zhou et al., 1997; Jennings, 2001; Korossis, 2002). The stress-strain behaviour of the
semilunar root wall has a similar three-phased behaviour to the leaflet tissue, with a
higher elastic and collagen modulus. The aortic root wall has been reported to have no
directional differences (Sauren et al., 1983) or a reduced anisotropy (Ferraresi et al.,
1999; Jennings, 2001; Korossis, 2002) compared to the leaflet tissue. Korossis (2002)
reported the uniaxial tensile properties of the fresh porcine aortic wall in his study The
elastin phase slope, collagen phase slope, failure stress and failure strain in the
circumferential direction were: (1.22 ± 0.15) × 10-4 GPa, (3.60 ± 0.77) × 10-3 GPa, 1.91
±0.30 MPa and 149.63 ± 6.15 %. The above parameters in the axial direction were:
(8.67± 2.13) × 10-5 GPa, (6.58 ± 1.34) × 10-4 MPa, 0.44 ± 0.04 MPa and 141.97 ±
19.99 %. The same trend might be expected for the pulmonary root wall, which does
not differ significantly in structure from that of the aortic root wall (Hokken et al.,
1997).
1.2.2.4 The hydrodynamic function of the semilunar heart valves
The function of the heart valve tissue is essentially related to the surrounding
haemodynamic environment. Understanding the interactions between the heart valve
and the local haemodynamic environment is critical to understand normal valve
function and disease progression, as well as to provide a standard to test the function of
a replacement heart valve. Although some anatomical differences do exist, the essential
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function of the semilunar heart valves, which is to facilitate the unidirectional flow of
blood while maximizing flow rate and minimizing flow resistance stays the same.
The aortic valve opens during systole when the ventricle is contracting and then closes
during diastole as the ventricle relaxes. The valve closes near the end of the deceleration
phase of systole with very little reverse flow through the valve. The axial pressure
differences cause the low inertial flow along the aortic wall to decelerate and then to
reverse direction, resulting in vortices in the sinuses behind the aortic valve leaflets
(Reul & Talukder, 1989). This action is thought to facilitate movement of the aortic
valve leaflets away from the aorta and towards the closed position, thus to assist the
effective and fast closure of the leaflets. Although in vitro studies have suggested that
the axial pressure difference alone is sufficient for valve closure (Reul & Talukder,
1989), the closure is not as efficient as when the vortices are present. In fact, the aortic
valve should functionally be considered as part of the entire left ventricular outflow
tract. For instance, during the cardiac cycle, the aortic annulus expands and contracts,
which clearly assists the opening and closure of the leaflets (Sacks et al., 2009).
The pulmonary flow profile has been reported to be similar to that of the aortic valve
with lower velocity magnitude (Sacks & Yoganathan, 2007). During acceleration of the
blood flow, the peak velocity is observed after the peak flow. The mean temporal
velocity profile is relatively flat and reverse flow occurs in late systole with an
instantaneous skewness that rotates counter clockwise, which may be representative of
flow separation (Sloth et al., 1994). Secondary flow patterns have also been observed in
the pulmonary artery and its bifurcation. In vitro laser Doppler anemometry experiments
have shown that these flow patterns are dependent on the valve geometry and thus can
be used to evaluate function and fitness of the heart valve (Sung & Yoganathan, 1990;
Sung et al., 1990).
Understanding valve hydrodynamics requires a knowledge of the dynamic deformations
that occur during valve function. However, due to the complexity of valve anatomy, it is
difficult to theoretically determine the functional role of each individual component
(Arts et al., 1983). Studies of heart valve root dynamics are limited due to difficulties in
performing in vivo studies (Thubrikar et al., 1993). A study carried out by Dagum et al.
(1999) showed that the ovine aortic root undergoes complex, asymmetric deformations
during the various phases of the cardiac cycle including elongation, compression, shear,
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and torsional deformation. Sacks et al. (2009) summarised the common behaviour of all
valvular tissues which are required for valve function as: (i) leaflets cycle between the
fully unloaded to fully loaded state every cardiac cycle, which is different to other
connective tissues that remain preloaded (e.g. blood vessels); (ii) leaflets experience
large, anisotropic stretches during closure in response to small transvascular gradients;
(iii) corresponding tension levels have been estimated to be in the range of 50 – 100
N.m-1 during peak loading; (iv) peak strain rates are very high, reaching values of
1000 %.s-1; (v) once the valve is closed, further leaflet deformation ceases; (vi) valve
tissue deformations are highly sensitive to the deformations of the surrounding tissues.
In vitro hydrodynamic testing using a pulsatile flow simulator has been employed to
evaluate the hydrodynamic function of heart valves (Fisher et al., 1986; Weerasena et
al., 1992; Zsolt et al., 2000; Jennings, 2001; Korossis et al., 2005). During the opening
phase, the semilunar valves experience the stellate, triangular and circular
configurations as described by Thubrikar et al. (1979). The bending deformations of the
valve leaflets can be analysed by high-speed image analysis throughout the cardiac
cycle during pulsatile flow testing by the determination of the curvatures of the free
leaflet edge (Corden et al., 1995; Korossis, 2002). The mean pressure difference across
the valve as a function of the root mean squared flow (which can be expressed as the
effective orifice area (EOA), with the larger the EOA the less obstruction to flow),
together with the reverse flow and the total energy loss, can be used to characterise
overall valve function (Fisher & Wheatley, 1988). The EOA also has an impact on the
specific flow behaviour of the heart valve (Sacks & Yoganathan, 2007).
Porcine and human aortic and pulmonary valve roots have been reported to have a low
pressure difference across their leaflets since the resistance to flow is very low (Lockie
et al., 1994; Nagy et al., 2000; Jennings, 2001). Normally, a peak pressure gradient of
40 mm Hg would be considered as conduit dysfunction following heart valve
replacement surgery (Brown, et al., 2011). Porcine and homograft pulmonary roots
have shown similar pressure/flow characteristics and EOA`s to aortic roots when tested
at systemic pressure. The pulmonary roots demonstrated better performance than their
aortic counterparts due to the larger dilation of the pulmonary root at systemic pressure
(Weerasena et al., 1992; Nagy et al., 2000; Jennings, 2001).
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1.3 Heart valve disease
Heart valve associated disease is one of the main causes of heart failure. Valvular
dysfunction usually involves regurgitation and/or stenosis. Regurgitation occurs when
the valve is not able to close completely, causing part of the blood to flow back to the
atrium or ventricle. In this case, the heart is required to increase its effort in pumping
blood, resulting in cardiac hypertrophy. In valvular stenosis the effective orifice of the
valve narrows or does not form properly, restricting the flow of blood out of the atria or
the ventricle. Thus, the heart is required to pump harder in order to pump enough blood
through the stenotic valve. Heart valves can have either one or both of the conditions at
the same time hampering the heart’s ability to pump blood adequately through the body
and, consequently, causing serious cardiac implications (Rector & Visitors, 2007). As
discussed previously, the left side of the heart is responsible for pumping blood through
the high-pressure systemic circulation whereas the right side of heart pumps blood to
the low-pressure pulmonary circulation. Therefore, the valves associated with the left
side of the heart (mitral and aortic) are more prone to disease than the valves of the right
heart. Statistics have shown that acquired valvular disease involves the mitral valve in
~80% of the cases, the aortic valve in ~50% of the cases, and the tricuspid valve in only
~10% of the cases. The pulmonary valve is almost never affected (Marks & Marks,
1993). When a heart valve is diseased severely and cannot be repaired, replacement is
normally the therapeutic choice. Although the mitral valve is most likely to be diseased
among the four heart valves, valve repair rather than replacement is most commonly
required. Heart valve replacement is mostly required for the aortic valve since severe
valve failure happens most frequently in the aortic position.
Researchers in the area have identified a number of underlying reasons for valvular
disease. According to Boudoulas et al. (1994), valvular disease can be classified as:
1. Heritable-congenital causes of valvular heart disease e.g., floppy mitral valve
with mitral valve prolapse, bicuspid aortic valve, and Marfan syndrome;
2. Inflammatory-immunologic causes such as rheumatic fever, acquired immune
deficiency syndrome, endocardial proliferative disorders, and antiphospholipid
syndrome;
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3. Myocardial dysfunction-ischemic cardiomyopathy, dilated or hypertrophic
cardiomyopathy-resulting in valvular heart disease;
4. Diseases and disorders of other organs as causes of valvular heart disease, e.g.,
chronic renal failure and carcinoid heart disease;
5. Valvular heart disease related to aging: calcific aortic stenosis and mitral annular
calcification;
6. Valvular disease following interventions such as valvuloplasty, valve
reconstructive surgery and valve replacement;
7. Valvular disease related to drugs and physical agents, such as chronic
ergotamine use, radiation therapy and trauma.
1.4 Heart valve replacement
Heart valve replacement is the second most common surgical operation in the heart in
the Western world (Brody & Pandit, 2007). Cardiac valve replacement was first
introduced in the 1950’s, by Charles Hufnagel who implanted caged-ball heart valves in
ten patients (six survived the operation). A similar valve was invented by Miles
Edwards and Albert Starr in 1960 (Lefrak & Starr, 1979; Starr et al., 2002; Winters &
Obriot, 2007). During the past 50 years, a variety of replacement valves have become
available, with the most commonly used being the mechanical and biological tissue
valves. Since the aortic valve is most likely to fail and replaced among the four valves,
it is important that a replacement valve can be used in the aortic position. Almost all of
the available mechanical or biological valves can be used in aortic valve replacement if
required. When selecting an appropriate valve replacement, the surgeon needs to take
into account a number of issues including age, sex, associated medical conditions, risk
factors, and even cultural beliefs (Treasure, 1990; Women’s heart foundation, 2007).
Currently, there is no ideal valve replacement. As more advanced understanding of
cardiac physiology, biomechanics and materials science, and clinical experience is
accumulated, workers in the field have concluded that an ideal valve replacement
should meet the following criteria (Schoen et al., 1982; Marks & Marks, 1993;
Sapirstein & Smith, 2001):
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- Function like a native valve, permitting unimpeded forward flow when open while
preventing regurgitant flow when closed, without leaking;
- Not generate turbulence so that haemolysis and stimulation of the clotting cascade is
limited;
- Biocompatible, and its blood-contacting surfaces not thrombogenic;
- Easy and safe to implant with surgical results comparable among surgeons;
- An associated morbidity which is low enough to yield reproducible clinical
outcomes;
- Durable and the need for re-operation minimal.
- Only affects the daily activities of the patient to a very limited level. This means that
anticoagulation should be unnecessary after the surgery, the risk of endocarditis is
low, and the sounds of the prosthetic valve are unnoticeable.
Although there is no replacement valve that can meet all these criteria, current
replacement valve designs offer acceptable solutions in most cases. In general, clinically
available heart valve replacements can be classified into two types: mechanical and
biological. Biological valves include bioprosthetic valves and human tissue valves.
Each has its own advantages and disadvantages.
1.4.1 Mechanical valves
Mechanical valves are entirely made from artificial components, according to
understanding of cardiac physiology and biomaterials. They were the first type of
replacement valve to be developed. To date, three types of mechanical valve have been
developed including the caged-ball valve, the tilting-disc valve and the bileaflet valve.
The first mechanical valve to be developed was the Starr-Edwards caged-ball valve.
This valve was designed as a mitral valve prosthesis using a silastic ball (Starr &
Edwards, 1961a; Figure 1.5 A). The first clinical operation was performed in 1960, and
in the following 4 to 5 years, further modifications were conducted with the first
commercial model developed in 1965 (Starr & Edwards, 1961b; Starr et al., 1967). The
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caged-ball mechanical valve retained its fundamental design for over 30 years of use.
The main problem with the caged-ball valve was that turbulence was caused due to the
ball’s central location in the outflow blood. Although there was an attempt to reduce
thromboembolic complications by covering the valve housing with cloth, this failed
because the cloth wear and unpredictable overgrowth of tissue could stop the motion of
the poppet (Khan, 1998; Sapirstein & Smith, 2001; Figure 1.5 B). The latest version of
the caged-ball valve was brought to market in 1980s. It was improved and subject to
reduced failure (Wernly & Crawford, 1998). An occluding poppet was used in the cage
in order to direct the blood flow. However, this poppet could result in turbulence and
the implantation of the valve required a relatively large dose of anticoagulants.
Moreover, these valves generated high transvalvular pressure gradients especially with
smaller diameter valves (Fisher & Wheatley, 1988). Another problem with the caged-
ball mechanical valve is that it had a relatively high profile due to the cage. Thus, it
could only be implanted in patients with relatively large left ventricular cavities or
aortic roots. Nowadays, the caged-ball valve is rarely used clinically (Sapirstein &
Smith, 2001).
Figure 1.5 The caged-ball mechanical valve. (A) The aortic model 1260 Starr
Edwards valve. (B) A four-strut mitral model 6400 Starr-Edward valve with a hollow
metal ball and the struts covered by cloth. (Modified from Butany et al., 2003a).
The second generation of mechanical valves was based on a tilting-disc principle. This
type of valve used a thin wafer to replace the ball in the caged-ball valve. Tilting-disc
valves experienced a number of problems when first developed, including low-velocity
eddy currents caused by turbulence, retrograde leaks (which occurred when the disc
approached the vertical position when fully open; Collins, 1991). Towards the end of
the 1960s, the Bjork-Shiley tilting disc valve (Figure 1.6 A), was developed (Bjork,
1969). This valve consisted of a spherically-shaped disc, which was made of pyrolytic
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carbon and positioned within a metal ring and sewing cuff. Across the inflow and
outflow of the valve orifice, two arching struts were designed, thus permitting the disk
to pivot between opened and closed positions. In order to decrease turbulence, an
occluder was designed within the valve ring. The free-floating disc occluder was also
retained by the struts. The Bjork-Shiley valve was widely used for several decades since
it had a much lower profile than the caged-ball valve, and thus had fewer limitations.
Nevertheless, the Bjork-Shiley valve still had several drawbacks that could cause
serious valve failure. During ventricular contraction, due to the repetitive stress of valve
closure, some larger-diameter mitral valves fractured at their welds, or the strut
completely separated from the ring. The Bjork-Shiley valve was withdrawn from the
market in 1986 (van Gorp et al., 2004).
Following the Bjork-Shiley valve, three other improved tilting disk valves became
clinically available. These include the Alliance Medical Technologies’ Monostrut valve
(uses a re-engineered strut contiguous with the metal of the valve ring; Figure 1.6 B),
the Omniscience valve (it moves by “hinging” against 2 sides of the valve ring; Figure
1.6 C), and the Medtronic-Hall valve (Figure 1.6 D). All have been used for either
mitral valve or aortic valve replacement. An improvement in the tilting disc valves is
that the opening angle is about 70°-80°, generating fairly low transvalvular pressure
gradients (Sapirstein & Smith, 2001).
Figure 1.6 Tilting disc valves. (A) Bjork-Shiley; (B) Alliance Medical Technologies
(C) Monostrut; Omniscience; (D) Medtronic-Hall. (Modified from Butany et al., 2003a)
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The invention of pyrolytic carbon by Dr Jack Bokros in 1969 was a great contribution to
the development of mechanical valves (DeBakey et al., 1971). Although this material
was originally developed for the encapsulation of nuclear fuel rods, it was widely used
in almost all new mechanical valves over the decade following its invention (Bokros,
1989; Gott et al., 2003). The discs in each of the tilting disk valves discussed above
were composed of graphite, and coated with pyrolytic carbon, which was synthesized
through repetitive heating. The use of this material gives the disc a very smooth and
strong surface, and thus reduces the formation of thrombus.
The most recent generation of mechanical valves is the bileaflet prosthesis. The bileaflet
mechanical valves are manufactured by St Jude Medical Inc. and Sulzer CarboMedics,.
The St Jude bileaflet valve (Figure 1.7) also used pyrolytic carbon as the disc material.
It contains 2 semicircular discs that open with independent hinge mechanisms with
nearly 90° opening angles. The larger opening angles provide excellent valve
haemodynamic function. Compared to the tilting-disc, the excursion of the occluder
beyond the plane is considerable less due to the fact that each leaflet covers only half of
the valve orifice. St Jude mechanical valves have been used for mitral, tricuspid, and
aortic valve replacement (Sapirstein & Smith, 2001; Starr et al., 2002).
Figure 1.7 The St Jude Mechanical valve. (obtained from St Jude Medical, Inc., 2011)
It is generally believed that the second and third generation mechanical valves are much
more superior to the caged-ball valves. They have a lower profile, longer durability,
reduced turbulence, and require a smaller dose of anticoagulants following implantation.
In addition, the second and third generation mechanical valves cause less frequent
thromboembolic complications after surgery compared with the caged-ball valves.
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The most important advantage of the mechanical valves is their long-term durability
compared to bioprosthetic and human tissue valves. However, even though the second
and third generation mechanical valves are significantly improved compared to older
designs, they are still highly thrombogenic due to the blood turbulence at the interface
with the device (Schoen, 1982; Grunkemeier & Rahimtoola, 1990; Butany et al., 2003a).
The occurrence of thrombosis may have catastrophic consequences because it can
occlude the valve and embolise to the brain or other vital organs. Among the available
mechanical valves, the St Jude valve has been reported to cause the least thrombosis. In
addition, blood clots are more likely to form after mechanical valve replacement due to
the more severe red blood cell damage that mechanical valves cause compared to
biological valves (Edmunds et al., 1987). Consequently, it is not surprising that life-
long administration of oral anticoagulants such as warfarin is mandatory following
valve replacement with a mechanical valve. Regular control of the coagulation state by
the plasma thromboplastin time is also necessary (Marks & Marks, 1993). Haemorrhage
is another complication associated with mechanical valve implantation due to the
necessary use of anticoagulants (Hammermeister et al., 2000; Grunkemeier et al., 2000;
Oxenham et al., 2003; Wheatley & Will, 2004). The structural deterioration of these
valves has become an increasingly recognized complication from the early 1980s,
particularly in younger patients (Wheatley & Will, 2004).
1.4.2 Biological valves
Biological valves are derived from animal or human tissue. Depending on their source,
biological valves are divided into bioprosthetic valves (porcine or bovine tissue valves)
and human tissue valves (further classified as homografts and autografts).
1.4.2.1 Bioprosthetic valves
Bioprosthetic valves are also referred to as xenografts or heterografts. They are
chemically-treated animal tissue valves which were first developed in the late 1960s in
an attempt to overcome the haemodynamic problems of the mechanical valves.
Bioprosthetic valves are generally designed to imitate the flow and materials properties
of the native counterpart. Thus, they are a much closer match than mechanical valves
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(Butany et al., 2003b). Both valvular tissue (such as porcine aortic or pulmonary valve)
and non-valvular tissue (typically bovine pericardium) have been used in the
manufacture of bioprosthetic valves. In bioprosthetic valves, the animal tissue is treated
with a cross-linking agent, usually glutaraldehyde, in order to strengthen the tissue,
reduce its immunogenicity, and provide tissue stability against biological breakdown
(Korossis et al., 2000; Mercuri et al., 2007). Subsequently, the cross-linked tissue is
mounted on a fabric-covered frame (sewing ring) or stent made of metal or plastic.
Nowadays, bioprosthetic valves are used in half or more of valve replacements
(Rahimtoola, 2010).
The first generation bioprosthetic valves were the Carpentier-Edwards and Hancock
Standard (Medtronic Inc) stented porcine aortic xenografts, which became available
during the 1970s. These prostheses were cross-linked with glutaraldehyde at high
pressure and mounted on stents. The Carpentier-Edwards valve utilised a stent which
was flexible and eccentric to compensate for the restricting muscle shelf which resides
under the right coronary cusp of the porcine aortic valve (Figure 1.8). The Hancock
Standard valve (Figure 1.9 A) utilised a semi-flexible stent with a radiopaque sewing
ring and demonstrated inferior hemodynamic performance in smaller sizes. In the
Hancock Modified Orifice (MO) valve (Figure 1.9 B) the right leaflet was replaced by a
non-coronary leaflet from another porcine aortic valve in order to eliminate the muscle
shelf. The Carpentier-Edwards and Hancock (Medtronic Inc) Standard xenografts had
an overall thromboembolic incident rate equivalent to those of fully anticoagulated
mechanical prostheses. Although low doses of anticoagulation were used
postoperatively for only several months, the increased risk of embolization after surgery
in some cases required long term anticoagulation (Sapirstein & Smith, 2001). The
postoperative results with the Carpentier-Edwards and Hancock Standard bioprostheses
were clinically acceptable. The most significant drawback with these valves was that
they faced predictable structural failure after several years (Bernal et al., 1995). A 10-
year clinical study of the Carpentier-Edwards (98 patients) and Hancock Standard
valves (65 patients) showed an average implant duration of 13.9 ± 3.9 years for the
Carpentier-Edwards valves, and 10.0 ± 5.1 years for the Hancock Standard valves.
Compared with Hancock Standard valves, Carpentier-Edwards valves also had a higher
incidence of stent deformation (41.5% vs. 14.3%), calcification (75.4% vs. 54.1%), and
pannus (100% vs. 91.8%) (Butany et al., 2007b). Butany et al. (2007a) reported on the
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longest duration of implantation of a porcine bioprosthesis Carpentier-Edwards valved
conduit excised after 25 years at the tricuspid valve position from a 50-year-old man.
They found significant thrombus (on the sinus surface of a cusp), mild structural valve
deterioration and pseudo-intimal formation within the conduit. The bioprosthesis'
longevity was likely related to low-pressure circulation in the right heart and to host
tissue (pannus) overgrowth that covered the cusps and thereby reduced tissue
degeneration.
Figure 1.8 The Carpentier-Edwards valves. (A) The inflow; (B) The outflow.
(Modified from Butany et al., 2003b)
Figure 1.9 The Hancock bioprosthetic valves. (A) Hancock standard valve; (B)
Hancock MO valve. (Modified from Butany et al., 2003b)
The second generation of porcine valves was developed with a view to improving the
durability of their predecessors. Attempts were made to treat the tissue with anti-
mineralization agents and the valve was fixed in glutaraldehyde at low pressure, to
prevent distorting the ECM. The outcome of the second generation valves has been
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good for older patients (lower than 10% failure after 10 years), yet not very satisfying in
younger patients (David et al., 1995; Jamieson et al., 1995).
In an effort the overcome the problems of the elevated transvalvular pressure gradient
associated with the stented porcine bioprostheses, stentless porcine bioprostheses were
developed (Figure 1.10 A). These valves were considered to have very low to zero
transvalvular pressure gradients, good to excellent haemodynamics and are associated
with regression of left ventricular hypertrophy (O’Brien et al., 1987; Bernard et al.,
1989; David et al., 1994b; Kon et al., 1999; Butany et al., 2003b). Recent clinical
outcomes in Toronto have shown that the stentless valves have a much lower freedom
from reoperation rate at 12 years than the Carpentier-Edwards valves. Cusp tear with
consequent aortic regurgitation was the most common cause of structural valve
deterioration. There is no general recommendation to use stentless bioprostheses in all
patients in the aortic position (Kobayash, 2011).
Bovine pericardial bioprosthetic valves, such as the Ionescu-Shiley valve (Figure 1.10
B), were designed in the 1970s. They were made of glutaraldehyde-treated bovine
pericardium and demonstrated better haemodynamics compared to the stented porcine
valves. However, these valves have demonstrated limited durability, especially in
patients younger than 60 (Sapirstein & Smith, 2001; Butany et al., 2003b).
Figure 1.10 Stentless porcine bioprosthetic valves. (A) Stentless porcine bioprosthetic
valve; (B) Ionescu-Shiley stentless bovine valve. (Modified from Butany et al., 2003b).
Bioprosthetic heart valves have acceptable haemodynamic function, and have become
an important clinical choice in heart valve replacement (Schoen, 2011a). One of their
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major advantages is that they are more thromboresistant than mechanical valves, and
therefore, life-long anticoagulation treatment is not necessary (Butany et al., 2003b). On
the other hand, functional deterioration and progressive structural failure are the major
drawbacks of bioprosthetic valves, which fail sooner and more frequently than
mechanical valves (Sapirstein & Smith, 2001). Clinical studies using bioprosthetic
valves in the pulmonary position in 181 patients suggested valve function was stable in
most patients until 5 years after operation. By 10 years, however, about 80% will
require reoperation or manifest valve dysfunction. It has also been suggested that the
stentless valve was less durable than stented valves (Lee et al., 2011).
Both biological responses and design criteria can contribute to bioprosthetic valve
failure: leaflet calcification leads to tearing and loss of adequate coaptation (Jamieson et
al., 1990; Schoen & Levy, 1986; Grabenwoger et al., 1996); high levels of cyclic
bending stress within the valve leaflets also exacerbate the structural deterioration
(Vesely et al., 1988; Butterfield et al., 1990); abrasion, thinning, as well as tearing can
cause the local fatigue of bioprosthetic valves in the stressed regions, and thus lead to
valve failure (Korossis, 2002). Furthermore, studies have indicated that bioprosthetic
valves do not perform as well in younger patients as they do in older patients, making
them unsuitable for this patient group and especially children (David et al., 1995;
Jamieson et al., 1995; Schoen, 1999a; Sapirstein & Smith, 2001; Butany et al., 2003b).
Relevant studies have demonstrated that bioprosthetic mitral valve structural
degeneration typically affects 20-40% patients at 10 years and 60% at 15 years
(Hammermeister et al., 2000; Grunkemeier et al., 2000; Oxenham et al., 2003;
Wheatley & Will, 2004).
During the preparation of bioprosthetic valves, chemical fixation with glutaraldehyde
destroys the viability of the resident cells of the tissues, which are either VIC`s of the
porcine valves, or fibroblasts of the bovine pericardial valves (Schoen, 2011a). This
process decreases the immunogenicity of the bioprosthetic valves through the cross-
linking and masking of the antigens (Okamura et al., 1980; Villa et al., 1980). However,
the glutaraldehyde fixation has several key consequences that contribute to durability
limitations of the bioprosthetic valves as summarised by Schoen (2011a): Firstly,
because non-viable cells are incapable of tissue remodelling, ongoing repair of the
bioprosthetic valve ECM by the cells of the transplanted tissue is impossible, and any
damage to the ECM is cumulative. Secondly, VIC fragments which are not removed
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from the matrix serve as nuclei for calcification. Thirdly, devitalized VEC`s of porcine
valve bioprostheses are largely denuded by handling, thereby increasing the
permeability of the tissue to fluid. Finally, fixation locks the collagenous network
mechanically into a configuration that inhibits the smooth, internal cuspal structural
rearrangements of the ECM that accompany normal valvular function, thereby inducing
buckling of the cuspal tissue during functional opening and closing of a fixed
bioprosthesis and causing cumulative internal structural damage (Vesely et al., 1988).
Of all the possible causes for bioprosthetic valve failure, calcification is the principal
mechanism of tissue damage. The major factors involved in the calcification are
believed to be associated with host related factors, mechanical stress and chemical
treatment (Simionescu, 2004). Host factors such as age of the recipient and altered
calcium metabolism have been reported to affect the durability of bioprosthetic valves
(Diaz-Jauanen et al., 1975, Manji et al., 2006). This has been explained by some
researchers as the high levels of blood calcium, phosphate, and enhanced parathyroid
hormone and vitamin D metabolism in the young patient population (Berrebi et al.,
2001; Simionescu, 2004). In addition, the areas in which mechanical stress is
concentrated, such as the points of flexion in heart valves have been found to be more
likely to calcify (Schoen et al., 2011).
However, whether calcification is also associated with immunological reactions remains
unclear and under debate (Schoen, 2001; Manji et al., 2006). Some researchers believe
that there is no obvious relationship between bioprosthetic valve calcification and the
immune system (Gong et al., 1993; Trantina-Yates et al., 2001). Others have reported
that immunological rejection mechanisms leading to secondary dystrophic calcification
is potentially a reason for glutaraldehyde-fixed bioprosthetic heart valve failure,
especially in young patients who are more immunocompetent than the elderly (Manji et
al., 2006). A better understanding of the role of the immune system in calcification
mechanisms in bioprosthetic valves would provide information that would benefit the
design of future longer-lasting valves for the treatment of the younger patient
population.
Attempts have been made to prevent calcification in bioprosthetic valves. Schoen and
Levy (2005) summarised the calcification-preventing strategies for biomaterial implants
and classified them into three generic categories: (1) systemic therapy with anti-
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calcification agents; (2) local therapy with implantable drug delivery devices; (3)
biomaterial modifications such as removal of a calcifiable component, addition of an
exogenous agent, or chemical alteration. For instance, ethanol pre-incubation of
glutaraldehyde cross-linked porcine valves has been suggested as an approach to
prevent cuspal calcification. It is believed that pre-treatment with ethanol can extract
almost all phospholipids and cholesterol from cusps, cause a permanent alteration in
collagen conformation, affect cuspal interactions with water and lipids, and enhance
cuspal resistance to collagenase (Vyavahare et al., 1997; Vyavahare et al., 1998;
Connolly et al., 2004). Other efforts have also been made to develop new cross-linking
systems. Rapopor et al. (2007) reported that porcine aortic xenografts treated with
triglycidyl amine (TGA) and mercapto bisphosphonate demonstrated superior
biocompatibility, mechanics, and calcification resistance (although not completely)
compared to glutaraldehyde-treated groups. In an attempt to reduce calcification, high
concentrations of the cross-linking agent have also been used. However, bioprosthetic
valves fixed with a high concentration of glutaraldehyde (about 5 to 10 times than the
conventional concentration, which is about 0.2-0.3%) were too stiff to be used clinically
(Zilla et al., 1997, Zilla et al., 2000; Schoen & Levy, 2005).
1.4.2.2 Human tissue valves
Autografts are tissues that are re-implanted in the same individual that they come from.
The first successful replacement of the aortic valve with a pulmonary valve autograft
was conducted by Donald Ross in 1967 (Ross, 1967). This operation is now commonly
referred to as the “Ross procedure”, which is usually used for patients (especially young
patients) suffering from serious aortic valve disease. The diseased valve is removed, and
replaced with the pulmonary valve of the same patient. The pulmonary valve is then
replaced with a homograft valve. The replacement of the pulmonary valve with a
homograft valve carries less risk since the stresses in the right side of the heart are much
lower than in the left side of the heart. The pulmonary autograft is considered to be the
perfect substitute for the diseased aortic valve, because it is a living tissue with very
similar structure to the native aortic valve.
The Ross procedure is considered as the best choice to treat complex multilevel left
ventricular outflow tract obstruction. The replacement valve functions well, and shows a
central and laminar flow. Also, anticoagulation is usually unnecessary. In addition, the
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grafted valve is from the same patient so it causes minimal host response after
implantation. Last but not least, the replacement valve has the ability to grow with the
patient, which makes this procedure very popular in children (Concha et al., 2004;
Brown et al., 2006a). Nevertheless, the Ross procedure is technically difficult to
perform since it actually involves two valve replacements. Moreover, endocarditis may
occur in the pulmonary position due to the homograft valve (Ross, 1989).
Homograft (or allograft) valves are aortic or pulmonary valves obtained from human
donors. They are cryopreserved in liquid nitrogen after harvesting until required
(Butany et al., 2003b). The first homograft was implanted in 1962 by Ross (Ross, 1962).
Although the surgical techniques for implanting homografts have gradually improved
since 1962, the optimum techniques for homograft procurement, preservation and
implantation have yet to be determined. The advantages of the homograft include:
haemodynamic function similar to the native valve with very low transvalvular pressure
gradients; reduced thromboembolic complications and infections compared to
bioprosthetic or mechanical valves; no need for anticoagulation (Barratt-Boyes et al.,
1977; Haydock et al., 1992). However, homograft valves lack long term durability and
have limited availability.
Homograft valve failure is multifactorial, depending on patient age, surgical technique,
homograft sizing and type, procurement and processing methods. Early investigations
of the failure mechanism covered the relevance of cellular viability (Messier et al., 1999;
Kitagawa et al., 2001), the biochemical aspects of ECM such as elastin and collagen
(Kano et al., 2001; Yokose et al., 2002), the role of immune response (Oei et al., 2002),
as well as the impact of damage caused by ice formation after preservation (Brockbank
et al., 2000). It has become clear though that immunogenicity of homograft valves is the
main reason for homograft valve failure. Blood group (ABO) or human leukocyte
antigen (HLA class I and class II) mismatching may trigger both humoral and cellular
immune responses in the host. In addition, the specific increase in the fraction of high-
avidity cytotoxic T-lymphocyte precursors (CTLp) may indicate immune-mediated
cellular destruction of homograft valves (Oei et al., 2000; Dignan et al., 2000). The
allogeneic T-cell response is initiated by recognition of non-self HLA-DR (major
histocompatibility complex (MHC) Class II) on graft dendritic and endothelial cells,
followed by an amplification phase against HLA-A and HLA-B (MHC Class I)
molecules in addition to HLA-DR on most parenchymal cells (Hogan & O’Brien, 2003).
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The clinical experience confirms that, although homografts have normal hemodynamic
function immediately after surgery, a mild to moderate increase in gradients is a
frequent observation associated with elevated anti- MHC class I and MHC Class II
antibodies in the circulation of patients receiving cryopreserved homografts (da Costa et
al., 2009).
Despite the disadvantages of lacking long term durability and having limited availability,
homografts have been widely used in heart valve replacement surgeries in the aortic,
pulmonary and mitral valve positions (Kitamura, 2011). The most important indications
for use of cryopreserved allograft valves are: important cardiac and valve malformation
in children, female patients of child-bearing age with diseased cardiac valves, cases with
contra-indications for anti-coagulation and patients with severe endocarditis with septal
or annular abscesses. Since 1988, a total of 4516 allograft valves (1391 aortic, 2620
pulmonary and 48 mitral) supplied by the European Homograft Bank (EHB) were
implanted in the left or right ventricular outflow tract for replacement of the diseased
aortic or pulmonary valve and for mitral or tricuspid valve replacement or repair
(Jashari et al., 2010).
The general outcome of homograft valve transplantation is acceptable. Kilian et al.
(2010) reported the clinical outcome of homografts used as aortic valve replacements
after 15 years. In total 360 homografts had been implanted in adult patients since 1992,
and the survival rates after 5, 10, and 15 years were 88.3%, 84.6%, and 76.0%,
respectively. By echocardiography, the transvalvular pressure gradient changed from
10.55 to 15.02, 19.9 and 37 mm Hg after 5, 10, and 15 years, respectively. The
hemodynamic performance was generally good, and hemorrhagic or thrombo-embolic
events were rare.
Pulmonary homografts have been widely used during the Ross procedure (Haydock et
al., 1992; da Costa et al., 2005b; da Costa et al., 2007). The general outcome has been
satisfactory with a high survival rate and low reoperation rate. A study of 259 patients
implanted with cryopreserved pulmonary homograft valves during the Ross procedure
showed a satisfactory result at mid-term follow-up. The mean follow up period was 3.8
years (range: 0.2-11.2 years). Homograft failure occurred in 9% patients, and homograft
dysfunction was 12 %. It was reported that a younger donor age was somehow related
to increased immunogenicity of the homograft and that this may be associated with
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severe homograft stenosis which developed within the first postoperative year in some
patients undergoing the Ross procedure (Niwaya et al., 1999).
Another intermediate-term follow-up (mean follow-up period: 3.2 years) reviewed the
results after the Ross procedure (in which cryopreserved pulmonary homografts were
used in the right ventricular outflow tract) in children and young adults (Ward et al.,
1997). A total of 113 children or young adults who received pulmonary homografts at
the Children’s Hospital of Oklahoma were evaluated. The result of this study also
indicated the occurrence of stenosis, as stated by Niwaya and Colleagues (1999). No
investigation of the relationship between age of the donor and increased
immunogenicity was undertaken. In this study, the following conclusions were drawn:
pulmonary homografts undergo significant annular reduction in most patients, though
this is usually not associated with the development of significant obstruction; in most
cases, the gradient was increased across the homograft after the operation; severe
homograft valve degeneration usually occurred within one year of implantation, which
may reflect an immune-mediated response.
During 1995 and 2005, the Ross procedure was conducted in 202 patients with aortic
valve diseases at the Cardiac Surgery Service of Alianca Saude Santa Casa- PUCPR.
For the reconstruction of the right ventricular outflow tract, cryopreserved pulmonary
homografts were used in 160 patients. None of the patients received anticoagulation
drugs, and no case of thromboembolism was detected in the late follow-up. The late
actuarial survival was considerably high (96.9%) (da Costa et al., 2005a).
In conclusion, nowadays, for patients suffering from serious heart valve disease,
different options for replacement valves are available with relatively mature surgical
techniques. Nevertheless, none of the currently available valve replacements meet all
the requirements of an “ideal heart valve”. Mechanical valve replacement carries a risk
of thromboembolism, and thus life-long anticoagulation therapy is required, increasing
the risk of haemorrhages. Biological valves, including bioprosthetic and homograft
valves, have a lower risk of thromboembolism but tend to fail sooner and more
frequently. Furthermore, the performance of most of the existing valve replacements is
highly variable in children. Although homograft valves are considerably superior to
other candidates, they are hard to implant, risky, and rarely available for the paediatric
population since they can only be obtained from donors of a similar size. A promising
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approach for reaching the holy grail of an “ideal valve replacement” is tissue
engineering. Especially for the paediatric population, tissue-engineered heart valves are
considered to be the best potential solution for valve replacement (Booth, et al., 2002;
Sapirsten & Smith, 2001; Veseley, 2005).
1.5 Tissue engineering of heart valves
Tissue engineering offers an attractive alternative for tissue reconstructions, involving
the development of biological or hybrid substitutes for implantation into the body with
the purpose of fostering remodelling and regeneration of diseased tissue. Potential
applications of tissue engineering range from structural tissues such as skin, cartilage,
bone, and cardiovascular tissues (blood vessels, myocardium, and heart valves), to
complex organs such as the liver, kidney, lungs and heart (Langer & Vacanti, 1993;
Booth et al., 2002; Dimmeler et al, 2005; Mendelson & Schoen, 2006; Lanza et al.,
2007).
A tissue-engineered heart valve has the potential to offer advantages, including low risk
of thrombosis, reduced risk of degradation and calcification, resistance to infection, as
well as ability to repair injury, remodel and grow. Effectively, a living tissue-engineered
heart valve, would overcome the drawbacks inherent in the currently available valve
replacements, by providing adequate strength, flexibility and durability and
accommodating the repetitive changes in shape, dimensions, and stress during valve
opening and closing (Mendelson & Schoen, 2006). The fact that tissue engineered heart
valves have the potential to grow, repair, and remodel makes them particularly attractive
for the paediatric population.
1.5.1 Scaffolds for heart valve tissue engineering
An ideal heart valve scaffold should be a template directing neo-tissue growth and
organization, and regulating cellular adhesion, proliferation, migration, and
differentiation. In addition, the scaffold should be able to degrade and be gradually
replaced by functionally integrated extracellular matrix (ECM). According to Brody &
Pandit (2006), an ideal scaffold for tissue engineering heart valves would:
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 Possess adequate mechanical properties to withstand the dynamic conditions in the
heart, in particular be sufficiently elastic to maintain a tight seal during the diastole
phase of the cardiac cycle.
 Have a micro-architecture and constituent content mimicking that of the native heart
valve, since collagen and elastin fibres, as well as the structural orientation of the
fibres may all influence cellular orientation through contact guidance, and thus
contribute to the mechanical properties of the heart valves.
 Incorporate nanotopography which is similar to that of the native valve basement
membrane since cellular growth is significantly influenced by nanotopography and a
confluent endothelium is critical in maintaining a non-thrombogenic surface.
 Support the adhesion, proliferation and phenotypic expression of VEC`s and VIC`s,
or any cell type, which is chosen to replicate their behaviour.
 Have a degradation rate similar to that at which extracellular matrix is being
produced, thus maintaining the ability of the construct to withstand the high pressure
fluctuations and a tight seal during diastole.
Currently, scaffolds being investigated for heart valve tissue engineering can be divided
into three broad categories, synthetic scaffolds, scaffolds made from natural materials
and acellular biological scaffolds.
1.5.1.1 Synthetic scaffolds
Generally, synthetic scaffolds can be fabricated using one of the following processes:
weaving, meshing, porogen leaching, emulsion freeze drying, expansion in high
pressure gas, 3D-printing, phase separation, and stereolithography (Sodian et al., 2000;
Shi et al., 2002; Brody & Pandit, 2007).
A range of biodegradable polymers have been investigated as scaffolds for heart valves
(Tuzlakoglu & Reis, 2009; Schoen, 2011b). Polyesters such as polyglycolic acid (PGA),
polylactide (PLA) and their copolymers are currently the most widely researched in
tissue engineering. PGA is a highly crystalline, linear, aliphatic polyester, which has a
high melting point and low solubility in organic solvents except for highly fluorinated
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organic solvents such as hexafluoro-isopropanol. PGA can be fabricated into different
forms using techniques such as extrusion, injection and compression moulding under
careful control of processing conditions due to its high sensitivity to hydrolytic
degradation (Mikos & Temenoff, 2000). An attractive feature of PGA is that its
degradation product (glycolic acid) is a natural metabolite. The degradation of PGA
occurs by the diffusion of water into the amorphous regions of the scaffold causing
hydrolytic chain scission of the ester groups (Gunatillake & Adhikari, 2003). PLA is
more hydrophobic, and more resistant to hydrolytic degradation compared to PGA. The
combination of PGA and PLA in different proportions increases the range of material
properties (Grayson et al., 2004; Mendelson & Schoen, 2006). Nonwoven PGA and
composites of poly(lactic-co-glycolic acid) (PLGA) layered with nonwoven PGA were
firstly investigated as valvular scaffolds by Shinoka et al. (1995; 1996; 1997) in the late
1990s. The results were generally favourable, although the leaflets were thicker and less
flexible than the native ones. However, it is generally considered that PGA, PLA, and
their copolymers are not suitable for cell growth in vitro (Kohn et al., 2004).
Other polymers such as polycaprolactone (PLC), polypropylene fumarates (PPF),
polyanhydrides, polyorthoesters (POE), poly-L-lactic acid (PLLA), poly-4-
hydroxybutyrate (P4HB), polyhydroxyalkanoates (PHA) have also been investigated as
scaffold materials. Both P4HB and PHA have been used to create heart valve scaffolds
using stereolithography (Sodian et al., 2000, Sodian et al., 2002). In a study reported by
Hoerstrup et al. (2000), P4HB was coated on PHA for use as a valvular scaffold.
Valvular scaffolds made of highly porous PGA combined with P4HB produced
promising results in a sheep model. Moreover, Schmidt et al. (2004, 2007) reported that
P4HB/PHA scaffolds demonstrated excellent attachment of human umbilical cord
blood-derived endothelial progenitor cells. Sutherland and colleagues (2005) developed
a valve scaffold by melt-extruding PGA/PLLA fibres and processing them into flat,
nonwoven sheets. The valve scaffolds were then assembled over moulds using needle
punching to provide bonding between layers. Subsequently, the scaffold was seeded
with ovine bone marrow mesenchymal derived stem cells (MSC`s) and implanted in an
ovine model, demonstrating satisfactory function for periods of over 4 months.
Synthetic scaffolds are relatively easy to control and produce. They can be fabricated
into various shapes with appropriate pore size, conducive to tissue growth. They can
also be tailored to possess certain mechanical properties and degradation rates.
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Chemically functional groups can also be introduced into the synthetic scaffolds to
induce the tissue growth. Moreover, the raw materials of synthetic scaffolds are
relatively easy to obtain and to preserve. However, synthetic scaffolds have the potential
to induce a toxic response due to degradation products, and lack the natural
histioarchitecture of the native tissue. In addition, inflammation may occur due to the
introduction of foreign material and incomplete scaffold degradation (Gunatillake &
Adhikari, 2003).
1.5.1.2 Scaffolds made from natural materials
Another approach that has been employed for generating valvular scaffolds is to
synthesise them using natural biological materials. Such materials include collagen,
chitosan, hyaluronic acid, fibrin and chondroitin sulphate (Schmidt & Baier, 2000;
Brody & Pandit, 2007; Owen & Shoichet, 2010).
Collagen is the principal structural component of the heart valve leaflets and is weakly
immunogenic compared to other structural proteins (Chevallay et al., 2000). Collagen
type I scaffolds manufactured using collagen from bovine tendons have been developed
using the rapid prototyping method. The 3D structure of the scaffold was created by
using 3D inkjet printing. In order to induce pore generation, the bovine collagen
solution was dispersed into the mould and then frozen at -30°C. The mould was then
dissolved away by immersion in ethanol and the collagen scaffold was critical point
dried with liquid carbon dioxide for 3 hours. Cross-linking was conducted with a non-
toxic, dehydrothermal treatment under vacuum. This scaffold has been used for seeding
human aortic VIC`s, as well as human bone marrow-derived MSC`s (Terrovitis et al.,
2006; Dreger et al., 2006; Taylor et al., 2006a).
Chitosan is a derivative of chitin. Advantages to use chitosan may include minimal
foreign body reaction, mild processing conditions, controllable degradation, structural
similarity to GAG`s, and availability of hydroxyl and amino functional groups, which
may be conjugated to molecules when used to produce bioactive scaffolds (Suh &
Mathew, 2000). Chitosan has been shown to support the growth of VEC`s and showed
better performance in terms of optimal VEC attachment, proliferation, and morphology
when compared to some synthetic materials such as polyhydroxyalkanoate (PHA)
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(Brody & Pandit, 2007). Chitosan may therefore be considered as a candidate for tissue
engineered heart valve scaffold design (Cuy et al., 2003)
Fibrin promotes cellular migration, proliferation, and matrix synthesis through the
release of platelet derived growth factor and transforming growth factor- (Sierra et al.,
1998). It can also serve as a reservoir for cell mediators, such as bioactive peptides,
alternative growth factors, and proteins (Lewis et al., 1997). These characteristics have
led to the investigations on the use of fibrin gel in heart valve tissue engineering
(Jockenhoevel et al., 2001). Injection molding was used to create heart valve constructs
from fibrin gel supplemented with aprotinin and chemically fixed with poly-L-lysine.
Constructs were seeded with human aortic myofibroblasts and after 4 weeks in culture,
a homogenous cell distribution and a well-developed ECM with organized collagen
bundles was formed (Brody & Pandit, 2007). However, the two main disadvantages of
fibrin gel, shrinking and low initial mechanical stiffness, may limit its potential use in
tissue engineered heart valve scaffold.
Although much research has been conducted on the design and manufacture of scaffolds
using synthetic or natural materials, this approach is still a long way from clinical
translation.
1.5.1.3 Acellular biological scaffolds
An alternative approach to synthetic polymer scaffolds or scaffolds made from natural
materials is the utilisation of decellularised natural allogeneic or xenogeneic heart
valves. Allogeneic valves are the optimal choice, however this approach is limited by
availability. Thus, recent research has focused on the development of decellularised
xenogeneic heart valve scaffolds. A ready-available xenogeneic scaffold with optimal
biological, histological and mechanical features similar to native valves holds great
potential. For a successfully decellularised valvular scaffold, all of the cells and cellular
debris should be removed from the tissue and damage to the surrounding ECM should
be minimal. The growth of seeded cells should not be inhibited and immunogenic
reactions and calcification should not be induced after implantation (Stock & Schenke-
Layland, 2006). Complete decellularisation is crucial for xenogeneic scaffolds, since
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residual animal cells or cell debris could lead to inflammatory reactions and
immunological rejection.
In the development of acellular xenogeneic scaffolds, the removal the α-gal (Galα1,3-
Galβ1-4GlcNAc-R) epitope is of particular concern. The α-gal epitope is the major 
xenoantigen causing hyperacute rejection of animal tissue in Man, and is an additional
blood group antigen in pigs (homologous to the ABO blood group antigens in humans).
It has a unique carbohydrate structure, which is conserved in all mammalian species
except old world primates and Man. Humans and Old World monkeys do not express
the α-gal epitope due to two frameshift mutations in the α 1,3-galactosyl-transferase 
gene (Galili & Swanson, 1991; Joziasse et al., 1991), and produce large amounts of
anti-α-Gal antibodies including IgG, IgM and IgA as a result of the constant exposure to 
intestinal bacterial that carry cross-reacting epitopes (Badylak & Gilbert, 2008). It has
been estimated that up to 1 % of circulating human antibodies are anti-α-Gal (Galili et
al., 1984; Galili et al., 1985). The presence of the α-gal epitope on the surface of the 
vascular endothelium is the primary cause of rejection of xenogeneic organ transplants
(Cooper et al., 1993; Oriol et al., 1993). The α-gal epitope is expressed in porcine valve 
endothelium (Fariva et al., 2003). When implanted, porcine tissue expressing the α-gal 
epitope elicits a specific hyperacute host immune response mediated by IgM antibodies
directly against α-gal (Farivar et al, 2001; Farivar et al., 2003; Konakci et al., 2005). In
order to eliminate the α-gal epitope in xenogeneic tissue transplants, there have been 
attempts to use transgenic pigs with the 1,3-galactosyl transferase gene knocked out
(Lai et al., 2002; Phelps et al., 2003). The α-gal epitope was not detected in the α-gal 
deficient tissues after transplantation in rat models (Lila et al., 2010; McGregor et al.,
2011). However, xenotransplants of 1,3-galactosyl transferase gene knockout hearts
were rejected over periods of 6 months due to an immune response that included the
formation of anti-non-α-Gal antibodies specific to porcine antigens (Kuwaki, et al.,
2005).  Although the level of anti-non-α-Gal antibodies to xenoantigens in humans is 
low compared to total anti-α-gal antibodies, they can result in acute rejection. It has 
been suggested by Burcin & Cooper (2008) that further genetic modification of 1,3-
galactosyl transferase gene knockout pigs might overcome the remaining
immunological barrier to xenotransplantation.
Hence the approach to utilising acellular biological scaffolds derived from xenogeneic
heart valve tissues is based upon removal of all the cells and cellular antigens. Porcine
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heart valves are considered to be the best candidate for use in the development of
acellular xenogeneic heart valve scaffolds because they are of similar size to the human
heart valves. In addition, the ECM proteins are highly conserved between pigs and
humans. Thus, a completely decellularised porcine heart valve scaffold should exhibit
very low immunogenicity in Man.
A successful decellularisation method should successfully remove all cellular
components without impairing the architecture and integrity of the ECM. In early
attempts, freeze-drying was used for heart valve decellularisation to produce a porous
scaffold for cellular growth. This method preserved the general histoarchitecture of the
scaffold, but ice crystals formed during freeze-drying caused the collapse of the scaffold
ECM. Moreover, adequate porosity of the scaffold, which is important for cellular
infiltration, was not achieved by this method (Curtil et al., 1997; Brody & Pandit, 2007).
Other attempts to produce decellularised porcine valves scaffolds have also been
reported. Wilson et al. (1995) reported a four-step decellularisation process utilising 1%
(w/v) Triton X-100, 1% (w/v) sodium dodecyl sulphate (SDS), deoxyribonuclease
(DNAse) and ribonuclease (RNAse). This protocol was reported to completely
decellularise the porcine valve while maintaining the integrity of the ECM. A triton X-
100 detergent based decellularisation protocol was also reported by Bader et al. (1998),
which also completely decellularised the porcine valve while maintaining the ECM.
Further attempts to decellularise heart valves focused on the utilization of ionic and
nonionic detergents, hypo- and hypertonic salt solutions and enzymes (generally
including ehylenediaminetetraacetic acid (EDTA), trypsin, SDS, DNAse, RNAse),
triton X-100 etc.; Booth et al, 2002). An enzyme based decellularisation protocol was
reported by Schenke-Layland et al. (2003, 2004), which utilised 0.05% (w/v) trypsin
and 0.02% (w/v) EDTA.
A successful decellularisation method for aortic valve leaflets was also developed by
Booth et al. (2002) using the detergents SDS at 0.03% -0.01 % (w/v) or sodium
deoxycholate at 0.5% w/v in hypotonic buffer. Following treatment, the major structural
components of the valve ECM were successfully maintained and functional analysis
showed the valve cusps to be fully competent under physiological pressures (120 mm
Hg) along with physiological leaflet kinematics (Korossis et al., 2002). It was also
reported that this method produced increased extensibility in the aortic leaflets but did
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not impair their strength. Since SDS alone was not sufficient to decellularise the whole
aortic root, and a modified protocol was developed by including a 1.25% (w/v) trypsin
digestion step. In this protocol, SDS was used at a concentration of 0.1% (w/v) (Wilcox
et al., 2005). Cytotoxicity studies showed that the decellularised scaffold was free of
residual SDS and biocompatible with porcine smooth muscle cells. This
decellularisation method was, subsequently, utilized by Vincentelli and colleagues
(2007) to decellularise porcine pulmonary valve scaffolds. The decellularised scaffolds
were seeded with ovine MSC`s and implanted to sheep. The valves demonstrated
satisfactory haemodynamic and histological aspects after 4 months.
Over the past few years, two general strategies have been employed by researchers in
the field of heart valve tissue engineering. These include: (1) implantation of heart valve
scaffolds without prior in vitro cell seeding with a view to the valves being repopulated
in vivo by endogenous cells; and (2) implantation of scaffolds which have been seeded
with cells in vitro either passively or dynamically in bioreactors. To seed or not seed
cells before implantation has become an important issue in the field of tissue engineered
heart valve conduits (Versely, 2005). It has been reported that cryopreserved homograft
valves fail to repopulate with recipients cells and become completely acellular within
months of implantation (Schoen, 1995). This finding was of particular concern because
the homograft was expected to be the ideal matrix for cell repopulation. Possibly due to
these findings, a number of investigators have attempted to seed the decellularised
scaffolds in vitro prior to implantation (Schenke-Layland et al., 2003). Some
researchers choose to seed decellularised valvular scaffolds only with endothelial cells
derived from patients, and the clinical outcome has demonstrated excellent
hemodynamic performance during long-term follow up (Dohmen et al., 2011). With
regards to in vivo tissue engineering, the scaffold may be implanted unseeded with a
view to attracting endogenous cells by facilitating repair mechanisms. In a long-term
animal model study in which decellularised seeded and non-seeded porcine valve
leaflets were implanted into goats, Kim et al. (2004) demonstrated good valve function
with no thrombosis and abundant cellular ingrowth was observed. Thus, the authors
suggested it was feasible to use decellularised valve conduits.
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1.5.2 Cells for heart valve tissue engineering
In the approach which utilises preseeding of heart valve scaffolds prior to implantation,
cells are required. Cells should have similar properties to that of the native tissue and
must be autologous from the patient. Basically, two types of cells exist in native heart
valves, the VEC`s (which are important to prevent thrombus formation), and the VIC`s
(which are responsible for synthesising and remodelling the ECM; Latif et al., 2007).
Potential cell sources for scaffold seeding in vitro include differentiated endothelial
and/or smooth muscle cells and stem cells.
Stem cells, with their unique properties such as multilineage differentiation and self-
renewing ability, are very attractive for tissue engineering applications (Oswald et al.,
2004; Mendelson & Schoen, 2006). There are two types of stem cells present in adult
bone marrow: hematopoietic stem cells (HSC`s; blood forming cells) and mesenchymal
stem cells (MSC`s; may develop into cells that form bone, muscle, cartilage, etc.)
(Majumdar et al., 1998). Bone marrow MSC`s are easily accessible, isolated and
cultured which has made them an ideal cell source for tissue engineering.
Endothelial progenitor cells (EPC`s) are stem cells which have the ability to
differentiate into the endothelial cells that line the blood vessels and cardiac valves.
EPC`s can be derived from either bone marrow or blood. EPC`s from bone marrow can
be mobilised either endogenously by tissue ischemia or exogenously by cytokine
stimulation or 3-hydroxy-3-methyl-glutaryl-Coenzyme-A (HMG-CoA) reductase
inhibitors (Llevadot et al., 2001; Dimmerler et al, 2001). Peripheral blood EPC`s can be
isolated by magnetic bead selection on the basis of CD34, CD133 expression and
vascular endothelial growth factor (VEGF) receptor 2 (Asahara et al, 1997; Oswald et
al., 2004). Wu et al. (2004) have reported that when blood-derived EPC`s are expanded
in vitro and consequently seeded on a biodegradable PGA-PLLA scaffold, they
successfully formed micro-vessels on the scaffold. Fang and colleagues (2007) have
successfully isolated and differentiated human umbilical cord blood-derived EPC`s into
EC`s by culturing them in endothelial basal medium EGM-2MV medium, containing
vascular endothelial growth factor (VEGF), human fibroblast growth factor (hFGF),
human recombinant long-insulin-like growth factor-1 (R3-IGF), human epidermal
growth factor (hEGF), gentamicin and amphotericin, hydrocortisone, heparin, ascorbic
acid and 5% (v/v) fetal bovine serum (FBS). The EPC-derived endothelial cells were
Chapter 1
42
histiocytic cobblestone in morphology and expressed specific markers of the endothelial
cell lineage, including von Willebrand factor (vWF) and CD31. They could bind to
human endothelial cell-specific lectin Ulex Europaeus agglutinin-1 (UEA-1) and took
up Dil-labeled low density lipoprotein (Dil-Ac-LDL). These cells were then seeded onto
a decellularised porcine heart valve scaffold, and showed excellent metabolic activity
and proliferation. As reported by Sales et al. (2010), EPC`s isolated from blood
appeared to have the potential to provide both interstitial and endothelial functions and
could potentially serve as a single-cell source for construction of tissue engineered heart
valves. These studies suggest that EPC`s may be a promising cell source for the
endothelialisation of tissue-engineered heart valves.
MSC`s have received much interest due to their clinical potential for tissue engineering
not only because they are multipotent and can easily be expanded in culture, but they
can also secrete a variety of paracrine angiogenic and cytoprotective factors, which have
the potential advantage to suppress many immune cell functions and to decrease
immune-mediated reactions (Uccelli et al., 2006; Ohnishi & Nagaya, 2007; Vincentelli
et al., 2007). Apart from bone marrow, MSC`s and MSC-like cells can also be found in
various other tissues including adipose tissue, amniotic fluid, periosteum, and foetal
tissues. MSC`s can be isolated from the mononuclear layer of the bone marrow after
density gradient centrifugation. The mononuclear cells are cultured in medium with 10%
(v/v) foetal calf serum, and the MSC`s adhere to plastic (Chamberlain et al., 2007).
Phenotypically, although not specific, MSCs express a number of markers. It is
generally agreed that they do not express the hematopoietic markers CD45, CD34,
CD14, or CD11, the adhesion molecules CD31 (platelet/endothelial cell adhesion
molecule-1 (PECAM-1)), CD18 (leukocyte function-associated antigen-1) or CD56,
and the co-stimulatory molecules CD80, CD86, or CD40. However, they can express
CD105, CD73, CD44, CD90, CD71, and Stro-1, as well as the adhesion molecules
CD106, CD166 and CD29 (Haynesworth et al., 1992; Chamberlain et al., 2007; Kolf et
al., 2007).
Numerous studies have been carried out demonstrating the migration and multi-organ
engraftment potential of MSC`s in animal models as well as in humans (Lanza et al.,
2007). Elaborating, MSC`s have the capability to migrate from the blood, across
endothelial cells, and into tissues. This is an exciting feature for tissue engineered heart
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valve scaffold seeding. Together with their capacity to differentiate into cardiac VIC`s,
MSC`s are believed to be a good candidate for VIC seeding in heart valve tissue
engineering (Jiang et al., 2005; Chamberlain et al., 2007).
Latif and colleagues (2007) compared the phenotypes of MSC`s and VIC`s with the aim
to demonstrate the potential application of MSC`s in heart valve tissue engineering. A
number of cell surface molecules, cytoskeletal proteins, cell junction and cell
communication molecules and ECM components were expressed by both MSC`s and
VIC`s. MSC`s and more than 80% of VIC`s expressed fibroblast surface antigen α-
smooth muscle actin (α-SMA), vimentin and CD44. The expression of MHC class I and 
II, and calponin were also comparable between the two cell types. CD105 was weakly
expressed by 10% of VIC`s while the expression level in MSC`s was more than 90%.
Both cell types made similar levels and patterns of ECM components. Elastin
expression was detected in neither of the cell types. Adhesion molecule expression was
highly variable among the MSC isolates and between the two cell types, with the
predominant integrins being α1, α3, α5, and β1 in both cell types. The WNT gene 
family is considered to secrete critical regulator proteins. The secreted proteins are
involved in cell proliferation, motility, cell polarity generation, and specification of cell
fate. Polymerase chain reaction (PCR) analysis of WNT/FZD/SFRP/LRP family
members revealed a greater range of the WNT family of genes being expressed in
MSC`s compared to VIC`s. The in vitro differentiation of MSCs into VIC`s could
possibly be controlled by mechanical and biological conditioning which mimics the in
vivo environment of the native valve (Ku et al., 2006). The composition of the scaffold
would also be crucial in the differentiation of the MSCs. A valvular scaffold closely
comparable to the native valve might contribute to the differentiation of MSC`s into
VIC`s.
Currently, detailed understanding of the pathways and processes involved in the
differentiation of MSC from different sources is insufficient. This information is desired
for the clinical application of MSC towards the in vitro generation of functional tissue
for implantation (Hilfiker et al., 2011).
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1.5.3 Bioreactors for heart valve tissue engineering
A tissue engineering heart valve bioreactor is a device able to ensure the biological and
physiological environment of the heart and the circulatory system (Gandaglia et al.,
2011). In general, a tissue engineering heart valve bioreactor should enable the culture
of bioartificial tissue under sterile, physiological (37 °C and 5 % v/v CO2) conditions
and should be easy to clean and maintain. In order to engineer functional valvular tissue,
it is essential that bioreactor systems are able to simulate the dynamic physiological,
biomechanical and biochemical conditions in vitro which mimics the human in vivo
circulation (Mertsching & Hansmann, 2009). Heart valve tissue engineering bioreactors
have been designed for two major purposes. The first is to study the mechanisms by
which the biochemical or biomechanical environment influences the interaction
between the valvular cell types or between cells and scaffold material, and the tissue
remodelling process in vitro. The second is to prepare cell-seeded tissue engineered
heart valve conduits for implantation (Berry et al., 2010).
The first attempt to assemble a bioreactor for the culture of heart valves dates back to
the year 2000 by Sodian et al. (2000). The authors applied a simple pulsatile flow
system which was designed to induce different levels and conditions of flow and
pressure in the bioreactor. Cells from ovine carotid artery were statically seeded onto
PHA scaffold prior to placing the conduit in the bioreactor. The results indicated an
increase in cell proliferation when compared to static culture. The cells were found to
have secreted ECM components collagen and GAG`s but not elastin following culture.
In the same year, Hoerstrup and colleagues (2000) developed a compact heart valve
bioreactor which consisted of an air chamber, medium chamber, and perfusion chamber
that held the heart valve. Ovine myofibroblasts and endothelial cells were seeded on a
biopolymeric scaffold (a combination of PGA and P4HB) statically prior to placing the
conduit in the bioreactor. The cultured tricuspid valve leaflets were subsequently
implanted into lambs. However, these tissue engineered valvular conduits had a poor
hemodynamic performance in vivo.
The use of a heart valve bioreactor for the culture of cell-seeded decellularised
biological xenograft (porcine) valve conduits was carried out by Zeltinger et al. (2001).
The bioreactor included a medium reservoir, pneumatic pressure chamber with an
elastomeric bladder which was placed below the heart valve to produce a back flow on
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the valve in order to generate negative pressure allowing the valve to the close. Human
neonatal fibroblasts were seeded onto the decellularised scaffold dynamically.
Unfortunately, the repopulated conduit resulted in a thickening of the leaflets which
finally lead to valve stenosis after implantation in an animal model.
A very compact diastolic pulse duplicator which consisted of a valve holding device and
a medium container was developed by Mol et al. (2005). Pulsatile flow was produced
by the release of air into a cylinder which compressed or decompressed tubing resulting
in a pressure differential. Cells harvested from the human saphenous vein were seeded
on trileaflet heart valve scaffolds which were fabricated on a Fastacryl® stent, and
cultured in the system for up to 4 weeks. Histological staining showed superior tissue
formation in the leaflets. Collagen could be identified in the leaflets. However, the
leaflets lost coaptation after releasing them from one another following culture, as they
had partly grown together.
Lichtenberg et al. (2006) engineered a heart valve bioreactor which included a pulsatile
pump, a heart valve reservoir, a medium reservoir, and a compliance chamber. This
system allowed the direct control of the flow rate via a pulsatile pump. The culture
conditions within the bioreactor were closely monitored by flow, pressure and
temperature transducers. Autologous EPC`s were seeded onto human cadaveric
pulmonary valves and preconditioned in the bioreactor for up to 21 days, and the seeded
conduits were implanted in two pediatric patients as pulmonary valve replacements. The
3.5 years follow-up showed normal patient growth and normal valve growth (Cebotati
et al., 2006).
Flanagan et al. (2007) developed a ventricular pulse duplicator lodged in an incubator.
The pulsatile flow was provided by the displacement of a silicon membrane, forcing the
medium to pass through the above ventricular chamber during the systolic phase, where
the heart valve was located (Gandaglia et al., 2011). Moulded fibrin-based tissue-
engineered heart valves seeded with ovine carotid artery-derived cells were subjected to
12 days of mechanical conditioning in the system. The authors demonstrated that the
pulsatile flow conditions in the bioreactor not only enhanced seeded cell attachment and
alignment within the fibrin-based heart valve scaffolds, but dramatically changed the
manner in which the cells generated ECM proteins and remodelled the valve matrix in
comparison to stirred controls in a beaker. This model was able to simulate the most
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appropriate stimulus for cardiovascular tissue engineering as described by Stock &
Vacanti (2001).
Lee et al. (2009) developed a computer-assisted pulsatile heart valve bioreactor for the
endothelialisation of decellularised pulmonary valves. The bioreactor was comprised of
a digital gear pump, and was suitable for shear stress modulation, but lacked the ability
to evaluate the transvalvular gradients. EPC`s derived endothelial cells were seeded on
decellularized porcine valve scaffolds and cultured in the bioreactor for 7 days.
Successful endothelialization was achieved by preconditioning the cell-seeded valves
with stepwise increases in volume flow rate up to 2 L.min-1 following culture.
A heart valve bioreactor developed by Ruel and Lachance (2009) used a compliance
chamber positioned between the valve holder and the variable resistance to reproduce
the elastic characteristic. This device was reported to be able to generate flow and
pressure waveforms comparable with that of healthy patients with a custom designed
bileaflet mechanical valve. However, no cells or tissue was tested in this bioreactor. The
success of this bioreactor still needs to be verified.
In addition to the clinical application of the pre-seeded allogeneic pulmonary valve
conduits in a bioreactor which has been described previously in this section (Cebotati et
al., 2006), Dohmen et al. (2002) reported the clinical use of tissue engineered
pulmonary heart valve scaffolds preseeded with endothelial cells in a specially designed
heart valve bioreactor. The long-term follow-up demonstrated the tissue engineered
pulmonary valves had excellent hemodynamic performance with no calcification for up
to 10 years (Dohmen et al., 2011).
A major step towards the understanding the design of efficient bioreactors for use in
heart valve tissue engineering has been achieved, but many unsolved issues remain. The
physiological hydrodynamics (e.g. cyclic stretch, flexure and shear stress) in vivo has
proved difficult to reproduce in the heart valve bioreactors to date (Gandaglia et al.,
2010). Currently, there is no agreement upon the conditioning protocol for heart valve
bioreactors. However, bioreactors should gradually introduce physiologic flex, stretch
and flow in order to properly condition the valves (Berry et al., 2010). Future studies
are needed to identify those forces and conditions within the heart valve bioreactors to
achieve appropriate physiological culture conditions.
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1.5.4 Heart valve replacement using natural acellular scaffolds
Currently, cryopreserved homografts are generally accepted as the ‘gold standard’ for
right ventricular outflow tract reconstruction. However, there are associated risk factors
including younger recipient age, previous bioprosthetic valve, low weight at operation,
small graft size and reoperation (Clarke, et al., 1993; Brown et al., 2001). Brockbank et
al. (2000) also suggested a possible cause of tissue failure and calcification due to
interstitial ice formation in cryopreserved homografts. The use of tissue engineered
valves in the pulmonary position is of major interest since they are potentially the best
substitute for use in the Ross procedure to reconstruct the right ventricular outflow tract.
Different decellularisation methods have been utilised to generate acellular pulmonary
valve conduits including the use of 0.1 % (w/v) SDS (da Costa et al., 2009; Navarro et
al., 2010) 0.1 % (w/v) deoxycholic acid (da Costa et al., 2004; da Costa et al., 2007).
Currently, some of the acellular pulmonary valves have been tested biologically and
biomechanically in vitro and have been studied in animal models or used clinically.
Two types of acellular pulmonary valves have been marketed: the decellularised
pulmonary homograft (SynerGraft™) which is marketed by Cyrolife Inc, USA, and the
decellularised xenogeneic heart valve Matrix P™ and Matrix P™ Plus porcine
pulmonary valve (AutoTissue, Germany).
The most widely reported attempt to develop an acellular heart valve scaffold was that
of SynergraftTM (Cryolife, USA), which comprised decellularised porcine valve tissue.
Preclinical reports on this valve indicated that the decellularisation process rendered a
completely acellular scaffold with biomechanical features comparable to those of the
native human aortic valve. Following the initial encouraging pre-clinical reports
(O`Brien et al., 1999; Goldstein et al., 2000), Synergraft valves were implanted in four
male children in 2001. Two of them were implanted in the aortic position and two in the
pulmonary position. All of the four grafts were cryopreserved after decellularisation and
prior to implantation. Unfortunately, a strong inflammatory response and structural
degradation of the valves lead to the death of three of the patients within one year. Later,
traces of α-gal epitope were found in the leaflets of the SynergraftTM valves, which
could have been responsible for their failure (Simon et al., 2003; Kasimir et al., 2006;
Brody & Pandit, 2007).
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Although the decellularised SynerGraft™ xenogeneic porcine valve for the aortic
position was a major failure probably due to the presence of residual xenogeneic cells,
the setbacks were not reflected in the SynerGraft™ human homograft pulmonary valves
(Knight et al., 2008). The SynerGraft™ pulmonary homograft was treated by a
proprietary process designed to substantially reduce leaflet and conduit cellularity
(Sievers et al., 2003). Biomechanical analysis showed no corresponding change in the
in vitro biomechanics, including suture retention, tissue extensibility and strength
(Knight et al., 2008). Compared to cryopreserved homografts, the SynerGraft™
pulmonary homograft has low pressure gradients at all flow conditions. Short term
clinical studies showed comparable or better outcomes than the conventional
cryopreserved human allografts, with regard to pressure gradients and subsequent
recipient immune response (Sievers et al., 2003; Hawkins et al., 2003; Bechtel et al.,
2003; Tavakkol et al., 2005). A mid-term follow up (mean: 52 months) conducted by
Bechtel et al. (2008) using SynerGraft™ pulmonary homografts in 23 patients,
compared to 49 patients implanted with cryopreserved homografts showed no
reoperations were required, and the echocardiographic results were stable after the first
postoperative year. Brown et al. (2011) reported the clinical outcome of 29 patients who
received the SynerGraft™ pulmonary homograft and 34 patients who received standard
cryopreserved homografts during the Ross procedure between the year 2000 and 2009.
No early or late deaths occurred during the mean follow-up of 4.9 ± 2.7 years. No
patient required reoperation. No deterioration in conduit valve function occurred in the
SynerGraft™ homograft group, while mild conduit regurgitation developed in several
patients in the cryopreserved homograft group. No patient from either group reached
conduit dysfunction by the authors’ definition (peak gradient: 40 mm Hg or > 2+
regurgitation). The SynerGraft™ pulmonary homografts appeared to be safe and have
comparable hemodynamic performance, and have been proposed to be an alternative to
the cryopreserved homografts according to current experience (Brown et al., 2010;
Brown et al., 2011). Further long term follow up will however be needed to evaluate the
SynerGraft™ pulmonary homografts.
The Matrix P™ porcine pulmonary valve (AutoTissue, Germany) is an acellular porcine
pulmonary valve which is surrounded by three glutaraldehyde-fixed equine pericardial
patches forming the conduit wall (Ruffer et al., 2010). It has been available since
February 2004. Decellularisation is achieved using 1% (w/v) deoxycholic acid (Konertz
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et al., 2005). Histology showed removal of the porcine cells from the pulmonary valve
matrix while the mechanical properties were maintained. The valve closing times,
closing volumes, and gradients were all superior compared to glutaraldehyde-fixed
xenograft bioprostheses (Dohmen et al., 2002). When used clinically, no cell reseeding
was conducted for Matrix P™. The general outcome was satisfying, with low
transvalvular gradients that did not tend to increase over time. The hemodynamic
characteristics of the Matrix P™ decellularised pulmonary xenograft were reported to
be similar to a physiologically normal valve in healthy subjects following short term
follow-up of 50 patients undergoing the Ross procedure (Konertz et al., 2005).
Konertz et al. (2011) reported on the clinical outcome of Matrix P™ (n=9) and Matrix
P™ Plus (n=52) implantation in 61 patients between 2006 and 2008. The early mortality
was 8.2 %, and no deaths occurred during the follow up period. In the authors’ opinion,
the intermediate-term performance of the grafts was favourable compared to that of
other currently available implants, and only four patients underwent reoperation due to
valve failure. However, Cicha et al. (2011) reported that the Matrix P™ Plus valve
displayed early obstruction following implantation in paediatric patients. A foreign
body-type reaction accompanied by severe fibrosis and massive neointima formation
around the Matrix P™ valve wall was found. Examination of the explanted valves
showed an inflammatory infiltrate, composed of T cells, B cells, plasma cells, dendritic
cells, macrophages and mast cells, in the tissue surrounding the conduit (Mahler &
Butcher). Inflammation and predominantly peripheral conduit narrowing were also
observed by Ruffer et al. (2010) in the clinical application of Matrix P™ Plus conduits
in 16 paediatric patients. The Matrix P™ and Matrix P™ Plus xenogeneic pulmonary
valve conduits do not seem to be an ideal conduit for right ventricular outflow tract
reconstruction according to the current outcomes. Due to the clinical outcomes, it is
possible that there may be toxicological problems due to glutaraldehyde preservation of
the equine pericardial patches present in the grafts. The quality control of
decellularisation during the manufacture of the Matrix P™ and Matrix P™ Plus grafts
should also be questioned in order to determine if complete decellularisation was
achieved.
Da Costa et al. (2005b) showed that homografts decellularised using deoxycholic acid
demonstrated a significantly reduced immune response and better hemodynamic
performance when compared to cryopreserved homografts over an 18 month clinical
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follow up when used in the Ross procedure. However, in a longer-term assessment with
a greater number of patients, the deoxycholic acid decellularised homografts showed
some rise in gradients due to residual cell persistence in some grafts (da Costa et al.,
2007).
Xenografts (porcine) decellularised with 0.1 % (w/v) SDS using the technique
developed in Leeds (Booth et al., 2002; Korossis et al., 2002) demonstrated more
complete repopulation than deoxycholic acid decellularised valves in sheep studies, and
a late rise in gradient was not observed in a short to medium term clinical study (da
Costa et al., 2007). da Costa et al. (2009) compared the clinical outcomes using
cryopreserved, deoxycholic acid decellularised, and SDS decellularised homografts for
the reconstruction of the right ventricular out flow tract in a report of their thirteen years’
experience with the Ross procedure. They demonstrated that the homografts
decellularised using 0.1 % (w/v) SDS had significantly lower gradients with not a single
case being observed with a gradient more than 40 mm Hg over a 24 months follow up.
During a reoperation due to the pulmonary autograft dysfunction in the aortic position,
it was shown that the SDS decellularised homograft was soft and pliable, while the
adventitia showed neovascularisation with no adhesions. A biopsy of the homograft
conduit wall showed good preservation of the ECM and partial repopulation with
autologous cells at 17 months postoperatively. An absence of any immunological
reaction without elevation of MHV Class I and II antibodies was further confirmed (da
Costa et al., 2009). Aortic valve homografts decellularised using 0.1% (w/v) SDS also
demonstrated stable structural integrity, low rate of calcification, and adequate
hemodynamics as shown in early and midterm clinical results (da Costa et al., 2010).
Based on the outcomes of the clinical use of acellular homograft pulmonary valve
conduits, it is apparent that acellular heart valve scaffolds implanted without a complex,
costly cell pre-seeding procedure have important clinical potential. However,
homografts, either cryopreserved or decellularised have limited availability. It would be
advantageous if an acellular xenogeneic heart valve scaffold could be developed. This
would have the potential of availability “off the shelf” in a range of different sizes.
Therefore in this project, porcine pulmonary roots will be decellularised using SDS
detergent based on the previous method developed by Booth et al. (2002), Wilcox et al.
(2005) and Korossis et al. (2002; 2005), which is similar to the method used by da
Costa et al. (2009).
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1.6 Aims and objectives
Aims:
The aims of this study were to develop methods to produce a decellularised,
biocompatible porcine pulmonary root conduit for the use in the Ross procedure to
reconstruct the right ventricular outflow tract. The biological and biomechanical
characteristics were determined by comparison to the fresh tissue. In addition, the
conditions for the culture of fresh porcine pulmonary roots under sterile conditions in a
novel dynamic heart valve bioreactor and a static culture system were investigated.
Objectives:
 To develop and optimise a process for the decellularisation of porcine
pulmonary valve conduits.
 To assess the effects of decellularisation on the histoarchitecture, the total
amount of DNA and the presence of functional DNA, the presence of specific
matrix and cytoskeletal proteins, and the presence of the α-gal epitope by 
comparison with the fresh tissue.
 To determine the in vitro biocompatibility of the decellularised porcine
pulmonary valve conduits.
 To assess the effects of decellularisation on the uniaxial tensile properties, the
hydrodynamic behaviour, and the leaflet kinematics of the decellularised tissues
by comparison to fresh porcine pulmonary root tissues.
 To determine the conditions for the culture of fresh porcine pulmonary roots in a
dynamic heart valve bioreactor by assessing the cell distribution, tissue
histoarchitecture, localisation of the specific matrix and cellular proteins, and
cell viability of the tissue.
Chapter 2
52
Chapter 2
General Materials and Methods
2.1 Materials
2.1.1 Equipment
The equipment used in this study and the UK suppliers are listed in Table 2.1.
Table 2.1 Equipment used throughout the study.
Equipment Model Supplier
Automatic pipettes Gilson P2-P1000 Anachem Ltd
Automatic Pipettes Finnipipette® P2-P1000 Thermo Fisher Scientific
Inc
Balances (Accuracy:
0.01g/0.0001g)
GR200/GX2000 Jencons PLC
Bench top centrifuge 5415R Eppendorf
Blood tissue spinner SB3 Stuart
Cell medium aspirator Vacusafe comfort Integra Biosciences
Centrifuge Harrier 15/80 SANYO Biomedical
Europe BV
Class II safety cabinet Heraeus 85 Kendro
Class II safety cabinet
(for heart valve
bioreactor)
Model 1.8 Holten
CO2 Incubator MCO-20AIC SANYO Biomedical
Europe BV
Confocal microscope LSM510 META Carl Zeiss Ltd
Cryo freezing pots
(Nalgene®)
- Thermo Fisher Scientific
Inc
E-gel DNA gel
electrophoresis
E Gel® Invitrogen
Freezer (-20°C) Electrolux 3000 Jencons Plc
Fridge Electrolux ER8817C Jencons Plc
Fume cupboard/fume
hood
- Whiteley
Gel imaging system LOGIC1500 KODAK
Heating forceps Speci-leps System II BIOS EUROPE
Histology cassettes CMB-160-030R Thermol Fisher Scientific
Ltd
Histology water bath MH8515 Barnstead Electrothermal
Hot forcepts Speci-leps BIOS EUROPE
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Hot plate E18.1 hotplate Raymond A Lamb
Hot wax dispenser E66 wax dispenser Raymond A Lamb
Magnetic stirrer Stuart SB161 Scientific Laboratory
Systems Ltd
Magnifying lamp D20251 Fisher Scientific
Micro plate
spectrophotometer
Multiskan spectrum Thermo Scientific
Microscope (upright) Olympus BX51 Microscopes, medical
Diagnostic Systems and
Olympus Patient systems
Ltd
Microtome RM2125 RTR Leica Microsystems
Microwave KM19W, 800w PROLINE
Nanodrop
Spectrophotometer
ND-1000 Labtech Int
Orbital shaker IKA KS130 basic Jencons Plc
Oven (hot air) OMT225 SANYO Biomedical
Europe BV
PCR machine PCR SPRINTThermal
Cycler
Thermo Electron
Corporation
pH meter Jenway 3010 VWR International
Plastic histology
cassettes
CMB-160-030R Thermo Fisher Scientific
Ltd
Plate reader Multiskan Spectrum 1500 Thermo
Plate shaker IKA KS130 basic Jencons Plc
Plate shaker 2 Cooke AM69 microshaker Dynatech Laboratories Ltd
Pipette boy Acu Intergra Biosciences
RT-PCR machine MX3000P Stratagene
Slide holder E102 Raymond A Lamb
Tensile testing machine AGS-10KNG Shimazu
Thickness gauge - Mitutoya
Tissue processor TP11020 Leica Microsystems
Tube-strip centrifuge Picofuge PMC-860 Stratagene
Vortexer TopMix FB15024 Fisher Scientific
Vortexer 2 MS2 minishaker IKA
Water bath Grant Jencons Plc
Water purifier Option 7 ELGA
Wax oven Windsor E18/31 Scientific Laboratory
Supplies
2.1.2 Chemicals
The chemicals and reagents used in this study and the UK suppliers are listed in Table
2.2.
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Table 2.2 Chemicals and reagents used throughout the study.
Chemical/Reagent Supplier
Acetone European Bios
Α-Gal BSA Dextra laboratories Ltd 
Α-SMA Sigma 
Acetic acid Thermo Fisher Scientific Ltd
Acetone European Bios
Agarose (Low melting point) Invitrogen
Alcian blue Raymond A Lamb
Aprotinin (10,000KIU.ml-1) Mayfair house
Blue JuiceTM gel loading buffer (10×) Invitrogen
Bovine serum albumin Sigma-Aldrich
Calcium chloride VWR International
Citric acid VWR International
Collagen type IV DAKO
DABCO Sigma-Aldrich
Desmin Vector
DMSO Sigma-Aldrich
DNeasy blood & tissue kit QIAgen
DNAse Sigma-Aldrich
DPX mountant Thermo Fisher Scientific Ltd
Dulbecco’s modified Eagle’s medium Invitrogen Ltd
Dulbecco’s PBS tablets Oxoid
E-gel 0.8% agarose Invitrogen
E-gel 4 % agarose Invitrogen
E-gel low range quantitative DNA
ladder
Invitrogen
Eosin VWR International
Ethanol Thermo Fisher Scientific Ltd
Ethylenediaminetetraacetic acid
(EDTA)
VWR International
Fibronectin DAKO
Foetal calf serum Biosera
Gel EluteTM PCR clean-up kit Sigma-Aldrich
Gentamycin Sigma-Aldrich
Giemsa solution VWR International
Glycerol Sigma-Aldrich
Haematoxylin Thermo Fisher Scientific Ltd
Heated blood agar University of Leeds
Hoechst 33258 Sigma-Aldrich
Horseradish peroxidise-conjugated
secondary rabbit anti-mouse antibody
DAKO
Hydrochloric acid (6M) VWR International
Hydrogen peroxide (30%, v/v) Sigma-Aldrich
IgM purification kit Pierce (Thermo Fisher scientific Ltd)
Isotype control DAKO
L-glutamine Invitrogen
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Live/Dead assay kit Invitrogen
Magnesium chloride Thermo Fisher Scientific Ltd
Methanol Vichers Laboratories
Miller’s stain Raymond A Lamb
Molecular grade water Sigma-Aldrich
Monoclonal IgG1 DAKO
Monoclonal IgG2a DAKO
Monoclonal IgM against α-Gal epitope Alexis 
MTT reagent Sigma-Aldrich
Neutral buffered formalin (10%, w/v) Genta Medical
Nuclease free water Fermentas
Nutrient agar University of Leeds
OPDfast tablets Sigma-Aldrich
Oxalic acid VWR International
Paraffin wax Thermo Fisher Scientific Ltd
PBSa tablets Oxoid
PCR master mix Fermentas
Penicillin Invitrogen Ltd
Peracetic acid Sigma-Aldrich
pH standards (4,7,10) Scientific Laboratory Supplies Ltd
Picric acid Sigma-Aldrich
Potassium permanganate Thermo Fisher Scientific Ltd
Quick-load PCR marker Biolabs
Rabbit immunoglobulin Fraction DAKO
RNAse Sigma-Aldrich
SAB agar University of Leeds
Sodium azide Sigma-Aldrich
Sodium chloride Thermo Fisher Scientific Ltd
Sodium dodecyl sulphate (SDS) Sigma-Aldrich
Sodium hydrogen carbonate VWR International
Sodium hydroxide VWR International
Streptomycin Invitrogen
Sulphuric acid Sigma-Aldrich
TE buffer Sigma-Aldrich
Trigene Scientific Laboratory Supplies Ltd
Tripsin Sigma-Aldrich
Tripsin inhibitor Sigma-Aldrich
Trizma base Sigma-Aldrich
Tween 20 Sigma-Aldrich
Ultravision Detection system Thermo Scientific
Vimentin Novacastra
Virkon Scientific Laboratory Supplies Ltd
Von Willebrand factor DAKO
Xylene Genta medical
Zinc acetate Thermo Fisher Scientific Ltd
Zinc Chloride Thermo Fisher Scientific Ltd
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2.1.3 Consumables
The consumables and plasticware used in this study are listed in Table 2.3 and Table 2.4
respectively.
2.1.3.1 General consumables
Table 2.3 General consumables used in this study.
Item Model/Size Supplier
Glass coverslips MIC3228 Scientific Laboratory
Supplies
Filter paper Whatman® Grades 1-5 Whatman International Ltd
ImmEdge Hydrophobic
Barrier Pen
H-000 Vector Laboratories
Microtome blades SD3050835 Fisher Scientific
Parafilm M - Sigma-Aldrich Ltd
Scalpel blade Size 22 Fisher Scientific
Superfrost Microscope
Slide
MIC3040 Scientific Laboratory
Supplies
Sutures Ethicon 4-0 Prolene Ethicon (Johnson &
Johnson Ltd)
Superfrost Plus
Microscope Slide
MIC3022 Scientific Laboratory
Supplies
Syringe needles - Thermo Fisher Scientific
Ltd
2.1.3.2 Plasticware
Table 2.4 Plasticware used in this study.
Item Model/Size Supplier
8 Strip PCR tubes 0.2 ml Starlab
Bijous 5 ml Scientific Laboratory
Supplies Ltd
Cell culture flasks 75 cm2 Thermo Fisher Scientific
Ltd
Conical tubes 15 ml Thermo Fisher Scientific
Ltd
Disposable plastic
syringes
1 ml, 2 ml, 5 ml, 10 ml, 20
ml, 50 ml
Scientific Laboratory
Supplies
Micro tube 1.5ml, loop
cap-simport
212-9573 VWR International
Nunc-ImmunoTM 96 well
plate, MaxisorbTM
456537 Scientific Laboratory
Supplies
Pipette tips (filtered and 10 µl, 20 µl, 200 µl, 1000 Star Labs
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non filtered) µl, 5000 µl
OptiplateTM 96-well PerkinElmerTM
Sterile containers 60 ml, 150 ml, 250 ml Scientific Laboratory
Supplies
StripetteTM (disposable
pipettes)
1 ml, 2 ml, 5 ml, 10 ml, 25
ml
Sigma Aldrich Ltd
Universals 25 ml Scientific Laboratory
Supplies
Well plates, Nunc® (flat
and round bottomed)
6-well, 12-well, 24-well,
48-well, 96-well plates
Thermo Fisher Scientific
Ltd
2.1.4 Cells
Cells used in the biocompatibility assays are listed in Table 2.5.
Table 2.5 Cell lines used in this study.
Cells Type Species Supplier
3T3 cells Fibroblast Murine European Collection of Cell cultures
L929 cells Fibroblast Murine European Collection of Cell cultures
2.1.5 General stock solutions
2.1.5.1 Phosphate buffered saline (PBS)
One PBS tablet was dissolved in 100ml of distilled water and the pH adjusted to pH 7.4-
7.6. The solution was sterilised by autoclaving and stored at room temperature until
needed.
2.1.5.2 Tris buffered saline (TBS)
Tris solution (pH 7.6), 2M 25 ml was mixed with 50 ml 3M NaCl solution. The volume
was made up to 1 L using distilled water. The pH of the solution was adjusted to pH 7.6.
The solution was sterilised by autoclaving and stored at room temperature until needed.
2.1.5.3 Cell culture medium
The standard cell culture medium used in this project was Dulbecco’s modified Eagle’s
medium (DMEM) with 10% (v/v) foetal bovine serum (FBS), 100 U.ml-1 penicillin, 100
U.ml-1 streptomycin, and 100 µM L-glutamine. The culture medium was stored at 4 °C
for up to 7 days.
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2.2 Methods
2.2.1 pH measurement
The pH of solutions was measured using a Jenway 3010 pH meter. Before each
measurement, the pH meter was calibrated using pH standard solutions at pH 4, 7 and
10. The solution for measurement was gently stirred using a magnetic stirrer while
measuring with the pH probe, and the values were taken when the reading reached a
steady state. To adjust the pH of the solutions, 1-6 M hydrochloric acid (HCl) or 1-6 M
sodium hydroxide (NaOH) was used.
2.2.2 Light Microscopy
Light microscopy was carried out using an Olympus BX51 microscope. In order to
perform polarized microscopy, the microscope was incorporated with a polarizer and an
analyser into the normal bright field set-up. With the fluorescent vertical illuminator
(BX51-RFA) and appropriate filters, fluorescent microscopy was also carried out using
this microscope. Images were taken using an Olympus XC50 digital camera controlled
through Cell B software (Olympus®, UK).
2.2.3 Sterilisation
2.2.3.1 Dry heat sterilisation
Items sterilised by dry heat sterilisation were placed in a hot air oven and sterilised at a
temperature of 190 °C for 4 h.
2.2.3.2 Moist heat sterilisation
Items sterilised by autoclaving were sterilised at 121 °C for 20 min, at 103 kPa pressure.
2.2.3.3 Filter sterilisation
Filter sterilisation was used for solutions that were not suitable for moist heat
sterilisation. The solutions were filtered through a filter with 0.2 µm pore size using a
disposable syringe. This procedure was carried out in a Class II safety cabinet.
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2.2.4 Dissection of porcine pulmonary heart valve tissue
Fresh porcine hearts were obtained from a local abattoir (Leeds) within 4 hours of
slaughter (Figure 2.1 A). The pericardium was removed to expose the aorta and
pulmonary artery. The aorta and the pulmonary artery were carefully separated using a
scalpel blade, forceps and dissecting scissors. Then, using a scalpel blade, the
pulmonary heart valve together with pulmonary artery and a myocardium skirt (from the
right ventricle) were separated from the heart. Any excess fat and connective tissue
were removed from the surface of the pulmonary artery and the myocardium skirt.
Special care was taken to remove the fat and connective tissue from the connection part
of the pulmonary artery, the myocardium, and the pulmonary leaflets. The pulmonary
artery wall and the myocardium skirt were trimmed to the appropriate length required
for the different experiments. The macroscopic integrity of the three pulmonary leaflets
as well as the pulmonary artery wall and the myocardium skirt was checked, and only
non-damaged pulmonary conduits were used in further experiments (Figure 2.1B). The
pulmonary conduits were washed in PBS to remove the excess blood. The dissected
porcine pulmonary roots were either used fresh, or wiped dry and wrapped in PBS-
soaked filter paper in a sealed container and stored at -20 °C for later use.
Figure 2.1 Dissection of porcine pulmonary valve roots. (A) Fresh porcine heart; (B)
The dissected and cleaned porcine pulmonary valve conduits.
2.2.5 Sizing of porcine pulmonary roots
Following the isolation and trimming of the porcine pulmonary roots, their internal
diameter was estimated using surgical obturators (Figure 2.2) and their external
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diameter using vernier callipers. The internal diameter was recorded as the size of the
obturator which fitted best the interior of the root (neither loose nor stretching the root).
The external diameter was measured while the roots were gently lifted with forceps to
allow the roots to open. The internal and external diameters of the roots were measured
from the pulmonary artery side.
Figure 2.2 Obturators used for measuring the internal diameter of valve conduits.
2.2.6 Histological techniques
2.2.6.1 Paraffin embedding
Tissue samples were completely immersed in 10% (v/v) neutral buffered formalin (NBF)
for 24 hrs at room temperature prior to further processing. Each root was cut into 6
pieces vertically (as illustrated in Figure 2.3). Thus, each piece incorporated a part of
the pulmonary wall, a part of the myocardium and half of a leaflet. The samples were
then placed in plastic cassettes (Histocasette®), and the cassettes placed into an
automated tissue processor for dehydration. The tissue processor sequentially immersed
the cassettes containing the tissue samples in: 10 % (v/v) NBF for 1 h, 70 % (v/v)
ethanol for 1 h, and 90 % (v/v) ethanol for 1 h, followed by three consecutive 1-hour
immersions in 100 % (v/v) ethanol, three consecutive 1-hour immersions in xylene, and
three consecutive 1-hour immersions in paraffin wax. The cassettes were transferred
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into a wax oven in hot wax at 60 °C for a maximum of 12 h. The tissue blocks were
removed quickly from the cassettes and oriented into metal wax block moulds using hot
forceps and fully covered in wax. The blocks were placed on ice to allow them to
completely cool and fully solidify. The moulds were then removed and the excess wax
was trimmed.
Figure 2.3 Schematic of the method used to cut the pulmonary roots for paraffin
embedding.
2.2.6.2 Tissue sectioning, and slide preparation of paraffin embedded tissues
The embedded tissue was sectioned in 10 µm thickness sections using a microtome. The
tissue sections were transferred to a water bath set at 42 °C and collected onto
Superfrost Plus® slides. These slides were electrostatically charged to prevent the
sections from floating off the slides during staining. The slides were placed onto a
drying rack to briefly drain the excess water, and then transferred onto a hot plate at
60 °C for at least 20 min to completely dry and melt the wax. This step also provided
firmer tissue fixation to the slides. The prepared slides were stored at room temperature
until stained.
2.2.6.3 Dewaxing and rehydration of paraffin embedded tissue sections
The slides with the tissue sections were placed twice in xylene for 10 min each time to
remove all the wax. They were then placed thrice into absolute alcohol for 3, 2, and 1
min respectively. Finally, the slides were placed into 70 % (v/v) ethanol for 1 min and
then rinsed gently in running tap water for 3 min.
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2.2.6.4 Dehydrating of tissue sections
Following staining of the sections, the slides were placed into 70 % (v/v) ethanol for 5 s
before they were immersed into absolute alcohol thrice for 1, 2 and 3 min respectively.
Subsequently, they were placed in xylene twice for 10 min each time.
2.2.7 Histological staining methods
2.2.7.1 Haematoxylin & eosin (H&E) staining
H&E staining was used to visualise tissue histoarchitecture and spatial distribution of
cell nuclei. The tissue sections for staining were dewaxed and rehydrated, then
immersed in Mayers Haematoxylin solution for 1 min before being placed in running
tap water until the water ran clear. The slides were then stained with eosin for 4 min
before dehydrating. Each section was mounted using DPX mountant and a coverslip.
The slides were left to completely dry overnight in a fume cupboard before viewing
under the microscope.
2.2.7.2 Hoechst staining
Hoechst 33258 dye binds to DNA, and was used to visualise cell nuclei and DNA
remnants. The Hoechst dye buffer contained 1.211 g.L-1 tris base, 0.372 g.L-1 EDTA,
and 0.006 g.L-1 NaCl, whereas the pH of the solution was adjusted to pH 7.4. This
solution was stored in a dark bottle away from light. The tissue sections for staining
were dewaxed and rehydrated as stated in Section 2.2.6.3. Subsequently, a hydrophobic
marker pen was used to mark out the tissue sections on the slides in order to keep the
following applied dye in the circled area. The tissue sections were then incubated in 1
µg.ml-1 Hoechst dye in Hoechst working solution for 30 min at room temperature in the
dark. Each slide was washed three times, each for 10 min, using TBS (pH 7.4). The
slides were mounted using glycerol: 1,4-diazabicyclo[2.2.2]octane (DABCO) (1:9). The
slides were kept in the dark until ready to view under a 4’,6-diamidino-2-phenylindole
(DAPI) filter using fluorescence microscopy at a wavelength of 415 nm.
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2.2.7.3 Alcian blue staining
Alcian blue staining was used to stain the GAG`s in the tissue. The sections were
dewaxed and rehydrated before rinsed in 3% (v/v) acetic acid for 5-10 s. The sections
were then immersed in 1% (v/v) alcian blue in 3 % (v/v) acetic acid for 5 min. After
briefly blot drying with filter paper, the sections were immediately stained with 0.5 %
(w/v) neutral red for 3 min and washed with distilled water. The slides were then
mounted with warmed up glycerol and coverslip. Microscopic visualization was
performed within hours after staining.
2.2.7.4 Miller’s staining
Miller’s staining was used to visualise elastin in the tissue. Following dewaxing and
rehydration, the tissue sections were immersed in 0.25 % (w/v) potassium permanganate
for 5 min. The tissue sections were washed thoroughly with running tap water and then
with distilled water, and bleached with 0.1 % (w/v) oxalic acid for 3 min. Subsequently,
the sections were washed again with running tap water and then distilled water, and
transferred to 95 % (v/v) alcohol. The sections were then immersed in undiluted
Miller’s stain for 2 h before being washed with 96 % (v/v) ethanol and then with
distilled water. Van Gieson’s stain was used to counterstain the tissue sections for 5 min
prior to dehydration. DPX mountant and a coverslip were used to mount each section.
2.2.8 Immunohistochemical labelling
2.2.8.1 Tissue fixation methods
Depending on the antibody, either 10 % (v/v) NBF fixation, or zinc fixation was used.
Tissue fixed using 10 % (v/v) NBF was directly placed into an automated tissue
processor as described in Section 2.2.6.1. The zinc fixation solution was 0.1 M Tris
solution with 0.5 % (w/v) calcium acetate, 0.5% (w/v) zinc acetate, and 0.05% (w/v)
zinc chloride. The pH was adjusted to pH 7.4, and the solution was stored at room
temperature until needed. The tissue was placed into the zinc fixative for 16-24 h,
before it was placed into the automated tissue processor (omitting the 10 % (v/v) NBF
for 1 h step) for paraffin embedding (Section 2.2.6.1). The optimal fixation method was
determined for each antibody. Fresh tissue samples were fixed with different methods
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and went through immunohistochemistry. The optimal fixation method was considered
as the one that gave strongest staining results for the fresh tissue samples.
2.2.8.2 Antigen retrieval methods
2.2.8.2.1 Citric acid microwave treatment
Reagents:
Citric acid solution (10mM citric acid) buffer was used as reagent. Prior to use, the pH
of the solution was adjusted to pH 6.0 using NaOH.
Method:
Slides were placed in a Pyrex dish, with the tissue sections facing upwards, and were
immersed in citric acid solution buffer (completely covering the tissue sections). The
Pyrex dish was covered with pierced cling film and then microwaved on full power
(800W) for 10 min. The slides were removed after the dish was cooled.
2.2.8.2.2 Trypsin retrieval method
2.2.8.2.2.1 Trypsin retrieval method 1 (0.1 % w/v trypsin)
Reagents:
Trypsin solution was prepared by dissolving 0.2 g trypsin and 0.2 g calcium chloride in
200 ml TBS (pH 7.6). The trypsin solution was warmed to 37 °C, and its pH was
adjusted to 7.8 by adding 1M sodium hydroxide dropwise.
Method:
Slides were placed in distilled water, which was pre-warmed to 37 °C for a minimum of
5 min. The sections were then incubated in the trypsin solution at 37 °C for 30 min
before being rinsed in running tap water.
2.2.8.2.2.2 Trypsin retrieval method 2 (0.5 % w/v trypsin)
This method was based on the trypsin retrieval method 1 (Section 2.2.8.2.2.1), but in
this case, 1g of trypsin instead of 0.2 g was used to make up the trypsin solution. This gave a
final trypsin concentration of 0.5 % (w/v).
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2.2.8.2.3 Antibodies
The antibodies, secondary antibody, isotypes, fixation methods and the antigen retrieval
methods used in this study are listed in Table 2.6. The concentration used for the isotype
control was the same as the specific primary antibody.
Table 2.6 The antibodies, secondary antibody, isotypes, fixation methods and the
antigen retrieval methods used in the study.
Antigen Supplier Clone Isotype Antigen
Retrieval/
fixation method
Diluted
concentration
Α-SMA Sigma 
A2547
1A4 Mouse
IgG2a
(Dako
X0943)
Trypsin (method
1)/ 10 % (v/v)
NBF
11.25 mg.L-1
Vimentin Novocas
tra NCL-
VIM
VIM
3B4
Mouse
IgG2a
(Dako
X0943)
Citrate/ 10 %
(v/v) NBF
50 mg.L-1
Desmin Vector
VP-
D502
DE-R-
11
Mouse
IgG1(Dako
X0931)
Citrate 10 %
(v/v) NBF
54 mg.L-1
Collagen-
IV
DAKO
M0785
CIV22 Mouse
IgG1(Dako
X0931)
Citrate/ Zinc
fixative
1.6 mg.L-1
Fibronectin DAKO
A0245
- DAKO
rabbit
immunoglo
bilin
Fraction,
code X0936
Trypsin (Method
2)/ 10 % (v/v)
NBF
10.2 mg.L-1
Von
Willebrand
DAKO
A0082
- DAKO
rabbit
immunoglo
bilin
Fraction,
code X0936
Citrate/ 10 %
(v/v) NBF
15.5 mg.L-1
Galα1-
3Galβ1-
4GlcNAc-R
(α-gal) 
ALEXIS
Biocheni
cals 801-
090
M86 - -/ Zinc fixative 0.51 mg.ml-1
Horseradish
peroxidise-
conjugated
secondary
rabbit anti-
mouse
antibody
DAKO
P0260
- - - 1.3 mg.L-1
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2.2.8.3 Immunohistochemistry procedure
Reagents:
 TBS pH 7.6
 TBS containing 0.05 % (v/v) Tween 20, pH 7.6
 Antibody diluent: 100 ml TBS (pH 7.6) containing 0.01 % (w/v) sodium azide
and 0.01 % (w/v) bovine serum albumin (BSA). The pH was adjusted to pH 7.6,
and the solution was stored at 4 °C and used within 1 month.
 PBS pH 7.6
 3 % (v/v) hydrogen peroxide (H2O2): 30 % (v/v) H2O2 was diluted 10 times
using PBS pH 7.6.
 Ultravision Detection kit (for antibodies raised in either mouse or rabbit)
Method:
Tissue sections were dewaxed and rehydrated before the appropriate antigen retrieval
was carried out. The sections were then placed into 3 % (v/v) H2O2 for 20 minutes at
room temperature for blocking, and washed in running tap water for three minutes. Each
section on the slides was ringed using a hydrophobic marker pen. The slides were then
placed into four well plastic slide holders. The sections were washed with TBS pH 7.6,
and incubated with V block from the Ultravision kit for 10 min. Slides were washed
twice using TBS pH 7.6 for 10 min on a plate rocker. The primary antibody or the
appropriate isotype control was then applied at a suitable dilution (diluted with antibody
dilute), and the slides were placed in a sealed container (containing moist tissue paper)
at room temperature for 1 h (90 min for α-gal). Subsequently, the sections were washed 
twice with TBS containing 0.05 % (v/v) Tween 20 pH 7.6, followed by two more
washes with TBS pH 7.6, each for 10 minutes on a plate rocker. The Ultravision One
HRP Polymer from the Ultravision kit was applied to the sections, and the sections were
incubated for 30 min at room temperature in the dark. The slides were then washed
twice with TBS containing 0.05 % (v/v) Tween 20 pH 7.6, followed by two more
washes with TBS pH 7.6, each for 10 min on a plate rocker. 3,3’-diaminobenzidine
(DAB) plus Chromogen from the Ultravision kit (made up by adding 20 µl of DAB plus
chromagen to 1 ml of substrate buffer and mixing thoroughly) was applied to each
section, and the sections were incubated for 10 min at room temperature. The sections
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were washed gently under running tap water and counterstained with haematoxylin for
15 seconds. The slides were rinsed using tap water until the water ran clear, prior to
dehydrating and mounting using DPX mountant and coverslips. The slides were air
dried overnight in a fume cupboard and viewed using an upright microscope.
2.2.9 Cell culture techniques
All cells used in this study were cultured in standard DMEM cell culture medium
(Section 2.1.5.3). All medium changes were performed aseptically in a Class II cabinet.
All medium and reagents added to the cells were allowed to equilibrate to 37 °C before
use. Cells were cultured at 37 °C in 5 % CO2 (v/v) in air.
2.2.9.1 Resurrection and maintenance of cells
Cells were removed from liquid nitrogen storage, and thawed in a 37 °C water bath. A
T75 cell culture flask with 13 ml cell culture medium was prepared. When the cells
were defrosted, 2 ml of the defrosted cell stock was slowly added into the T75 flask.
The flask was incubated at 37 °C in 5 % CO2 (v/v) in air for at least overnight to allow
the cells to attach to the flask. The medium was changed every two days until the cells
became confluent and ready to be passaged.
2.2.9.2 Cell Passaging
The culture medium was aspirated from the cell culture flasks, and the cell layer was
washed in PBS without calcium or magnesium for 2 min. Trypsin/EDTA (1.5 ml) was
added to each T75 culture flask, and the flasks were then incubated in 5 % CO2 (v/v) in
air at 37 °C for 3 min. Following incubation, the cells were detached by gently tapping
the flasks. The action of the trypsin/EDTA was terminated by adding 10 ml of culture
medium to each flask. The cell suspension was transferred into a universal tube and
centrifuged for 10 min at 150 g. Following centrifugation, the supernatant was carefully
removed and the cell pellet was resuspended in 5 ml of cell culture medium. A viable
cell count (Section 2.2.9.3) was performed to allow the cells to be seeded into fresh
flasks at the appropriate density. The cell culture medium was changed every other day
until the cells became confluent and ready to be passaged again.
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2.2.9.3 Cell viability using Trypan blue
Trypan blue dye permeates into dead cells due to the loss of their membrane potential.
Thus, live cells appeared transparent while dead cells were stained blue when examined
under the microscope after staining with Trypan blue.
In order to perform the viability test, 20 µl of cell suspension was mixed with 20 µl of
Trypan blue dye in a bijou tube. This mixture was added to an Improved Neubauer
counting chamber. Viable cells were counted in n of the 9 grids (n = the number of grids
which allowed the viable cell count to fall between 100 and 300). The total number of
viable cells per ml in the cell suspension was calculated as follows:
Number of cells.ml-1 =
୬୳୫ ୠ ୰ୣ୭୤୴୧ୟୠ୪ୣ ୡୣ ୪୪ୱ
௡
× 104 × Dilution factor
n was the number of grids used to count the cells
Dilution factor was the correction required due to the dilution of the cell suspension
with Trypan blue dye (in this case, Dilution factor = 2)
2.2.9.4 Cell storage
Cells were isolated from the flasks (Section 2.2.9.2), and then diluted to 106.ml-1 with
chilled cryopreservation medium (DMEM containing 20 % (v/v) FBS, 10 % (v/v) filter
sterilised Dimethyl sulfoxide (DMSO)). The addition of DMSO prevented the formation
of ice crystals during freezing, but it is toxic to the cells. In order to avoid the toxic
effects, the cells were frozen immediately after the addition of DMSO. The cell
suspension was aliquoted to 1 ml into cryovials, and placed into a cryo freezing pot
which contained isopropanol. The pot was then placed in a -80 °C freezer for 12-36 hrs.
The cell vials were subsequently transferred to liquid nitrogen for long-term storage.
2.2.10 Uniaxial tensile testing
The biomechanical properties of fresh and acellular porcine pulmonary valve conduits
were compared using uniaxial tensile testing to failure in order to determine any
significant effects of the decellularisation procedure on the mechanical properties of the
tissue. The method used in this project was based to the protocol described by Korossis
et al. (2002).
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2.2.10.1 The uniaxial tensile test system
The uniaxial tensile testing was performed in a Shimadzu tensile testing system (Figure
2.4).
Figure 2.4 The Shimadzu tensile testing system.
A purpose built stainless steel tissue holder system (Figure 2.5) was used to hold the
tissue samples for testing and to define their gauge length. The two holder parts (load
cell and base), which were used to attach the tissue holder to the tensile tester, were
aligned with a removable bracket. A central stainless steel block which was fixed onto
the bracket was used to separate the two holder parts in order to define the gauge length
of the tissue samples. A 10 mm wide separating block was used for the pulmonary
artery wall samples to define a gauge length of 10 mm, and a 6 mm wide separating
block was used for pulmonary leaflet samples to define a gauge length of 6 mm. The
specimen was clamped in the holder with two grip blocks which were screwed onto
each of the holder parts. Special care was taken during clamping to make sure that the
tissue sample was in a completely un-stretched state. Once the tissue was secured onto
the holder, the base part was fitted onto the base of the tensile tester, and the top part
was screwed onto the load cell of the tensile tester. Subsequently, the bracket was
removed, without disturbing the gauge length of the specimen.
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Figure 2.5 Tissue sample holder for tensile testing machine.
2.2.10.2 Tissue sample preparation
The specimens were dissected using parallel razor blades fitted onto a cutting block
(Figure 2.6). The spacer between the two blades defined the width of the tissue strip.
Using spacers of different thickness, the tissue was cut to its desired width. The length
of the specimen was kept to approximately 20 mm for the pulmonary artery, and 15mm
for the pulmonary valve leaflets, in order to allow mounting to the tissue holder. The
thickness of the tissue was measured using a Mitutoya thickness gauge (Figure 2.7) with
a resolution of 0.01 mm. Three measurements were taken for each specimen at different
positions along its long axis, and the average thickness was recorded.
Figure 2.6 Cutting block used for the dissection of tissue strips.
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Figure 2.7 Thickness gauge.
The specimen groups used in the study, as illustrated in Figure 2.8, were:
 Circumferential and radial leaflet strips: 6mm long by 3 mm wide;
 Circumferential and axial pulmonary wall strips: 10 mm long by 5 mm wide.
(The lengths stated here were the specimen gauge lengths used in the tests)
Figure 2.8 Specimen dissection for pulmonary wall and pulmonary valve leaflets.
2.2.10.3 Test procedure
All specimens were tested under uniaxial low-strain-rate loading to failure. The test
sample was mounted onto the tissue holder with the bracket, and then fitted onto the
tensile testing machine. Once the bracket was removed, the state of the tissue (at its
relaxed state with no stress applied) was used to zero the load and the stroke channels.
Specimen information, including thickness, gauge length, width, tissue type, treatment
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type and serial numbers were inputted in the operating programme (MTTE.exe), which
was installed on a personal computer.
To obtain an accurate measure of the tissue gauge length, the tensile machine was set to
produce a sample preloading of 0.02 N before the operating program started to acquire
any data. Therefore, zero extension was taken at the point where a 0.02 N was detected.
The final gauge length, which was used for strain calculations, was automatically
recorded by the programme as the manually inputted gauge length plus the extension
that was needed to produce the 0.02 N preloading. A crosshead speed of 10 mm per
minute was applied during testing, using a positive ramp function. Specimen failure was
taken as the first decrease in the recorded load during extension. The real-time load was
observed during the test run, to ensure the sample behaviour was normal (without
slipping from the grips or being torn). During testing, load and extension data was
recorded automatically at a rate of 20 Hz and stored in DAT files together with the
specimen parameters. All tests were performed at 20 °C. Preconditioning was not
performed in this study since it has been reported that preconditioning does not
contribute to the generation of repeatable stress-strain curves for heart valve tissue
(Carew et al., 2004). In addition, the major purpose of the testing was to compare the
mechanical properties before and after treatment and not to determine the material
properties of the tissue persay.
2.2.10.4 Data processing
The tensile testing machine operating programme, MTTE.exe, was used to analyze the
data for each test run. Using the recorded force/extension data, the engineering stress
was calculated for each data point according to:
σEng =
୊
୅
where σEng represents the engineering stress in MPa, F the recorded force in Newtons (N)
and A the cross-sectional area (CSA) of the specimen in mm2. The CSA was calculated
as A = specimen width × specimen thickness. The changes in thickness and width
during preloading to 0.02 N were very small and considered negligible. The engineering
strain for each corresponding data point was calculated according to:
εEng =
୼୪
୪ା୪ட
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where εEng represents the unitless engineering strain, Δl the extension of the specimen in 
mm, l the original gauge length (10 mm for pulmonary wall strips, and 6 mm for
pulmonary leaflet strips), and l0 the length increased by the extension needed to produce
the 0.02 N preloading. The stress-strain behaviour of each tested sample was
characterised using six parameters; namely the elastic phase slope, the collagen phase
slope, the transition stress, the transition strain, the ultimate tensile strength, and the
failure strain. A typical stress-strain curve of heart valve leaflet tissue is illustrated in
Figure 2.9, indicating how the six parameters were determined.
Figure 2.9 Typical stress-strain curve of heart valve leaflet tissue subjected to
uniaxial tensile loading to failure.
The DAT files that were obtained during testing were exported from the operating
program of the tensile testing machine and imported to Microsoft Excel (version 2003
and 2007, Microsoft Corporation) as spreadsheets for further processing. In Excel, the
load and extension data was manually converted to stress and strain, respectively, as
described above.
The analysis of the results was carried out per treatment group (at least 5 replicates from
6 different pig hearts per group). The engineering stress-strain curves for the specimens
of each group, calculated in Excel, were averaged over the number of samples in each
test group using the Origin software program (Version 8.5, Microbal). In addition, the
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six parameters for each specimen obtained from MTTE.exe and described above, were
averaged over the number of specimens in the group, and the results were presented as
means ± 95 % confidence intervals (C.I.). The comparisons of the different groups were
analysed by one-way analysis of variance (ANOVA) or the Student’s t-test.
2.2.11 Statistical analysis
In this study, all numerical data was analysed using Microsoft Excel (Version 2003 or
2007, Microsoft), and all numerical values are presented as means ± 95 % C.I. The
Student’s t-test was used for comparison of groups of two means, and one-way
ANOVA was applied for the comparison of data from more than two groups. Individual
differences between group means were calculated using the minimum significant
difference (MSD) (Sokal & Rohlf, 1981). The difference was considered as significant
when the p value was smaller than 0.05.
x: individual value
n: sample number
StDev = ∑୶
୬
SE Mean = StDev
√n95 % C. I. = Mean ± t × SE Mean
MSD = critical value × SE Mean
Critical value = Q α [k, v]  
α = p = 0.05 
k = number of groups
v = degrees of freedom (n-1)
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Chapter 3
Development of methods for the decellularisation of
porcine pulmonary valve conduits
3.1 Introduction
3.1.1 Decellularisation
Ideally, a successfully decellularised porcine heart valve should have close to 100 % of
the cells and cell remnants removed, with its ECM well retained. The ECM has been
shown to have an impact on cell mitogenesis and chemotaxis (Bornstein & Sage, 2002;
Vorotnikova et al., 2010), cell differentiation (Stern et al., 2009; Allen et al., 2010;
Barkan et al., 2010), and constructive host tissue remodelling responses (Valentin et al.,
2010). Since there is evidence that residual cellular material can reduce the constructive
tissue remodelling advantages of biologic scaffold materials in vivo, the tissue
processing methods, especially decellularisation, can be critical for the success of
acellular heart valves in vivo (Brown et al., 2009; Zhang et al., 2010; Burch et al., 2010;
Crapo et al., 2011). The decellularisation process should ideally retain the macro and
micro-scale biomechanical and biological properties of the ECM in order to facilitate
appropriate cell response in vivo. A fully decellularised porcine heart valve scaffold
with similar biological, histological and mechanical characteristics to the native heart
valve has the potential to be used in heart valve replacement surgeries.
Although single treatment methods have been studied for their decellularisation
potential, decellularisation methods have included a combination of physical, chemical
and enzymatic treatments. Normally, physical treatments are applied at the beginning of
a decellularisation method to lyse the cell membranes, followed by enzymatic
treatments to separate the cellular components from the ECM and to remove nuclear
material. Detergents are utilised to solubilise cell membranes by disrupting lipid/protein
and protein/protein interactions. Mechanical agitation can be coupled with these steps to
increase the effectiveness of the treatments. Washing steps are necessary to remove the
products of cell lysis and detergent action and residual chemicals to avoid host tissue
responses.
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Physical methods such as freeze-thawing, direct pressure, sonication and agitation have
been used to facilitate tissue decellularisation. The freeze-thawing of tissue causes the
formation of intracellular ice crystals, which disrupts the cellular membranes, therefore
lysing the cells. Freeze-thawing treatments have previously been applied for
ligamentous tissue, tendons and nerve tissues (Jackson et al., 1988; Gulati, 1988;
Jackson et al., 1991; Roberts et al., 1991). One cycle of freeze-thawing has been
reported to reduce adverse immune responses such as leukocyte infiltration following
vascular tissue decellularisation (Lehr et al., 2011). Multiple cycles of freeze-thawing
have also been used in decellularisation (Stapleton et al., 2008) without significantly
decreasing the amount of ECM proteins (Patel et al., 2008). Kim and colleagues (2002)
have also studied the effects of freeze-thawing on porcine pulmonary heart valve leaflet
decellularisation. However, the treatment failed to produce decellularisation since the
tissue remained cellular as revealed by histology. Direct pressure provides mechanical
force on the tissue with a view to bursting the cells (Freytes et al., 2004). However, the
applied force can cause damage to the ECM. Mechanical agitation has been used
together with chemicals to facilitate the removal of cellular materials (Schenke-Layland
et al., 2003; Wilcox et al., 2005). In general, physical treatments have been shown to be
effective for cell lysis, but additional processes are required to achieve complete cell
removal.
Enzymes that have been used in tissue decellularisation methods include nuclease,
trypsin, collagenase, thermolysin, lipase, dispase and α-galactosidase (Kasimir et al.,
2003; Rieder et al., 2004; Chen et al., 2004; Wilcox et al., 2005; Xu et al., 2008; Yang
et al., 2010; Funamoto et al., 2010; Broun et al., 2010). Nucleases, such as DNAses and
RNAses have been reported to aid in the removal of nuclear material by cleaving DNA
and RNA in tissues after cell lysis (Crapo et al., 2011). Trypsin is the most commonly
used proteinase. It works by cleaving proteins at peptide bonds on the C-side of arginine
and lysine. Schenke-Layland and colleagues (2003) reported efficient removal of
cellular material from porcine pulmonary valves after treatment with 0.05 % (w/v)
trypsin and 0.02 % (w/v) EDTA for 24 h with agitation. Wang and colleagues (2005)
also reported complete decellularisation of porcine aortic valve leaflet tissue using 0.05 %
(w/v) trypsin. However, there have been other studies, which have shown less efficient
decellularisation using trypsin for 17 h (Grause et al., 2005). Schenke-Layland et al.
(2003) reported that the effect of trypsin is time-dependent, and complete
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decellularisation by trypsin alone may require long incubation, even for thinner tissues
such as heart valve leaflets. The main concern regarding the use of trypsin in tissue
decellularisation is its adverse effects on the ECM. Although trypsin has been reported
to give better preservation of GAG content, it has also been reported to disrupt the
elastin and collagen network of the ECM. Trypsin disruption of the ECM proteins can
also result in detrimental changes to the mechanical properties of the tissue (Yang et al.,
2009). Following trypsin treatment of heart valves, the remaining ECM has been shown
to support endothelial cell growth despite the removal of ECM components (Schenke-
Layland et al., 2003; Grause et al., 2005). Trypsin is effective at disrupting the ECM of
the tissue and, subsequently, at improving the penetration of decellularisation agents.
Therefore, the use of trypsin as the initial step in a tissue decellularisation protocol may
be necessary, especially for denser tissues (Yang et al., 2010)
Hypotonic and hypertonic solutions have been widely used in tissue decellularisation.
Hypotonic solutions cause cell lysis by the osmotic flow of water into the intracellular
space, causing cell bursting, with minimal changes to the ECM proteins (Xu et al.,
2007). Hypertonic saline has been shown to dissociate DNA from proteins (Cox &
Emili, 2006). Additional treatments are required to facilitate the removal of cellular
fragments. Hypo- and hypertonic solutions have also been reported to rinse cell residues
from tissues following lysis (Cox & Emili, 2006; Xu et al., 2007).
Non-ionic, ionic, and zwitterionic detergents have been shown to be effective in
removal of cellular material by solubilising cell membranes and dissociating DNA from
proteins (Cox & Emili, 2006; Giusti et al., 2009). However, these detergents may also
disrupt and dissociate proteins in the ECM. By increasing the tissue exposure time to
detergents, more complete decellularisation can be achieved, but also more ECM
proteins may be denatured.
Non-ionic detergents contain uncharged, hydrophilic head groups. They disrupt lipid-
lipid and lipid-protein interactions, but leave protein-protein interactions intact so that
proteins within a tissue following non-ionic detergent treatment are generally left in
their functional conformation (Gilbert et al., 2006; Bhairi & Mohan, 2007). Triton X-
100 is the most commonly used non-ionic detergent in tissue decellularisation. It has
been reported to effectively remove cell residues from thicker tissues such as heart
valve conduits in which enzymatic and osmotic methods are insufficient. Triton X-100
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has also been associated with ECM protein loss accompanied by decreased adverse
immune responses in vivo (Meyer et al., 2006). Mixed results have been reported of the
decellularisation efficacy using Triton X-100. The removal of cells seems to be more
effective for thin tissues. Some studies have reported that Triton X-100 caused
disruption of the ECM ultrastructure and removal of GAG`s (Cho et al., 2005). Wang et
al. (2005) applied 0.25 % (v/v) Triton X-100 in porcine aortic heart valve leaflet
decellularisation for 48 h. Although complete decellularisation was achieved, strong
structural alterations and changes to the tissue’s tensile properties were reported. When
Triton X-100 was used to decellularise whole aortic roots, although complete removal
of nuclear material was observed in the valve leaflets, cellular material was found in the
adjacent myocardium and aortic wall (Grause et al., 2005).
Ionic detergents, such as SDS and Triton X-200, contain a head group with a net charge,
and are effective for solubilising both cytoplasmic and nuclear cellular membranes, but
may denature proteins by disrupting protein-protein interactions when used in high
concentrations (Seddon et al., 2004; Gilbert et al., 2006). SDS is the most widely used
ionic detergent. It solubilises membrane proteins by mimicking the lipid bi-layer and
solubilises proteins by inducing conformational changes. SDS has been shown to be
very effective in removing cellular components of tissues at different concentrations,
including pericardium, porcine heart valves, human amniotic membrane, tendon (Booth
et al., 2002; Wilcox et al., 2005; Grauss et al., 2005; Wilshaw et al., 2006). SDS
appears to be more effective in removing cell residues from tissues compared to other
detergents, but it has also been associated with ECM disruption (such as loss of GAG`s
and collagen integrity) and growth factor elimination (Courtman et al., 1994; Kasimir et
al., 2003; Reing et al., 2010). Booth et al. (2002) tested a range of detergents including
SDS, Triton X-100, sodium deoxycholate and Tween 20, and found that low
concentration SDS (0.03-0.1 %) achieved complete porcine aortic heart valve leaflet
decellularisation. Korossis et al. (2002) reported that porcine aortic leaflets treated with
this method had equal strength compared to fresh samples. Complete decellularisation
was also achieved using 0.1 % (w/v) SDS for porcine aortic whole roots (Wilcox et al.,
2005). Korossis et al. (2005) reported that whole porcine roots treated with this method
demonstrated complete valve leaflet competence and kinematics achieved under
physiological conditions.
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Zwitterionic detergents offer the combined properties of ionic and non-ionic detergents
(Bhairi & Mohan, 2007). They have a greater tendency to denature proteins than non-
ionic detergents but do not have the same effect of solubilising lipid membranes as ionic
detergents (Gilbert et al., 2006). The 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS) is an example of a zwitterionic detergent. It has been shown
to be most effective for cell removal from thinner tissues (Peterson et al., 2010) and less
effective for thicker tissues (Du et al., 2011). A study on peripheral nerve
decellularisation showed better preservation of the ECM using non-ionic and
zwitterionic detergents but better cell removal using ionic detergents (Hudson et al.,
2004). However, due to the low concentration of cell bodies in peripheral nerves and the
size of the tissue, the translation of these results to other tissues is limited. In the study
conducted by Booth et al. (2002) for porcine heart valve decellularisation, it was found
that although no significant damage to the ECM was observed, the use of CHAPS was
not able to achieve complete decellularisation even when extending the incubation time
to up to 72 h.
Following the production of the scaffold, it is necessary to be sterilised prior to
implantation or in vitro cell seeding. Sterilisation methods have included incubation in
acids or solvents, ethylene oxide exposure, gamma irradiation and electron beam
irradiation (Hodde & Hiles, 2002; Corschewsky et al., 2005). However, the use of oxide
exposure, gamma irradiation and electron beam irradiation has been shown to change
the ECM histoarchitecture and biomechanical properties (Freytes et al., 2008; Sun &
Leung, 2008; Gouk et al., 2008). Peracetic acid (PAA) is an oxidising agent and an
effective chemical sterilant (Hodde & Hiles, 2002; Pruss et al., 1999), without any
adverse effect on the mechanical behaviour of scaffolds (Freytes et al., 2004). It can
also aid in the solubilisation of the cytoplasmic component of the cells and remove
nucleic acids (Badylak et al., 1995).
This chapter describes the development of a method for the decellularisation of porcine
pulmonary roots, based on a previously developed method for porcine aortic roots
(Booth et al., 2002; Wilcox et al., 2005). In the studies conducted by Booth et al. (2002)
and Wilcox et al. (2005), the porcine aortic roots were successfully decellularised while
maintaining the integrity and biomechanical properties of the ECM. The
decellularisation process developed in the present study included freeze-thawing, a
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combination of trypsin, SDS, hypotonic and hypertonic buffers and nuclease treatments,
as well as a final sterilisation step using PAA.
3.1.2 Mechanical behaviour of valvular tissue
The mechanical behaviour of a material refers to its deformation under load. Most
frequently, the mechanical behaviour is expressed as the stress generated in a material
subjected to a particular strain (stress-strain behaviour). Uniaxial tensile testing is a
popular method used in the characterisation of the mechanical behaviour of soft tissues
since it is a relatively straightforward procedure. It has been frequently used for the
evaluation of the mechanical properties of both fresh and acellular heart valve tissue
(Mayne et al., 1989; Korossis et al., 2002; Stradins et al., 2004; Korossis et al., 2005;
Seebacher et al., 2007; Tudorache et al., 2007).
The typical stress-strain behaviour of valvular tissue has been illustrated in Section
2.2.10.4. This type of stress-strain behaviour has three distinct phases. The initial linear
portion of the graph represents the elastin phase of the tissue and is characterised by a
low elastic modulus (large increases in strain with small increases in stress). During this
phase, the collagen layer in the tissue unfolds having a minimal contribution to load
bearing. Force transmission in this phase is provided solely by the elastin fibres within
the heart valve tissue. The next phase is the non-linear transition phase, during which
the collagen fibres start to gradually uncrimp and align, increasing their contribution to
force transmission. The second linear portion of the graph represents the collagen phase
and it is characterised by a high modulus. During this phase, the tissue has a reduced
compliance and a small extension of the tissue would produce a high tension. This
reflects the material properties of the strong network of collagen fibres. The collagen
phase of heart valve tissue usually continues beyond the physiological range,
corresponding to its reserved strength. At the end of the collagen phase the slope of the
graph starts decreasing and a further increase in the strain would result in tissue failure
(Sauren et al., 1983).
Chemical treatment of biologically derived tissues has been shown to affect the
mechanical properties of the ECM (Courtman et al., 1995, Palsson & Bhatia, 2004).
Therefore, for tissues serving a mainly mechanical function in the body it is important
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to study the effect of a particular tissue decellularisation protocol on the biomechanical
properties of the tissue by comparing the behaviour of fresh decellularised tissue.
Uniaxial tensile testing can be used to assess the effect of decellularisation on the
mechanical integrity of a tissue scaffold and thus provide an insight on its potential
function in vivo.
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3.2 Aims and objectives
Aims:
The aim of the study presented in this chapter was to develop and optimise a process for
the decellularisation of porcine pulmonary valve conduits.
Objectives:
 To characterise the fresh porcine pulmonary valve root histologically.
 To develop a decellularisation method for porcine pulmonary valve roots that is
able to remove the cells and cellular remnants whilst preserving the
histoarchitecture and the biomechanical integrity of the ECM.
 To characterise the decellularised porcine pulmonary valve roots histologically
and biomechanically.
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3.3 Methods
3.3.1 Decellularisation solutions
3.3.1.1 Antibiotic disinfection solution
This solution consisted of PBS containing 100 U.ml-1 penicillin, 100 μg.ml-1
streptomycin and 50 µg.ml-1 gentamicin. This solution was prepared fresh before use.
3.3.1.2 Trypsin treatment paste
Trypsin solution: trypsin was dissolved in PBS at a concentration of 2.25 × 104 U.ml-1.
Agarose solution (1 % w/v): 1 g low temperature melting point agarose was added to
100 ml distilled water. The agarose was dissolved and sterilised by autoclaving.
In order to make the trypsin treatment paste, the 1 % (w/v) agarose gel was heated in a
water bath at 70 °C until fully melted. The water bath was adjusted to 40 °C, and the
agarose solution was allowed to equilibrate. The 2.25 × 104 Unit.ml-1 trypsin and the 1 %
(w/v) agarose solution were mixed at a 1:1 ratio, and the mixture was allowed to cool at
4 °C until it became a paste. This trypsin treatment paste consisted of 1.125 × 104
Unit.ml-1 trypsin and 0.5 % (w/v) agarose. This paste was prepared fresh prior to use.
3.3.1.3 Trypsin inhibitor solution
Buffer: 10 PBS tablets were dissolved in 1000 ml of distilled water containing 0.1 %
(w/v) EDTA and 10 KIU.ml-1 aprotinin. The PBS solution with EDTA was sterilised by
autoclaving. Aprotinin was added to the PBS EDTA solution aseptically, using a needle
and deposable syringe. The sterile buffer was stored at room temperature for up to one
month. Trypsin inhibitor (45 mg; 1mg will inhibit 1.5 mg 10,000 U.mg-1 trypsin) was
added to 20 ml of the reaction buffer and filter sterilised prior to adding to the
remaining 980 ml buffer just before use.
3.3.1.4 Hypotonic buffer (10mM Tris pH 8.0, 0.1 % w/v EDTA, 10 KIU.ml-1
aprotinin)
Tris solution (2 M, pH 8.0): Tris (24.23 g) was dissolved in 75 ml distilled water. The
pH was adjusted to 8.0 using 6 M HCl before the volume was made up to 100 ml with
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distilled water to give 2 M Tris solution pH 8.0. The solution was sterilised by
autoclaving and stored for up to one month at room temperature.
EDTA stock solution: EDTA (10 g) was dissolved in 80 ml distilled water and the pH
was adjusted to 8.0 with NaOH pellets and 1 M NaOH solution. The solution was
sterilised by autoclaving and stored for up to one month at room temperature.
The hypotonic buffer was prepared by adding 5 ml 2 M Tris solution pH 8.0, 10 ml of
10 % (w/v) EDTA to 900 ml of distilled water. The solution was made up to 1 L with
distilled water and sterilised by autoclaving. The solution was stored at room
temperature for up to one month. Aprotinin (1 ml, 10,000 KIU.ml-1) was added
aseptically to the solution just before use.
3.3.1.5 Hypotonic SDS buffer (0.1 % w/v SDS, 10mM Tris pH 8.0, 0.1 % w/v
EDTA, 10 KIU.ml-1 aprotinin)
SDS stock solution (10 % w/v): SDS (10 g) was added to 100 ml distilled water. The
solution was sterilised by autoclaving and stored for up to one month at room
temperature.
SDS (10 ml, 10 % w/v) was added to 990 ml sterile hypotonic buffer. The unused
hypotonic SDS buffer was stored for up to one week at 4 °C if it was opened aseptically.
3.3.1.6 Nuclease treatment solution (RNase at 1 U.ml-1 and DNase at 50 U.ml-1 in
treatment buffer)
Tris solution (2 M, pH 7.5): Tris (24.23 g) was dissolved in 75 ml distilled water. The
pH was adjusted to 7.5 using 6 M HCl before the volume was made up to 100ml with
distilled water to give 2 M Tris solution pH 7.5. The solution was sterilised by
autoclaving and stored for up to one month at room temperature.
Magnesium chloride (MgCl2) solution (1 M): MgCl2.6H2O (20.3 g) was dissolved in
100 ml distilled water and autoclaved. The solution was stored at room temperature for
up to one month.
BSA solution (5 mg.ml-1): 250 mg BSA was dissolved in 50 ml distilled water. The
solution was sterilised by filter sterilisation. Aliquots of 5 ml of the solution were made
in sterile bijous, and stored frozen at -20 °C for up to six months.
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DNAse reconstitution buffer (5 mM sodium acetate, 1 mM calcium chloride (CaCl2),
50 % v/v glycerol): sodium acetate (0.68 g) and CaCl2 (0.11g) were dissolved in 500 ml
distilled water. Glycerol (500 ml) was added to this solution and mixed by inverting.
The pH of the solution was adjusted to pH 5 by adding 6 M HCl or 6 M NaOH
dropwise whist stirring using a magnetic stirrer. The buffer was stored at room
temperature for up to three months.
DNAse stock solution (10,000 U.ml-1): DNAse was rehydrated to a final concentration
of 10,000 U.ml-1 (according to the label of activity on the bottle) using DNAse
reconstitution buffer. The solution was sterilised by filter sterilisation. Aliquots (5ml)
were made in bijous and stored at -20 °C for up to three months.
RNAse stock solution (100 U.ml-1): RNAse was rehydrated to a final concentration of
100 U.ml-1 (according to the label of activity on the bottle) using distilled water. The
solution was sterilised by filter sterilisation. Aliquots (5ml) were made in bijous and
stored at -20 °C for up to three months.
Nuclease treatment buffer: 12.5 ml sterile Tris buffer (2 M, pH 7.5), 5 ml of 1 M sterile
MgCl2 solution, and 5 ml of 5 mg.ml-1 filter sterilised BSA solution were mixed with
470 ml sterile distilled water. The buffer was made fresh prior to use.
Nuclease treatment solution: RNAse (5 ml, 100 U.ml-1) and DNAse (2.5 ml, 10,000
U.ml-1) were added to the nuclease treatment buffer just prior to use.
3.3.1.7 Hypertonic buffer (1.5 M NaCl, 50 mM Tris pH 7.5)
Tris buffer pH 7.5 (2 M, 12.5 ml) was added to 487.5 ml distilled water. NaCl (43.83g
was dissolved in the buffer which was then sterilised by autoclaving. The hypertonic
buffer was stored for up to one month at room temperature.
3.3.1.8 PAA solution
PAA (32 %, 1.56 ml) was added to 500 ml of PBS. The pH was adjusted to 6.0 by
adding 6 M NaOH dropwise with agitation. The solution was made fresh just prior to
use.
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3.3.1.9 Wash buffer I (10 KIU.ml-1 aprotinin, 0.1 % w/v EDTA in PBS)
EDTA (10 % w/v, 10 ml) was added to 1 L of PBS. The buffer was sterilised by
autoclaving. This solution was stored at room temperature for up to one month.
Aprotinin (1 ml, 10,000 KIU.ml-1) was added aseptically to the solution just before use.
3.3.1.10 Wash buffer II (10 KIU.ml-1 aprotinin in PBS)
Aprotinin (1 ml, 10,000 KIU.ml-1) was added aseptically to autoclaved 1 L of PBS just
before use.
3.3.2 Histological evaluation of fresh and decellularised porcine pulmonary heart
valve roots
The histoarchitecture of fresh and decellularised porcine pulmonary valve roots was
determined by histology. Tissue samples (n=6 for the fresh and each of the treatment
groups) were fixed with 10 % (v/v) NBF for 24 to 48 hrs. Histological evaluation was
performed as described in Section 2.2.7. Tissue sections of 10 µm were used for
histological staining, and the slides were viewed under bright-field microscopy or
fluorescent microscopy with a DAPI filter. Sections were collected when the leaflet,
pulmonary artery and myocardium all appeared on the tissue section. At least 3 sections
were examined by each histological method. For each decellularised tissue block, at
least 10 tissue sections were collected every 20 sections, and these sections were all
examined by histology to study the effects of decellularisation. H&E staining was used
to study tissue architecture and cell distribution. Connective tissue was stained red/pink
and cell nuclei were stained blue. Hoechst staining was performed to locate cell nuclei
or DNA residues in the tissue. Cell nuclei were present as bright blue dots under
fluorescent microscopy. This helped to evaluate the extent of decellularisation. Miller’s
staining was used to identify the distribution of elastin in the tissue. Elastin stained
blue/black. Alcian blue staining was used to identify the GAG`s in the tissue. GAG`s
were stained blue, and cell nuclei were stained red.
3.3.3 Decellularisation of porcine pulmonary roots (Method 1)
Six porcine hearts were procured from a local abattoir within 4 h of slaughter, and
dissected immediately (Section 2.2.4). The pulmonary roots were trimmed of excess
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tissue, rinsed in PBS and stored dry at -20 ºC. All decellularisation treatments were
carried out in 150 ml containers (1 root per container).
Decellularisation commenced with defrosting the roots in a 37 ºC oven for 30 min or
until the roots were completely defrosted. Using fine pointed forceps, the outside layer
of the pulmonary wall was peeled off to thin it to approximately 1.5-2 mm thickness
(Figure 3.1). The roots were then disinfected with antibiotic disinfection solution (100
ml per root) overnight (16-17 h) at 4 ºC. The following day, before trypsin treatment,
the valve leaflets were masked using cotton wool soaked with 50 % (v/v) FBS in PBS
(Figure 3.2). For each pulmonary root, three soaked cotton wool balls were placed
between each of the three leaflets and the pulmonary artery (Figure 3.2 A, B, C), and a
soaked cotton wool pad was placed at the ventricular side of the leaflets (Figure 3.2 D).
The positions of the cotton wool balls and pad in a cut open pulmonary root are shown
in Figure 3.2 D and Figure 3.2 E. Trypsin treatment was performed by brushing a layer
of trypsin treatment paste on both the outside and the inside of the pulmonary artery
wall, as well as the remaining myocardium bar using a hog haired wooden handle artists’
paint brush (Figure 3.3 A). The roots were incubated for 2 h at 37 ºC in a humidified
container (Figure 3.3 B). The trypsin treatment paste was removed and replaced, and the
roots were incubated for a further 2 h under the same conditions. Following treatment,
each pulmonary root was washed in 120 ml trypsin inhibitor solution at 45 ºC with
shaking at 240 rpm (containers were placed horizontally) three times for 30 min. The
pulmonary roots were then placed into hypotonic buffer (120 ml per root) for 24 h at 45
ºC with agitation at 240 rpm (containers were placed horizontally), followed by
incubation in 120 ml of hypotonic SDS buffer for 24 h at 45 ºC with agitation at 240
rpm (containers were placed horizontally). Two 30-min washes and one overnight wash
(16-17 h) were then performed using PBS containing 10 KIU.ml-1 aprotinin (wash
buffer II) at 45 ºC (120 ml per root each time, containers were placed horizontally, 240
rpm). The roots were then incubated in 120 ml nuclease solution for 4 hours at 37 ºC
with agitation at 80 rpm (containers were placed horizontally). Subsequently, the roots
were washed twice for 30 min in 120 ml wash buffer I at 45ºC, followed by a 66 h wash
in the same solution (containers were placed horizontally; 240 rpm). The roots were
incubated in hypertonic buffer for 24 h at 45ºC with agitation at 240 rpm (containers
were placed horizontally), and then incubated in 120 ml 0.1 % (w/v) PAA solution for 3
h at room temperature with agitation at 240 rpm (containers were placed horizontally).
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Three final washes were conducted using 120 ml wash buffer I at 45 ºC for 30 min each
(containers were placed horizontally; 240 rpm). The process is summarised in Figure
3.4.
Figure 3.1 Peeling of porcine pulmonary roots. (A) fresh porcine pulmonary root for
decellularisation; (B) A thin layer was peeled off with a pair of fine point forceps,
starting from the pulmonary artery side; (C) The peeling continued all the way towards
the ventricular side; (D) A thinned-wall porcine pulmonary root.
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Figure 3.2 Protection of pulmonary leaflet during trypsin treatment. (A) Soaked
cotton wool balls were placed between each of the three leaflets and the pulmonary
artery; (B) Pulmonary artery view after the three soaked cotton wool balls were placed;
(C) Ventricle view after the three soaked cotton wool balls were placed; (D) A soaked
cotton wool pad was placed at the ventricular side to cover the leaflets; (E) The cut-
open pulmonary root with the leaflets protected with soaked cotton wool balls and pad.
PA: pulmonary artery; M: myocardium; L: pulmonary leaflet; CB: cotton wool ball; CP:
cotton wool pad.
Figure 3.3 Trypsin treatment of porcine pulmonary roots. (A) Trypsin treatment
paste was brushed onto the pulmonary artery and the myocardium bar; (B) The
pulmonary roots with trypsin treatment paste were placed in a humidified container for
incubation.
Chapter 3
90
Figure 3.4 Process flow diagram of decellularisation Method 1.
3.3.4 Biomechanical evaluation of fresh and decellularised porcine pulmonary
heart valve roots
The biomechanical properties of native and decellularised (Method 3, Section 3.4.4)
porcine pulmonary roots were evaluated using uniaxial tensile testing. Circumferential
and axial specimens were dissected from fresh intact porcine pulmonary arteries (n=7
and 6, respectively), fresh peeled porcine pulmonary arteries (n=6 and 6, respectively),
and decellularised (according to Method 3, Section 3.4.4) porcine pulmonary arteries
(n=6 and 9, respectively) and tested under uniaxial tensile loading to failure in order to
characterised their stress-strain behaviour and failure characteristics. All pulmonary
artery specimens tested were 5 mm in width and 10 mm in length (initial gauge length).
The test samples and controls are listed in Table 3.1.
Table 3.1 The test samples and controls of uniaxial tensile testing for porcine
pulmonary arteries. C: circumferential direction; A: axial direction.
Fresh intact Fresh peeled Decellularised (Method 3)
C A C A C A
Numbers of sample 7 6 6 6 6 9
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Circumferential and radial fresh (n=6 and 6, respectively), and decellularised (Method 3,
Section 3.4.4) (n=5 and 6, respectively) pulmonary leaflets were also tested under
uniaxial tensile loading to failure. The pulmonary leaflet specimens were 3 mm in width
and 6 mm in length (initial gauge length). Tissue specimens were taken from different
animals within each test group, and randomly from the three pulmonary leaflets for both
fresh and decellularised groups. The methodology followed during uniaxial tensile
testing was described in Section 2.2.10. The test samples and controls are listed in Table
3.2.
Table 3.2 The test samples and controls of uniaxial tensile testing for porcine
pulmonary leaflets. C: circumferential direction; R: radial direction.
Fresh Decellularised (Method 3)
C R C R
Numbers of sample 6 6 5 6
The mean stress-strain curves for each group were generated using the Origin 8.0
software package. A cubic spline was fitted to each data set and equally spaced data
points were interpolated from the cubic spline at 100 fixed intervals along the spline.
The 100 fixed intervals were determined by dividing the mean engineering strain into
100 equal portions. The interpolated data set was then used to fit an exponential decay,
thus the mean stress-strain behaviour was generated for each test group.
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3.4 Results and further development of the decellularisation process
3.4.1 Histological evaluation of fresh porcine pulmonary valve conduits
In order to characterise the fresh pulmonary root tissue, tissue sections were stained
with H&E, Hoechst, Miller’s and Alcian blue. Images of the pulmonary root tissue
stained with H&E are shown in Figure 3.5. Cells were stained blue after H&E staining,
and could be seen throughout the fresh porcine pulmonary root. The VEC`s and the
VIC`s were visible in the images of the leaflets (Figure 3.5 A). Connective tissue
(collagen and elastin) were stained red with H&E, and seen in the pulmonary leaflet,
pulmonary artery and myocardium. The red colour was deeper in the ventricularis and
fibrosa, but lighter in the spongiosa, indicating more collagen and elastin distributed in
the ventricularis and fibrosa layers than the spongiosa layer. The structure of the
spongiosa seemed to be more loosely arranged and less organised than the other two
layers. The myocardium bundles were recognised when stained with H&E (Figure 3.5
B). Depending on the orientation when preparing the tissue section, the myocardium
bundles appeared in longitudinal or cross section. In Figure 3.5 B, both longitudinal and
cross sectioned myocardium bundles could be recognised. The pulmonary artery was
sectioned along its long axis. Both endothelial cells and valvular smooth muscle cells
were present (Figure 3.5 C). The smooth muscle cells were aligned parallel to the long
axis of the pulmonary artery. The leaflet connection is the region where the root of the
pulmonary leaflet attaches to the myocardium and the pulmonary artery. The pulmonary
leaflet appeared to be thickest in this region. Both leaflet tissue and myocardium tissue
were recognisable in the image of the leaflet connection area (Figure 3.5D).
Images of the pulmonary root tissue stained with Hoechst are shown in Figure 3.6. The
bright blue dots in the Hoechst stained tissue indicated cell nuclei. Hoechst staining
further demonstrated that cells were distributed throughout the whole fresh pulmonary
root tissue. The VEC`s were distributed closer to each other than the VIC`s (Figure 3.6
A). The cells in the pulmonary artery were clearly aligned parallel to the long axis of the
artery (Figure 3.6 C). Images of the pulmonary root tissue stained with Miller’s and
Alcian blue are shown in Figure 3.7 and 3.8 respectively. Referring to the tissue
sections stained with Millers stain, elastin fibres (stained black) were distributed mainly
in the pulmonary wall, whereas they were hardly distinguishable in the myocardium
(Figure 3.7 B, C). Elastin fibres could also be seen in the leaflets, with the ventricularis
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layer demonstrating higher elastin content compared to the fibrosa and spongiosa layers
(Figure 3.7 A). Elastin fibres were observed on the ventricular side of the myocardium
(Figure 3.7 B). Following Alcian blue staining, blue coloured GAG`s were observed in
the leaflets, pulmonary wall, and leaflet connection, but hardly in the myocardium
(Figure 3.8). The centrally located spongiosa appeared to contain abundant GAG`s,
which were less apparent in the fibrosa and ventricularis (Figure 3.8 A).
Figure 3.5 Sections of fresh porcine pulmonary root tissue stained with H&E. (A)
Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); The VEC`s and
VIC`s are indicated by arrows; (B) Myocardium, 40 ×; The red circle indicates
longitudinal section of myocardium bundles and the green circle indicated cross
sectioned myocardium bundles (C) Pulmonary wall, 40 ×; (D) Leaflet connection, 40 ×.
M: myocardium; L: leaflet. Scale bars are: (A) 100 µm; (B), (C), (D) 250 µm.
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Figure 3.6 Sections of fresh porcine pulmonary root tissue stained with Hoechst. (A)
Pulmonary valve leaflet, 40 × (v: ventricularis; s: spongiosa; f: fibrosa); (B) Myocardium,
40 ×; (C) Pulmonary wall, 40 ×; (D) Leaflet connection, 40 ×. M: myocardium; L:
leaflet. Scale bars are: all 250 µm.
Figure 3.7 Sections of fresh porcine pulmonary root tissue stained with Miller’s. (A)
Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B) Myocardium,
40 ×; (C) Pulmonary wall, 40 ×; (D) Leaflet connection, 40 ×. M: myocardium; L:
leaflet. Scale bars are: (A) 100 µm; (B), (C), (D) 250 µm.
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Figure 3.8 Sections of fresh porcine pulmonary root tissue stained with Alcian blue.
(A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B)
Myocardium, 100 ×; (C) Pulmonary wall, 40 ×; (D) Leaflet connection, 40 ×. M:
myocardium; L: leaflet. Scale bars are: (A), (B) 100 µm; (C), (D) 250 µm.
3.4.2 Histological evaluation of decellularised porcine pulmonary valve conduits
(Method 1)
Following decellularisation of the porcine pulmonary roots using Method 1,
decellularised tissue sections were stained with H&E (Figure 3.9) and Hoechst (Figure
3.10) to determine the extent of decellularisation. No cell nuclei could be observed in
the leaflets, pulmonary wall or myocardium. However, cells or cell residues were
observed in the connection area of the leaflet to the myocardium (Figure 3.9 B). Under
400 × magnification, cell nuclei in the pulmonary root-myocardium connection area
were about the same size as those in fresh pulmonary roots from the same area (Figure
3.9 E, F). Blue fluorescent nuclei were identified in the connection area of the
myocardium and leaflet connection in Hoechst stained images (Figure 3.10 C, D), but
no nuclei were identified in the pulmonary leaflets or wall (Figure 3.10 A, B). The
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results indicated the presence of cells or cell residues in the connection area of the
leaflet and the myocardium after decellularisation using Method 1.
Figure 3.9 Sections of decellularised porcine pulmonary root tissue stained with
H&E (Method 1). (A) Pulmonary valve leaflet, 40 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×, the circle indicates the remaining cells after
decellularisation (Method 1); (C) Pulmonary wall, 100 ×; (D) Leaflet connection, 40 ×;
(E) Cell residues at the connection area, 400 ×, arrows indicate cell residues; (F) Cells
in the same area as (E) In fresh pulmonary root, 400 ×, arrows indicated cells. M:
myocardium; L: leaflet. Scale bars are: (A), (D), (E), (F) 250 µm; (B), (C) 100 µm.
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Figure 3.10 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst (Method 1). (A) Pulmonary valve leaflet, 40 ×, (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Pulmonary wall, 40 ×; (C), Leaflet connection and myocardium, the circle
indicates the remaining cells after decellularisation (Method 1), 40 ×; (D) Cell residues,
40 ×. M: myocardium; L: leaflet. Scale bars are: all 250 µm.
3.4.3 Further development of the decellularisation method for porcine pulmonary
valve roots (Method 2)
3.4.3.1 Method
The results from the porcine pulmonary roots decellularised according to Method 1
showed cell residues present in the leaflet connection area. In order to improve the cell
removal in the connection area, 2 cycles of the hypotonic SDS buffer wash were
introduced in Method 2. Since the pulmonary roots were relatively small compared to
the aortic roots, and the porcine pulmonary walls were thinner, it was considered that
trypsin treatment might not be necessary to decellularise the pulmonary root. In addition,
since the pulmonary wall was thinner than the aortic wall, it was hypothesised that it
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might not be necessary to thin the wall prior to decellularisation. Thus, Method 2 was
modified to Method 1 with the following changes:
a) the pulmonary wall was not peeled;
b) Trypsin treatment was not performed;
c) Two cycles of incubation in hypotonic buffer and hypotonic SDS buffer were
performed instead of one.
Two porcine pulmonary roots were decellularised using Method 2.
3.4.3.2 Results
Sections of porcine pulmonary valve tissue were stained with H&E (Figure 3.11),
Hoechst (Figure 3.12) and Miller’s (Figure 3.13) to study the effect of decellularisation
using Method 2. From the images of H&E stained sections, no cell nuclei were
observed in the pulmonary leaflets, inside the pulmonary wall, or the myocardium
(Figure 3.11 A, B, C). The connection of the leaflet and myocardium was also clear of
cell nuclei (Figure 3.11 D). However, some residual nuclei were observed on the
outside surface of the pulmonary wall (Figure 3.11 C). This was further confirmed by
Hoechst stain (Figure 3.12 C, D), since some fluorescence was observed on the
adventitia of the pulmonary wall. The fluorescence was not as defined as that observed
in the Hoechst stained sections of the fresh pulmonary root, and was more diffuse. No
blue fluorescence was present in the pulmonary leaflets, myocardium, or the inside of
the pulmonary wall (Figure 3.12 A, B, C). Following Millers staining, elastin was
observed in the pulmonary leaflets (mostly on the ventricularis layer), pulmonary wall,
and the leaflet connection area, but not in the myocardium (Figure 3.13). The outside
surface of the pulmonary wall demonstrated “fluffy” connective tissue, and not was not
as smooth as the inside surface (Figure 3.11 C, Figure 3.13 C). The residual DNA
observed in H&E and Hoechst stained sections was inside this “fluffy” area (Figure 3.
11 C, Figure 3.12 C).
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Figure 3.11 Sections of decellularised porcine pulmonary root tissue stained with
H&E (Method 2). (A) Pulmonary leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa);
(B) Myocardium, 40 ×; (C) Pulmonary wall, 40 ×, the circle indicated the remaining
cells on the adventitial surface after decellularisation (Method 2); (D) Leaflet
connection, 100 ×. M: myocardium; L: leaflet. Scale bars are: (A), (D) 100 µm; (B), (C)
250 µm.
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Figure 3.12 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst (Method 2). (A) Pulmonary leaflet, 40 × (v: ventricularis; s: spongiosa; f: fibrosa);
(B) Myocardium, 40 ×; (C) Pulmonary wall, 40 ×, the circle indicates the remaining
cells on the adventitia of the wall after decellularisation (Method 2); (D) Cell residues
on the adventitia of the wall, 100 ×. Scale bars are: (A), (B), (C) 250 µm; (D) 100 µm.
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Figure 3.13 Sections of decellularised porcine pulmonary root tissue stained with
Miller’s (Method 2). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) Pulmonary wall, 40 ×, the circle indicated the
connective tissue on the adventitial surface of the pulmonary wall; (D) Leaflet
connection, 40 ×. M: myocardium; L: leaflet. Scale bars are: (A), (B) 100 µm; (C), (D)
250 µm.
3.4.4 Further development of the decellularisation methods for porcine pulmonary
roots (Method 3)
3.4.4.1 Method
The histological results of the tissue treated with Method 2 indicated that the only
region that still retained cell residues was the outer layer of the adventitia of the
pulmonary wall. Thus, it was realised that peeling of an external layer of the pulmonary
artery was necessary to achieve complete decellularisation of the pulmonary roots.
Method 3 was modified from method 2 with only one change: the external layer of the
pulmonary artery wall was peeled prior to decellularisation. Six porcine pulmonary
roots were decellularised using Method 3.
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3.4.4.2 Results
Sections from the porcine pulmonary roots were stained with H&E (Figure 3.14),
Hoechst (Figure 3.15) and Miller’s (Figure 3.16) to study the effect of decellularisation
using Method 3. No residual cell nuclei were observed in the H&E stained sections of
decellularised pulmonary roots (Method 3) (Figure 3.14). In addition, no blue
fluorescence was observed in the sections stained with Hoechst (Figure 3.15). The
sections stained with Miller’s stain indicated that elastin was mainly distributed in the
pulmonary wall, the surface surrounding the myocardium, and the ventricle side of the
pulmonary leaflets (Figure 3.16). Unlike the tissues treated with Method 2, the outer
surface of the pulmonary wall treated with Method 3 was clear of cells (Figure 3.14 C,
Figure 3.15 C). The adventitia layer of the pulmonary artery was peeled off from the
roots treated with this decellularisation method (Figure 3.14 C, figure 3.16 C).
Complete decellularisation of porcine pulmonary roots was achieved by using
decellularisation Method 3.
Figure 3.14 Sections of decellularised porcine pulmonary root tissue stained with
H&E stain (Method 3). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa;
f: fibrosa); (B) Myocardium, 100 ×; (C) Pulmonary wall, 100 ×; (D) Leaflet connection,
100 ×. M: myocardium; L: leaflet. Scale bars are: all 100 µm.
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Figure 3.15 Decellularised porcine pulmonary root tissue stained with Hoechst
(Method 3). (A) Pulmonary leaflet, 40 ×; (B) Myocardium, 40 ×; (C) Pulmonary wall,
40 ×. M: myocardium; L: leaflet. Scale bars: (A) 100 µm; (B), (C), (D) 250 µm.
Figure 3.16 Sections of decellularised porcine pulmonary root tissue stained with
Miller’s (Method 3). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 40 ×; (C) Pulmonary wall, 100 ×; (D) Leaflet connection,
100 ×.M: myocardium; L: leaflet. Scale bars are: (A), (C), (D) 100 µm; (B) 250 µm.
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3.4.5 Biomechanics of fresh and decellularised (Method 3) porcine pulmonary
valve roots
3.4.5.1 Biomechanical evaluation of pulmonary leaflets
Since decellularisation of the porcine pulmonary roots using Method 3 demonstrated
complete removal of cells and cell nuclei as determined by H&E and Hoechst staining
with no gross changes to the tissue histoarchitecture, it was decided to determine
whether Method 3 had any effects on the biomechanical properties of the tissue.
Therefore, circumferential and radial leaflet specimens were dissected from fresh
pulmonary roots and pulmonary roots treated with Method 3 and subjected to uniaxial
tensile loading to failure. The methodology followed for these tests has been described
in Sections 2.2.10 and Section 3.3.4.
The mean stress-strain behaviour of the fresh and decellularised (Method 3) leaflet
groups is illustrated in Figure 3.17 (circumferential) and Figure 3.18 (radial). The
curves demonstrated the typical quasi-linear characteristics with a low modulus region
during the elastin phase and a high modulus region during the collagen phase until the
tissue failed. The analysis of the results showed no significant difference between the
fresh and acellular groups for the following parameters: the elastin phase slope in
circumferential and radial directions (Figure 3.19), the collagen phase slope in the
circumferential and radial directions (Figure 3.20), the transition stress in the
circumferential and radial directions (Figure 3.21), the transition strain in the
circumferential and radial directions (Figure 3.22), the failure stress in the
circumferential direction (Figure 3.23), the failure strain in the circumferential and
radial directions (Figure 3.24), and the thickness of pulmonary leaflets in the
circumferential and radial directions (Figure 3.25). The results indicated a significant
decrease (p<0.05) in the failure stress of the decellularised radial leaflet (Figure 3.23).
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Figure 3.17 Mean stress-strain behaviour of the fresh (n=6) and decellularised (n=5;
Method 3) circumferential leaflet groups. The error bars indicate the 95% C.I.s.
Figure 3.18 Mean stress-strain behaviour of the fresh (n=6) and decellularised (n=5;
Method 3) radial leaflet groups. The error bars indicate the 95% C.I.s.
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Figure 3.19 Elastin phase slope for the fresh and decellularised (Method 3) leaflets
tested in the circumferential and radial directions. The error bars indicate the 95%
C.I.s. Fresh circumferential and radial groups and decellularised radial group: n=6;
decellularised circumferential group: n=5. The data was analysed using the student t-test,
which showed no significant difference between fresh and decellularised tissue.
Figure 3.20 Collagen phase slope for the fresh and decellularised (Method 3)
leaflets tested in the circumferential and radial directions. The error bars indicate
the 95% C.I.s. Fresh circumferential and radial groups and decellularised radial group:
n=6; decellularised circumferential group: n=5. The data was analysed using the student
t-test, which showed no significant difference between fresh and decellularised tissue.
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Figure 3.21 Average transition stress for the fresh and decellularised (Method 3)
leaflets tested in the circumferential and radial directions. The error bars indicate
the 95% C.I.s. Fresh circumferential and radial groups and decellularised radial group:
n=6; decellularised circumferential group: n=5. The data was analysed using the student
t-test, which showed no significant difference between fresh and decellularised tissue.
Figure 3.22 Average transition strain for the fresh and decellularised (Method 3)
leaflets tested in the circumferential and radial directions. The error bars indicate
the 95% C.I.s. Fresh circumferential and radial groups and decellularised radial group:
n=6; decellularised circumferential group: n=5. The data was analysed using the student
t-test, which showed no significant difference between fresh and decellularised tissue.
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Figure 3.25 Average thickness for the fresh and decellularised (Method 3) leaflets
tested in the circumferential and radial directions. The error bars indicate the 95%
C.I.s. Fresh circumferential and radial groups and decellularised radial group: n=6;
decellularised circumferential group: n=5. The data was analysed using the student t-test,
which showed no significant difference between fresh and decellularised tissue.
3.4.5.2 Biomechanical evaluation of pulmonary artery
Uniaxial tensile loading to failure was also used to evaluate the changes in the
mechanical behaviour of the porcine pulmonary artery tissue after decellularisation
according to Method 3. According to this decellularisation method, the pulmonary
artery was peeled of an external layer before SDS treatment. The pulmonary artery
therefore had no adventitial layer during the decellularisation, which was a physical
change that could directly affect the mechanical properties of the tissue. Thus, three
groups were investigated to fully understand the mechanical changes to the pulmonary
artery tissue after decellularisation: a fresh group (circumferential group: n=7; axial
group: n=6), a peeled fresh group (circumferential and axial group: n=6) and a
decellularised group (circumferential group: n=6; axial group: n=9).
The porcine pulmonary arteries mean stress-strain behaviours are illustrated in Figure
3.26 and Figure 3.27. The curves showed similar characteristics to the valve leaflet
samples, with a low modulus region during the elastin phase and a high modulus region
during the collagen phase. The results for the elastin phase slope, collagen phase slope,
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transition stress and strain, failure stress and strain, and the average thickness for control
and test groups are illustrated in Figure 3.28 through to Figure 3.34.
There was no significant difference among the three groups for the following
parameters: the transition stress in the circumferential and axial directions (Figure 3.30),
the transition strain in the circumferential direction (Figure 3.31), the failure stress in
the axial direction (Figure 3.32), the failure strain in the circumferential direction
(Figure 3.33) and the thickness in the circumferential direction (Figure 3.34).
Significant differences were found in: the elastin phase slope between the fresh group
and the decellularised group in the circumferential and the axial directions (Figure 3.28),
the collagen phase slope between the fresh and peeled group in the circumferential
direction and axial directions (Figure 3.29), the transition strain between the fresh group
and the decellularised group in the axial direction (Figure 3.31), the failure stress
between the fresh and peeled group in the circumferential direction (Figure 3.32), the
failure stress between the peeled group and the decellularised group in the
circumferential direction (Figure 3.32), the failure strain between the fresh group and
the peeled group in the axial direction (Figure 3.33), the failure strain between the fresh
group and the decellularised group in the axial direction (Figure 3.33), the porcine
pulmonary wall thickness between the fresh and the peeled group (Figure 3.34), and the
wall thickness between the fresh and decellularised group (Figure 3.34). The only
significant difference found between the peeled fresh and the decellularised groups was
for the failure stress along the circumferential direction (Figure 3.32).
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Figure 3.26 Mean stress-strain behaviour for the fresh (n=7), peeled fresh (n=6)
and decellularised (n=6; Method 3) circumferential pulmonary artery groups. The
error bars indicate the 95% C.I.s.
Figure 3.27 Mean stress-strain behaviour for the fresh (n=6), peeled fresh (n=6)
and decellularised (n=9; Method 3) axial pulmonary artery groups. The error bars
indicate the 95% C.I.s.
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Figure 3.30 Average transition stress for fresh, peeled fresh and decellularised
(Method 3) pulmonary artery groups tested in the circumferential and axial
directions. The error bars indicate the 95% C.I.s. Fresh circumferential: n=7; peeled
fresh circumferential, decellularised circumferential, fresh axial and peeled fresh axial:
n=6; decellularised axial: n=9. Data was analysed using one way ANOVA, which
showed no significant difference within the circumferential and axial groups.
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Method 4 compared to Method 3. Two porcine pulmonary roots were decellularised
using method 4.
3.4.6.2 Results
Sections of porcine pulmonary roots were stained with H&E (Figure 3.35) and Hoechst
(Figure 3.36) to study the effect of decellularisation using Method 4. No cells or cell
residues were observed in the porcine pulmonary valve leaflets, the pulmonary artery or
the myocardium (Figure 3.35 & Figure 3.36). The outer surface of the adventitia of the
pulmonary artery was clear from cells or cell residues using scraping in Method 4
(Figure 3.35F & Figure 3.36E).
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Figure 3.35 Sections of decellularised porcine pulmonary root tissue stained with
H&E (Method 4). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) Pulmonary wall, 40 ×; (D) Leaflet connection, 40
×; (E) The lumen surface of the pulmonary wall, 100 ×; (F) The adventitial surface of
the pulmonary wall 100 ×. M: myocardium; L: leaflet. Scale bars are: (A), (B), (E), (F)
200 µm; (C), (D) 500 µm.
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Figure 3.36 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst (Method 4). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) Leaflet connection, 100 ×; (D) The lumen surface
of the pulmonary wall, 100 ×; (E) The adventitial surface of the pulmonary wall 100 ×.
M: myocardium; L: leaflet. Scale bars are: all 250 µm.
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3.4.7 Further development of decellularisation method for porcine pulmonary
roots (Method 5)
3.4.7.1 Method
Although no cells or cell residues were present in the roots decellularised according to
Method 3, significant changes to the biomechanical properties were observed when
compared to the fresh roots. Comparing decellularisation Method 3 of the present study
and the decellularisation method for aortic roots used in the study by Korossis et al.
(2002) in which no significant changes were observed for the failure stress after
decellularisation, it was apparent that the difference was that Method 3 included another
cycle of hypotonic buffer and 0.1 % (w/v) SDS. It was considered that the additional
SDS buffer wash might have had an impact on the leaflets’ failure stress properties.
Changes were made to Method 1 as follows:
a) Instead of peeling an outer layer, the adventitia of the pulmonary artery was
carefully scraped with a scalpel blade (since the results from Method 4 showed
successful decellularisation of the pulmonary wall with the scraping);
b) Trypsin treatment was only applied on the outer surface of the adventitia of the
pulmonary artery and the myocardium bar (considering that application of trypsin
paste only on the adventitial surface could be sufficient to achieve complete
decellularisation for the relatively thin pulmonary artery wall).
Six porcine pulmonary roots were decellularised using Method 5.
3.4.7.2 Results
Sections of the porcine pulmonary roots were stained with H&E (Figure 3.37) and
Hoechst (Figure 3.38) to study the effect of decellularisation using Method 5. All roots
were clear of cells in their leaflets, pulmonary arteries and myocardium (Figure 3.37 A,
B, C and D, Figure 3.38 A, B, C and D). Regarding to the leaflet connection region, no
cells were observed in the H&E stained sections for four out of the six roots that were
subject to decellularisation (Figure 3.37E). For the other two roots, H&E staining
showed some cell residues in the leaflet connection region (Figure 3.37F). Hoechst
staining confirmed this observation. Blue nuclei were identified in the leaflet connection
region for 2 out of 6 decellularised roots (Figure 3.35F).
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Figure 3.37 Sections of decellularised porcine pulmonary root tissue stained with
H&E (Method 5). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) The lumen surface of pulmonary wall, 100 ×; (D)
The adventitial surface of pulmonary wall, 100 ×; (E) Leaflet connection, 40 ×; (F)
Leaflet connection, 100 ×, the circle indicated the area with cell residues presented. M:
myocardium; L: leaflet. Scale bars are: all 200 µm, except for (E) 500 µm.
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Figure 3.38 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst (Method 5). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×;
(D) The adventitial surface of the pulmonary wall 100 ×; (E) Leaflet connection, 100 × ;
(F) Leaflet connection, 400 ×, the arrows indicated cell residues. M: myocardium; L:
leaflet. Scale bars are: all 200 µm, except for (F) 50 µm.
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3.4.8 Further development of the decellularisation method for porcine pulmonary
roots (Method 6)
3.4.8.1 Method
Since no intact cells were identified after decellularisation according to Method 5, but
only nucleic residues were recognised in two out of six pulmonary roots, an additional
nuclease wash was included in decellularisation Method 6 to completely remove the cell
nuclei. Method 6 evolved from Method 5 with the following change: Two continuous 3
h treatments with nuclease buffer were carried out to replace the one 4 h nuclease wash
in Method 5. The process is summarised in Figure 3.39. Six porcine pulmonary roots
were decellularised according to Method 6.
Figure 3.39 Flow diagram of decellularisation Method 6.
3.4.8.2 Results
Sections of the pulmonary roots were stained with H&E (Figure 3.40) and Hoechst
(Figure 3.41) to study the effect of decellularisation using Method 6. No cells or cell
residues were observed in any of the sections from the 6 porcine pulmonary roots that
were subjected to decellularisation (Figure 3.40, Figure 3.41). Complete
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decellularisation was achieved using decellularisation Method 6 as indicated by
histology.
Figure 3.40 Sections of decellularised porcine pulmonary root tissue stained with
H&E (Method 6). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×;
(D) The adventitial surface of the pulmonary wall, 100 ×; (E) Leaflet connection, 100 ×.
M: myocardium; L: leaflet. Scale bars are: all 200 µm.
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Figure 3.41 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst (Method 6). (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f:
fibrosa); (B) Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×;
(D) The adventitial surface of the pulmonary wall, 100 ×; (E) Leaflet connection, 100 ×.
M: myocardium; L: leaflet. Scale bars are: all 200 µm.
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3.4.9 Summary of the decellularisation method development for porcine
pulmonary roots
In this study, in total 6 methods were assessed of their decellularisation effects. The
differences of these methods concentrated on the following steps: the use of trypsin, the
peeling or scraping method applied on the outer layer of the adventitia of the pulmonary
arteries, the cycles of hypotonic SDS buffer washes, and the cycles and lengths of
nuclease treatments. The other steps in the decellularisation procedure (hypotonic buffer
wash, hypertonic buffer wash, and peracetic acid wash) stayed the same for all of the 6
methods used. A summary of the steps that were used differently in the decellularisation
methods and the key results are demonstrated in Table 3.3.
Table 3.3 A summary of the steps that were used differently in the
decellularisation methods and the accordingly key results.
Method Pulmonary
artery
Trypsin
treatment
SDS
wash
Nuclease
treatment
Results
1 Peeled Yes 1 × 1 × 4 h Cell residues in the leaflet
connection area
2 Native No 2 × 1 × 4 h Tissue DNA on the
adventitial surface of the
pulmonary arteries
3 Peeled No 2 × 1 × 4 h Complete
decellularisation, but
biomechanical properties
changed (significant
decreases for failure
stresses in the pulmonary
leaflets (radial direction)
and the pulmonary arteries
(circumferential direction))
4 Scraped No 2 × 1 × 4 h Scraping of the pulmonary
arteries achieved similar
decellularisation result to
peeling
5 Scraped Yes 1 × 1 × 4 h 2 out of 6 roots had
remaining DNA in leaflet
connection area
6 Scraped Yes 1 × 2 × 3 h Complete decellularisation
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3.5 Discussion
The aim of the work presented in this chapter was to develop a method for the
decellularisation of porcine pulmonary roots which retained the histoarchitecture and
mechanical integrity of the fresh tissue. Initially, the histology of fresh pulmonary roots
was evaluated. Cells were distributed throughout the fresh pulmonary roots. This was
revealed by H&E staining, Millers elastin staining and Hoechst staining of pulmonary
root sections. In the porcine pulmonary leaflets, the density of connective tissue
(red/pink in H&E stain) was much higher in the fibrosa and ventricularis than that in
spongiosa of the leaflets. The elastin content was higher in the ventricularis compared
to the fibrosa, probably due to the ventricularis directly facing blood flow from the
ventricle side, and the high elastin content could absorb the shock from the blood.
Elastin fibres were also identified in the pulmonary artery, but they were quite sparse in
the myocardium. Similarly, GAG`s were distributed in the leaflets and wall, but could
hardly be observed in the myocardium. In the leaflets, the layer containing the most
GAG`s was the spongiosa. A high content of GAG`s was also present at the base of the
leaflets, in the connection area.
In the decellularisation processes used in this study, hypotonic buffer was used to lyse
the cells using osmosis. The mode of action of SDS is to solubilise the lipid bi-layer of
the cells and form micelles which incorporate the biological membrane and its
associated proteins. SDS has been shown to achieve better results in porcine heart valve
tissue decellularisation whilst maintaining the histoarchitecture and biomechanical
properties of the tissues when compared to a series of other detergents such as triton X-
100. Trypsin treatment of the pulmonary wall tissue leads to loosening of the
interfibrillar spaces (Bader et al., 1998; Bader et al., 2000), and could also be applied in
tissue decellularisation (Kasimir et al., 2003; Leyh et al., 2003). Trypsin treatment was
included as an additional step in order to achieve complete decellularisation of the aortic
wall (Wilcox et al., 2005). The utilisation of trypsin treatment was also considered in
this project to decellularise porcine pulmonary roots. DNAse and RNAse treatment was
applied to digest nucleic acids. Hypertonic buffer was used to further remove cellular
proteins and α-gal epitopes. The activation of proteases in natural tissues during 
decellularisation can lead to extensive autolysis of ECM proteins and can cause major
damage to the structure and function of the scaffold (Bodnar et al., 1986; Courtman et
al., 1994; Pachence, 1996, Walles et al., 2003). Protease inhibitors were thus necessary
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in all stages of decellularisation to maintain the ECM components. EDTA was selected
to inhibit the matrix metalloproteases, and aprotinin was used as a broad-spectrum
inhibitor of serine proteases such as the members of the plasminogen activation cascade
(Booth et al., 2002). The protease inhibitors were not applied prior to and during
nuclease treatment in order not to compromise the action of nucleases.
Decellularisation Method 1 was based on the method reported by Wilcox et al. (2005).
This method was developed for the decellularisation of whole porcine aortic roots, and
it was based on the decellularisation method reported by Booth et al. (2002) for aortic
valve leaflet. For leaflets in situ in the aortic root, 0.1% (w/v) SDS was sufficient to lyse
the cells and 0.03 % (w/v) SDS was sufficient to lyse the cells in excised leaflets which
had a second free edge. However, since the aortic wall is much thicker than the leaflet
itself, 0.1% (w/v) SDS was not sufficient to lyse all the cells in the whole aortic root
(Wilcox et al., 2005). Thus, both 0.1% (w/v) SDS and 2.25 × 104 Unit.ml-1 trypsin were
used for decellularisation. During trypsin treatment, the leaflets were protected by
cotton wool soaked with 50% (v/v) FBS in PBS so that the thin, fragile leaflets were not
damaged by trypsin digestion. On the other hand, the cotton wool made it difficult for
the enzyme to enter the leaflet root connection area, making it difficult to achieve
complete digestion of the connection area. Wilcox et al. (2005) made another attempt to
decellularise the whole aortic root by thinning the aortic root wall to allow maximal
diffusion of SDS and trypsin. The connective tissue layer as well as a thin layer of the
valve wall was peeled from the outside using fine tip forceps. This method produced
completely decellularised whole aortic roots with excellent leaflet kinematics,
hydrodynamic performance, and biomechanical characteristics (Korossis et al., 2005).
Following decellularisation of the porcine pulmonary roots in the present study, four
areas of the valve roots were closely observed, namely the leaflet, the wall, the
myocardium, and the connection of the leaflet to the root. The first three sites were
examined because they represented a particular structure of the root. The latter was
selected because it was the thickest site within the whole root, and the most difficult to
decellularise, since it was difficult for the detergent or enzymes to enter the central area
of the tissue in this region.
Following decellularisation with Method 1, no cells were observed in the leaflets, wall,
or myocardium. However, cells or cell residues were observed in the leaflet root
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connection area, by the edge of the myocardium. When magnified to 400 ×, the blue
stained residues in this area appeared very similar to the cells of the fresh pulmonary
root in the same area. To further investigate the extent of decellularisation using this
method on pulmonary roots, Hoechst staining was performed. Bright blue fluorescence,
representing DNA or its residues, was observed in the same area where the cell nuclei
were observed in H&E stained sections.
According to Method 2, which was a modification of Method 1, two cycles of 0.1%
(w/v) SDS buffer treatment were applied to improve cell removal in the connection area.
Neither peeling of an external layer of the pulmonary artery or trypsin treatment was
performed in Method 2, with the consideration that since the pulmonary artery is thinner
than the aorta, extra steps in decellularisation might not be necessary for the porcine
pulmonary artery. Using Method 2, no cells were observed in the leaflet, pulmonary
wall, myocardium, or the leaflet-root connection area. In addition the gross
histoarchitecture of the ECM was successfully retained. However, cells or cell residues
were observed in regions of the outside surface of the pulmonary wall featuring a ‘fluffy’
layer of connective tissue. Millers staining showed that connective tissue including
elastin was present in this layer. Further Hoechst staining revealed diffuse blue
fluorescence in this area, indicating that cells were lysed during decellularisation but
that DNA was not totally cleared from this layer. The reason for this was probably
because the outside of the pulmonary artery was covered with fat and connective tissue,
and trimming during dissection alone did not eliminate it. Owing to this, cellular content
was trapped in that region by the connective tissue during decellularisation.
Decellularisation Method 3 was based on Method 2, with the peeling procedure
included again in order to remove the connective tissue which trapped the cellular
contents. In total six porcine pulmonary roots were decellularised according to Method
3. Histological staining showed no evidence of cells using this method. No cells were
observed in H&E stained sections, and no fluorescence was observed after Hoechst
staining. Miller’s staining results showed no obvious changes in the distribution of
elastin, whereas the histoarchitecture of the tissue was well retained. Compared to the
histological results reported by Wilcox et al. (2005) for decellularised aortic roots, the
pulmonary roots decellularised by Method 3 achieved similar results.
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Uniaxial tensile testing has been used in the majority of studies on the biomechanical
properties of heart valve tissues (Lee et al., 1984a, b; Vesely & Noseworthy, 1992;
Stradins et al., 2004). Uniaxial tensile testing was carried out on fresh and
decellularised (Method 3) porcine pulmonary leaflets and on fresh, peeled fresh and
decellularised (Method 3) pulmonary arteries. The reason for adding the additional
control group of peeled fresh pulmonary arteries was that the peeling procedure was
very likely to affect the mechanical properties of the tissue.
The stress-strain behaviour of porcine pulmonary leaflets and pulmonary arteries
demonstrated similar trends to the results described in previous studies (Jennings, 2001;
Korossis et al., 2002; Stradins et al., 2004; Korossis et al., 2005; Seebacher et al., 2007),
with the typical quasi-linear behaviour characterised by a low modulus region during
the elastin phase and high modulus region during the collagen phase. The stress-strain
properties of the pulmonary leaflets indicated the reduced extensibility and increased
strength of the circumferential specimens compared to the radial specimens. This was
due to the anisotropy of the valvular tissue inherited by the directionality of the ECM.
The decrease (p<0.05) in the failure stress of the decellularised radial leaflet group
compared to the fresh control indicated a loss of strength of the leaflets in their radial
direction after decellularisation according to Method 3. However, in the results for
porcine aortic leaflets reported by Korossis et al. (2002), significant differences were
only observed for the elastin phase slope in circumferential and radial directions, and
the collagen phase slope of the circumferential specimens, but not for the failure stress
or strain. The decrease in the failure stress of the radial leaflet group was most likely to
have been caused by the additional 0.1 % (w/v) SDS treatment that was used in Method
3.
Method 4 was very similar to Method 3. The only difference was the scraping of the
outer surface of the adventitia of the pulmonary artery instead of peeling an external
layer prior to decellularisation. The purpose of Method 4 was to test the effect of
scraping in the decellularisation of the porcine pulmonary root. The peeling procedure
removed connective tissue as well as a layer of the adventitia of the pulmonary artery.
Although it has been shown by Korossis et al. (2005) that the peeling of aorta did not
compromise the strength of the tissue since no significant difference was observed in
the failure stress, in the present study a significant difference in the failure stress for the
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circumferential direction between the fresh and decellularised (Method 3) pulmonary
arteries was found. One reason for the different result between the porcine aorta and the
porcine pulmonary artery was because the pulmonary artery is naturally thinner than the
aorta, so peeling a layer could have removed a larger portion of the pulmonary artery
wall. Hence, the mechanical properties of the acellular pulmonary artery were affected
more by the removal of a larger portion of the wall. Another reason could have been
that the peeling was not consistent. It was really difficult to control the tissue thickness
to be peeled. Peeling techniques would also vary from person to person. Following
decellularisation using Method 4, no cells or cell residues were identified from both
H&E staining and Hoechst stained sections. Special attention was paid to the adventitial
surface of the pulmonary artery, where cell nuclei were likely to be trapped if no peeling
was carried out (Method 2). No fluorescence was observed upon Hoechst staining.
Decellularisation according to Method 4 confirmed the success in removing cell
components by scraping the adventitia of the porcine pulmonary arteries. However, no
further evaluation of the acellular scaffold was carried out since it was realised that the
two cycles of 0.1 % (w/v) SDS would still damage the pulmonary valve leaflets.
Decellularisation Method 5 was developed with purpose view to retaining the leaflet
biomechanical properties as much as possible after decellularisation. In Method 5, the
scraping technique that was included in Method 4 was applied because of its success in
removing the cellular components trapped on the outer surface of the adventitia of the
pulmonary artery. Method 5 also incorporated only one cycle of 0.1 % (w/v) SDS buffer
wash in order to minimise the effect on the leaflet biomechanics. Scraping and trypsin
treatment were utilised to aid decellularisation of the pulmonary artery and the leaflet
connection. In the six roots that were subject to decellularisation according to Method 5,
histology showed complete decellularisation of the leaflets, pulmonary arteries and
myocardium bars for all roots. However, Hoechst staining indicated that two out of the
six roots treated featured cell nucleic residues in their leaflet connection regions. The
reason that two roots out of the six were not completely decellularised was probably due
to the increased size of these roots or due to the pulmonary arteries being thicker
compared to the other four roots.
Since no whole cells were identified after decellularisation with Method 5, but only
nucleic residues were recognised in two out of six pulmonary roots, an additional
nuclease wash was included in decellularisation Method 6 to completely remove the cell
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nuclei. Complete decellularisation was achieved using decellularisation Method 6
according the histology results. All of the six roots were decellularised with their
histoarchitectures well retained as shown in the Figure 3.40 and Figure 3.41. Further
characterisation of the decellularised porcine pulmonary roots according to Method 6
will be discussed in subsequent chapters.
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3.6 Conclusion
A decellularisation method for porcine pulmonary valve root was developed based on
the original method described by Wilcox et al. (2005). The method with two cycles of
0.1 % (w/v) SDS buffer washes and peeling of the pulmonary artery (Method 3)
achieved complete decellularisation. Although the histoarchitecture of the tissue was
retained after decellularisation, uniaxial tensile testing to failure indicated a significant
decrease (p<0.05; t-test) in the failure stress of the decellularised radial leaflet and
circumferential wall groups compared to the fresh control. No significant differences
were observed in the other biomechanical parameters between treated and native leaflet
and pulmonary wall tissues (p≥0.05). Another method which achieved complete
decellularisation of the whole porcine pulmonary root was developed using trypsin
treatment on the scraped adventitia of the pulmonary artery, one cycle of 0.1 % (w/v)
SDS buffer wash and two cycles of nuclease buffer washes (Method 6). H&E and
Hoechst staining results showed complete decellularisation. Further evaluation of
decellularisation Method 6 will be discussed in Chapter 4 and Chapter 5.
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Chapter 4
Biological Characterisation of Fresh and Acellular
Porcine Pulmonary Valve conduits
4.1 Introduction
The acellular porcine pulmonary root scaffold produced by decellularisation should
ideally be biocompatible with complete cell removal and retention of the ECM. The
porcine pulmonary root scaffold should also not be immunogenic when used in human
transplantation. Thus it was important to assess the extent of decellularisation and
removal of major antigens. The decellularisation procedure designed for cell removal
however has the potential to alter the native histoarchitecture and composition of the
ECM. The detergents and enzymes remaining in the scaffold after decellularisation
could also be toxic to cells. Should this happen, the function of the scaffold (such as the
support of cell repopulation) could be compromised and hence could negate the
advantages gained by the use of natural scaffolds. Therefore, following the production
of the decellularised porcine pulmonary roots, the biological characteristics of the
scaffolds required investigation for: (i) the extent of cell and cellular component
removal, (ii) the retention of ECM components, and (iii) the biocompatibility of the
scaffold.
The determination of the extent of DNA removal following decellularisation has been
considered very important in the assessing of the success of a decellularisation method.
The removal of DNA can be qualitatively assessed by histological staining (i.e. Hoechst
staining) and/or determination of the residual DNA content in tissue (Gilbert et al., 2009;
Boer et al., 2011). DNA represents an easy quantifiable integral part of the cell. Thus,
the determination of residual DNA content in decellularised tissue can provide
understanding of cell removal. Moreover, porcine DNA remnants have been suggested
to be immunogenic following the implantation of porcine derived scaffolds (Zheng et
al., 2005; Lotze et al., 2007, Nagata et al., 2010). It was unlikely that the
decellularisation process would, however, remove 100 % of the total DNA. Previous
studies have shown that trace amounts of DNA are present in experimental and
commercially available naturally derived scaffolds (Gilbert et al., 2009; Boer et al.,
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2011; Wilshaw et al., 2011). Short lengths of remnant DNA (less than 300 bp) however,
are unlikely to be of concern, since they would be subject to degradation via enzymatic
breakdown to nucleotides for use by the cells after implantation (Bennett et al., 1985;
McCoy et al., 2004; Gilbert et al., 2007; Gilbert et al., 2009). On the other hand, the
remnant DNA fragments in the decellularised scaffold should not be able to be
functional to encode xenogenic cellular protein components.
In addition to DNA, other components from dead cells have been reported to initiate
host immune responses (Nagata et al., 2010). For the successful production of a tissue-
engineered heart valve from porcine material, elimination of any residual inflammatory
stimulus in the matrix is crucial. In particular, the α-gal epitope is known to be involved 
in rejection of xenogeneic organ transplants and causes hyperacute immune reactions
since high titres of preformed anti--gal antibodies are present in normal humans
(Sandrin & McKenzie, 1994; Kobayashi et al., 1999). The first decellularised porcine
heart valve substitute, SynerGraft, which was commercially introduced in Europe by
CryoLife (Kennesaw, GA), failed early in children with disasterous consequences
because of a severe inflammatory reaction (Simon et al., 2003) which was subsequently
shown to be most likely due to incomplete removal of the α-gal epitope by the 
decellularisation procedure (Kasimir et al., 2005).
The detection of particular cytoskeletal components indicative of particular cell types is
able to provide supportive evidence for the extent of cell removal following
decellularisation. The presence of these components can be determined by
immunohistochemical labelling with antibodies. Alpha-SMA, vWF, desmin and
vimentin represent the cytoskeleton components of the different cell types in the porcine
heart root tissue. Alpha-SMA is present in high amounts in vascular smooth muscle
cells. The protein is localised in microfilament bundles of smooth muscle (Skalli et al.,
1989). vWF is a glycoprotein involved in haemostasis. The basic vWF monomer is a
2050-amino acid protein. It is produced constitutively in endothelium, megakaryocytes,
and subendothelial connective tissue, and expressed in membrane and cellular vesicles.
Thus, vWF is commonly used as a marker for the detection of endothelial cells (Sadler,
1998). Desmin is a protein of 52 kD which has been identified as the constitutive
subunit of the intermediate filaments in skeletal, cardiac, and smooth muscle (Lazarides
& Hubbard, 1976; Small & Sobieszek, 1977; Geisler & Weber, 1982; Li et al., 1997). In
skeletal and cardiac muscles, the staining of desmin is confined to the Z-bands giving a
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characteristic striated appearance. Vimentin is a cytoskeletal component in fibroblasts
and smooth muscle cells.
The ECM is constantly undergoing remodelling (assembly and degradation). It has a
dynamic interaction with the resident cells in response to changes in the
microenvironment. The ECM regulates cell behavior by influencing cell proliferation,
survival, shape, migration and differentiation (Bornstein & Sage, 2002; Daley et al.,
2008; Vorotnikova et al., 2010; Barkan et al., 2010; Crapo et al., 2011). It is highly
likely that the 3-dimensional structure and composition of the ECM both contribute to
these effects. The ECM consists of a complex mixture of structural and functional
proteins. The primary components are fibrous structural proteins (e.g. collagens,
laminins, fibronectin, vitronectin and elastin), specialised proteins (e.g. growth factors,
small matricellular protein) and proteoglycans. The precise composition varies from
tissue to tissue (Badylak, 2002; Daley et al., 2008).
Collagen is the most abundant ECM protein in mammals. Collagens are synthesized by
fibroblasts predominantly, but epithelial cells may also synthesize some collagens.
There are at least 30 different collagen genes in the human genome which combine in a
variety of ways to create over 20 different types of collagen fibrils (Bateman et al.,
1996). Collagen types I, II and III which have a long-recognised characteristic fibre
bundle structure are the most abundant collagen types. Collagen type IV forms a two-
dimensional reticulum and is a major component of the basement membrane. The basic
conformation of collagen is the triple-helix structure. This was first deduced from high
angle x-ray diffraction studies on collagen type I in tendon (Rich & Crick, 1961; Fraser
& MacRae, 1983). Each of the three polypeptide chains in the molecule forms an
extended left-handed helix with 3.3 amino acids per turn, which is stablilised by the
high imino acid content. The three chains are supercoiled around a common axis in a
right-handed way to form the triple-helix. In this helical structure, a glycine residue
occurs every third amino acid. Glycine is the smallest amino acid thus allows the close
packing along the central axis and hydrogen bonding between the three chains.
Therefore, collagens have the general structure of (Glycine-X-Y)n with X and Y
frequently being the amino acids (a.a.) proline and hydroxyproline. The hydroxyproline
is important for stabilising the collagen triple helix structure by the formation of extra
hydrogen bonds. The number of repeats (n) varies in different collagen types. In the
case of the fibrillar collagens, this helix-forming glycine-X-Y repeat is continuous over
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the approximately 1000 amino acid length of the three α-chain subunits of the molecule, 
while the non-fibrillar collagens commonly contain imperfections and non-collagenous
interruptions in the helical sequence (Bateman et al., 1996).
The elastin molecule is a chemically inert and extremely hydrophobic protein. It is
insoluble under most conditions including strong alkali in the fully cross-linked form.
This is because at least 60 % of the a.a. side chains in elastin are non-polar. These
properties of insoluble elastin make it one of the most stable proteins in the body.
Elastic tissues are characterised by their rubber-like properties, including long range
extensibility and the capacity to return to their original dimensions when the stress is
removed (Gleary & Gibson, 1996). Elastin is secreted from the cells as a soluble protein
of 60,000-70,000 molecular weight called tropoelastin. The tropoelastin associates with
fibrillin rich microfibrillar components to allow assembly into elastic fibres. These are
cross-linked within the ECM to form 3-dimentional networks by the action of copper
dependent lysyl oxidase (Ayad et al., 1994). Other properties of elastin include
promotion of cell adhesion and elastin peptides have been shown to be chemotactic
(Ayad et al., 1994; Kielty et al., 2002).
The GAG`s are an important family of highly functionalised, linear, and negatively
charged polysaccharides present in animal tissues which with the exception of
hyaluronic acid are covalently bound to a protein core in macromolecular assemblies
known as proteoglycans (Yeung et al., 2001; Mavrilas et al., 2005). GAG`s play
important roles in the binding of growth factors and cytokines, water retention, and the
gel properties of the ECM. The heparin binding properties of numerous cell surface
receptors and of many growth factors (e.g. fibroblast growth factor family, vascular
endothelial cell growth factor) make the heparin-rich GAG`s essential components of
the ECM as substrates for cell growth (Badylak, 2002; Badylak, 2004). The GAG`s
present in the ECM include chondroitin sulfates A and B, heparin, heparin sulphate and
keratan sulphate (Entwistle et al., 1995; Hodde et al., 1996).
Proteoglycans are proteins substituted with at least one GAG chain (Ayad et al., 1994;
Vogel, 1994). GAG`s in the ECM are linked covalently to a core protein except for the
hyaluronan. The number and length of GAG chains attached to a core protein may vary.
Proteoglycans of the ECM are generally divided into three categories based on the GAG
type: those with chondroitin sulphate or dermatan sulphate chains, those with heparin
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sulphate chains, and those substituted with keratan sulphate. The proteoglycans have
been shown to be important in the physical behaviour of connective tissues. They confer
lubrication either between tissues (joints) or between collagen and elastin fibres (Ayad
et al., 2004).
The ECM plays an important role in heart valve function in maintaining the normal
physical and mechanical properties. The principle ECM components of the native valve
are collagen (type I (~74%), type III (~24%), type V (~2%)), elastin and proteoglycans
(Taylor et al., 2006b). Each component is responsible for the unique physical and
mechanical properties for valve function. The heart valve tissue composes of about 50 %
collagen and 13 % elastin by dry weight (Bashey et al., 1967). Collagen fibrils confer
mechanical and tensile strength, but are stiff with limited extensibility. Elastin is highly
extensible but has very low stiffness, existing as a sponge-like matrix of fibres and
sheets with tubular openings surrounding and interconnecting the collagen fibre bundles.
The elastin in the heart valve leaflets maintains the specific wave-like configuration of
collagen fibre orientation and returns to its original state after loading (Scot & Vesely et
al., 1995; Vesely, 1998). The highly negatively charged GAG side chains of the
proteoglycans produce a hydrated gel-like substance, which allows interaction with
other matrix molecules. In addition, the GAGs are involved in the function and survival
of endothelial and possibly other cells (Taylor et al., 2006b).
Fibronectin is a multifunctional adhesive protein which has a primary role in cell
attachment. It is a large glycoprotein with a size of approximately 450 kDa, and
consisting of two chains held together by disulfide bonds (Ramzi et al., 1999).
Fibronectin exists in a soluble protomeric form in blood plasma and as an insoluble
multimeric form in the ECM. It is produced by fibroblasts, chondrocytes, endothelial
cells and macrophages as well as certain epithelial cells (Hynes, 1990). Fibronectin
contains binding domains for collagen, heparin, some proteoglycans, DNA, hyaluronic
acid, and fibrin (Haralson & Hassell, 1995). The cells bind to fibronectin via receptors
that recognise the specific amino acid sequence of the tripeptide arginine-glycine-
aspartic acid (RGD). The RGD recognition element plays a key role in cell-matrix
adhesion (Ramzi et al., 1999). These structural domains also provide the chemical basis
for the diverse biological functions of fibronectin including the regulation of growth,
differentiation, cell shape, and migration, as well as its interactions with other matrix
components (Haralson & Hassell, 1995; Magnus et al., 1998).
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The reaction of the host to the implantation of natural or synthetic materials may be in
the form of regeneration or rejection. Failure to remove the reagents used during the
decellularisation of the tissue might cause adverse effects such as cytotoxicity and
calcification. SDS detergent used in the decellularisation process in this study is
cytotoxic as it disrupts cell membranes (Newby et al., 2000). EDTA and aprotinin have
also been reported to be cytotoxic (Koulaouzidou et al., 1999; Rakhi et al., 2004). PAA
which was used for sterilisation of the decellularised heart roots in this study has also
been reported to be a potent cytotoxic disinfectant (Sagripanti & Bonifacino, 2000). To
ensure that the reagents used in the decellularisation protocol were removed adequately
from the tissues, it would be necessary to carry out in vitro biocompatibility tests.
The acellular porcine pulmonary valve plus roots used in all of the studies in this
chapter were produced using decellularisation Method 6 (described in Section 3.4.8.1).
The extent of decellularisation, the presence and location of ECM proteins and
cytoskeletal proteins, the presence of antigenic α-gal epitopes and the in vitro
biocompatibility of the decellularised porcine pulmonary root scaffold were assessed in
this Chapter.
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4.2 Aims and objectives
Aims:
The aims of this chapter were to investigate the effects of decellularisation of porcine
pulmonary roots using the method developed in Chapter 3 on the biological
characteristics of the tissue.
Objectives:
 To determine the effects of decellularisation on the histoarchitecture of the
decellularised matrix by comparison with fresh porcine pulmonary roots.
 To determine the effects of decellularisation on the total amount of DNA and the
presence of functional DNA by comparison with fresh porcine pulmonary roots.
 To determine the effects of decellularisation on the presence of specific matrix
and cytoskeletal proteins by comparison with fresh porcine pulmonary roots.
 To determine the presence of α-gal epitope in the decellularised matrix by 
comparison with fresh pulmonary roots.
 To determine the biocompatibility of the acellular scaffold using in vitro
techniques.
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4.3 Methods
Decellularisation of porcine pulmonary roots was performed according to the
methodology described in Section 3.4.8 (Method 6). Six roots were decellularised and
used for histology, immunohistochemistry and investigation of the expression of α-gal. 
Six roots were decellularised and utilised for DNA extraction and PCR analysis.
Another six roots were decellularised and used for contact cytotoxicity (for pulmonary
leaflets) and extract cytotoxicity (for pulmonary arteries) analyses.
4.3.1 Histology
Histology was used to determine the histoarchitecture of the decellularised porcine
pulmonary heart valve conduits. Tissue samples from six decellularised roots from
different animals were fixed with 10 % (v/v) NBF for 24 to 48 h. Histological
evaluation was performed as described in Section 2.2.7. Tissue sections of 10 µm were
prepared longitudinally such that the leaflet, pulmonary artery and myocardium all
appeared on the same tissue section. At least 10 sections were collected every 20
sections, and these sections were all examined by histology to study the effects of
decellularisation. The H&E stain was used to study the tissue architecture and cell
distribution. The Hoechst stain was performed to locate cell nuclei or DNA residues in
the tissue. Miller’s stain was used to identify the distribution of elastin in the tissue. The
Alcian blue stain was used to identify the GAG`s in tissue. The slides were viewed
using light microscopy or fluorescent microscopy with a DAPI filter.
4.3.2 DNA quantification
DNA quantification was used to determine the total remaining DNA in porcine
pulmonary roots following decellularisation. By comparing the DNA levels in
decellularised and the fresh tissue, the efficiency of DNA removal by the
decellularisation process could be determined. The greater extent of DNA removal
during decellularisation the better, however, it is very difficult to remove 100 % of
DNA from the tissue. During decellularisation, the porcine DNA was cleaved into small
fragments by nuclease treatment and fragments removed by the wash procedures. A
small amount of remaining DNA was acceptable as long as it did not contain any coded
functional genes which might be introduced into the patient following implantation. The
effect of decellularisation on DNA removal was therefore further assessed by PCR
Chapter 4
141
using selected functional genes as targets. This was to determine if the remaining DNA
in the tissue after decellularisation contained any large fragments of DNA that may have
been functional.
4.3.2.1 DNA extraction
DNA was extracted from fresh and decellularised porcine pulmonary roots using a
commercially available DNeasy blood and tissue kit from QIAgen.
DNA was extracted from tissues from six fresh and six decellularised porcine
pulmonary roots. DNA was extracted from 4 different regions (leaflet, pulmonary artery,
myocardium, and leaflet connection) of the porcine pulmonary roots. For each region
from each root, triplicate samples were taken for DNA extraction.
Each sample consisted of 25 mg tissue, which was macerated using a scalpel blade and
placed in a sterile 1.5 ml microcentrifuge tube. Buffer ATL (180 µl) and proteinase K
(20 µl), both from the QIAgen kit, were mixed with the macerated tissue by vortexing,
and incubated at 56 °C for three hours or until the tissue was completely digested. Pulse
vortexing (5 to 10 s) was performed every 30 min to disperse the sample. Each sample
was vortexed for 15 s at the end of the incubation. Buffer AL (200 µl) from the QIAgen
kit was added to the sample, and mixed thoroughly immediately by vortexing and 200
µl of ethanol (100 %, v/v) was added, and mixed thoroughly immediately by vortexing.
Each sample was transferred to a separate DNeasy Mini spin column placed in a 2 ml
collection tube, and centrifuged at 6,000 × g for 1 min. The flow-through was discarded
together with the collection tube. The DNeasy Mini spin column was placed in a fresh 2
ml collection tube, and Buffer AW1 (500 µl) was added to the column. The DNeasy
membrane at the bottom of the DNeasy Mini spin column was dried by centrifuging at
15,000 × g for 3 min. The flow-through was discarded together with the collection tube.
The DNeasy Mini spin column was placed in a clean 1.5 ml microcentrifuge tube, and
Buffer AE (200 µl) was added directly to the centre of the DNeasy membrane. After
incubation for 1 min, the 1.5 ml microcentrifuge tube was centrifuged for 1 min at 6,000
× g to elute. The extracted DNA was in Buffer AE in the flow-through. The DNeasy
Mini spin column was discarded. The extracted DNA was subjected to quantification
immediately or stored at – 20 °C until needed.
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4.3.2.2 DNA quantification by spectrophometry
The concentration of extracted DNA was determined spectrophometrically using a
Nanodrop spectrophotometer. Buffer AE (2 µl) was used as a blank. Extracted DNA
sample (2 µl) was loaded onto the Nanodrop, and the absorbance was determined at 260
nm. Three readings were taken for each sample, and the mean was considered as the
absorbance of the sample. The DNA concentration (ng.µl-1) in the sample was directly
displayed in the Nanodrop software. This concentration was used to calculate the DNA
weight/tissue weight (µg/mg) according to:
DNA weight/tissue weight (µg/mg) =
஼ൈଶ଴଴
ଶହൈଵ଴଴଴
where C represents the DNA concentration in the Buffer AE (ng.µl-1). The volume of
the Buffer AE containing extracted DNA was 200 µl. The total weight for each tissue
sample was 25 mg.
The mean ± 95 % C.I. of the DNA weight/tissue weight (µg.mg-1) for each region of
fresh (n=6) or decellularised (n=6) tissue was calculated.
4.3.2.3 Polymerase chain reaction (PCR)
4.3.2.3.1 Target genes and primers
The presence of four functional genes in fresh and decellularised porcine pulmonary
roots was studied: glyceraldehyde 3-phosphate dehydrogenase (GAPDH), swine
leukocyte antigen 2 (SLA-2), β 2-microglobulin and β actin. The complete or partial 
coding sequences were obtained from the nucleotide database
(http://www.ncbi.nlm.nih.gov/nuccore). The coding sequences used in this study are
listed in Appendix 1. Primers were designed using Primer 3 programme (Version 0.4.0)
to have a product length of 150 to 250 base pairs (bp). All primers were custom-made
by Sigma, and made to a working concentration of 20 mM using 1 × Tris-EDTA (TE)
buffer (pH 8.0, 10 mM Tris, 1 mM EDTA). The information for target genes and
primers is shown in Table 4.1.
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Table 4.1 Target genes and primers used for PCR analysis
Target gene Primer sequences 5’ – 3’ Predicted product
length (bp)
GAPDH Forward: GGGCATGAACCATGAGAAGT
Reverse: AAGCAGGGATGATGTTCTGG
230
SLA-2 Forward: ACCTTCCAGAGCATGTACGG
Reverse: CCTTCCCCATCTCCAGGTAT
250
β 2-microglobulin Forward: GAAAAACGGGGAGAAGATG 
Reverse: GTGATGCCGGTTAGTGGTCT
189
β actin Forward: ACATCTGCTGGAAGGTGGAC 
Reverse: ACATCTGCTGGAAGGTGGAC
210
4.3.2.3.2 PCR conditions
For each primer pair, gradient PCR with a range of different melting temperatures (Tm)
was first applied to determine a suitable Tm. PCR was then performed with the suitable
Tm and a suitable concentration of each component. Fresh porcine pulmonary wall
(Valve 3) DNA extract was used for GAPDH gradient PCR, and the fresh porcine
pulmonary leaflet (Valve 1) DNA extract was used for gradient PCR for SLA-2, β 2-
microglobulin and β actin. For each PCR reaction, a blank reaction with all of the 
reaction components except the gene template was included to control for
contamination.
Gradient PCR for GAPDH, SLA-2, β 2-microglobulin and β actin 
The gradient PCR mixture used for GAPDH, SLA-2, β 2-microglobulin and β actin 
genes comprised PCR master mix, nuclease-free water, forward and reverse primers and
the template DNA in the quantities indicated below.
Sample (µl)
PCR master mix (2×) (Fermentas) 25
Nuclease-free water (Fermentas) 21
F primer 1
R primer 1
Template DNA 2
Total 50
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The gradient PCR programme used for GAPDH, SLA-2, β 2-microglobulin and β actin 
genes is given below, with the different Tm ranges for each gene.
STEP Temprature (°C) Time Cycles
Initial denaturation 95 3 min 1
Denaturation 95 30 s
Annealing * 30 s 35
Extension 72 30 s
Final extension 72 10 min 1
End
*: Tm used for GAPDH: 55.4 °C, 56.3 °C, 57.5 °C, 59.2 °C, 61.4 °C, 63.9 °C, 66.1 °C,
67.7 °C; Tm used for SLA-2, β 2-microglobulin and β actin: 53.6 °C, 54.9 °C, 57.0 °C, 
59.6 °C, 62.6 °C, 65.2 °C, 67.2 °C, 68.2 °C.
PCR for GAPDH
The PCR mixture used for GAPDH gene PCR comprised PCR master mix, nuclease-
free water, forward and reverse primers and the template DNA in the quantities shown
below.
Sample (µl) Blank (µl)
PCR master mix (2×) (Fermentas) 25 25
Nuclease-free water (Fermentas) 21 23
F primer 1 1
R primer 1 1
Template DNA 2 0
Total 50 50
The programme used for GAPDH gene PCR is listed below, with 3 min denaturation,
35 cycles of the PCR (annealing temperature: 56 °C) and 10 min final extension.
STEP Temprature (°C) Time Cycles
Initial denaturation 95 3 min 1
Denaturation 95 30 s
Annealing 56 30 s 35
Extension 72 30 s
Final extension 72 10 min 1
End
Chapter 4
145
PCR for SLA-2
The PCR mixture used for SLA-2 gene PCR comprised PCR master mix, nuclease-free
water, forward and reverse primers and the template DNA in the quantities shown
below.
Sample (µl) Blank (µl)
PCR master mix (2×) (Fermentas) 25 25
Nuclease-free water (Fermentas) 23.4 24.4
F primer 0.3 0.3
R primer 0.3 0.3
Template DNA 1 0
Total 50 50
The programme used for SLA-2 gene PCR is shown below, with 3 min denaturation, 35
cycles of the PCR (annealing temperature: 55 °C) and 10 min final extension.
STEP Temprature (°C) Time Cycles
Initial denaturation 95 3 min 1
Denaturation 95 30 s
Annealing 55 30 s 35
Extension 72 30 s
Final extension 72 10 min 1
End
PCR for β 2- microblobulin 
The PCR mixture used for β 2- microblobulin gene PCR comprised PCR master mix, 
nuclease-free water, forward and reverse primers and the template DNA in the
quantities shown below.
Sample (µl) Blank (µl)
PCR master mix (2×) (Fermentas) 25 25
Nuclease-free water (Fermentas) 22.4 24.4
F primer 0.3 0.3
R primer 0.3 0.3
Template DNA 2 0
Total 50 50
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The programme used for β 2- microblobulin gene PCR is shown below, with 3 min
denaturation, 35 cycles of the PCR (annealing temperature: 55 °C) and 10 min final
extension.
STEP Temprature (°C) Time Cycles
Initial denaturation 95 3 min 1
Denaturation 95 30 s
Annealing 55 30 s 35
Extension 72 30 s
Final extension 72 10 min 1
End
PCR for β actin 
The PCR mixture used forβ actin gene PCR comprised PCR master mix, nuclease-free
water, forward and reverse primers and the template DNA in the quantities shown
below.
Sample (µl) Blank (µl)
PCR master mix (2×) (Fermentas) 25 25
Nuclease-free water (Fermentas) 21 23
F primer 1 1
R primer 1 1
Template DNA 2 0
Total 50 50
The programme used for β actin gene PCR is shown below, with 3 min denaturation,
35 cycles of the PCR (annealing temperature: 55 °C) and 10 min final extension.
STEP Temprature (°C) Time Cycles
Initial denaturation 95 3 min 1
Denaturation 95 30 s
Annealing 55 30 s 35
Extension 72 30 s
Final extension 72 10 min 1
End
4.3.2.3.3 DNA agarose gel electrophoresis
Agarose gel electrophoresis was used to identify and separate DNA fragments after
PCR. Commercially available E-gels (Invitrogen) of 0.8 % (for gradient PCR products)
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and 4% (for PCR products) were used. The E-gels contained 0.8 % (w/v) or 4 % (w/v)
agarose and ethidium bromide. The gels were run for 15 min for the 0.8 % gels and 30
min for the 4 % gels at 12 V in an E-gel PowerbaseTM (Invitrogen). The migration rate
of DNA on the agarose gel after electrophoresis corresponded to the molecular size. The
more bp`s the DNA, the slower it migrated on the gel. Quick-Load® PCR marker
(Biolabs) and E-gel® low range quantitative DNA ladders (Invitrogen) were used to
determine the sizes of DNA fragments (Table 4.2 & Table 4.3). By comparing to the
bands of the markers, the sizes of DNA fragments in the samples were determined.
Table 4.2 Quick-Load® PCR marker (Biolabs)
Fragments Quick-Load® PCR marker (Biolabs) (Conc. 30 ng.10 µl-1)
Base pairs Mass (ng)
1 766 62
2 500 40
3 300 48
4 150 61
5 50 89
Table 4.3 E-gel® low range quantitative DNA ladder (Invitrogen)
Fragments E-gel® low range quantitative DNA ladder (Invitrogen)
(Conc. 175 ng. 10 µl-1)
Base pairs Mass (ng)
1 2,000 100
2 800 40
3 400 20
4 200 10
5 100 5
For each sample that was loaded on the gel, 9 µl of PCR product was mixed with 1 µl of
10× Blue JuiceTM gel loading buffer (Invitrogen). The DNA ladder was loaded at 10 µl
per well.
4.3.3 Immunohistochemical evaluation of decellularised pulmonary roots
Specific matrix and cytoskeletal proteins were localised using immunohistochemical
labelling. Fresh (n=6 from separate animals) and decellularised (n=6 from separate
animals) pulmonary root tissue samples were fixed with either 10 % (v/v) NBF or Zinc
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fixation solution and immunohistochemical evaluation was performed as described in
Section 2.2.8. Each tissue sample was serially sectioned at 10 µm and a minimum of 3
sections per sample were evaluated using immunohistochemistry. For each tissue
sample, immunohistochemistry was performed for a section incubated with specific
antibody, a section incubated with an isotype control antibody of the same concentration,
and a section incubated with antibody diluent alone (no primary antibody as a negative
control) at the same time to verify antibody specificity and rule out non-specific
antibody binding. The porcine pulmonary leaflets, pulmonary artery and myocardium
were carefully examined for antibody specific binding. Slides were examined using
light microscopy. The antibodies used in this study were specific to: α-SMA, vWF, 
desmin, vimentin, fibronectin, collagen-IV and α-gal.  
4.3.4 In vitro biocompatibility assays
In order to determine the biocompatibility of the decellularised tissues in vitro,
decellularised porcine pulmonary valve leaflets were assessed using a qualitative
contact cytotoxicity assay and decellularised porcine pulmonary artery wall was
assessed using a quantitative extract cytotoxicity assay. For each assay, two types of
cells were used: 3T3 murine fibroblasts and L929 murine fibroblasts. The cells were
obtained from the European Collection of Animal Cell Cultures and resurrected from
frozen, cultured and passaged as described in Section 2.2.9. 3T3 murine fibroblasts at
passage 11 and L929 murine fibroblasts at passage 24 were used for contact cytotoxicity
assay. 3T3 murine fibroblasts at passage 13 and L929 murine fibroblasts at passage 26
were used for the extract cytotoxicity assay.
4.3.4.1 Contact cytotoxicity assay
Tissue samples (2 of approx 5 mm2) were dissected aseptically from the central part of
each of six leaflets (from different decellularised porcine pulmonary roots). The leaflet
samples were stored in PBS temporarily to avoid dehydration. The samples were
attached to the centre of each well of a six-well tissue culture plate using collagen gel
prepared from rat tails (prepared by Andrew Aldridge) and sterile 0.1 M NaOH (2:1).
The collagen gel took about 20 min to set. A drop of cyanoacrylate contact adhesive
was placed in the centre of control wells (n=3). This was used as a positive control, as it
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has been demonstrated to produce a reproducible cytotoxic response. Collagen gel (20
µl) was carefully added to the centre of negative control wells. The gel was neutralised
with 10 µl of 0.1 M sterile NaOH. This served as a negative control as collagen gel from
rat tail is biocompatible. All the wells containing samples, positive and negative
controls were washed three times using sterile PBS, each for 10 min. Cells (3T3 and
L929) were added to each well at a concentration which allowed the cells to become
approximately 80 % confluent at a final volume of 2 ml (i.e. approximately 3 × 105 cells
per well in DMEM cell culture medium). The plates were covered and incubated at
37 °C in 5 % (v/v) CO2 in air for 48 h. Following incubation, the culture medium was
carefully aspirated, and the wells were gently washed using PBS containing calcium and
magnesium. The cell layers were fixed with 10 % (v/v) NBF for 10 min. Following
fixation, the 10 % (v/v) NBF was carefully aspirated and the cell monolayers were
stained using Giemsa solution (2 ml per well) for 5 min. The wells were then gently
rinsed with running tap water until the water ran clear. The plates were air dried at room
temperature before microscopy. A bright-field microscope was used to observe any
changes in cell morphology and density.
4.3.4.2 Extract cytotoxicity assay
4.3.4.2.1 Extract cytotoxicity assay
Pulmonary arteries (n=6, from separate animals) from decellularised porcine pulmonary
roots were finely macerated and placed into sterile 1.5 microcentrifuge tubes. The tubes
containing tissue were re-weighed to determine the weight of tissue. DMEM (1ml per
100 mg tissue) was added before incubation at 37 °C for 72 h on a blood rotator at 30
rpm. Following incubation, the tissue-containing microcentrifuge tubes were
centrifuged at 15,000 × g for 15 min. The supernatants (tissue extracts) were collected.
The sterility of the tissue extracts was checked by plating onto agar plates. Three types
of plate were used for each sample: nutrient agar (NA, plates incubated at 37 °C for 48
h), heated blood agar (HBA, plates incubated at 37 °C for 48 h), and Saboraud dextrose
agar (SAB, plates incubated at 30 °C for 72 h). The tissue extracts were stored at –
20 °C until needed. Cells (3T3 of P13 and L929 of P26) were seeded into a 96-well
plate at a confluence of approximately 80 % (approximately 1 × 104 cells per well), and
incubated overnight at 37 °C in 5% (v/v) CO2 in air. The tissue extracts were thawed at
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37 °C on the day of test. The cell culture medium was aspirated from the 96-well plate,
and replaced with 100 µl of DMEM containing 20% (v/v) FBS, 200 U.ml-1 penicillin,
200 U.ml-1 streptomycin, and 200 µM L-glutamine. Test reagents of 100 µl (the tissue
extracts, n=6 for each root) were added to appropriate wells. The positive controls (n=6)
consisted of 200 µl 40 % (v/v) DMSO in DMEM. The negative controls (n=6) consisted
of 200 µl cell culture medium alone. The 96-well plates with cells were incubated at
37 °C in 5 % (v/v) CO2 in air for 48 h. The cell viability was then determined using the
ATPLite-M® assay.
4.3.4.2.2 ATPLite-M® assay for cell viability
Solutions:
 Mammalian cell lysis solution: stored at 4 °C.
 Substrate solution: one vial of lyophilised substrate solution was reconstituted
by adding 25ml of substrate buffer. The substrate solution was made into 5 ml
aliquots and stored at -20 °C in the dark.
Methods:
The ATPLite-M® assay was used to determine cell viability following the
manufacture’s instruction. ATPLite-M® reagents were allowed to warm to room
temperature. For each well containing cells in the 96-well plate, the original culture
medium was aspirated from the well, and 50 µl of fresh cell culture medium added to
each well. Mammalian cell lysis solution (50 µl) was added into each well and
incubated at room temperature with agitation at 500 rpm for 5 min. Solution (100 µl)
from each well was then transferred into a 96-well OptiplateTM. Substrate solution (50
µl) was added to each well and the OptiplateTM was agitated at 500 rpm for five min.
The luminescence was measured using TopCountTM. Data was expressed as counts per
minute (cpm).
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4.4 Results
4.4.1 Histological evaluation of decellularised porcine pulmonary roots
Histology was used to determine if the decellularisation process affected the
histoarchitecture of the porcine pulmonary roots and the extent of decellularisation.
Tissue sections were stained with H&E (Figure 4.1), Hoechst (Figure 4.2), Miller’s
(Figure 4.3) and Alcian blue (Figure 4.4).
No blue stained cells were observed in any of the sections following H&E staining
(Figure 4.1) of the decellularised porcine pulmonary roots. Pink/red stained connective
tissue (collagen and elastin) was observed in the pulmonary leaflet, pulmonary artery
and myocardium. In the porcine pulmonary leaflet (Figure 4.1 A), there was more
collagen and elastin distributed in the ventricularis and fibrosa layers than the
spongiosa layer, since the red staining was deeper in ventricularis and fibrosa but
lighter in spongiosa. The structure of the ventricularis and the fibrosa appeared to be
more organised and more compact than the spongiosa. The myocardium bundles were
regularly arranged as shown in Figure 4.1 B. No damage to the pulmonary artery, either
the luminal side or the adventitial layer, was observed as shown in Figure 4.1 C and
Figure 4.1D. The connective tissue structure was aligned parallel to the long axis of the
pulmonary artery. In the leaflet connection area, the histoarchitecture seemed to be
intact (Figure 4.1 E). No damage was observed to the structure of connective tissue.
Images of the decellularised pulmonary root tissue stained with Hoechst are shown in
Figure 4.2. No fluorescence indicating cell nuclei was observed throughout the whole
pulmonary roots. This result provided further evidence of removal of cells from porcine
pulmonary roots after decellularisation. The ECM was stained brighter with Hoechst in
the myocardium (Figure 4.2 B) than in the pulmonary leaflet and artery (Figure 4.2 A, C,
D). In Miller’s stained images (Figure 4.3), it was observed that a large amount of
elastin fibres was distributed in the pulmonary wall (Figure 4.3 C). The ventricularis
seemed to have larger elastin content than the fibrosa. After Alcian blue staining, blue
coloured GAG`s were not readily observed in the leaflet and pulmonary wall tissues
(Figure 4.4 A, C), but were evident in the leaflet connection and in the myocardium
(Figure 4.4 B, D).
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Figure 4.1 Sections of decellularised porcine pulmonary root tissue stained with
H&E. (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Leaflet connection, 100 ×. M:
myocardium; L: leaflet. Scale bars are: all 200 µm.
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Figure 4.2 Sections of decellularised porcine pulmonary root tissue stained with
Hoechst. (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Leaflet connection, 100 ×. M:
myocardium; L: leaflet. Scale bars are: all 200 µm.
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Figure 4.3 Sections of decellularised porcine pulmonary root tissue stained with
Miller’s. (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B)
Myocardium, 100 ×; (C) The pulmonary wall, 40 ×; (D) Leaflet connection, 40 ×. M:
myocardium; L: leaflet. Scale bars are: (A), (B) 200µm; (C), (D) 500 µm.
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Figure 4.4 Sections of decellularised porcine pulmonary root tissue stained with
Alcian blue. (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa);
(B) Myocardium, 100 ×; (C) The pulmonary wall, 100 ×; (D) Leaflet connection, 100 ×.
M: myocardium; L: leaflet. Scale bars are: all 200 µm.
4.4.2 DNA content analysis of fresh and decellularised porcine pulmonary roots
4.4.2.1 DNA spectrophometry
The DNA extracted from fresh and decellularised porcine pulmonary roots was
quantified using nanodrop spectrophotometry. The results are shown in Figure 4.5 and
Table 4.4. For all of the four regions (leaflet, pulmonary artery, myocardium, and leaflet
connection) of decellularised porcine pulmonary roots (n=6 from different animals)
there was a significant reduction in DNA content compared to fresh samples (p<0.05,
students t-test). Greater than 90 % of the DNA was removed from the porcine
pulmonary roots after decellularisation.
Chapter 4
156
Figure 4.5 DNA content of fresh and decellularised porcine pulmonary root tissue
determined by Nanodrop spectrophotometry at 260 nm. Data is presented as the
mean (n=6) ± 95 % C.I.. Data was analysed using the students t-test, which showed a
significant reduction of DNA content in decellularised tissue compared to the fresh
tissue of the same region (p<0.05 *).
Table 4.4 DNA content of fresh (n=6) and decellularised (n=6) porcine pulmonary
root tissue determined by Nanodrop spectrophotometry at 260 nm (mean ± 95 %
C.I.) and percentage of DNA removal after decellularisation.
DNA content of fresh
tissue (µg.mg-1)
DNA content of
decellularised tissue
(µg.mg-1)
Percentage of DNA
removal (%)
Leaflet 0.187±0.021 0.016±0.003 91.27
Wall 0.228±0.029 0.020±0.006 91.04
Myocardium 0.193±0.019 0.019±0.004 90.10
Connection 0.197±0.020 0.020±0.004 90.01
4.4.2.2 PCR
4.4.2.2.1 Gradient PCR results for GAPDH, SLA-2, β 2-microglobulin and β actin 
Gradient PCR with a range of different Tm was used to determine the suitable PCR
conditions for each gene. The agarose gel image for GAPDH gradient PCR is shown in
Figure 4.6. Different Tm`s of 55.4 °C to 67.7 °C were used. The PCR product was
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detected in Lane 2-7. The product band was most obvious in Lanes 2-4 (which had a
Tm range of 55.4°C to 57.5°C). It was decided from this result that 56 °C was to be
used as the melting temperature for GAPDH PCR.
The agarose gel image for SLA-2 is shown in Figure 4.7. Tm`s of 53.6 °C to 68.2 °C
were used. The PCR product was detected in Lanes 2-7. The product band appeared to
be most bright in lane 3 (which had a Tm of 54.9 °C). It was decided from this result
that 55 °C was to be used as the melting temperature for SLA-2 PCR.
The agarose gel image for β 2-microglobulin is shown in Figure 4.8. Tm`s of 53.6 °C to 
68.2 °C were used. The PCR product band was observed on Lane 2-7. The clearest
bands were observed in Lane 2-5 (which had a Tm range of 53.6 °C to 59.6 °C). It was
decided from this result that 55 °C was to be used as the melting temperature for β 2-
microglobulin PCR.
The agarose gel image for β actin is shown in Figure 4.9. Tm’s for gradient PCR ranged 
from 53.6 °C to 68.2 °C. The PCR product band was observed in all of the lanes that
loaded with samples (Lane 2-9). In Lane 2-7, a second band was observed on the gel at
around 150 bp. The PCR product seemed to have the highest concentration in Lane 3
(Tm=57.0 °C). However, since the concentration of the second band was also the
highest, the Tm for Lane 2 (54.9 °C) was considered as a better option because at this
melting temperature, the PCR product had a clear band whilst the unwanted band was
less clear. It was decided 55 °C was to be used as the melting temperature for β actin 
PCR.
Figure 4.6 Gradient PCR products for GAPDH on a 0.8 % E gel. Lane 1: E-gel®
low range quantitative DNA ladder (Invitrogen); Lane 2-9: DNA from fresh porcine
pulmonary wall with Tm of 55.4 °C, 56.3 °C, 57.5 °C, 59.2 °C, 61.4 °C, 63.9 °C,
66.1 °C, and 67.7 °C. Lane 2-7 showed a band at around 600bp on the gel.
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Figure 4.7 Gradient PCR products for SLA-2 on a 0.8 % E gel. Lane 1: Quick-
Load® PCR marker (Biolabs); Lane 2-9: DNA from fresh porcine pulmonary leaflet
with Tm of 53.6 °C, 54.9 °C, 57.0 °C, 59.6 °C, 62.6 °C, 65.2 °C, 67.2 °C, and 68.2 °C.
Lane 2-7 showed a band at around 250 bp on the gel.
Figure 4.8 Gradient PCR products for β 2-microglobulin on a 0.8 % E gel. Lane 1:
Quick-Load® PCR marker (Biolabs); Lane 2-9: DNA from fresh porcine pulmonary
leaflet with Tm of 53.6 °C, 54.9 °C, 57.0 °C, 59.6 °C, 62.6 °C, 65.2 °C, 67.2 °C, and
68.2 °C. Lane 2-7 showed a band at around 760 bp on the gel.
Figure 4.9 Gradient PCR products for β actin on a 0.8 % E gel. Lane 1: Quick-
Load® PCR marker (Biolabs); Lane 2-9: DNA from fresh porcine pulmonary leaflet
with Tm of 53.6 °C, 54.9 °C, 57.0 °C, 59.6 °C, 62.6 °C, 65.2 °C, 67.2 °C, and 68.2 °C.
Lane 2-9 showed a band at around 300 bp on the gel.
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4.4.2.2.2 PCR results for GAPDH, SLA-2, β 2-microglobulin and β actin 
PCR was used to detect the presence of functional genes in DNA extracted from fresh
and decellularised porcine pulmonary roots. The gel image of GAPDH PCR is shown in
Figure 4.10. A clear band localised at around 600 bp was observed in DNA extracted
from fresh porcine pulmonary leaflet, artery, myocardium and leaflet connection tissue.
No band was observed in the decellularised samples or the blank reaction.
The gel image of SLA-2 PCR is shown in Figure 4.11. A clear band of a size around
250 bp was observed in fresh porcine pulmonary leaflet, artery, myocardium and leaflet
connection. No band was observed in DNA extracted from the decellularised samples or
the blank reaction.
The gel image of β 2-microglobulin PCR is shown in Figure 4.12. A clear band of 
around 760 bp was observed in DNA extracted from fresh porcine pulmonary leaflet,
artery, myocardium and leaflet connection tissue. No band was observed in the PCR
product with template DNA from decellularised tissue or the blank reaction.
The gel image of β actin PCR is shown in Figure 4.13. A clear band of around 300 bp 
was observed in DNA extracted from fresh porcine pulmonary leaflet, artery,
myocardium and leaflet connection tissue. No band was observed in the PCR product
with template DNA from decellularised tissue or the blank reaction.
Figure 4.10 PCR products for GAPDH on a 4 % E gel. Lane 1: Quick-Load® PCR
marker (Biolabs); Lane 2-5: fresh porcine pulmonary leaflet, fresh porcine pulmonary
wall, fresh porcine myocardium, fresh porcine pulmonary leaflet connection; a band at
around 600 bp is present on the gel. Lane 6-9: decellularised porcine pulmonary leaflet,
decellularised porcine pulmonary wall, decellularised porcine myocardium,
decellularised porcine pulmonary leaflet connection; no band is present on the gel. Lane
10: blank; no band is present on the gel.
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Figure 4.11 PCR products for SLA-2 on a 4 % E gel. Lane 1: Quick-Load® PCR
marker (Biolabs); Lane 2-5: fresh porcine pulmonary leaflet, fresh porcine pulmonary
wall, fresh porcine myocardium, fresh porcine pulmonary leaflet connection; a band at
around 250 bp is present on the gel. Lane 6-9: decellularised porcine pulmonary leaflet,
decellularised porcine pulmonary wall, decellularised porcine myocardium,
decellularised porcine pulmonary leaflet connection; no band is present on the gel. Lane
10: blank; no band is present on the gel.
Figure 4.12 PCR products for β 2-microglobulin on a 4 % E gel. Lane 1: Quick-
Load® PCR marker (Biolabs); Lane 2-5: fresh porcine pulmonary leaflet, fresh porcine
pulmonary wall, fresh porcine myocardium, fresh porcine pulmonary leaflet connection;
a band at around 760 bp is present on the gel. Lane 6-9: decellularised porcine
pulmonary leaflet, decellularised porcine pulmonary wall, decellularised porcine
myocardium, decellularised porcine pulmonary leaflet connection; no band is present on
the gel. Lane 10: blank; no band is present on the gel.
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Figure 4.13 PCR products for β actin on a 4 % E gel. Lane 1: Quick-Load® PCR
marker (Biolabs); Lane 2-5: fresh porcine pulmonary leaflet, fresh porcine pulmonary
wall, fresh porcine myocardium, fresh porcine pulmonary leaflet connection; a band at
around 300 bp is present on the gel. Lane 6-9: decellularised porcine pulmonary leaflet,
decellularised porcine pulmonary wall, decellularised porcine myocardium,
decellularised porcine pulmonary leaflet connection; no band is present on the gel. Lane
10: blank; no band is present on the gel.
4.4.3 Immunohistochemical evaluation of fresh and decellularised porcine
pulmonary roots
Antibody labelling was used to localise specific proteins in porcine pulmonary roots. By
comparing the images of the fresh and decellularised samples, it was possible to
determine if there was any change in specific matrix and cytoskletetal components and
the extent removal of the α-gal epitope during the decellularisation process.  
4.4.3.1 Alpha smooth muscle actin (α-SMA) 
The images of porcine pulmonary root tissue sections labelled with antibody to α-SMA 
are shown in Figure 4.14. The surfaces of fresh porcine pulmonary leaflet were stained
brown (positive with α-SMA antibody) especially the ventricular surface (Figure 4.14 
A). The cells within the pulmonary artery were also stained with a deep brown colour,
with the ECM of the pulmonary artery stained a light brown colour. The blood vessels
within the myocardium and the pulmonary artery were also stained positive (Figure 4.14
D, Figure 4.14 G). No brown coloured staining was observed in the decellularised
leaflet, myocardium or wall (Figure 4.14 B, E, and H). The ECM of the decellularised
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porcine pulmonary root had background staining of brown colour, which appeared more
positive than the isotype control for the leaflet and wall tissue (Figure 4.14).
Figure 4.14 Localisation of α-SMA in fresh and decellularised porcine pulmonary 
root tissue. (A) Fresh pulmonary valve leaflet, 100 ×, the arrow indicates the
ventricular side of the pulmonary leaflet that has been positively stained; (B)
Decellularised pulmonary valve leaflet, 100 ×; (C) Decellularised pulmonary valve
leaflet isotype control, 100 ×; (D) Fresh myocardium, 100 ×, the arrow indicates a blood
vessel in the myocardium that has been positively stained; (E) Decellularised
myocardium, 100 ×; (F) Decellularised myocardium isotype control, 100 ×; (G) The
lumen surface of the fresh pulmonary wall, 100 ×; (H) The lumen surface of the
decellularised pulmonary wall, 100 ×; (I) The lumen surface of the decellularised
pulmonary wall isotype control, 100 ×. v: ventricularis; s: spongiosa; f: fibrosa; M:
myocardium; L: leaflet. Scale bars are: all 200 µm.
4.4.3.2 Von Willebrand factor (vWF)
The images of porcine pulmonary root tissue sections stained with antibodies to vWF
are shown in Figure 4.15. Positive staining (brown colour) were observed in the
endothelial layers of the fresh pulmonary leaflets (Figure 4.15 A), as well as the
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endothelial layer of the lumen of the fresh pulmonary artery (Figure 4.15 G). The small
blood vessels within the fresh myocardium and the connective tissue layer of the
adventitia of the fresh pulmonary artery were also positively stained (Figure 4.15 D, J).
No positive staining was observed in the decellularised porcine pulmonary roots (Figure
4.15 B, E, H, K) or the isotype control sections (Figure 4.15 C, F, I, L).
4.4.3.3 Desmin
Images of porcine pulmonary root tissue sections labelled with antibodies to desmin are
shown in Figure 4.16. The myocardium tissue was stained brown for both fresh and
decellularised sections (Figure 4.16 D, E). Some small brown coloured areas were
observed within the connective tissue layer on the adventitia of fresh pulmonary artery
(Figure 4.16 J). No brown colour was observed in the sections stained with the isotype
control.
4.4.3.4 Vimentin
The results of porcine pulmonary root tissue labelled with antibodies to vimentin are
shown in Figure 4.17. Cells throughout the fresh porcine pulmonary leaflet,
myocardium and artery were stained brown (Figure 4.17 A, D, G, J). No positive
staining was observed throughout the decellularised tissue (Figure 4.17 B, E, H, K). No
brown colour was observed in the sections stained with the isotype control.
4.4.3.5 Fibronectin
Following labelling using a monoclonal antibody against fibronectin, the results
indicated that the fresh and decellularised porcine pulmonary root tissues were stained
positive throughout (Figure 4.18). The fresh pulmonary leaflets and wall were more
intensely stained compared to the decellularised leaflets and wall, however the staining
in the fresh and decellularised myocardium was similar. The darkest colour was
observed in the surfaces of the pulmonary leaflets and arteries in both fresh and
decellularised tissue sections. The regions close to the surfaces of decellularised
pulmonary artery had a lighter brown colour than the centre of the pulmonary artery
(Figure 4.18 H, K). Minimal brown colour was observed in the sections stained with the
isotype control.
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Figure 4.15 Localisation of vWF in fresh and decellularised porcine pulmonary
root tissue. (A) Fresh pulmonary valve leaflet, 100 ×, the arrows indicate the surfaces
of pulmonary leaflet that has been positively stained; (B) Decellularised pulmonary
valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype control, 100 ×;
(D) Fresh myocardium, 100 ×, the arrow indicates a blood vessel in the myocardium
that has been positively stained; (E) Decellularised myocardium, 100 ×; (F)
Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the fresh
pulmonary wall, 200 ×, the arrow indicates the surface cell layer of pulmonary wall that
has been positively stained; (H) The lumen surface of the decellularised pulmonary wall,
100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control, 100
×; (J) The adventitial surface of the fresh pulmonary wall, 100 ×, the arrow indicates a
blood vessel that has been positively stained; (K) The adventitial surface of the
decellularised pulmonary wall, 100 ×; (L) The adventitial surface of the decellularised
pulmonary wall isotype control, 100 ×. v: ventricularis; s: spongiosa; f: fibrosa; M:
myocardium; L: leaflet. Scale bars are all 200 µm except for (G), 100 µm.
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Figure 4.16 Localisation of desmin in fresh and decellularised porcine pulmonary
root tissue. (A) Fresh pulmonary valve leaflet, 100 ×; (B) Decellularised pulmonary
valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype control, 100 ×;
(D) Fresh myocardium, 100 ×; (E) Decellularised myocardium, 100 ×; (F)
Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the fresh
pulmonary wall, 100 ×; (H) The lumen surface of the decellularised pulmonary wall,
100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control, 100
×; (J) The adventitial surface of the fresh pulmonary wall, 100 ×; (K) The adventitial
surface of the decellularised pulmonary wall, 100 ×; (L) The adventitial surface of the
decellularised pulmonary wall isotype control, 100 ×. v: ventricularis; s: spongiosa; f:
fibrosa; M: myocardium; L: leaflet. Scale bars are: all 200 µm.
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Figure 4.17 Localisation of vimentin in fresh and decellularised porcine pulmonary
root tissue. (A) Fresh pulmonary valve leaflet, 100 ×; (B) Decellularised pulmonary
valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype control, 100 ×;
(D) Fresh myocardium, 100 ×; (E) Decellularised myocardium, 100 ×; (F)
Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the fresh
pulmonary wall, 100 ×; (H) The lumen surface of the decellularised pulmonary wall,
100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control, 100
×; (G) The adventitial surface of the fresh pulmonary wall, 100 ×; (H) The adventitial
surface of the decellularised pulmonary wall, 100 ×; (L) The adventitial surface of the
decellularised pulmonary wall isotype control, 100 ×. v: ventricularis; s: spongiosa; f:
fibrosa; M: myocardium; L: leaflet. Scale bars are: 200 µm.
Chapter 4
167
Figure 4.18 Localisation of fibronectin in fresh and decellularised porcine
pulmonary root tissue. (A) Fresh pulmonary valve leaflet, 100 ×; (B) Decellularised
pulmonary valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype
control, 100 ×; (D) Fresh myocardium, 100 ×; (E) Decellularised myocardium, 100 ×;
(F) Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the
fresh pulmonary wall, 100 ×; (H) The lumen surface of the decellularised pulmonary
wall, 100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control,
100 ×; (J) The adventitial surface of the fresh pulmonary wall, 100 ×; (K) The
adventitial surface of the decellularised pulmonary wall, 100 ×; (L) The adventitial
surface of the decellularised pulmonary wall isotype control, 100 ×. v: ventricularis; s:
spongiosa; f: fibrosa; M: myocardium; L: leaflet. Scale bars are: all 200 µm.
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4.4.3.6 Collagen IV
The results of porcine pulmonary root tissue labelled with antibody to collagen IV are
shown in Figure 4.19. A brown line was observed on the surfaces of the fresh porcine
pulmonary leaflets (Figure 4.19 A) as well as the lumen surface of the fresh pulmonary
artery (Figure 4.19 G). Positive staining was also observed in the blood vessels within
the connective tissue layer outside the adventitia of fresh porcine pulmonary artery
(Figure 4.19 J). Following decellularisation, no evidence of the presence of collagen IV
was found in any location within the porcine pulmonary root (Figure 4.19 B, E, H, K).
No brown colour was observed in the sections stained with the isotype control.
4.4.3.7 α-gal 
Images of porcine pulmonary root tissue labelled with antibody to α-gal are shown in 
Figure 4.20. The endothelial layer of the pulmonary leaflet and VIC`s (Figure 4.20 A)
and the small blood vessels in the myocardium (Figure 4.20 D) were stained brown. No
brown colour was observed in the pulmonary artery (Figure 4.20 G). No evidence of
positive staining was observed throughout the decellularised porcine pulmonary roots
(Figure 4.20 B, E, H). No brown colour was observed in the sections stained with the
isotype control.
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Figure 4.19 Localisation of collagen IV in fresh and decellularised porcine
pulmonary root tissue. (A) Fresh pulmonary valve leaflet, 100 ×, the arrow indicated
the surface of pulmonary leaflet that has been positively stained; (B) Decellularised
pulmonary valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype
control, 100 ×; (D) Fresh myocardium, 100 ×; (E) Decellularised myocardium, 100 ×;
(F) Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the
fresh pulmonary wall, 100 ×, the arrow indicated the surface layer of pulmonary wall
that has been positively stained; (H) The lumen surface of the decellularised pulmonary
wall, 100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control,
100 ×; (J) The adventitial surface of the fresh pulmonary wall, 100 ×, the arrow
indicates a blood vessel that has been positively stained; (K) The adventitial surface of
the decellularised pulmonary wall, 100 ×; (L) The adventitial surface of the
decellularised pulmonary wall isotype control, 100 ×. V: ventricularis; s: spongiosa; f:
fibrosa; M: myocardium; L: leaflet. Scale bars are: all 200 µm.
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Figure 4.20 Localisation of α-gal in fresh and decellularised porcine pulmonary 
root tissue. (A) Fresh pulmonary valve leaflet, 100 ×; (B) Decellularised pulmonary
valve leaflet, 100 ×; (C) Decellularised pulmonary valve leaflet isotype control, 100 ×;
(D) Fresh myocardium, 100 ×; (E) Decellularised myocardium, 100 ×; (F)
Decellularised myocardium isotype control, 100 ×; (G) The lumen surface of the fresh
pulmonary wall, 100 ×; (H) The lumen surface of the decellularised pulmonary wall,
100 ×; (I) The lumen surface of the decellularised pulmonary wall isotype control, 100
×. v: ventricularis; s: spongiosa; f: fibrosa; M: myocardium; L: leaflet. Scale bars are:
all 200 µm.
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4.4.4 In vitro biocompatibility assays
Contact cytotoxicity assay and extract cytotoxicity assay were used in this study to
evaluate the in vitro biocompatibility of the decellularised porcine pulmonary root tissue.
The effect of the decellularised tissue on the cell growth (murine 3T3 fibroblasts and
murine L929 fibroblasts) was evaluated.
4.4.4.1 Contact cytotoxicity assay
The contact cytotoxicity assay was used to study the in vitro biocompatibility of the
decellularised porcine pulmonary valve leaflets by culturing cells directly in contact
with the tissue. The images (Figure 4.21; Figure 4.22) taken by microscopy recorded the
cell growth and morphology after culture. When 3T3 cells and L929 cells were cultured
with cyanoacrylate contact adhesive (positive control), no evidence of cells was found
in a circular area around the adhesive. Cells started to appear at about 1,500 µm far
from the edge of the cyanoacrylate contact adhesive (Figure 4.21 A; Figure 4.22 A).
Collagen gel (negative control) had no effect on either of the cell types that were used in
this study (Figure 4.21 B; Figure 4.22 B). Cells were able to grow to the edge and into
the collagen gel. The contact cytotoxicity results of the 6 porcine pulmonary roots
indicated the decellularised leaflets had no effect in changing the cell growth or cell
morphology for both cell types (Figure 4.21 C, D, E, F, G, H; Figure 4.22 C, D, E, F, G,
H). Cells grew in contact with the decellularised tissue. No difference was observed
between the morphology of cells cultured with decellularised porcine pulmonary leaflets
and cell cultured with the collagen gel.
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Figure 4.21 Contact cytotoxicity assays of decellularised porcine pulmonary valve
leaflets following 48 h culture with murine 3T3 fibroblasts. (A) Cyanoacrylate
contact adhesive (positive control), 40 ×, the arrow indicates cells; (B) Collagen gel
(negative control), 40 ×; (C) Porcine pulmonary valve leaflet 1, 40 ×; (D) Porcine
pulmonary valve leaflet 2, 40 ×; (E) Porcine pulmonary valve leaflet 3, 40 ×; (F)
Porcine pulmonary valve leaflet 4, 40 ×; (G) Porcine pulmonary valve leaflet 5, 40 ×;
(H) Porcine pulmonary valve 6, 40 ×. L: leaflet. Scale bars are: all 500 µm.
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Figure 4.22 Contact cytotoxicity assays of decellularised porcine pulmonary valve
leaflets following 48 h culture with murine L929 fibroblasts. (A) Cyanoacrylate
contact adhesive (positive control), 40 ×, the arrow indicates cells; (B) Collagen gel
(negative control), 40 ×; (C) Porcine pulmonary valve leaflet 1, 40 ×; (D) Porcine
pulmonary valve leaflet 2, 40 ×; (E) Porcine pulmonary valve leaflet 3, 40 ×; (F)
Porcine pulmonary valve leaflet 4, 40 ×; (G) Porcine pulmonary valve leaflet 5, 40 ×;
(H) Porcine pulmonary valve 6, 40 ×. L: leaflet. Scale bars are: all 500 µm.
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4.4.4.2 Extract cytotoxicity assay
The extract cytotoxicity assay was used to determine the effect of soluble components
of decellularised porcine pulmonary artery on the viability of 3T3 cells and L929 cells.
The relative ATP levels of cells following culture with tissue extracts are shown in
Figure 4.23 (for murine 3T3 fibroblasts) and Figure 4.24 (for murine L929 fibroblasts).
Data was analysed using one way ANOVA. The relative ATP levels were significantly
lower in the positive control (cultured with DMSO; p<0.05) compared to the negative
control (cells cultured in cell culture medium) for both cell types. The mean relative
ATP content of the cells cultured with the 6 decellularised porcine pulmonary artery
extracts showed no significance difference compared with the negative control for both
cell types. When comparing the relative ATP level between individual decellularised
pulmonary roots and the negative control, a significant reduction in ATP levels was
observed in 3 out of 6 decellularised pulmonary artery extracts cultured with 3T3 cells.
No significant difference was observed between individual decellularised pulmonary
artery extracts and the negative control when cultured with L929 cells.
Figure 4.23 Cell viability of murine 3T3 fibroblasts following 72 h cultured in vitro
with decellularised porcine pulmonary artery extracts. Data is presented as the mean
(n=6) ± 95 % confidence limits. Data was analysed using one way ANOVA followed by
calculation of the MSD by the T-method (p<0.05). +: DMSO positive control; -: cell
culture medium negative control. “*” indicates a significant difference when compared
with the negative control group.
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Figure 4.24 Cell viability of murine L929 fibroblasts cultured in vitro with
decellularised porcine pulmonary arteries extracts following 72 h. Data is presented
as the mean (n=6) ± 95 % confidence limits. Data was analysed using one way ANOVA
followed by calculation of the MSD by the T-method (p<0.05). +: DMSO positive
control; -: cell culture medium negative control. “*” indicates a significant difference
when compared with the negative control group.
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4.5 Discussion
In this chapter, the biological characteristics of the acellular porcine pulmonary roots
were evaluated and compared to fresh tissues. The decellularisation method used to
obtain the acellular tissue in this chapter was referred to as ‘Method 6’ in Chapter 3.
This method involved trypsin treatment of the adventitial surface of the scraped
pulmonary artery, together with 1 cycle of SDS-hypotonic buffer treatment and 2 cycles
of nuclease treatment. This method was developed with care to remove the cells while
causing minimal damage to the ECM.
Histology was used to evaluate the extent of decellularisation and the integrity of the
ECM. H&E and Hoechst stained images showed no evidence of cell presence in the
decellularised tissue, which indicated the removal of cells throughout the decellularised
porcine pulmonary roots. H&E staining showed no evidence of damage to the
decellularised tissue, and the histoarchitecture of the ECM was not altered following
decellularisation. The connective tissue distribution in the acellular porcine pulmonary
valve leaflet was comparable to the fresh tissue. The density of connective tissue
(pink/red in H&E stain) in the leaflets was much higher in the fibrosa and ventricularis
than that in spongiosa. The myocardium bundles and the pulmonary artery structure
were not changed after decellularisation. The elastin fibre distribution was not altered
after decellularisation as revealed by Miller’s staining. However, an absence of GAG`s
was observed in acellular pulmonary leaflet and artery tissues following Alcian blue
staining. This revealed a difference from the fresh tissue, in which GAG`s were
observed in the leaflets, pulmonary wall and the leaflet connection. This indicated a
significant amount of GAG was lost during the decellularisation procedure. A similar
finding was reported by Miradraee (2005) for human pericardium tissue
decellularisation, Stapleton (2008) for porcine meniscus tissue decellularisation and
Cheng et al. (2009) in porcine cartilage. In the above studies, SDS was also used as a
detergent during decellularisation. SDS has been reported to remove GAG`s from tissue
(Gilbert et al., 2006; Yang et al., 2010). The lost of GAG`s may have aided the success
in decellularisation because the removal of GAG`s would allow increased access of the
decellularisation reagents to diffuse into the tissue. GAG`s are, however, very important
components in the loosely arranged spongiosa layer of the porcine pulmonary leaflets,
and are believed to perform an important role in the integrity and mechanical properties
of the leaflets. Thus, although no evidence of change in the structure of the leaflet ECM
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was observed by histology, it will be essential to evaluate the hydrodynamic properties
of the acellular porcine pulmonary root, in order to assess the functional significance of
GAG loss.
The amount of DNA removal is very important in evaluating the success of
decellularisation. DNA was extracted and the total quantities of DNA in fresh (n=6) and
decellularised (n=6) porcine pulmonary roots were quantified by spectrophotometry at
260 nm, which is the most straight-forward method for DNA quantification. The fresh
samples demonstrated around 0.2 µg DNA per mg tissue. After decellularisation, the
DNA content demonstrated a reduction of more than 90 % throughout the porcine
pulmonary root tissue. The majority of DNA was therefore successfully removed after
decellularisation. A limitation of this method was: the DNA concentration detected by
Nanodrop spectrophotometry is only accurate when it reaches a certain level. The
lowest end of sensitivity of the nanodrop spectrophotometer is 2 ng.µl-1, which was very
close to the readings for decellularised samples. Thus, it is highly likely that the actual
amount of DNA removed following decellularisation was even greater than the
percentage presented in this study. In future studies, the amount of DNA in tissue could
be assessed by extracting DNA from a greater mass of decellularised tissue, in order to
obtain more accurate result of the DNA removal effect of decellularisation.
PCR was used to determine target gene expression in porcine pulmonary root tissue.
Housekeeping genes of GAPDH (involved in carbohydrate metabolism), SLA-2
(porcine histocompatibility antigen), β 2-microglobulin (involved in the expression of 
MHC class I molecules) and β actin (a cytoskeleton actin that is important in cell 
motility, structure and integrity) were selected as target genes (Eisenberg & Levanon,
2003; Barber et al., 2005). Housekeeping genes were selected because they are
universal in cell DNA and the expression of the genes remains constant in the tissues,
thus providing a reliable standard to investigate the presence of any remaining
functional DNA in the tissue.
The same DNA extracts for Nanodrop spectrophotometry were used for PCR. Gradient
PCR was conducted initially to determine the appropriate Tm for each gene. Fresh
tissue DNA extracts provided sufficient template DNA to study appropriate PCR
conditions. Fresh porcine pulmonary artery DNA extracted from valve No 3 was used
as the template for GAPDH gradient PCR, and fresh porcine pulmonary valve leaflet
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DNA extracted from Valve No 1 was randomly selected to be used as the template for
gradient PCR for SLA-2, β 2-microglobulin and β actin. The concentrations of primer 
and template for PCR were also optimised to obtain maximum product yields (data not
shown). Once the PCR conditions for each gene had been determined, all of the samples
from fresh and decellularised porcine pulmonary roots were subjected to PCR. For each
PCR, a blank reaction containing all reaction components except the DNA template was
included to ensure no contamination (DNA from other sources) was introduced during
the experiment. No contamination was observed in any of the reactions. The results of
fresh DNA extract PCR analyses showed single clear product bands on the gels. The
GAPDH PCR had a predicted product size of 230 bp, but the PCR products had a size
of around 600 bp. The β 2-microglobulin PCR had a predicted product size of 189 bp, 
but the PCR products had a size of around 760 bp. The β actin PCR was predicted to 
have a product size of 210 bp while the actual amplified fragments were around 300 bp.
The reason that the PCR product sizes were larger than predicted was because: mRNAs
which only included the exons were used for primer design and product size prediction,
but fresh porcine pulmonary root tissue DNA extract contained the complete genomic
DNA which included both exons and introns. When the PCR primers targeted a gene
fragment which included the complete or part of two or more exons, the actual PCR
product would contain the introns between those exons that were amplified from the
genomic DNA. The SLA-2 PCR product had a size of around 250 bp, which is the same
as predicted. The fact that no PCR product band was seen in any of the decellularised
samples indicated that no template of the target genes was present in the decellularised
tissue extracts. This result provided further evidence of the successful removal of DNA
after decellularisation.
Immunohistochemical labelling was used to localise specific proteins in the porcine
pulmonary roots. Tissue sections stained with α-SMA were observed to be positively 
stained in fresh pulmonary artery and small blood vessels within the porcine pulmonary
root tissue. This was as expected since smooth muscle cell is the major cell type in fresh
arteries and vessels. Positive staining was also observed on the surface layer of the fresh
pulmonary leaflets especially in the ventricularis. It has been reported that the smooth-
muscle-like cells are distributed in the ventricularis and spongiosa due to the pressure
level on the leaflets (DellaRocca et al., 2000). The result from this study was in
agreement with the study conducted by Bertiplaglia et al. (2003) in which smooth
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muscle cells distributed more prevalent in the ventricularis than in the fibrosa. Residual
α-SMA was detected in the matrix of the decellularised porcine pulmonary roots 
indicating that upon cell lysis, some of the intracellular protein may have remained in
the matrix. A blast search for similarity of the porcine and human α-SMA was carried 
out using the NCBI online tool BlastP. The porcine and human α-SMA sequences had 
100 % (377/377 a.a.) identity. Thus, the residual α-SMA would not be antigenic if the 
xenogenic acellular scaffold was transplanted into humans. Tissue sections stained with
vWF, which is a marker for the endothelial cells, were shown to be positive in the
endothelial cell layers on the surface of the fresh pulmonary leaflets and the pulmonary
artery, as well as the small blood vessels in the porcine pulmonary root tissue. The
staining was negative throughout the decellularised porcine pulmonary root tissue,
indicating the successful removal of the endothelial cells following decellularisation.
The level and localisation of desmin remained the same after decellularisation. Desmin
is a cytoskeletal protein expressed by muscle cells. A blast search for similarity of the
porcine and human desmin was done using the NCBI online tool BlastP. The porcine
desmin sequence had 98 % (463/470 a.a.) identity to the human desmin. Query
coverage (the length coverage of high scoring pairs) of 100 % had also been identified.
Because of the very high similarity of the porcine and human desmin proteins, it is
unlikely the remaining desmin would be antigenic if the xenogenic decellularised
scaffold was transplanted into humans. Positive staining for vimentin was observed in
all cells in the fresh porcine pulmonary root tissue because it is a very important
cytoskeletal component. No evidence of vimentin expression was found in the acellular
porcine pulmonary roots, which was a result of the successful cell removal during the
decellularisation procedure.
The levels of fibronectin appeared to be lower in decellularised leaflet and artery tissues
compared to fresh, and most fibronectin was lost in the surface exposed regions
indicating that the protein may have been partially removed during the wash processes.
Collagen IV was used in immunohistochemistry as a marker to detect the presence of
the basement membrane. The basement membrane is a specialised form of the ECM that
supports and facilitates the growth of epithelial cell populations, thus is considered very
important in the endothelialisation of tissue engineered scaffolds after implantation
(Brown et al., 2006b). In this study, sections of fresh samples showed specific staining
in the basement membrane of pulmonary leaflets and arteries. The decellularised
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samples on the other hand, showed the complete removal of collagen IV. The removal
of basement membrane is not in agreement with studies reported by others which also
used SDS as a decellularisation detergent for porcine pulmonary heart valve tissue
(Tudorache et al., 2007). Recent experimental results in the laboratory conducted by Dr
Stacy-Paul Wilshaw have demonstrated that the PAA sterilisation treatment is
responsible for the basement membrane removal during decellularisation of arteries.
Therefore, PAA treatment may not be the ideal method of sterilisation and it may be
necessary to develop an alternative method to replace the PAA treatment in order to
retain the basement membrane to support the endothelial cell attachment after
transplantation.
The α-gal epitope is the major xenoantigen causing hyperacute rejection. If α-gal 
epitope remained in the decellularised tissue scaffold, it may have the potential to incite
a strong inflammatory response if implanted due to the presence of anti-α-gal antibodies 
in humans (Simon et al., 2003). The presence of the α-gal epitope was detected and 
localised using immunohistochemistry in this study. The results revealed the absence of
α-gal in the decellularised porcine pulmonary roots. Further quantitative analysis of the 
α-gal levels should be carried out in the future to validate this study. 
Contact cytotoxicity assays were performed to determine the effect of any remaining
chemicals within the porcine pulmonary valve leaflets on the growth of murine 3T3
fibroblasts and murine L929 fibroblasts in vitro. The results indicated that the cells
proliferated normally around and in direct contact with the decellularised porcine
pulmonary leaflets. The cell morphology remained normal when cultured with the
decellularised tissue. The decellularised porcine pulmonary leaflets were not cytotoxic
to cells. Extract cytotoxicity assays were applied to quantify cell viability (murine 3T3
fibroblasts and murine L929 fibroblasts) after culturing with the soluble extracts of the
decellularised porcine pulmonary arteries by detecting their relative cell ATP content.
The mean level of relative ATP for the six porcine pulmonary arteries showed no
significant difference compared with the negative controls for both cell types. To look at
each sample individually, 3 out of 6 samples showed significant reduction in the relative
ATP levels compared with the negative control for 3T3 cells. All of the 6 samples
showed no significant difference in the relative ATP levels compared to the negative
control for L929 cells. In this study, three times 30 min washes with PBS at 37 °C were
applied at the end of decellularisation to remove any remaining chemicals. These results
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showed that it will be necessary to increase the final wash process duration to help
remove remaining chemicals in individual pulmonary arteries, and thus provide
biocompatible scaffolds. The contact and extract cytotoxicity results are in agreement of
the results obtained by Wilcox et al. (2005), who also used 0.1 % (w/v) SDS and
trypsin in porcine aortic heart valve decellularisation.
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4.6 Conclusion
The decellularisation method for porcine pulmonary roots used in this chapter applied
trypsin treatment on the adventitial surface of the scraped pulmonary artery, together
with 1 cycle of hypotonic SDS buffer treatment and 2 cycles of nuclease treatment
(referred to as ‘Method 6’ in Chapter 3). Histology results confirmed that complete
decellularisation was achieved using this method, with histoarchitecture well retained.
The levels of collagen and elastin remained qualitatively similar in porcine pulmonary
roots after decellularisation, but a loss of GAG`s was observed by Alcian blue staining
of tissue sections. Nanodrop spectrophotometry results showed that greater than 90 % of
DNA was successfully removed throughout the porcine pulmonary roots following
decellularisation. House keeping genes GAPDH, SLA-2, β 2-microglobulin and β actin 
were not detected by PCR in decellularised tissue. Immunohistochemistry results further
confirmed the absence of cells in the decellularised scaffolds. However, the basement
membrane protein collagen IV was removed following decellularisation. The major
xenoantigen α-gal was not detected in decellularised tissue by immunohistochemistry. 
In vitro cytotoxicity assays demonstrated the decellularised pulmonary leaflets were not
cytotoxic to murine 3T3 and L929 fibroblasts. In vitro extract cytotoxicity assays
demonstrated the decellularised pulmonary arteries were not cytotoxic to L929
fibroblasts, while 3 out of 6 decellularised pulmonary artery samples under test
significantly decreased the viability of murine 3T3 fibroblasts. In conclusion, the
decellularised porcine pulmonary root scaffold demonstrated cell removal with good
biocompatibility. The biomechanical properties of the acellular porcine pulmonary roots
will be further evaluated in the next chapter.
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Chapter 5
Biomechanical & Hydrodynamic Characterisation of
Fresh and Acellular Porcine Pulmonary Valve Roots
5.1 Introduction
As discussed in the previous chapter, the acellular porcine pulmonary root scaffold
demonstrated cell removal and good biocompatibility. This chapter describes, the
biomechanical and hydrodynamic assessments of the acellular pulmonary roots in terms
of low-strain-rate uniaxial tensile loading to failure testing and pulsatile flow testing,
respectively. Uniaxial tensile testing was utilised to determine the stress-strain
behaviour of the decellularised root tissues, whereas near physiological pulsatile flow
testing was used to evaluate the mean pressure drop across the acellular valves during
the cardiac cycle and their effective orifice area (EOA). Pulsatile flow testing was also
used to assess the kinematics and the bending stress and strain of the free leaflet edge of
the acellular valves during the cardiac cycle. During all three types of assessment, the
performance of the decellularised roots was compared to the performance of the native
pulmonary root.
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5.2 Aims and objectives
Aims:
The aim of the work described in this chapter was to investigate the effects of the
decellularisation method developed in Chapter 3 on the biomechanical and
hydrodynamic characteristics of porcine pulmonary roots.
Objectives:
 To assess the effects of decellularisation on the uniaxial tensile properties of the
decellularised tissues by comparison to fresh porcine pulmonary root tissues.
 To characterise the hydrodynamic behaviour of fresh and decellularised porcine
pulmonary roots under simulated pulsatile flow conditions.
 To determine the leaflet kinematics of fresh and decellularised porcine
pulmonary roots under simulated pulsatile flow conditions.
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5.3 Methods
5.3.1 Uniaxial tensile testing
The biomechanical properties of native and decellularised (Method 6, Section 3.4.8.1)
porcine pulmonary roots were assessed under uniaxial tensile loading to failure testing,
according to the methodology described in Section 2.2.10. Circumferential (n=6) and
axial (n=6) specimens were dissected from scraped fresh and decellularised porcine
pulmonary arteries. The size of the pulmonary artery specimens was 5 mm in width by
approximately 20 mm in length. Following mounting in the holder, the actual test length
(initial gauge length) of the pulmonary wall specimens was 10 mm. Circumferential
(n=6) and radial (n=6) specimens were also dissected from the left pulmonary leaflets of
fresh and decellularised (Method 6, Section 3.4.8.1) pulmonary roots and tested under
uniaxial tensile loading to failure. The pulmonary leaflet specimens were 3 mm in width
by approximately 15 mm in length. Following mounting in the holder, the test length
(initial gauge length) of the leaflet specimens was 6 mm, which similar to the case of
the pulmonary wall, gave a testing aspect ratio of 2:1. In order to obtain a more
representative set of data, the specimens of each of the control and test groups were
procured from the pulmonary roots of different animals. The results for the control
(fresh) and test (decellularised) groups were compared with respect to the anatomical
direction (circumferential vs. axial wall and circumferential vs. radial leaflet) and with
respect to treatment (fresh vs. decellularised). Moreover, the results for the pulmonary
wall were also compared to the results obtained from the fresh intact pulmonary arteries
described in Section 3.4.5. The wall and leaflet groups are listed in Tables 5.1 and 5.2,
respectively.
Table 5.1 The test and control groups used in the uniaxial tensile testing of porcine
pulmonary arteries.
Fresh intact Scraped fresh Decellularised (Method 6)
C A C A C A
No of samples 7 6 6 6 6 6
C: circumferential direction; A: axial direction. Fresh intact refers to the group the
testing of which was described in Section 3.4.5.
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Table 5.2 The test and control groups used in the uniaxial tensile testing of porcine
pulmonary leaflets.
Fresh Decellularised (Method 6)
C R C R
No of samples 6 6 6 6
C: circumferential direction; R: radial direction.
The recorded force and extension data was converted to stress and strain, respectively,
as described in Chapter 2 (Section 2.2.10.4), and the elastin and collagen phase slopes,
transition stress and strain, and failure stress and strain were obtained from the stress-
strain responses of each specimen. Subsequently, each of the aforementioned
biomechanical parameters were averaged over the number of specimens in each of the
control and test groups. The stress-strain responses of the specimens in each group were
further processed in Origin 8.0 software package, which was used to generate the mean
stress-strain response for each group. In order to do this, a cubic spline was fitted to
each data set (stress-strain response of each specimen) and the data set was
extrapolated/interpolated up to the mean failure strain of the particular control or test
group. The data set for each group then had the same normalised strain, thus the
combined mean stress-strain curves could be generated for each test groups.
Subsequently, 100 data points (out of approximately 3,000) were interpolated from each
data set, at 100 equally-spaced intervals (the same for all samples in a particular group)
of the engineering strain into 100 equal portions. The interpolated data sets of the
specimens in each group were then averaged over the number of specimens in each
group to produce the mean stress-strain behaviour of the group. The mean stress-strain
curves do not present the true stress-strain behaviour of each specimen. However, the
mean trend of each test group could be visualised by these mean stress-strain behaviour
curves.
5.3.2 Hydrodynamic function testing
5.3.2.1 The pulsatile flow simulator
The pulsatile flow simulator used in this study was originally developed by Fisher et al.
(1986) (Figure 5.1). It was designed to mimic the function of the left or right side of the
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heart for testing prosthetic valves in the mitral/tricuspid or aortic/pulmonary position.
The simulator allows valves to be repeatedly tested under standard controllable pulsatile
flow conditions. The simulator comprised a pulsatile pump (positive displacement linear
actuator, Model SP3891, Vivitro Systems Inc, Victoria BC, Canada), a viscoelastic
impedance adapter, two test chambers for testing valves in the aortic/pulmonary or
mitral/tricuspid valve positions, a ventricular and an atrial chamber, a compliance
chamber or afterload, silicon tubing simulating the peripheral circulation, a peripheral
resistance tap, and the pressure and flow measurement (Model PT43-604, Vivitro
Systems Inc, Victoria BC, Canada) instruments. The simulator was controlled and
monitored by the ViviTest software (Vivitro Systems Inc, Victoria BC, Canada) which
was installed in the attached computer. The ViviTest software was also used to record
and process the data during testing. The blood substitute used in the simulator was
physiological saline (0.9 % w/v NaCl).
Figure 5.1 The pulsatile flow simulator. The simulator comprised a pulsatile pump
(positive displacement linear actuator), a viscoelastic impedance adapter, two test
chambers for testing valves in the aortic/pulmonary or mitral/tricuspid valve positions, a
ventricular and an atrial chamber, a compliance chamber or afterload, silicon tubing
simulating the peripheral circulation, a peripheral resistance tap, and the pressure and
flow measuring instruments.
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The schematics of the pulsatile flow simulator are shown in Figure 5.2. The waveform
of the pulsatile flow was produced by a programmable waveform generator (Model
WG5891, Vivitro Systems Inc, Victoria BC, Canada). The waveform generator was
able to reproduce 5 different waveforms to match the blood flow characteristics of the
cardiac cycle. However, only waveform C (sinusoidal) was used throughout this study
since in previous studies (Jennings, 2001) it has been found to produce smoother mean
pressure difference versus root mean square flow characteristics for tissue roots. During
this study, the pulmonary roots were tested at the aortic/pulmonary test section (Figure
5.2 B), which comprised a ventricular chamber and pulmonary artery chamber. The
ventricular chamber was attached to the linear actuator. The pulmonary artery was
simplified as a straight tube with a diameter of 28 mm. The tissue root under
investigation was mounted in-between the ventricular chamber and the pulmonary
artery. The aortic chamber was connected to the afterload downstream, via stiff tubing
of 25 mm in diameter. An electromagnetic flowmeter, which was used to measure the
flow rate of the test medium, was incorporated in the tube. The afterload consisted of a
vertical Perspex cylinder partially filled with saline and partially with air, which was
sealed to the atmosphere. The afterload chamber acted as a damper in the pulsatile flow
rig circulation, by minimising the abrupt peaks in the flow and pressure waveforms,
which resulted from the flow of the incompressible test fluid in the rigid sections of the
simulator. Physiological pressure ranges in the simulator were created by adjusting the
variable peripheral resistance tap downstream of the afterload. The pressure in the
simulated peripheral circulation was monitored by a pressure gauge attached to the top
of the cylinder. The afterload was connected to the atrial reservoir via silicon rubber
tubing, which featured the peripheral resistance tap. The atrial reservoir was opened to
the atmosphere and produced a constant pressure head to the mitral/tricuspid valve
section during systole. A 29 mm Bjork-Shiley tilting disc valve was used as the standard
test valve in the mitral/tricuspid position throughout this study. The mitral/tricuspid
valve section was connected to the ventricular chamber by a stiff tube, 25 mm in length.
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Figure 5.2 Schematic diagrams of the pulsatile flow simulator set up for
mechanical valve testing in the aortic/pulmonary position (A), and for whole tissue
root testing in the aortic/pulmonary position (B) (modified from Korossis, 2002).
Valve function in the pulsatile flow simulator was assessed by measuring the pressure
difference across and flow through the test valve or valve root placed in the pulmonary
position. An electromagnetic flowmeter (Spectramed Blood Flow Meter, Model SP2202)
and electromagnetic probe were used to measure the flow through the valve under test.
The probe was positioned approximately 200 mm downstream of the pulmonary valve
position, and contained an electromagnet that produced a pulsed magnetic field at right
angles to the direction of fluid flow. As the conducting fluid passed through this
magnetic field, a pulsatile voltage was produced, which was directly proportional to the
fluid velocity. The flow meter had a range of 10 ml.min-1 to 30 L.min-1, with a full scale
output signal voltage of ±1.414 V pulsatile, and ±1.414 V DC mean. The pulsatile
reading gave the undamped output. For direct recording purposes the mean flow signal
was produced. The pressure difference across the valve under test was monitored using
a Gaeltec differential pressure transducer (Model 3CT/Perspex), which had a measuring
range of 0 to 200 mmHg and a sensitivity of 5 µV/V/mm Hg and an excitation voltage
of ± 5 V. For the testing of tissue roots, the pressure transducers were connected at 25
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mm upstream and 50 mm downstream of the root. The atrium pressure transducer was
placed 50 mm upstream of the reference mechanical tricuspid valve.
5.3.2.2 Calibration of the pulsatile flow simulator
Prior to testing, the pressure transducers were calibrated with reference pressures of 0
and 200 mm Hg using a manometer. A standard test valve (Bjork-Shiley Monostrut 23
mm) was tested before each use of the simulator under the conditions listed in Table 5.3.
The acquired data was compared to the historical data. Deviations from the previous
recordings of ± 5 % were considered as acceptable, and indicated that the simulator was
in its proper working condition.
Table 5.3 Test conditions used in the hydrodynamic function testing for Bjork-
Shiley Monostrut 23 mm standard test valve.
Condition Waveform Heart
rate
(bpm)
Stroke
volume (ml)
Cardiac
output
(L.min-1)
Systematic
pressure (mm Hg)
1 C 60 60 3.60 120/80
2 C 72 70 5.04 120/80
3 C 80 80 6.40 120/80
4 C 100 80 8.00 120/80
5 C 120 80 9.60 120/80
5.3.2.3 Tissue preparation
The porcine pulmonary roots were dissected according to the methodology described in
Section 2.2.4. The size of the roots used for the pulsatile flow testing was approximately
18 mm, as sized by the obturators. The lengths of the myocardial skirt and the
pulmonary artery of the tested roots were kept as long as possible during dissection in
order to be able to mount the roots onto the spigots of the pulsatile flow simulator. The
thickness of the myocardial skirt was trimmed to approximately 5 mm throughout. The
fresh roots were tested within 10 h of slaughter. In total six fresh and six decellularised
porcine pulmonary roots were tested. Both fresh and decellularised roots were kept in
PBS prior to testing.
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5.3.2.4 Testing procedure
All porcine pulmonary roots were tested under the three different pulsatile flow
conditions listed in Table 5.4.
Table 5.4 Test conditions used in the hydrodynamic function testing for porcine
pulmonary roots.
Condition Waveform Heart rate
(bpm)
Stroke
volume (ml)
Cardiac
output
(l.min-1)
Pulmonary pressure
(mm Hg)
1 C 60 60 3.60 35/5
2 C 72 70 5.04 45/10
3 C 80 70 5.60 50/10
The pressure and flow transducers were connected to the pulsatile flow simulator at the
positions described in Section 5.3.2.1. The porcine pulmonary root under investigation
was mounted with cable ties to appropriate sizes of acetal spigots which were
prepositioned in the rig. PBS was pipetted onto the root surface at regular intervals
during testing to prevent the tissue from drying out. The test rig was filled with saline
and degassed with a syringe. The appropriate linear actuator waveform and heart rate
(cycling rate) were set on the waveform generator. The actuator was set going by
adjusting its stroke on the actuator control box, until the stroke volume monitored by the
computer reached the required value (± 0.1 ml) at each test condition. The pulmonary
pressures (systolic/diastolic) of each condition were obtained by completely releasing
the pressure resistance tap. The pressures applied at each condition were the minimum
pressures that could be obtained by this pulsatile flow simulator at the required cardiac
output. These pressures were the closest pressures to the physiological pulmonary
pressures that the rig could generate. When the test rig conditions were stabilised, the
Vivitest software was run in data acquisition mode for ten cycles, and the pressure and
flow data was stored in ACQ format files for subsequent analysis. Three test runs were
performed at each condition for each root. The means of each hydrodynamic parameter
were considered as the obtained value at each condition for each root. A high speed
camera (Redlake® MotionScope, Model PCI 1000S) was used to record the motion of
the heart valve leaflets during the cardiac cycle at flow condition 2 (72 bpm / 70 ml) and
using a recording rate of 250 frames per second.
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5.3.2.5 Data processing
The ACQ files recorded during each test run with each root, including the signal
histories from the pressure transducers, the electromagnetic flow meter and the stroke of
the linear actuator. Following testing, the ACQ files were analysed using the Vivitest
analysis software. The differential pressure and flow waveforms were displayed on the
computer screen, and the reference points were marked manually. An illustration of the
differential pressure and flow waveform, together with the seven reference points is
shown in Figure 5.3.
Figure 5.3 Differential pressure signals and flow waveform showing the reference
time points used in data analysis. 1: Start of forward flow; 2: End of forward flow; 3:
End of closing regurgitation; 4: Start of positive pressure difference; 5: End of positive
pressure difference; 6: Maximum flow; 7: Maximum pressure (adapted from Korossis
2002).
The reference time points allowed the analysis to be performed during the forward flow
interval (1-2), valve closing interval (2-3), valve closed interval (3-1), valve opening
interval (1-6), valve closing interval (6-2), total systole (1-3), pressure-flow interval (4-
2), and pressure-pressure interval (4-5). The function of the tested roots was assessed by
means of the mean pressure difference across the valve (Δp), the root mean square 
forward flow through the valve (QRMS), and the valve EOA. The Δp across each valve 
was measured in the pressure-flow interval (4-2) as a function of the QRMS. The EOA is
a measure of the resistance to the flow through the valve under test, and it was also
Chapter 5
193
analysed in the pressure-flow interval. The calculation of the EOA was based on the
formula that was derived by Gabbay et al. (1978) experimentally:EOA = Qୖ୑ ୗ51.6 × ඥΔp
The calculation of the three parameters was carried out by the Vivitest analysis
programme based on the flow and differential pressure signals and the manually marked
reference points. The calculated results were exported as .TXT files and transferred to a
Microsoft Excel® (Version 2007) spreadsheet for statistical analysis. The results for
each root were averaged over the number of test runs at each flow condition (n=3). All
results were presented as means ± 95 % C.I.. The results for the fresh and decellularised
roots were analysed by the Student’s t-test, and the statistical significance was
determined at the 95 % confidence level.
5.3.2.6 Image and leaflet bending deformation analysis
The leaflet kinematics of fresh (n=6) and decellularised (n=6) porcine left pulmonary
leaflets was analysed during a complete cardiac cycle at pulsatile flow condition 2 (72
bpm/70 ml). During testing, the images were recorded using a high speed camera
(Redlake® MotionScope, Model PCI 1000S) at a recording rate of 250 frames per
second. Due to the anatomical obstructions, the motion of only one leaflet could usually
be recorded in full for the whole duration of the cardiac cycle and thus, only the left
pulmonary leaflets were used in the assessment of the bending deformation of the leaflet
free edge. The acquired video sequences allowed the opening, open, closing and closed
phase characteristics of the valves to be described. The opening, open, closing and
closed phase durations, the shapes and bending deformations of the free edge of the left
leaflets at four different time points (start opening, fully open, start closing, fully closed)
were assessed.
The leaflet reference state (t=0) was defined at the instance where the leaflets were fully
closed immediately prior to the start of the opening phase. This was denoted as start
opening (SO). The fully open (FO) point referred to the beginning of the fully open
leaflet phase. The start closing (SC) point was identified as the first point of the closing
phase of the leaflets. The fully closed (FC) point was identified as the time point when
the valve leaflets closed fully for the first time after opening. The opening, open, closing
and closed phases referred to the time intervals between SO and FO, FO and SC, SC
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and FC, and FC and SO of the next cardiac cycle, respectively. The phase durations
were determined by counting the number of video frames between the reference points
(SO, FO, SC, FC, SO) and multiplying it by the frame acquisition interval (4 ms).
The leaflet bending deformation was determined by the curvature of the leaflet free
edge. The curvatures at each of the phase points (SO, FO, SC, FC) for each valve leaflet
studied, were calculated along the circumferential direction according to the
deformation of their free edge. The video frames corresponding to the phase points
studied, were extracted from the video sequences using the Corel Photo Paint (Version
X4) manufacture software package. Once extracted, the frames were further processed
in Image Pro Plus (Version 4.51) manufacture software package by mapping the free
edge of each leaflet at each of the phase points. In order to do this, each frame was
calibrated using the measured internal diameter (19 mm) of the spigots used to mount
the pulmonary artery of the roots in the pulsatile flow simulator, which was visible in
the video frames captured. In order to improve the accuracy the edge of the spigot was
placed as close to the leaflets as possible, without obstructing their motion during
pulsatile flow testing.
Subsequently, a reference origin was defined at the same position for all frames
analysed, which ensured that for any valve the co-ordinates of each leaflet had the same
frame of reference at all time points. The shape of the leaflet free edge was then
digitised by drawing along the leaflet free edge a polyline consisting of n points
connected by n-1 straight lines (n was typically between 25 and 40), and the coordinates
of the points (Xn, Yn) were recorded. The calculation of the curvature required that there
was one-to-one mapping of the free leaflet edge and that the domain of Xn values were
monotonically increasing (i.e. Xn+1>Xn). Unless the condition of monotony was satisfied,
the video frame was rotated until Xn+1>Xn was satisfied. The Xn, Yn co-ordinates of
each point making up the polyline were exported to Microsoft Excel® for further
analysis.
A cubic spline was fitted to the variably spaced (Xn, Yn) data points of the leaflet free
edge in the Origin (Version 8.0) software package. Equally spaced (Xi, Yi) data points
were interpolated from the cubic spline at 94 fixed intervals. From the interpolated,
equally spaced (Xi, Yi) data points the Ki at each fixed interval along the spline was
calculated. A smoothing routine was then used to eliminate the possibility of
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introducing false curvatures when the shape of the leaflet free edge was digitised. This
resulted in the calculation of an average curvature (Ki,avg) profile. The rationale behind
the averaging routine, together with the relevant formulae, is described in Appendix 2.
The Ki,avg profile of each left leaflet at each time point was calculated in Microsoft
Excel®. The Ki,avg was then used to calculate the average bending radius (Ri,avg) as:R୧ǡୟ୴୥ = 1K୧ǡୟ୴୥
Subsequently, the minimum bending radius (maximum deformation) for each leaflet at
each phase point studied was calculated. The results for the fresh and decellularised
valves were compared using the Student’s t-test at the 95 % significance level.
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5.4 Results
5.4.1 Biomechanics of fresh and decellularised porcine pulmonary roots
As discussed in Chapter 4, the decellularised porcine pulmonary roots demonstrated
removal of cells and cell nuclei with the biological properties and histoarchitecture well
retained. The biomechanical properties of the tissues were assessed under uniaxial
tensile loading to failure in order to assess the effect of the decellularisation treatment
on the mechanical behaviour of the porcine pulmonary leaflet and arterial wall.
5.4.1.1 Biomechanical characterisation of the pulmonary leaflets
The mean stress-strain behaviour and the individual stress-strain behaviours for each
test sample of the fresh and decellularised pulmonary left leaflet groups is illustrated in
Figure 5.4 (circumferential) and Figure 5.5 (radial). The curves demonstrated the typical
quasi-linear characteristics of biological tissue with a low modulus region during the
elastin phase and a high modulus region during the collagen phase, followed by
specimen failure. The statistical analysis demonstrated no significant difference between
the fresh and decellularised groups for the elastin phase slope (Figure 5.6), the collagen
phase slope (Figure 5.7), the transition stress (Figure 5.8), the transition strain (Figure
5.9), the failure stress (Figure 5.10), and the failure strain (Figure 5.11) in the
circumferential or radial directions. In addition, there was no significant difference in
the leaflet thickness between the two groups along the radial direction (Figure 5.12).
The results indicated a significant decrease (p=0.009) in the leaflet thickness of the
decellularised circumferential group (Figure 5.12). The elastin slope of the leaflet
pulmonary leaflet in the circumferential direction (7.55×10-4 ± 2.86×10-4 GPa) was
about two fold compared to that in the radial direction (3.42×10-4 ± 1.19×10-4 GPa)
(Figure 5.6). The collagen slope, transition stress and failure stress of the left pulmonary
leaflet in the circumferential direction were about 10 fold compared to those in the
radial direction (Figure 5.7; Figure 5.8; Figure 5.10). The transition and failure strains
of the left pulmonary leaflet in the circumferential direction were at similar level of
those in the radial direction.
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(A)
(B)
Figure 5.4 Stress-strain behaviour of the fresh and decellularised circumferential
left pulmonary leaflet groups. (A) Mean stress-strain behaviour of the fresh and
decellularised circumferential left pulmonary leaflet groups (n=6). Error bars indicate
the 95% C.I.s. (B) Individual stress-strain behaviour of the fresh and decellularised
circumferential left pulmonary leaflet groups (n=6).
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(A)
(B)
Figure 5.5 Stress-strain behaviour of the fresh and decellularised radial left
pulmonary leaflet groups. (A) Mean stress-strain behaviour of the fresh and
decellularised radial left pulmonary leaflet groups (n=6). Error bars indicate the 95%
C.I.s. (B) Individual stress-strain behaviour of the fresh and decellularised radial left
pulmonary leaflet groups (n=6).
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Figure 5.6 Average elastin phase slope for the fresh and decellularised left
pulmonary leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no
significant difference between fresh and decellularised tissue.
Figure 5.7 Average collagen phase slope for the fresh and decellularised left
pulmonary leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no
significant difference between fresh and decellularised tissue.
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Figure 5.8 Average transition stress for the fresh and decellularised left pulmonary
leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no significant
difference between fresh and decellularised tissue.
Figure 5.9 Average transition strain for the fresh and decellularised left
pulmonary leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no
significant difference between fresh and decellularised tissue.
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Figure 5.10 Average ultimate tensile stress for the fresh and decellularised left
pulmonary leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no
significant difference between fresh and decellularised tissue.
Figure 5.11 Average failure tensile strain for the fresh and decellularised left
pulmonary leaflet groups (n=6). The error bars indicate the 95% C.I.s. There was no
significant difference between fresh and decellularised tissue.
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transition stress and strain, and failure stress and strain, for the control and test groups
are illustrated in Figure 5.15 through to Figure 5.21.
The results indicated no significant difference between the three groups for the
following parameters: the collagen phase slope in the circumferential and axial
directions (Figure 5.16), the transition stress in the circumferential and axial directions
(Figure 5.17), the transition strain in the circumferential direction (Figure 5.18), the
failure stress in the circumferential and axial direction (Figure 5.19), and the failure
strain in the circumferential and axial direction (Figure 5.20). Significant differences
were found in the elastin phase slope between the fresh group and the decellularised
group in the circumferential and the axial directions (Figure 5.15), the transition strain
between the fresh group and the decellularised group in the axial direction (Figure 5.18),
the thickness between the scraped fresh and the decellularised groups in the
circumferential and axial directions, and the thickness between the fresh and the
decellularised groups in the axial direction (Figure 5.21). The mechanical testing data of
elastin and collagen slopes, and the transition and failure stresses of the pulmonary
artery of the circumferential and axial directions had a ratio of approximately 3:2.
Similar to the pulmonary leaflets, the transition and failure strains of the pulmonary
artery had a similar level for both directions.
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(A)
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Figure 5.13 Stress-strain behaviour for the fresh (n=7), scraped fresh (n=6) and
decellularised (n=6) circumferential pulmonary artery groups. (A) Mean stress-
strain behaviour for the fresh (n=7), scraped fresh (n=6) and decellularised (n=6)
circumferential pulmonary artery groups. The error bars indicate the 95 % C.I.s. (B)
Individual stress-strain behaviour for the fresh (n=7), scraped fresh (n=6) and
decellularised (n=6) circumferential pulmonary artery groups.
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Figure 5.14 Stress-strain behaviour for the fresh (n=7), scraped fresh (n=6) and
decellularised (n=6) axial pulmonary artery groups. (A) Mean stress-strain
behaviour for the fresh (n=7), scraped fresh (n=6) and decellularised (n=6) axial
pulmonary artery groups. The error bars indicate the 95 % C.I.s. (B) Individual stress-
strain behaviour for the fresh (n=7), scraped fresh (n=6) and decellularised (n=6) axial
pulmonary artery groups.
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Figure 5.17 Average transition stress for the fresh (circumferential: n=7; axial:
n=6), scraped fresh (n=6) and decellularised (n=6) pulmonary artery groups along
the circumferential and axial directions. The error bars indicate the 95 % C.I.s. There
was no significant difference between the groups in the circumferential or axial
direction.
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Figure 5.19 Average ultimate tensile stress for the fresh (circumferential: n=7;
axial: n=6), scraped fresh (n=6) and decellularised (n=6) pulmonary artery groups
along the circumferential and axial directions. The error bars indicate the 95% C.I.s.
There was no significant difference between the groups in the circumferential or axial
direction.
Figure 5.20 Average failure tensile strain for the fresh (circumferential: n=7; axial:
n=6), scraped fresh (n=6) and decellularised (n=6) pulmonary artery groups along
the circumferential and axial directions. The error bars indicate the 95 % C.I.s. There
was no significant difference between the groups in the circumferential or axial
direction.
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5.4.2 Hydrodynamic assessment of fresh and decellularised
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QRMS of 181.67 ± 1.87 ml.s-1 recorded for the fresh group, and a Δp of 4.50 ± 0.79 mm 
Hg and a QRMS of 169.39 ± 18.54 ml.s-1 recorded for the decellularised group (p=0.012
and 0.035, respectively).
The average EOA of the fresh (n=6) and decellularised (n=6) groups at each test
condition is shown in Figure 5.23. No significant difference was observed in any of the
test conditions between the two groups (p>0.05).
5.4.3 Leaflet kinematics of fresh and decellularised pulmonary roots
The leaflet kinematics of the fresh and decellularised pulmonary roots was assessed by
recording their leaflet motion during a test run at condition 2 (72 bpm/70 ml). The
leaflet kinematics was assessed during the opening, open, closing and closed phases.
The durations of the opening, open, closing and closed phases averaged over the
number of leaflets studied in the fresh (n=6) and decellularised (n=6) groups are shown
in Figure 5.24. The opening phase duration of the decellularised group (188.7 ms) was
considerably longer than that of the fresh roots (108.7 ms), and the mean of the closed
phase duration of the decellularised roots (284.0 ms) was much shorter than that of the
fresh ones (372.0 ms). However, no statistically significant difference was observed
between the fresh and decellularised groups in any of the phases studied.
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Figure 5.23 Average EOA for the fresh (n=6) and decellularised (n=6) porcine
pulmonary roots at each test conditions. The error bars indicate the 95% C.I.s. No
significant differences were found between the two groups.
Figure 5.24 Phase times for the fresh (n=6) and decellularised (n=6) pulmonary
roots at test condition 2. The error bars indicate the 95% C.I.s. No significant
differences were found between the two groups.
Both fresh and decellularised valves demonstrated a synchronous opening and closing
leaflet motion, as illustrated in the frames in Figure 5.25 and Figure 5.26 for a
representative fresh and decellularised valve, respectively. All valves demonstrated
fully closed leaflet configurations with no visible leakage orifices or coaptation flaws
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during diastole. At peak systole, the fully opened valve configuration was circular for
all fresh and decellularised valves. The free leaflet edge shapes generated by the
interpolated Xi, Yi data points, as described above, and the corresponding averaged
leaflet curvatures (Ki,avg) for the representative fresh and decellularised valves are also
illustrated in Figure 5.25 and Figure 5.26, respectively.
The variation of the averaged minimum bending radius (maximum deformation) during
the cardiac cycle, calculated for the start opening, fully open, start closing and fully
closed leaflet configurations, and averaged for the fresh (n=6) and decellularised (n=6)
left pulmonary leaflet groups is illustrated in Figure 5.27. In all four configurations,
both leaflet groups demonstrated similar variation in their minimum bending radius
during the cardiac cycle. No significant difference was observed between the fresh and
the decellularised groups.
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e 5.25 Sequence of video images and curves showing the deformation and
ponding curvatures of the left pulmonary leaflet (leaflet A) of a
sentative fresh valve at start opening, fully open, start closing, and fully
positions.
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e 5.26 Sequence of video images and curves showing the deformation and
sponding curvatures of the left pulmonary leaflet (leaflet A) of a
sentative decellularised valve at start opening, fully open, start closing, and
closed positions.
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Figure 5.27 Average minimum bending radius at start opening, fully open, start
closing and fully closed positions for the fresh (n=6) and decellularised (n=6) left
pulmonary leaflets. The error bars indicate the 95% C.I.s. No significant differences
were found between the two groups at any of the time points studied.
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5.5 Discussion
Following the characterisation of the biological properties in Chapter 4, the
biomechanical characteristics of the acellular porcine pulmonary roots were assessed
and compared to fresh tissue in this chapter. The decellularisation method used to
produce the acellular tissue used in the studies presented in this chapter was referred to
as ‘Method 6’ in Chapter 3. Uniaxial tensile testing was carried out to determine the
biomechanical properties of the acellular pulmonary leaflets and arteries by comparison
to the fresh tissues. The hydrodynamic function and leaflet motion of the acellular
pulmonary roots were assessed by pulsatile flow testing and compared to the fresh
control.
The stress-strain behaviour of both fresh and decellularised groups demonstrated the
typical quasi-linear behaviour of biological tissue, with a low modulus region during the
elastin phase and a high modulus region during the collagen phase. This trend was
similar to the results obtained for the fresh and decellularised tissues (Method 3 in
Chapter 3) and described in Chapter 3, as well as to the results described in previous
studies (Jennings, 2001; Korossis et al., 2002; Stradins et al., 2004; Korossis et al.,
2005; Seebacher et al., 2007).
In the uniaxial tensile tests of the fresh and decellularised (Method 3 in Chapter 3)
pulmonary leaflets described in Chapter 3, the samples were randomly selected from the
three leaflets in the pulmonary valve for both the circumferential and radial directions.
However, in the uniaxial tensile testing described in the present chapter, only the left
pulmonary leaflets were used in order to minimise tissue inhomogeneity effects.
Moreover, in the tensile testing results described in Chapter 3 for the pulmonary leaflets
decellularised according to Method 3, a significant decrease (p<0.05) was observed in
the failure stress along the radial direction, which led to the conclusion that the
pulmonary valve tissue decellularised according to this method may not be competent to
be used in heart valve replacement surgery.
The tensile testing results presented in the present chapter for the decellularised left
pulmonary leaflets (Method 6 as described in Chapter 3) showed no significant
difference in any of the tensile testing parameters when compared to the fresh tissue.
These results were in general agreement with the results reported by Korossis et al.
(2002), who applied 1 cycle of 0.1 % (w/v) SDS to decellularised porcine aortic leaflets.
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This result confirmed the hypothesis raised in Chapter 3 that the additional cycle of
SDS treatment (Method 3 in Chapter 3) would compromise the mechanical behaviour of
the pulmonary leaflets. The fact that the elastin slope of the left pulmonary leaflet (both
fresh and decellularised) in the circumferential direction was about two fold compared
to that in the radial direction, the collagen slope and transition failure stresses in the
circumferential direction were about 10 fold compared to those in the radial direction
confirmed the anisotropy property of the leaflets. Gerosa et al. (1994) reported a
fourfold difference in the mechanical properties of the circumferential and radial
directions within a human valve, and Christie & Barratt-Boyes (1995) showed the
circumferential/radial ratio of mechanical parameters to be 6.0 for porcine aortic leaflets.
In the study carried out by Korossis (2002), which applied a very similar testing method
to the present study on porcine fresh and decellularised aortic leaflets, the elastin slope
of the leaflet (both fresh and decellularised) in the circumferential direction was about
two fold greater than that in the radial direction, the circumferential/radial ratio of
collagen slope was about 15, and the circumferential/radial ratio of the transition and
failure strain was approximately 6. The data presented in this study were in agreement
with the trends in the previous studies.
Nevertheless, the present study indicated a significant decrease in the thickness of the
decellularised left pulmonary leaflets compared to the fresh leaflets in the
circumferential direction. This was probably due to the different sizes of valve roots
used for the fresh and decellularised groups, which was in turn due to the limitation of
the tissue supply from the local abattoir. The difference in the leaflet thickness, however,
did not affect the comparison of the relevant biomechanical parameters (elastin and
collagen phase slopes, transition and the failure stress) between the different groups
since these parameters were normalised with respect to the specimen thickness.
The biomechanical properties of the decellularised pulmonary artery were determined in
both circumferential and axial directions, and compared to two control groups: the fresh
group and the scraped fresh group. Scraping of the outer surface of the adventitia of
pulmonary artery was applied in the decellularisation protocol. Thus, in order to identify
the mechanical effect of scraping, a control group of scraped fresh porcine pulmonary
arteries was included in the study. The same tensile testing results for the fresh group
used in Chapter 3 were also used for comparison in the present chapter. The pulmonary
artery group used in this chapter, which was decellularised according to Method 6
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(Section 3.4.8.1), demonstrated a significantly decreased elastin phase slope in both the
circumferential and axial directions, and decreased transition strain in the axial direction
compared to the fresh control. No significant difference was observed in the tensile
parameters between the acellular and the scraped fresh control groups. In the study
conducted by Korossis et al. (2005), in which a similar decellularisation method with
trypsin and 0.1 % (w/v) SDS was used on porcine aortic arteries, similar changes to the
acellular tissue were also described. The reduction in elastin phase slope indicated that
the decellularisation treatment produced a more compliant tissue in the initial elastin
phase (physiological range). Similar to the pulmonary leaflets, the pulmonary artery
also showed anisotropic properties. In the present study, the circumferential/axial ratio
of mechanical parameters was approximately 3:2 for the pulmonary artery. In the study
conducted by Korossis (2002), the ratio was determined to be approximately 4:1 for
porcine aorta. The anisotropic properties of the porcine pulmonary artery were therefore
less apparent than for the pulmonary leaflet and the porcine aorta.
Despite the differences between the acellular and the fresh pulmonary artery groups, the
treatment did not compromise the strength of the tissue since no significant difference
was observed in the failure stress. As discussed in Chapter 3, the peeling of the
relatively thin pulmonary artery, which was applied in decellularisation Method 3, could
have caused the significant reduction in the tissue strength. It has been confirmed by the
results shown in this chapter that the scraping of the adventitial surface of the
pulmonary artery did not compromise the strength of the tissue whilst decellularisation
was achieved. Thus, scraping instead of peeling an outer layer of the adventitia of the
porcine pulmonary artery was considered as an optimal method for removing the
connective tissue from the outer surface of the pulmonary artery during decellularisation.
A significant decrease in the thickness of the decellularised pulmonary artery was
observed in both the circumferential and the axial directions compared to the fresh
control. This result was in agreement with that of the pulmonary leaflets. As discussed
previously, the decrease in pulmonary artery thickness was probably due to variability
of the tissue supply from the local abattoir.
The hydrodynamic function of the acellular porcine pulmonary roots was assessed in
comparison to the fresh tissue using simulated pulsatile flow testing. The purpose was
to assess the effect of the decellularisation treatment on the hydrodynamic parameters of
the porcine pulmonary roots. Three conditions were used for the hydrodynamic function
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assessment as described in Section 5.3.2.4. The pressure ranges used in this study were
the minimum pressure ranges that could be achieved by the pulsatile flow simulator at
each flow condition. These pressures were close to physiological pulmonary pressures,
and since the intention for the decellularised pulmonary valve scaffolds is to be used for
the replacement of the native pulmonary valve following the Ross procedure, the
particular pressures were deemed appropriate for assessing the function of the
pulmonary scaffolds.
No significant difference was observed in the mean pressure difference and the QRMS
between the acellular and the fresh pulmonary roots at flow condition 1 and 3 (Figure
5.22). However, a significant decrease in the mean pressure difference and QRMS of the
decellularised groups compared to the fresh control was observed at flow condition 2. In
general, the performance of the acellular roots was superior to that of the fresh roots
since lower mean pressure differences across the acellular roots were observed. The
fresh pulmonary roots had a mean pressure difference of 4.5 ± 0.79 mm Hg (95 % C.I.)
at flow condition 2, which corresponded very well with the previous study carried out
by Nagy et al. (2000), who demonstrated a mean pressure difference for fresh porcine
pulmonary roots of 4.6 ± 2.6 mm Hg at very similar testing conditions. The results of
the mean pressure difference and QRMS in this study also corresponded well to the
results reported by Weerasena et al. (1992) for the fresh pulmonary roots tested at
pulmonary pressures.
The EOA showed no significant difference between the decellularised and fresh
pulmonary roots at each of the three flow conditions used. The average EOA for all
flow conditions and all fresh roots was 1.49 ± 0.08 cm2 (95 % C.I.), and the
corresponding average EOA for the decellularised roots was 1.55 ± 0.10 cm2. The EOA
of fresh porcine pulmonary valve reported by Jennings (2001) ranged from 1.82 to 4.04
cm2 with a root size of approximately 23 mm. The flow conditions used by Jennings
(2001) were similar to this ones used in this study, except that the pressure was 120/80
mm Hg, which was much higher than the pressure used in this study (45/10 mmHg).
Higher pulmonary pressures lead to larger dilation of the root, thus resulting in larger
EOA`s. Nagy et al. (2000) tested fresh porcine pulmonary roots with sizes ranging from
20 mm to 25 mm, and demonstrated an average EOA of 2.69 ± 0.53 cm2 at flow
condition (72 bpm/70 ml) and pulmonary pressure of 25/10 mmHg. In this study, the
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average EOA was smaller compared to the previous studies, but this was due to the
smaller pulmonary root size (approximately 18 mm) used.
Korossis (2002) conducted hydrodynamic function testing of decellularised porcine
aortic roots treated with 0.1 % (w/v) SDS. In that study, the decellularised aortic roots
demonstrated a significant decrease in the Δp and significant increase in the EOA 
compared to fresh aortic valves. In the present study, in which 0.1 % (w/v) SDS was
also used for the decellularisation of the porcine pulmonary roots, similar finding was
observed for the mean pressure difference, and no significant difference was observed
for the EOA between the fresh and decellularised roots. This demonstrated the
consistency of the changes in the hydrodynamic function of porcine heart valves treated
with 0.1 % (w/v) SDS.
The leaflet kinematics of the decellularised pulmonary roots were assessed at test
condition 2 (72 bpm/ 70 ml) and compared to the leaflet kinematics of fresh pulmonary
roots. During opening, all fresh and decellularised roots demonstrated the same stellate,
triangular and circular configurations as described for the semilunar valves by
Thubrikar et al. (1979). All decellularised roots demonstrated a circular configuration at
peak systole (FO) and no visible leakage orifices or coaptation flaws during diastole
(FC). The average durations of opening, open, closing and closed phases for the fresh
group (n=6) were 108.7 ± 18.6 ms (mean ± 95 % C.I.), 176.0 ± 29.6 ms, 177.3 ± 45.7
ms and 372.0 ± 18.8 ms, respectively. These phase durations in this study were in good
agreement with the times estimated by Jennings (2001), who reported corresponding
durations of 100, 183, 90, and 457 ms for fresh porcine pulmonary roots. The
differences between the durations in this study and those reported by Jennings (2001)
were most likely due to the small sample size (only one sample) used in the study by
Jennings (2001). The phase durations in this study are in a very good agreement with
the results reported by Korossis (2002) for the fresh aortic roots, in which the mean
durations were 89.5, 160.8, 188.7 and 396.0 for opening, open, closing, and closed
phases based on 10 samples. The phase durations of the decellularised porcine
pulmonary roots (n=6) in the present study showed no statistically significant difference
compared to the fresh control. It was noticed however, that the duration of 188.7 ± 63.2
ms obtained for the opening phase of the decellularised group was increased compared
to the opening phase duration of 108.7 ± 18.6 ms for the fresh control. This result was in
agreement with that reported by Korossis (2002) who used a very similar method for the
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decellularisation of porcine aortic roots. In the study by Korossis (2002), the increased
duration of the opening phase of the decellularised aortic roots was attributed to the
increased compliance of the leaflets, which caused them to take longer time to respond
to the dilation of the aorta generated by the increase in pressure during systole. In the
present study, however, no significantly increased compliance of the pulmonary leaflets
was observed, as demonstrated by the similar elastin phase slopes (no significant
difference) of the fresh and decellularised leaflet groups.
Finally, no significant difference was observed in the minimum bending radius of the
fresh and decellularised left pulmonary leaflets at the start opening, fully open, start
closing, and fully closed configurations. This result further proved that the
decellularised pulmonary leaflets demonstrated similar characteristics to the fresh
control.
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5.6 Conclusion
The decellularisation method for porcine pulmonary roots used in this chapter
incorporated trypsin treatment on the adventitial surface of the scraped pulmonary
artery, together with 1 cycle of SDS-hypotonic treatment and 2 cycles of nuclease
treatments (referred to as ‘Method 6’ in Chapter 3). Uniaxial tensile testing indicated no
significant difference (p > 0.05; t-test) between the fresh and acellular left pulmonary
leaflets in all biomechanical parameters studied. Although the elastin phase slope
showed a significant decrease (p < 0.05; ANOVA) for the acellular pulmonary artery
compared to the fresh tissue, the strength of the pulmonary arteries following
decellularisation was not compromised significantly. The hydrodynamic performance of
the pulmonary roots was grossly preserved following decellularisation. The
decellularised pulmonary leaflets demonstrated similar leaflet kinematics and
deformation compared to the fresh leaflets. Overall the decellularised porcine
pulmonary roots demonstrated very good biomechanical and hydrodynamic function
compared to the fresh control. These results indicate that the decellularised porcine
pulmonary valve scaffold has the potential to be used for at least short term
implantation in the pulmonary position.
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Chapter 6
Investigation of fresh porcine pulmonary valve
conduits in a novel heart valve bioreactor
6.1 Introduction
A major challenge in tissue engineering is to create viable and functional replacement
heart valves that have the ability to remodel and regenerate in vivo after transplantation.
Although some of the currently available acellular heart valves have been assessed for
their biological and biomechanical properties, and have been used clinically either cell
seeded or non-seeded (Dohmen et al., 2007; Mulinari et al., 2008; da Costa et al., 2009;
da Costa et al., 2010; Dohmen et al., 2011), there are currently no in vitro models for
investigating the regeneration of acellular cardiac valves. The in vivo remodelling of
tissue engineered heart valves will probably display considerable variation between
patients, due to inherent biological heterogeneity between individuals in physiological
tissue remodelling potential (Schoen, 2011). The current scientific data are insufficient
to understand the complex mechanobiological stimuli and signalling mechanisms in
vivo (Gandaglia et al., 2011). In order to determine the mechanisms by which VIC and
VEC regenerate acellular heart valves, it would be valuable to be able to study this
process in vitro. Evidence has shown that biomechanical simulation has a significant
impact on cell behaviour including in vitro differentiation. Moreover, physiological
hemodynamic conditioning has been shown to promote new tissue development
(Gandaglia et al., 2011). In vitro mechanical conditioning which reproduces the
developmental process of native heart valves is considered important for the study of
functional heart valve tissue engineering (Hjortnaes et al., 2009). The matrix
remodelling and cellular regeneration of an acellular heart valve scaffold may be
possible to study in vitro with a bioreactor device which can mimic the physiological
conditions in vivo. Using a bioreactor, the mechanisms by which the biochemical or
biomechanical environment influences the interaction between the valvular cell types or
between cells and scaffold could be studied (Berry et al., 2010).
A heart valve bioreactor is a device that is able to recapitulate the biological and
physiological environment of the heart and the circulatory system (Carrier et al., 1999).
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Both mechanical and biochemical conditions are crucial for maintaining heart valve
tissue viability in a bioreactor, namely the concentration of O2 and CO2, pH,
temperature, nutrients, flow conditions and physiological pressure. The maintenance of
a sterile culture environment is essential. There are generally two types of heart valve
bioreactors: the static bioreactor and the dynamic bioreactor. The static bioreactors do
not provide culture medium circulation. Both static and dynamic bioreactors can
provide consistent O2 and CO2 concentration, suitable pH, temperature and nutrients.
Flow conditions and physiological pressure, which are important elements for the
function of a heart valve, are however provided only by dynamic bioreactor systems
(Gandaglia et al., 2011). In order to mimic physiological flow and pressure conditions,
dynamic bioreactors have been designed to deliver culture medium under pulsatile flow
that simulates in vivo pressure (80-120 mmHg for the systemic circulation in the left
heart, and 15-35 mmHg for the pulmonary circulation in the right heart), heart rate (60-
100 bpm), and stroke volume (50-70 ml). To achieve such conditions, peristaltic,
centrifugal, or pneumatic pumps have been used, coupled with programmable waveform
generators that recreate cardiac physiological flow. Moreover, a compliance chamber to
simulate the elastic loading sustained in vivo by the arteries is usually included. This
chamber is responsible for the delay and shape of the pressure waveform (Ruel &
Lachance, 2009). In addition, a flow resistor is usually positioned downstream of the
heart valve to simulate the vasculature narrowing in precapillary arterioles, capillaries
and veins (Gandaglia et al., 2011).
A dynamic heart valve bioreactor generally consists of the following components: a
ventricle chamber driven by a motor (mechanical, pneumatic, or electric) which is able
to provide physiological pressure and flow conditions; a system to control and adjust
compliance and resistance; a chamber to house the heart valve; probes and sensors for
measuring and adjusting flow and pressure, temperature, pH, O2 and CO2
concentrations plus hardware, and software to control the whole system (Dvir et al.,
2006). Moreover, a dynamic heart valve bioreactor should also have the potential to
allow the setting and adjusting of parameters such as stroke volume and number of
cycles, as well as the possibility to remove or add fresh medium under sterile conditions.
Ideally, the heart valve under culture should be visible and monitored during the whole
culture period (Gandaglia et al., 2011).
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Although the ultimate goal of these studies was to use a heart valve bioreactor to study
the regeneration of acellular pulmonary heart valve scaffolds by appropriate cell types,
suitable conditions to apply during culture in order to maintain valve function and cell
viability in the bioreactor had to be determined using fresh tissue. In this chapter, fresh
porcine pulmonary roots were cultured in dynamic conditions in a novel heart valve
bioreactor and compared to valves cultured in static culture for one week, and the
histology, cell viability, expression of cellular and matrix proteins were compared to
fresh tissue which was not subject to organ culture.
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6.2 Aims and objectives
Aims:
The aims of this chapter were to determine the conditions for the culture of fresh
porcine pulmonary roots under sterile conditions in a dynamic heart valve bioreactor
and a static culture system, and to compare the tissue properties with fresh porcine
pulmonary roots.
Objectives:
 To determine the cell distribution and tissue histoarchitecture of fresh porcine
pulmonary roots cultured statically and dynamically in a heart valve bioreactor
and to compare with fresh, non-cultured tissue.
 To detect and localise specific matrix and cellular proteins in dynamically and
statically cultured fresh porcine pulmonary roots and to compare with fresh,
non-cultured tissue.
 To determine cell viability in the dynamic and static cultured porcine pulmonary
roots compared to fresh non-cultured roots.
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6.3 Methods
6.3.1 Pulmonary root tissue culture medium
The medium used in this study for pulmonary root tissue culture in both dynamic and
static culture systems was DMEM with 10 % (v/v) FBS, 100 U.ml-1 penicillin, 100
U.ml-1 streptomycin, 250 ng.ml-1 amphotericin B, 25 µg.ml-1 gentamicin, 100 µM L-
glutamine, and 0.1 % (v/v) anti foaming reagent polypropylene glycol. The medium
was prepared fresh and used immediately.
6.3.2 Porcine pulmonary root tissue preparation
The fresh porcine pulmonary roots used in this chapter were dissected as described in
Section 2.2.4. The dissection procedure was carried out aseptically in a Class II safety
cabinet. All the roots were used immediately after dissection. The length of the
myocardium skirt of the dissected porcine pulmonary root was kept at around 2.5 cm,
and the myocardium skirt was thinned to have a thickness of around 3 mm. The length
of the myocardium skirt in the roots dissected for culture was longer than those subject
to decellularisation. The reason for this was that when sewing the porcine pulmonary
root to the tissue holder of the dynamic bioreactor, the three pulmonary leaflets needed
to reside in the middle of the holder in order to free the annulus for expansion during
dynamic culture. Only when the annulus was free, could the porcine pulmonary heart
valve leaflets open and close properly during dynamic culturing (data not shown). The
roots used for static culture were kept the same as those used for dynamic culture. The
integrity of the whole roots was carefully examined before they were placed in the
culture system. An image of a dissected fresh porcine pulmonary root for dynamic and
static culture is shown in Figure 6.1.
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Figure 6.1 A fresh porcine pulmonary root dissected for dynamic or static
culturing.
6.3.3 The dynamic and static heart root culture systems
6.3.3.1 The dynamic culture system
A dynamic heart valve bioreactor designed by Dr Sotirios Korossis was used in this
study for the dynamic culture of fresh porcine pulmonary roots. A schematic image of
the bioreactor in its vertical section is shown in Figure 6.2, and images of the bioreactor
are shown in Figure 6.3. This bioreactor worked by mimicking either the left or the right
side of the heart. There were three main parts of the bioreactor: the pump, the left/right
heart simulator and the biostat.
The bioreactor was driven by an electric pump (Vivitro systems Inc, Canada; Industrial
Devices Corporation, CA, USA), which was attached to a control panel to obtain the
desired pumping rate, stroke volume and waveform. The pump directly provided
pressure to the water inside the membrane housing chamber during pumping, so the
silicone membrane which was attached on top of the membrane housing chamber
expanded in response to the pressure. The expansion of the silicone membrane produced
pressure in the ventricular chamber, which was connected to the membrane housing
chamber, thus forcing medium circulation inside the culture system. The silicone
membrane also provided separation of the sterile ventricular chamber and the non-
sterile electric pump so that the internal environment of the circulation system which
contained the tissue was kept sterile. The pulmonary valve roots were placed in stations
which were positioned downstream of the ventricular chamber. There were six stations
Chapter 6
229
in total, and when attached encompassed the main body of the bioreactor. Thus, this
bioreactor was designed to be able to accommodate six valve roots at the same time.
Viewing windows with glass were incorporated at both ends of each station, to allow
monitoring of valve root behaviour during the culture process. The pulmonary root was
fitted onto a holder which was then positioned into a heart root station (Figure 6.3 B).
Images of a fresh porcine pulmonary valve root during culture which were taken from
the viewing window of the root station are shown in Figure 6.4. During operation, the
ventricular chamber was pressurised, and the culture medium was forced to circulate
through the pulmonary valves in the stations, the compliance chamber, the atrial
reservoir, the mechanical valve (which represented either the mitral valve in the left
heart or the tricuspid valve in the right heart), and back to the ventricular chamber
(Figure 6.2). A peripheral resistance was positioned between the compliance chamber
and the atrial reservoir in order to mimic the vasculature narrowing in precapillary
arterioles, capillaries, and veins. The peripheral resistance could be adjusted manually to
control the internal pressure of the circulating system. The internal pressure was
monitored with a pressure meter residing on top of the compliance chamber (Figure 6.3
A). The medium temperature, pH and O2 concentration were monitored and controlled
by the biostat (Model ADI 1025, Applikon® Biotechnology) which was connected to
the left/right heart simulator (Figure 6.3 C). The medium in the medium resevoir of the
biostat was continuously stirred. A heating wrap was placed around the resevoir to
maintain the temperature of the medium at 37 °C. The culture medium circulated
between the bioreactor and medium resevoir of the biostat, and the circulation rate was
monitored so the level of the medium was dynamically balanced. The constant medium
circulation made the composition and the parameters of the medium inside the left/right
heart simulator and the biostat the same.
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Figure 6.3 The 6-station dynamic heart valve bioreactor. (A) The left/right heart
simulator and the pump inside a Class II safety cabinet; (B) An opened heart root station
with illustration of the heart root holder position; (C) The biostat and culture medium
resevoir connected to the bioreactor.
Figure 6.4 Images of a fresh porcine pulmonary valve root during dynamic culture.
The images were taken from the viewing window of the heart valve station. (A) Fully
closed fresh pulmonary valve; (B) Fresh pulmonary valve during opening; (C) Fully
opened fresh pulmonary valve.
6.3.3.2 The static culture system
The static culture system for valve roots is shown in Figure 6.5. The system consisted of
three 250 ml tissue culture pots. Each pot was able to accommodate one pulmonary root.
There were four valves on the lid of each pot for air-in and out, and medium-in and out.
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A sterile filter was positioned upstream of the air-in valve in order to block any
microorganisms from the air entering the culture. When the system was working, 5 %
(v/v) CO2 in air was continuously bubbled into the bottom of each pot. The pressure of
the 5 % (v/v) CO2 in air was monitored by a pressure meter (Figure 6.5 B) that was
connected upstream of the air-in valve sterile filter. The pressure used in the culture
system was 0.5 L.min-1 (this value was for the 3 pots together, so each of them was 1/3
of this value). Tests had shown that a flow rate of 0.5 L.min-1 in this system would keep
the oxygen level in the medium of the static culture pots at 21%. The whole system
except for the pressure meter was placed in a 37 ° C incubator.
Figure 6.5 The static heart valve culture system. (A) The static heart valve culture
pots inside the incubator; (B) The pressure meter.
6.3.4 Sterilisation of the heart valve culture systems
The sterility of the heart valve culture systems was crucial to the success of culture
experiments with porcine pulmonary roots. Autoclaving was carried out as described in
Section 2.2.3.2, and dry heat sterilisation was carried out as described in Section 2.2.3.1.
Prior to experiments, the dynamic bioreactor, the static bioreactor and the biostat culture
medium resevoir and tubing were soaked in 1% (v/v) Trygene for 1 hour, with all the
valves open, and all the parts separated. All of the air filters were taken off the system.
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The parts of the bioreactor and the medium resevoir were then rinsed in running tap
water until clear. Following that, all the parts of the bioreactor and the biostat culture
medium resevoir were rinsed in distilled water three times. The parts were air-dried on
the bench, and the air filters were assembled in their correct positions. Autoclaving was
used to sterilise the heart valve bioreactor. Prior to autoclaving, all of the valves were
opened, and covered with double layers of foil and fixed with autoclave tape, including
the air filters. The mechanical valve was kept in place during autoclaving. To autoclave
the biostat culture medium resevoir, the lid of the medium tank was loosely fixed, and
around 50 ml of distilled water was in the resevoir to protect the pH probe during
autoclaving. All of the connecting tubes were also cleaned and autoclaved prior to use.
Trygene (1 %, v/v) was pumped into the tubes and they were soaked for 1 hour, and
then Trygene was completely rinsed by pumping tap water through the tubes until the
water ran clear. The final step was to pump distilled water through the tubes. The tubes
were left on the bench to dry before autoclaving. Both ends of the tubes were opened
and covered with double layers of foil, and sealed loosely with autoclave tape prior to
autoclaving. Valve root holders and sealing rings for valve root holders were autoclaved
separately in autoclave bags. All the parts that were autoclaved were left to completely
dry in 37 °C drying room for one week prior to use. Dissection tools, along with
bioreactor fixing clips were sterilised by dry heat sterilisation.
6.3.5 The dynamic culture of fresh porcine pulmonary roots
6.3.5.1 Suturing the fresh porcine pulmonary root onto the tissue holder
In order to position the pulmonary valves in the stations of the bioreactor, a root holder
was specially designed (Figure 6.6 A). Small holes for suturing were made on both
sides of the holder. Dissected fresh porcine pulmonary valve roots were sutured onto the
holder aseptically in a Class II safety cabinet with 3/0 non-absorbable polypropylene
monofilament suture with a 3/8c, 24mm needle (Premilene®). The myocardium was
sutured onto the holder first. The pulmonary artery was then sutured onto the holder
with the pulmonary root positioned in its natural state (not to disturb to its natural
bending). The extra length of the pulmonary artery was trimmed off after suturing. The
tissue was rinsed in PBS every few minutes during the suturing procedure to prevent the
tissue from drying and to maintain the maximum viability of the cells in the porcine
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pulmonary root. Sealing rings were used on both sides of the holder when it was placed
in the bioreactor station to ensure the medium circulated only through the porcine
pulmonary roots. Images of a pulmonary valve root holder with a fresh porcine root
sutured in place are shown in Figure 6.6 B, C, and D.
Figure 6.6 Suturing of a fresh porcine pulmonary root onto a holder for the
dynamic bioreactor. (A) An image of a pulmonary valve root holder for the heart valve
dynamic bioreactor; (B) An image of a pulmonary valve root holder for the heart valve
dynamic bioreactor with a fresh porcine pulmonary valve root sutured in place; (C) An
image of a pulmonary valve root holder for the heart valve dynamic bioreactor with a
fresh porcine pulmonary heart root sutured in place (a view from the pulmonary artery
side); (D) An image of a pulmonary valve root holder for the heart valve dynamic
bioreactor with a fresh porcine pulmonary heart root sutured in place (a view from the
myocardium skirt side). A: leaflet annulus; M: myocardium skirt; PA: pulmonary artery;
L: pulmonary leaflet.
6.3.5.2 Tissue disinfection
Each of the sutured fresh porcine pulmonary roots with the holder were incubated in
100 ml Cambridge antibiotics solution in a 250 ml container for 16-17 h at 4 °C for
surface disinfection before culturing in the dynamic bioreactor. The Cambridge
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antibiotics solution (Sigma) consisted of 14.7 g.L-1 Medium 199, 0.2 g.L-1 vancomycin
HCl USP, 0.2 g.L-1 polymyxin B sulphate, 2.5 million unit.L-1 nystatin, 0.25 g.L-1
imipenem/cilastatin sodium and 4 g.L-1 gentamicin sulphate.
6.3.5.3 The dynamic culture procedure
The dynamic heart valve bioreactor was assembled aseptically in the class II safety
cabinet, and connected to the biostat. Tissue culture medium was aseptically pumped
into the bioreactor (~ 5 L) and the biostat medium resevoir (~ 5 L). A valve root station
with a mechanical valve was fitted to the bioreactor. The bioreactor was operated with
the culture medium and mechanical valve for a period of one week prior to inserting any
fresh pulmonary roots in order to check for sterility and equilibrate the system. During
this period, the culture medium was equilibrated to the required O2 concentration, pH,
and temperature. After everything was balanced, the pump was set at 60 bpm, and
produced a stroke volume of 4.2 L.min-1. A sinusoidal waveform was used. The
pressure inside the bioreactor during operation was 15-33 mmHg. The culture medium
within the bioreactor and the chemostat had an O2 concentration of 21 %, and the pH
was pH 7.4. The temperature of the medium was 37 °C. The same conditions were
applied to the dynamic culture of fresh porcine pulmonary roots. After the bioreactor
had operated with a mechanical valve for one week, three fresh porcine pulmonary roots
were dissected and sutured onto valve root holders aseptically. The holders were placed
in the stations for valve roots prior to fitting the stations to the bioreactor. The station
with the mechanical valve was removed at this stage. The three fresh porcine pulmonary
roots were cultured in the dynamic bioreactor for one week. Following culture, the roots
were removed from the stations, and the cultured roots were assessed for cell viability
and examined by histology and immunohistochemistry.
6.3.6 The static culture procedure of fresh porcine pulmonary roots
The static culture system was assembled in a Class II safety cabinet. Three fresh
pulmonary roots were dissected and disinfected in Cambridge antibiotics solution for
16-17 h at 4 °C, prior to being placed in the three pots of the static culture system
individually. Culture medium (150 ml) was used for the culture of each fresh porcine
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pulmonary root in each pot. The culture system was then placed in a 37 °C incubator
with 5 % (v/v) CO2 in air continuously bubbled into the culture medium. The three fresh
porcine pulmonary roots were cultured in the static system for one week, and the
cultured roots were assessed for cell viability and examined by histology and
immunohistochemistry.
6.3.7 Histology
Following culture of fresh porcine pulmonary roots in the dynamic (n=3) and static (n=3)
systems, histology was carried out to determine the cell distribution and tissue
histoarchitecture. Tissue samples for histology were fixed with 10 % (v/v) NBF for 24
to 48h, and histology was carried out as described in Section 2.2.7. Tissue sections for
histology were collected when the leaflet, pulmonary artery and myocardium all
appeared on the same sections. The H&E stain was used to study the cell distribution
and tissue histoarchitecture. The Hoechst stain was used to study the localisation of cell
nuclei. Each tissue sample was serially sectioned at 10 µm, and at least 3 sections were
stained. Slides were viewed with a bright-field microscope or a fluorescent microscope
with a DAPI filter after staining.
6.3.8 Immunohistochemistry
Immunohistochemistry was utilised to localise specific matrix and cellular proteins in
tissue sections. Porcine pulmonary root samples (n=3 for dynamic cultured tissue; n=3
for static cultured tissue) were fixed with 10 % (v/v) NBF or zinc fixation solution, and
immunohistochemical analyses were performed as described in Section 2.2.8. A
minimum of 3 sections per sample from serial sections of 10 µm were evaluated.
Sections from each tissue sample were incubated with specific antibody, isotype control
of the same concentration as the antibody, and antibody diluent (omitting the primary
antibody as a negative control). Antibody specific binding was carefully examined
using light microscopy. Monoclonal antibodies used in this study were specific to: α-
SMA, vWF, desmin, vimentin, fibronectin, and collagen-IV.
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6.3.9 Live/dead staining of porcine pulmonary leaflets
6.3.9.1 Live/dead staining
Solutions:
Live/dead stain solution was prepared using PBS at pH 7.6, and comprised 1mM calcein
AM and 1mM ethidium homodimer-1 (1.2 µl calcein and 5 µl of ethidium homodimer-1
in 5ml of PBS pH 7.6).
Method:
Live/dead staining was used to visualise the viability of cells in the pulmonary leaflets.
Pulmonary leaflet tissue was dissected and placed into individual wells of a 12-well
tissue culture plate. Live/dead stain solution was added into each well to completely
cover the tissue. The plate was fitted with its lid, and incubated at room temperature in
the dark for 45 min. The tissue was washed three times in TBS pH 7.6 for 10 min on a
plate rocker. The tissue was then wet mounted with glycerol: DABCO (1:9) onto a
microscope slide and covered with a glass coverslip. The tissue was viewed using a
confocal microscope (Zeiss LSM510 META) and a conventional fluorescent long pass
filter. Live cells were stained green while dead cells were stained red.
6.3.9.2 Confocal Microscopy
A Zeiss LSM510 META confocal microscope was used to examine the cell viability in
the leaflet tissue. The pre-stained porcine pulmonary leaflets were wet mounted with
glycerol/DABCO (1:9) onto a microscope slide and covered with a glass coverslip. The
two laser injectors of the confocal microscope, Argon/2 and HeNel1 were turned on,
and the live/dead assay setting was selected using the LSM510 control programme. The
signals of the two dyes from the live/dead stain assay were captured at 448 nm (for
calcein), and 514 nm (for ethidium homodimer-1) at different depths of the tissue.
Images were captured using the 40 times magnification observation lens.
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6.3.10 Cell viability assay (MTT assay) for porcine pulmonary leaflets
Solutions:
 MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution:
5mg.ml-1 MTT was made in PBS pH 7.6. This solution was stored in a foil
wrapped container in -20 °C, and thawed to room temperature when used.
 DMSO
Method:
The MTT assay was used to study the cell viability within the heart valve leaflet tissue.
Tissue samples of 20 mg were macerated with a scalpel blade, weighted, and then
placed in 1.5 ml microtubes. MTT solution (200 µl) and 400 µl PBS were added to each
microtube. The tubes were incubated on a blood rotator at 30 rpm for 2.5 h at 37 °C.
Following incubation, the tubes were centrifuged in a micro centrifuge at 6,000 g for 5
min, the supernatant was removed and 1ml of DMSO was added into each tube. The
tubes were further incubated on the blood rotator at 30 rpm for 17 h at 37 °C,
centrifuged at 6,000 g for 5 min in a micro centrifuge. Aliquots of 200 µl supernatant
were transferred from the micro tubes to a clear flat-bottomed 96-well plate. The
absorbance was read at 570 nm with a reference filter at 630 nm. DMSO was used as a
blank. The readings for acellular pulmonary leaflet samples were compared to those of
the fresh tissue, in order to compare the cell viability. Data was analysed by one way
ANOVA followed by calculation of the MSD using the T-method.
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6.4 Results
6.4.1 The fresh porcine pulmonary roots cultured in dynamic and static culture
systems for one week
After culture for one week in the dynamic and static culture systems, the porcine
pulmonary roots were removed. Images of the cut-open porcine pulmonary roots are
shown in Figure 6.7. No damage was seen to the pulmonary leaflets or any other parts
of the roots for both dynamic and static cultured tissue. No apparent change in gross
tissue morphology was observed. The porcine pulmonary leaflets and pulmonary
arteries were found to have taken up the pink colour of the phenol red in the tissue
culture medium.
Figure 6.7 Images of cut-open fresh porcine pulmonary roots after one week of
culture in the dynamic and static culture systems. (A) An image of a cut-open fresh
porcine pulmonary root cultured in the dynamic culture system for one week; (B) An
image of a cut-open fresh porcine pulmonary root cultured in the static culture system
for one week.
6.4.2 Histological evaluation of fresh porcine pulmonary valve conduits cultured in
the dynamic and static heart root culture systems for one week
Tissue sections of the porcine pulmonary roots cultured in the dynamic and static
culture systems for one week were stained with H&E and Hoechst. Histology images of
the pulmonary roots cultured in the dynamic system are shown in Figure 6.8 (H&E) and
Figure 6.9 (Hoechst). Histology images of the pulmonary roots cultured in the static
system are shown in Figure 6.10 (H&E) and Figure 6.11 (Hoechst). Cells that were
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stained blue after H&E staining were observed throughout the dynamic and static
cultured porcine pulmonary roots (Figure 6.8 & Figure 6.10). The connective tissues
that were stained red could be seen in the pulmonary leaflets, pulmonary artery and
myocardium. The loosely arranged spongiosa and the more organised ventricularis and
fibrosa in the pulmonary leaflets were recognised (Figure 6.8 A & figure 6.10 A). The
tips of the pulmonary leaflets remained intact after culturing in the dynamic and static
systems (Figure 6.8 B & Figure 6.10 B). In the H&E images for myocardium (Figure
6.8 C & Figure 6.10 C), the cross-sectioned myocardium bundles were observed. The
connective tissue and smooth muscle cells were aligned parallel to the long axis of the
pulmonary arteries after culture (Figure 6.8 D, E; Figure 6.10 D, E). Hoechst staining
results further confirmed the cell distribution was throughout the whole porcine
pulmonary roots cultured in the dynamic and static systems (Figure 6.9 & Figure 6.11).
Cells were recognised in both the endothelial region and the internal region of the
pulmonary leaflets and pulmonary arteries.
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Figure 6.8 Sections of fresh porcine pulmonary root tissue cultured in the dynamic
system for one week stained with H&E. (A) Pulmonary valve leaflet, 100 × (v:
ventricularis; s: spongiosa; f: fibrosa); (B) The tip of the pulmonary valve leaflet, 100 ×;
(C) Myocardium, 100 ×; (D) The lumen surface of the pulmonary artery, 100 ×; (E) The
adventitial surface of the pulmonary artery, 100 ×. M: myocardium; L: leaflet. Scale
bars are: all 200 µm.
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Figure 6.9 Sections of fresh porcine pulmonary root tissue cultured in the dynamic
system for one week stained with Hoechst. (A) Pulmonary valve leaflet, 100 × (v:
ventricularis; s: spongiosa; f: fibrosa); (B) The tip of the pulmonary valve leaflet, 100 ×;
(C) Myocardium, 100 ×; (D) The lumen surface of the pulmonary artery, 100 ×; (E) The
adventitial surface of the pulmonary artery, 100 ×. M: myocardium; L: leaflet. Scale
bars are: all 200 µm.
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Figure 6.10 Sections of fresh porcine pulmonary root tissue cultured in the static
system for one week stained with H&E. (A) Pulmonary valve leaflet, 100 × (v:
ventricularis; s: spongiosa; f: fibrosa); (B) The tip of the pulmonary valve leaflet, 100 ×;
(C) Myocardium, 100 ×; (D) The lumen surface of the pulmonary artery, 100 ×; (E) The
adventitial surface of the pulmonary artery, 100 ×. M: myocardium; L: leaflet. Scale
bars are: all 200 µm.
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Figure 6.11 Sections of fresh porcine pulmonary root tissue cultured in the static
system for one week stained with Hoechst. (A) Pulmonary valve leaflet, 100 × (v:
ventricularis; s: spongiosa; f: fibrosa); (B) The tip of the pulmonary valve leaflet, 100 ×;
(C) Myocardium, 100 ×; (D) The lumen surface of the pulmonary artery, 100 ×; (E) The
adventitial surface of the pulmonary artery, 100 ×. M: myocardium; L: leaflet. Scale
bars are: all 200 µm.
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6.4.3 Immunohistochemical evaluation of fresh porcine pulmonary valve conduits
cultured in the dynamic and static heart root culture systems for one week
Specific cytoskeletal and ECM proteins of the porcine pulmonary roots cultured in
dynamic and static systems for one week were localised using immunohistochemical
stainings. All negative control sections (including isotype controls and omission of
primary antibody controls) showed an absence of staining.
6.4.3.1 Alpha-SMA
The images of porcine pulmonary root tissue sections labelled with α-SMA are shown 
in Figure 6.12 (cultured in the dynamic system) and Figure 6.13 (cultured in the static
system). The ventricular surface of the pulmonary leaflet that was cultured in the
dynamic system was positively stained with α-SMA antibody (Figure 6.12 A). However, 
no staining was observed in the leaflets cultured in the static system (Figure 6.13 A).
Positive staining was also observed in the blood vessels within the myocardium of
dynamic and static culture porcine pulmonary roots (Figure 6.12 B; Figure 6.13 B). The
cells within the pulmonary arteries from both dynamic and static cultured porcine
pulmonary roots were stained positive, while the ECM of the pulmonary arteries stained
a light brown colour (Figure 6.12 C; Figure 6.13 C). No positive staining was observed
in the tissue sections stained with isotype control (Figure 6.12 D, E, F; Figure 6.13 D, E,
F).
6.4.3.2 vWF
The images of porcine pulmonary root tissue sections stained for vWF are shown in
Figure 6.14 (cultured in the dynamic system) and Figure 6.15 (cultured in the static
system). No brown coloured positive staining was observed in the pulmonary leaflets or
the luminal surface of the pulmonary arteries of either the dynamic cultured or the static
cultured porcine pulmonary roots (Figure 6.14 A, C; Figure 6.15 A, C). This result
indicated a loss of endothelial cells in the porcine pulmonary roots after dynamic and
static culturing. However, the small blood vessels within the myocardium and the
adventitial connective tissue layer of the pulmonary arteries were stained positive
(Figure 6.14 B, D; Figure 6.15 B, D). No positive staining was observed in the tissue
sections stained with isotype control (Figure 6.14 E, F; Figure 6.15 E, F).
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Figure 6.12 Localisation of α-SMA in fresh porcine pulmonary root tissue cultured 
in the dynamic system for one week. (A) Pulmonary valve leaflet, 100 ×, the arrow
indicates the ventricular side of the pulmonary leaflet that has been positively stained;
(B) Myocardium, 100 ×, the arrow indicates a blood vessel in the myocardium that has
been positively stained; (C) Pulmonary wall, 100 ×; (D) Pulmonary valve leaflet isotype
control, 100 ×; (E) Myocardium isotype control, 100 ×; (F) Pulmonary wall isotype
control, 100 ×. v: ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are:
all 200 µm.
Figure 6.13 Localisation of α-SMA in fresh porcine pulmonary root tissue cultured 
in the static system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×, the arrow indicates a blood vessel in the myocardium that has been
positively stained; (C) Pulmonary wall, 100 ×; (D) Pulmonary valve leaflet isotype
control, 100 ×; (E) Myocardium isotype control, 100 ×; (F) Pulmonary wall isotype
control, 100 ×. v: ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are:
all 200 µm.
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Figure 6.14 Localisation of vWF in fresh porcine pulmonary root tissue cultured in
the dynamic system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×, the arrow indicates a blood vessel in the myocardium that has been
positively stained; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×, the arrow indicates a blood vessel that
has been positively stained; (E) Pulmonary valve leaflet stained with isotype control,
100 ×; (F) Pulmonary wall stained with isotype control. v: ventricularis; s: spongiosa; f:
fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.15 Localisation of vWF in fresh porcine pulmonary root tissue cultured in
the static system for one week. (A) Pulmonary valve leaflet, 100 ×; (B) Myocardium,
100 ×, the arrow indicates a blood vessel in the myocardium that has been positively
stained; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The adventitial
surface of the pulmonary wall, 100 ×, the arrow indicates a blood vessel that has been
positively stained; (E) Pulmonary valve leaflet stained with isotype control, 100 ×; (F)
Pulmonary wall stained with isotype control. v: ventricularis; s: spongiosa; f: fibrosa; M:
myocardium. Scale bars are: all 200 µm.
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6.4.3.3 Desmin
Images of porcine pulmonary root tissue sections labelled with a monoclonal antibody
against desmin are shown in Figure 6.16 (cultured in the dynamic system) and Figure
6.17 (cultured in the static system). The myocardium of the dynamic cultured
pulmonary roots was stained positive (Figure 6.16 B). No positive staining was
observed in the static cultured pulmonary root sections. No positive staining was
observed in the tissue sections stained with isotype control (Figure 6.16 E, F; Figure
6.17 E, F).
6.4.3.4 Vimentin
Following labelling using a monoclonal antibody against vimentin, the results indicated
that the cells within the porcine pulmonary roots cultured in the dynamic and static
systems for one week were stained positive (Figure 6.18; Figure 6.19). The cells within
the myocardium of the static cultured porcine pulmonary roots (Figure 6.19 B) were
stained less intensely than those of the dynamic cultured porcine pulmonary roots
(Figure 6.18 B). No positive staining was observed in the tissue sections stained with
isotype control (Figure 6.18 E, F; Figure 6.19 E, F).
6.4.3.5 Fibronectin
The porcine pulmonary roots cultured in the dynamic and static system for one week
were stained brown throughout following labelling with fibronectin (Figure 6.20; Figure
6.21). The darkest colour was observed in the surfaces of the pulmonary leaflets and the
lumen surface of the pulmonary arteries. No positive staining was observed in the tissue
sections stained with isotype control (Figure 6.20 E, F; Figure 6.21 E, F).
6.4.3.6 Collagen IV
The images of porcine pulmonary root sections stained for collagen IV are shown in
Figure 6.22 (cultured in the dynamic system) and Figure 6.23 (cultured in the static
system). The darkest brown colour indicating positive staining was observed on the
surfaces of the porcine pulmonary leaflets (Figure 6.22 A; Figure 6.23 A) as well as the
lumen surface of the fresh pulmonary artery (Figure 6.22 C; Figure 6.23 C). The ECM
of porcine pulmonary arteries and myocardium were also stained a light brown colour.
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No positive staining was observed in the tissue sections stained with the isotype control
(Figure 6.22 E, F; Figure 6.23 E, F).
Figure 6.16 Localisation of desmin in fresh porcine pulmonary root tissue cultured
in the dynamic system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×. M: myocardium; (E) Pulmonary valve
leaflet stained with isotype control, 100 ×; (F) Pulmonary wall stained with isotype
control. v: ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200
µm.
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Figure 6.17 Localisation of desmin in fresh porcine pulmonary root tissue cultured
in the static system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
myocardium, 100 ×; (C) the lumen surface of the pulmonary wall, 100 ×; (D) the
adventitial surface of the pulmonary wall, 100 ×; (E) pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.18 Localisation of vimentin in fresh porcine pulmonary root tissue
cultured in the dynamic system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.19 Localisation of vimentin in fresh porcine pulmonary root tissue
cultured in the static system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
myocardium, 100 ×; (C) the lumen surface of the pulmonary wall, 100 ×; (D) the
adventitial surface of the pulmonary wall, 100 ×; (E) pulmonary valve leaflet stained
with isotype control, 100 ×; (F) pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.20 Localisation of fibronectin in fresh porcine pulmonary root tissue
cultured in the dynamic system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.21 Localisation of fibronectin in fresh porcine pulmonary root tissue
cultured in the static system for one week. (A) Pulmonary valve leaflet, 100 ×; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.22 Localisation of collagen IV in fresh porcine pulmonary root tissue
cultured in the dynamic system for one week. (A) Pulmonary valve leaflet, 200 ×, the
arrow indicates the surface of pulmonary leaflet that has been positively stained; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×, the arrow
indicates the surface layer of pulmonary wall that has been positively stained; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: Scale bars are all
200 µm except (A), 100 µm.
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Figure 6.23 Localisation of collagen IV in fresh porcine pulmonary root tissue
cultured in the static system for one week. (A) Pulmonary valve leaflet, 100 ×, the
arrows indicates the surfaces of pulmonary leaflet that has been positively stained; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×, the arrow
indicates the surface layer of pulmonary wall that has been positively stained; (D) The
adventitial surface of the pulmonary wall, 100 ×; (E) Pulmonary valve leaflet stained
with isotype control, 100 ×; (F) Pulmonary wall stained with isotype control. v:
ventricularis; s: spongiosa; f: fibrosa; M: myocardium. Scale bars are: all 200 µm.
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6.4.4 Live/dead staining for porcine pulmonary leaflets
The viability of cells in the porcine pulmonary leaflets was assessed using live/dead
stain, in which viable cells were stained green and dead cells were stained red. The cells
on the surface of the pulmonary leaflets following staining were observed using
confocal microscopy. The pulmonary leaflets of fresh, 10 % (v/v) NBF treated (for 1 h),
dynamic cultured, and static cultured porcine pulmonary roots were stained and
examined. Fresh leaflets that had not been cultured were used as negative control, and
the 10 % (v/v) NBF treated leaflets were used as positive control. The results are shown
in Figure 6.24. Most cells appeared to be green in the image of fresh leaflet (Figure 6.24
A) with approximately 10 % cells stained red. The cells appeared to reside close to each
other in the image for the fresh sample. All of the cells were stained red in the 10 % (v/v)
NBF treated leaflet (Figure 6.24 B). Most cells were stained both green and red in the
sections of dynamic and static cultured porcine pulmonary leaflets (Figure 6.24 C, D).
The size of the cells appeared to be a lot smaller than the ones in the fresh leaflets.
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Figure 6.24 Sections of the porcine pulmonary leaflets stained with live/dead stain.
(A) Fresh porcine pulmonary leaflet, 400 ×; (B) Fresh porcine pulmonary leaflet fixed
with 10 % (v/v) for 1 h, 400 ×; (C) Porcine pulmonary leaflet cultured in the dynamic
system for one week, 400 ×; (D) Porcine pulmonary leaflet cultured in the static system
for one week, 400 ×.
6.4.5 Cell viability assay (MTT assay) for porcine pulmonary leaflets
The viability of cells in the porcine pulmonary leaflets was further assessed
quantitatively using MTT assay. The assay was performed on porcine pulmonary
leaflets from fresh, 10 % (v/v) NBF treated (for 1 h), dynamic cultured, and static
cultured porcine pulmonary roots. The fresh leaflets were used as positive control, and
the 10 % (v/v) NBF treated leaflets (tissue with dead cells) were used as negative
control for cell viability. The absorbance was read at 570 nm with a reference filter at
Chapter 6
260
630 nm. Data was analysed by one way ANOVA. The results are shown in Figure 6.25,
which indicated a significant decrease of the cell viability in the 10 % (v/v) NBF treated
leaflets, dynamic cultured and static cultured samples compared to the fresh sample.
The cell viability of the dynamic cultured and static cultured leaflet samples was
significantly higher in comparison with that of the 10 % (v/v) NBF treated leaflet
sample.
Figure 6.25 Cell viability of porcine pulmonary leaflets determined by MTT assay.
Data is presented as the mean (n=3) ± 95 % C.I.. Data was analysed using one way
ANOVA followed by calculation of the MSD using the T-method (p<0.05) “*”
indicated significant difference when compared with the fresh leaflet group.
6.4.6 Study the effect of Cambridge antibiotics on cell viability and the endothelial
cells in fresh porcine pulmonary heart roots
The immunohistochemistry results indicated a loss of endothelial cell layers in the
dynamic and static cultured porcine pulmonary leaflets and the lumen surface of the
pulmonary arteries. From the live/dead staining results and the MTT assay results, it
was observed that the cell viability in the porcine pulmonary leaflets was significantly
reduced after dynamic and static culture compared with that of the fresh tissue. Since
Cambridge antibiotics solution was used for the disinfection of porcine pulmonary roots
before culturing in the dynamic and static system, it was deemed necessary to study the
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effect of Cambridge antibiotics on the leaflet cell viability and the presence of
endothelial cells on the porcine pulmonary roots.
6.4.6.1 Method
Five conditions were applied to the fresh porcine pulmonary roots in order the study the
effect of Cambridge antibiotics prior to evaluation:
(1) Fresh porcine pulmonary roots dissected within 4 hours of slaughter;
(2) Fresh porcine pulmonary roots stored in PBS for 16-17 h at 4 °C;
(3) Fresh porcine pulmonary roots stored in DMEM cell culture medium for 16-17 h at
4 °C;
(4) Fresh porcine pulmonary roots cultured in Cambridge antibiotics solution in the
static culture system with continuous pumping of 5 % (v/v) CO2 in air at 37 °C for 16-
17 h.
(5) Fresh porcine pulmonary roots stored in Cambridge antibiotics solution for 16-17 h
at 4 °C.
Conditions (1), (2), (3) and (4) were used as controls; condition (5) was the same
procedure that was taken prior to the porcine pulmonary roots being cultured in the
dynamic and static systems.
The leaflet cell viabilities of the treated and non treated porcine pulmonary roots were
studied using MTT. Sections of the pulmonary roots were labelled with monoclonal
antibody to von Willebrand factor to study the presence of the endothelial cells.
6.4.6.2 Results
6.4.6.2.1 Cell viability assay (MTT assay) for porcine pulmonary leaflets
Following the MTT assay, the absorbance was read at 570 nm with a reference filter at
630 nm. The data was analysed using one way ANOVA. The results are shown in
Figure 6.26. A significant difference increase in cell viability for the leaflets cultured
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with DMEM cell culture medium for 16-17 h at 4 °C compared to fresh leaflets. No
other significant differences were found.
Figure 6.26 Cell viability of porcine pulmonary leaflets determined by MTT assay.
Data is presented as the mean (n=3) ± 95 % C.I.. Data was analysed using by one way
ANOVA followed by calculation of the MSD using the T-method (p<0.05). “*”
indicated significant difference when compared with the fresh leaflet group.
6.4.6.2.2 Immunohistochemistry evaluation of porcine pulmonary roots labelled
with vWF
The non treated and treated porcine pulmonary root sections were labelled with
monoclonal antibody against vWF to study the presence of endothelial cells. The results
are shown in Figure 6.27 for fresh tissue, Figure 6.28 for tissue stored in PBS for 16-17
h at 4 °C, Figure 6.29 for tissue stored in DMEM culture medium for 16-17 h at 4 °C,
Figure 6.30 for tissue cultured in Cambridge antibiotics solution in the static culture
system for 16-17 h at 37 °C, and Figure 6.31 for tissue stored in Cambridge antibiotics
solution for 16-17 h at 4 °C. Positive staining was observed on both surfaces of
pulmonary leaflets and the lumen surface of the pulmonary artery of the fresh, PBS
stored, and DMEM cell culture medium stored porcine pulmonary roots (Figure 6.27 A
&C; Figure 6.28 A&C, Figure 6.29 A&C). The small blood vessels in the myocardium
of Cambridge antibiotics stored tissue (at 4 °C and 37 °C) were stained positive, but no
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brown colour was recognised on the surfaces of the pulmonary leaflets and pulmonary
arteries of the above two groups (Figure 6.30 B, Figure 6.31 B).
Figure 6.27 Localisation of vWF in fresh porcine pulmonary root tissue. (A)
Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa), the arrows
indicate the surfaces of the pulmonary leaflet that has been positively stained; (B)
Myocardium, 100 ×; (C) The lumen surface of the pulmonary wall, 100 ×, the arrow
indicates the surface cell layer of the pulmonary wall that has been positively stained; M:
myocardium. Scale bars are: all 200 µm.
Figure 6.28 Localisation of vWF in fresh porcine pulmonary root tissue stored in
PBS for 16-17 h at 4 °C. (A) Pulmonary valve leaflet, 100 × (v: ventricularis; s:
spongiosa; f: fibrosa), the arrows indicates the surfaces of the pulmonary leaflet that has
been positively stained; (B) Myocardium, 100 ×; (C) The lumen surface of the
pulmonary wall, 100 ×, the arrow indicates the surface cell layer of the pulmonary wall
that has been positively stained; M: myocardium. Scale bars are: all 200 µm.
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Figure 6.29 Localisation of vWF in fresh porcine pulmonary root tissue stored in
DMEM culture medium for 16-17 h at 4 °C. (A) Pulmonary valve leaflet, 100 × (v:
ventricularis; s: spongiosa; f: fibrosa), the arrow indicates the surface of the pulmonary
leaflet that has been positively stained; (B) Myocardium, 100 ×; (C) The lumen surface
of the pulmonary wall, 100 ×, the arrow indicates the surface cell layer of the
pulmonary wall that has been positively stained; M: myocardium. Scale bars are: all 200
µm.
Figure 6.30 Localisation of vWF in fresh porcine pulmonary root tissue cultured in
Cambridge antibiotics solution in the static culturing system for 16-17 h at 37 °C.
(A) Pulmonary valve leaflet, 100 × (v: ventricularis; s: spongiosa; f: fibrosa); (B)
Myocardium, 100 ×, the arrow indicates a blood vessel that has been positively stained;
(C) The lumen surface of the pulmonary wall, 100 ×; M: myocardium. Scale bars are:
all 200 µm.
Figure 6.31 Localisation of vWF in fresh porcine pulmonary root tissue stored in
Cambridge antibiotics solution for 16-17 h at 4 °C. (A) Pulmonary valve leaflet, 100
× (v: ventricularis; s: spongiosa; f: fibrosa); (B) Myocardium, 100 ×, the arrow indicates
a blood vessel that has been positively stained; (C) The lumen surface of the pulmonary
wall, 100 ×; M: myocardium. Scale bars are: all 200 µm.
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6.5 Discussion
This chapter has described the culture of fresh porcine pulmonary roots in the dynamic
and static heart root culture systems. Fresh porcine pulmonary roots were dissected and
cultured in the systems for one week. The cultured roots were characterised and
compared with the fresh tissue. The development of a fully functional heart valve
bioreactor which is able to provide physiological biological and mechanical
environment of the heart and circulatory system is still under research (Chen & Hu,
2006; Mertsching & Hansmann, 2009; Shaikh et al., 2009; Ruel et al., 2009; Vismara et
al, 2010; Berry et al., 2010). In order to validate the performance of heart valve
bioreactor systems it is necessary to investigate their capacity to support the viability
and function of fresh cardiac valves.
During the one week-culture in the dynamic and the static systems, the pulmonary roots
were observed daily. No changes were observed in the pulmonary root morphology
during this time. The pulmonary leaflets opened and closed properly during the culture
period in the dynamic bioreactor. The porcine pulmonary roots were taken out of the
culture systems, the roots were cut open, and the leaflets were examined for damage. No
damage was observed on the pulmonary leaflets of the roots that were cultured either
dynamically or statically. These results demonstrated the dynamic conditions applied
during culture did not have any effect on the pulmonary leaflet morphology, and did not
alter the pulmonary leaflets’ behaviour. The pulmonary leaflets and the pulmonary
arteries were stained pink following the culture. However, this was due to the
penetration of the DMEM medium, and did not affect the biological and mechanical
behaviour of the tissue.
H&E and Hoechst staining was utilised to evaluate the distribution of cells and the
integrity of the pulmonary root tissue. The results were compared with the histological
images of the fresh porcine pulmonary roots (Section 3.4.1). The cell distribution and
density of the dynamic and static cultured porcine pulmonary roots appeared to be no
different compared to that of the fresh tissue. No damage to the tissue was observed,
and the integrity, shape and distribution of the connective tissue fibres were well
preserved after culture in the dynamic and static systems in comparison with the fresh
tissues. No difference was observed in cell distribution and tissue ECM between the
dynamic and static cultured porcine pulmonary roots. The culture conditions of the
Chapter 6
266
dynamic and the static systems did not result in any overt cell loss or changes to the
porcine pulmonary roots.
The immunohistochemistry results of the dynamic and static cultured porcine
pulmonary roots were compared with the results of the fresh roots which were described
in Section 4.4.3. The results of the dynamic cultured porcine pulmonary roots were in
agreement with the fresh tissue when labelled with α-SMA. The static cultured porcine 
pulmonary leaflets were however markedly negative for α-SMA. Since positive staining 
was observed in the ventricularis of the fresh pulmonary leaflets, the results indicated
the loss of α-SMA in the static cultured pulmonary leaflets. Previous studies have 
shown that the smooth-muscle-like cells are distributed in the ventricularis in the
semilunar valves because this layer faces the blood flow and bears the most pressure
during leaflet function (DellaRocca et al., 2000; Bertiplaglia et al., 2003). In the mitral
valves, α-SMA has also been reported to positively label the arterial side of the leaflet, 
which is also the side that is most stressed (Dal-Bianco et al., 2009). Since the
ventricularis in the static cultured pulmonary leaflet was in a condition that did not bear
any pressure during culture, it is hypothesised that the flow pressure during leaflet
function is important for the cells in the ventricularis of pulmonary leaflets to have
smooth-muscle cell properties. The dynamic culture system, which mimicked the
physiological hydrodynamic conditions, contributed to retaining the smooth-muscle-like
cell properties in the ventricularis of the pulmonary leaflets during the culture process.
The tissue sections of dynamic and static cultured porcine pulmonary roots labelled
with vWF showed positive staining in the small blood vessels in the myocardium and
the connective tissue on the adventitial surface of the pulmonary artery, which was in
agreement with the results of the fresh tissue. However, the fact that no positive staining
was observed on the surfaces of pulmonary leaflets and the lumen surfaces of the
pulmonary arteries indicated a loss of endothelial cells following culture in the dynamic
and static systems. The VEC`s are believed to regulate vascular tone, inflammation,
thrombosis and remodelling (Leask et al., 2003; Sacks & Yoganathan, 2007). Thus, it
was considered important that the valve root culture system had the potential to
accommodate and maintain the viability and function of the endothelial cells on the
pulmonary valve leaflets. The dynamic and static culture techniques in this study
however failed to support the retention of endothelial cells. The reasons could be: (1)
the process during the preparation of porcine pulmonary roots prior to culture had
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accidentally removed or damaged the endothelial cells; (2) the culture medium used
during dynamic and static culture was not appropriate for endothelial cell viability (i.e.
lack of growth factor); (3) or/and the hydrodynamic conditions in the dynamic
bioreactor was not appropriate to retain the cells. The fact that the loss of endothelial
cells was mainly in areas that were exposed directly to the external environment (the
surfaces of pulmonary leaflets and pulmonary arteries, but not the internal tissue e.g.
myocardium and pulmonary arteries), lead to the hypothesis that the loss of endothelial
cells was due to the solutions/medium that had contacted directly with the tissue. Thus,
in this study, Cambridge antibiotics solution, which was used for tissue disinfection
prior to culture, was evaluated for its effect on endothelial cell retention.
The immunohistochemical results of the fibronectin labelled porcine pulmonary roots
following both dynamic and static culture were very similar to that of the fresh tissue,
indicated the retention of this root ECM protein after culture. In the images of desmin
and vimentin labelled porcine pulmonary roots following the dynamic culture, it was
observed that the distribution and the strength of positive staining were in agreement
with that of the fresh tissue. However, in the static cultured myocardium, the brown
colour was lighter than that of the fresh tissue. These results indicated that the level of
desmin and vimentin were reduced in the cardiac muscle cells that were cultured
statically. Thus, although the myocardium was not contracting in the dynamic culture
system, the medium flow and the stress provided during leaflet opening and closing
could still be important to the function of the cardiac muscle cells. Nevertheless, since
the acellular pulmonary heart roots would not consist of any cardiac muscle cells, and
the myocardium in the pulmonary root grafts that were subject to replacement surgery
would only be necessary as a suturing material during surgery and not be intended to
have functional cells, the viability of the myocardium cells was not of a major interest
in the study of the performance of the culture systems. The positive staining for
collagen IV, which served as a marker for the basement membrane, was found at the
same locations as that of the fresh tissue. The basement membrane remained intact after
the fresh porcine pulmonary roots had been cultured in the dynamic and static systems
for one week.
Live/dead cell staining was used to visualise the viability of pulmonary leaflet cells
using confocal microscopy. The confocal microscope captured cells from the layer that
was closest to the surface of the tissue. The captured cells of fresh porcine pulmonary
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leaflet sample were mostly alive and arranged close to each other. Judging from the
shape, size (~20 µm) and arrangement of the cells, they were considered to be
endothelial cells. The cells observed in the dead tissue control (10 % v/v NBF treated
porcine pulmonary leaflets) were all dead and smaller in size compared to the cells from
the fresh tissue. However, since dead cells shrink in size, and to judge from their
arrangement, the cells were considered to be endothelial cells as well. The cells
observed in the dynamic and static cultured porcine pulmonary leaflets were mostly
dead, although a small number of the cells were alive (green colour only). Cells that
took up both green-coloured calcein dye and red-coloured ethidium homodimer-1 dye
indicated that they were dying, and they were considered as ‘dead cells’. From the size
and arrangement of the cells, it was concluded that these cells from cultured porcine
pulmonary leaflets that were captured by confocal microscopy were VIC`s. This result
further indicated the loss of the endothelial layer in the dynamic and static cultured
porcine pulmonary leaflets.
The viability of cells from the porcine pulmonary leaflets was further assessed by MTT
assay, with the fresh tissue as the positive control, and the 10 % (v/v) NBF treated dead
tissue as the negative control. Although the cell viability of the dynamic and static
cultured leaflet tissue were significantly higher than the dead tissues control, neither
was comparable to the fresh tissue control. The reason for the reduction in cell viability
following tissue culture could be: (1) the tissue processing method prior to culturing had
affected the cell viability; (2) the culture medium used in the culture system was not
suitable for the cell viability; (3) the hydrodynamic conditions were not suitable to
maintain the viability of the porcine pulmonary leaflet cells. Regardless, the cell
viability data indicated the hydrodynamic conditions used during culture did not
promote cell viability in comparison to the static culture.
The Cambridge antibiotics solution that was used for tissue surface disinfection prior to
dynamic and static culture of porcine pulmonary roots could have contributed to the loss
of endothelial cell layers and the reduction in leaflet cell viability of the cultured tissues.
The MTT cell viability assay and immunohistochemical labelling with vWF were used
to assess the tissue properties after treatment with Cambridge antibiotics. The leaflet
cell viability was not significantly different between the Cambridge antibiotics cultured
tissue (either at 4 °C or 37 °C) and the fresh leaflet or the PBS treated leaflets. This
result indicated the pre-disinfection with antibiotics solution procedure did not affect the
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cell viability of the pulmonary leaflet tissue. The cell viability of tissue stored in
DMEM cell culture medium was significantly higher than that of the fresh tissue,
indicating that DMEM cell culture medium was suitable for the growth and
repopulation of cells in the porcine pulmonary leaflets. The differences between the
standard DMEM cell culture medium and the culture medium used in the valve root
culture systems were: the latter contained 250 ng.ml-1 amphotericin B, 25 µg.ml-1
gentamicin and 0.1 % (v/v) anti foaming reagent polypropylene glycol. The 250 ng.ml-1
amphotericin B and 25 µg.ml-1 gentamicin were standard dose used in tissue culture,
thus should not have any effect on the reduction of leaflet cell viability. The 0.1 % (v/v)
of polypropylene glycol was also a standard dose used as an anti foaming purpose. A
study by Routledge et al. (2011) has also shown that a concentration of up to 1 % (v/v)
of polypropylene glycol does not affect the growth rate of cells. Thus, of the three
possible reasons that could affected the cell viability during dynamic and static culture
of porcine pulmonary roots, the Cambridge antibiotics and the tissue culture medium
were excluded. Since the static culture system did not mimic the physiological
conditions for heart valve leaflet functioning, after culturing for one week, the reduction
of cell viability in porcine pulmonary leaflets was not unexpected. However, the cell
viability assay results for the dynamic cultured tissue have highlighted the need to
further study the conditions to apply in the system for valve root culture, or even to
modify the system itself in order to improve the leaflet cell viability during the dynamic
culture.
The results of porcine pulmonary root sections labelled with anti-vWF clearly indicated
the effect of Cambridge antibiotics solution in removing the endothelial cells. The
Cambridge antibiotics solution was initially used by the National Blood & Transplant
Tissue Services for the disinfection of cryopreserved allografts. The maintenance of cell
viability was less of a consideration than the disinfection of the tissue prior to
transplantation. Thus, for the purpose of this study, which was to maintain the cell and
tissue properties of the fresh porcine pulmonary root tissue during culture, and
eventually to repopulate the cells in the acellular tissue in the dynamic valve root culture
system, Cambridge antibiotics solution was not an ideal choice for surface disinfection
prior to tissue culture. However, because the dynamic valve root culture system had
failed to provide cultured porcine pulmonary root tissue with satisfying leaflet cell
viability and the limitation of time in this project, no further steps were taken to choose
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a suitable disinfection solution. Further attempts could be to exclude certain
components in the Cambridge antibiotics cocktail that could possibly affect the viability
of endothelial cells, and/or to reduce the doses of certain components. Sterility tests
could be applied to optimise the disinfection solution.
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6.6 Conclusion
Fresh porcine pulmonary roots were dissected, disinfected and cultured in dynamic and
static heart root culture systems for one week prior to characteriseation and comparison
with fresh tissue. Histology results showed no changes in cell distribution or alterations
in the ECM structure of the dynamic and static cultured porcine pulmonary roots.
Immunohistochemical results indicated a loss of endothelial cells in both dynamic and
static cultured porcine pulmonary valve leaflets. Further studies confirmed this result
was due to the use of Cambridge antibiotics solution for tissue disinfection prior to
culturing. The porcine pulmonary leaflet cell viabilities were significantly reduced
following culture in the dynamic and static systems. These experiments indicated the
need to further study the conditions to apply in the system for valve root culture, or even
to modify the system itself in order to improve leaflet cell viability during dynamic
culture. The culture of fresh porcine pulmonary roots in the dynamic and static systems
for one week had partially retained the natural properties of the tissue.
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Chapter 7
General Discussion
Heart valve dysfunction is a leading cause of death in the modern world. Among the
four human heart valves, the aortic valve is most often replaced. Replacement valves
may be mechanical, bioprosthetic, cryopreserved homografts or autografts. The Ross
procedure (Ross, 1967) is a surgical technique used to treat severe aortic valve disease
in young patients in which the patient’s own pulmonary valve is used to replace the
diseased aortic valve. The pulmonary autograft is considered to be the best substitute for
the diseased aortic valve since it is a living tissue with very similar structure to the
aortic valve. The pulmonary valve used to reconstruct the right ventricular outflow tract
is usually a cryopreserved homograft. Cardiac valve replacements each have their own
advantages and disadvantages. However, none of the replacement options is ideal.
Tissue engineering offers an opportunity to create an “ideal replacement valve” which
would overcome almost all of the limitations of currently available replacement valves,
including the risk of thromboembolism, requirement for life-time anticoagulation
therapy, poor durability and abnormal hydrodyanics. In addition, for the paediatric
population, tissue-engineered heart valves may be considered to be the optimal potential
solution for valve replacement since they should have the potential to grow, repair and
remodel (Sapirsten & Smith, 2001; Booth, et al., 2002; Veseley, 2005).
The overall aim of this study was to produce and characterise an acellular porcine
pulmonary root conduit. The long term goal is to translate the acellular valved conduit
for use in the clinic as a replacement valve, in particular in the Ross procedure to
reconstruct the right ventricular outflow tract. During the course of this study, a
decellularisation process was developed which was shown to remove the xenogeneic
cells from the porcine pulmonary root with minimum effect on the histoarchitecture and
composition of the ECM. The biomechanical and hydrodynamic function of the
decellularised porcine pulmonary root was characterised and compared to fresh
untreated tissue. In addition, attempts were made to investigate the culture conditions
required to maintain valve function and cell viability in a novel dynamic heart valve
bioreactor using fresh porcine pulmonary roots.
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The decellularisation process is the key step in determining the success of production of
an acellular xenogeneic heart valve conduit. Residual cellular material can be antigenic
and can reduce the capacity of the acellular scaffold to remodel in vivo which would
negate the advantages of using a biological scaffold (Brown et al., 2009; Burch et al.,
2010; Crapo et al., 2011). A fully decellularised porcine heart valve scaffold should
have similar biological, histological and mechanical characteristics to the native tissue
with close to 100 % of cells and cell remnants removed.
Various attempts have been made to produce a decellularised heart valve scaffold. In
early attempts, freeze-drying was used for heart valve decellularisation (Curtil et al.,
1997). However, not surprisingly decellularisation of the scaffold was not achieved
since the approach made no attempt to physically remove dead cell components.
Subsequent attempts to decellularise heart valves focused on the use of hypo-and
hypertonic solutions to lyse the cells and detergents such as Triton X-100 (Bader et al.,
1998; Wang et al., 2005) or 1 % (w/v) SDS (Courtman et al., 1994) to solublise cell
membranes and enzymes such as trypsin (Schenke-Layland et al., 2003; Yang et al.,
2010). However, the results were not ideal since, for example, the use of trypsin was
reported to disrupt the elastin and collagen network of the ECM leading to changes in
the mechanical properties of the tissue (Yang et al., 2009); Triton X-100 did not achieve
adequate decellularisation of the whole valve root (Grause et al., 2005) and 1% (w/v)
SDS changed the mechanical properties of valve leaflet tissue (Courtman et al., 1994).
A more effective way to achieve decellularisation of heart valve tissues without
affecting the integrity of the ECM is to utilise a combination of gentle treatments. A
successful method for the decellularisation of porcine aortic valve leaflets was
developed by Booth et al. (2002) using a combination of hypotonic buffer and low
concentration (0.03-0.1% w/v SDS) in the presence of proteinase inhibitors. The
approach taken was based on the hypothesis that the previous report of damage to ECM,
was not due to SDS treatment but caused by the release of numerous proteinases from
the cells following lysis. The acellular scaffold was shown to retain biomechanical
properties (Korossis et al., 2002). This process was further developed for whole porcine
aortic roots by Wilcox et al. (2005) with the addition of 1.25% (w/v) trypsin treatment
to the thinned aortic wall. The method also incorporated a freeze-thaw cycle at the
beginning, and a nuclease treatment cycle following the SDS-hypotonic wash.
Following treatment, the major structural components of the valve ECM were observed
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to be successfully maintained through histological analysis, and functional analysis
showed the valve leaflets to be fully competent under physiological pressures (120 mm
Hg) along with physiological leaflet kinematics (Korossis et al., 2005).
In this study, the development of the decellularisation process for porcine pulmonary
roots was based on that developed by Wilcox et al. (2005) for porcine aortic roots.
Porcine aortic and pulmonary roots share very similar structures, but still have
anatomical differences. In total six decellularisation methods were tested on porcine
pulmonary roots. Basic histological assessment with H&E and Hoechst staining was
used to assess the extent of cell removal from the tissue. Method 3, which incorporated
two cycles of SDS-hypotonic buffer washes with no trypsin treatment on the thinned
pulmonary artery and one cycle of nuclease treatment, showed cell removal throughout
the pulmonary root. The tissue histoarchitecture was well retained as determined by
histology. However, in subsequent biomechanical assessment using uniaxial tensile
testing, it was found that the tensile properties, namely the failure stress of the
pulmonary leaflet in the radial direction and the failure stress of the pulmonary artery in
the circumferential direction were significantly reduced compared to the fresh tissue.
These results indicated a loss of strength in the decellularised pulmonary roots which
was not the case for the aortic roots decellularised following the original protocol
(Korossis et al., 2005) developed by Wilcox et al. (2005). Biomechanical properties
play a very important role in the function of heart valve tissue. By comparison of the
modified and the original decellularisation methods, it was concluded that the loss of
leaflet strength was probably due to the application of the additional cycle of 0.1 % (w/v)
SDS-hypotonic buffer, since SDS has been reported to affect the mechanical properties
of the tissue, probably due to its effects on protein/protein interactions of importance to
the integrity of a collagenous matrix (Courtman et al., 1994). Although Booth et al.
(2002) and Wilcox et al. (2005) had successfully minimised the effects of SDS on the
ECM proteins by using a low concentration (0.1 % w/v) of SDS for aortic root
decellularisation, it was highly likely that the additional 0.1 % (w/v) SDS-hypotonic
buffer wash caused the loss of leaflet strength in the thin and delicate pulmonary leaflets.
In addition, although the same process of peeling the outer layer of the pulmonary wall
was taken in this study to the process reported by Wilcox et al. (2005) and Korossis et
al. (2005) for the aortic wall, the peeling of the pulmonary artery wall was most likely
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to have caused a reduction in its strength due to the fact that the pulmonary artery is
naturally thinner than the aorta.
Further development of the decellularisation process for porcine pulmonary roots
therefore used only one cycle of 0.1 % (w/v) SDS-hypotonic buffer as in the original
protocol developed by Wilcox et al. (2005) and omitted peeling the pulmonary artery
wall. This led to the development of Method 6, which used 1.25% (w/v) trypsin
digestion on the adventitial surface of the scraped pulmonary artery, one cycle of 0.1 %
(w/v) SDS-hypotonic buffer wash and two cycles of nuclease treatment. This process
was shown to achieve removal of cells as demonstrated by an absence of cells and an
absence of DNA throughout the tissue following staining with DNA specific fluorescent
Hoechst dye.
The DNA in the decellularised porcine pulmonary roots was extracted from individual
parts of the conduits including the leaflets, pulmonary artery, myocardium and leaflet
connection with the purpose to determine the levels of residual DNA and the presence
of functional genes in comparison to fresh tissues. The levels of residual DNA in the
pulmonary roots were determined by Nanodrop spectrophotometry. The results
indicated that greater than 90% of the DNA had been removed from all parts of the
conduits by the decellularisation process. A limitation of the experimental procedure
used to assess the DNA levels was that the absorbance values for the DNA extracted
from the decellularised tissue were at the lowest sensitivity of the Nanodrop
spectrophotometer. Thus, the actual reduction in total DNA levels in the decellularised
tissues was likely to have been inaccurate with the actual levels of residual DNA being
lower than the estimated values. A solution to this problem would be to start the DNA
extraction with greater masses of decellularised tissue (e.g. 10 times more mass of tissue
than used in this study). The quantity of residual DNA recovered would then be
proportionally higher and more accurate readings obtained using Nanodrop
spectrophotometry. Although it is unlikely that any decellularisation procedure would
remove 100 % of the DNA, it is generally accepted that short lengths of remnant DNA
(less than 300 bp) would not to be of concern in the decellularised scaffold (McCoy et
al., 2004; Gilbert et al., 2009). PCR was performed to detect the presence of functional
genes which would encode xenogenic cellular protein components in the decellularised
scaffold with target product lengths shorter than 250 bp. GAPDH, SLA-2, β 2-
microglobulin and β actin genes were not detected in the decellularised porcine 
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pulmonary leaflet, pulmonary artery, leaflet connection or myocardium. These results
provided evidence for an absence of functional DNA in the decellularised pulmonary
roots. This approach to assessing the extent of DNA removal from acellular xenogeneic
cardiac valves has not been previously reported by others in the field.
Particular cytoskeletal components of the different cell types within the pulmonary roots
were assessed by immunohistochemical labelling to further determine the extent of
decellularisation. There was no evidence for the presence of vWF or vimentin. This
provided evidence for the successful removal of endothelial and fibroblast cells.
However, there was evidence of residual levels of the intracellular proteins α-SMA and 
desmin in the decellularised scaffold. Similarity searches of porcine and human α-SMA 
revealed 100 % identity. Porcine desmin had 98 % identity to human desmin. Hence it
was considered unlikely that these residual proteins would be of immunological concern
following implantation in Man.
The connective tissue distribution in the ECM of the decellularised porcine pulmonary
root was comparable to the fresh tissue as determined by H&E and Miller’s elastin
staining. However, a significant reduction in the level of GAG`s was observed in the
pulmonary leaflet and pulmonary arteries following decellularisation as determined by
Alcian blue staining. Similar findings of GAG loss have been reported for different
types of tissues that were also decellularised using SDS (Mirsadraee, 2005; Stapelton,
2008; Cheng et al., 2009). The use of SDS in the decellularisation method was most
likely to have caused this result (Gilbert et al., 2006; Yang et al., 2010). Since GAG is
the major component in the spongiosa of the pulmonary leaflets and believed to perform
an important role in the integrity and mechanical properties of the leaflets, it was
important to examine the effect of GAG loss on the function of acellular pulmonary
valves through hydrodynamic testing. Although not performed in this study, the level of
GAG`s can be determined quantitatively using the dimethylene blue assay and it will be
important to quantify the GAG loss in future studies. The other major components of
the ECM such as collagen and elastin can also be quantitatively assessed using
biochemical assays. Future studies should also investigate total collagen and elastin
levels in acellular valve tissues compared to fresh tissues to provide better
understanding of the effects of the SDS based decellularisation treatment on the ECM of
the valvular tissue.
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The integrity of the ECM was also assessed by immunohistochemical labelling of
specific ECM proteins, fibronectin (a multifunctional adhesive EMC protein for cell
attachment) and collagen IV (a basement membrane marker). The results indicated a
reduction in the level of fibronectin and a total loss of collagen IV in the decellularised
porcine pulmonary roots. The removal of fibronectin was most likely due to the
continuous washing procedure during decellularisation based on the fact that the regions
close to the surface of tissue had lost more fibronectin than the internal parts of the
tissue. The loss of collagen IV in the decellularised scaffold indicated the loss of
basement membrane. The basement membrane is considered very important in tissue
endothelialisation (Brown et al., 2006). Thus, the pulmonary root scaffold produced in
this study may not be able to be repopulated with endothelial cells either in vitro or in
vivo. It will be important to determine whether loss of basement membrane collagen IV
does have an effect on the endothelialisation of the acellular pulmonary heart valve
conduits in vitro and in vivo in future studies. As discussed in Chapter 4, recent findings
in the laboratory by Dr Stacy-Paul Wilshaw have shown that the PAA sterilisation
treatment is responsible for loss of collagen IV during decellularisation of arteries. It is
therefore highly likely PAA was also responsible for the removal of basement
membrane in the pulmonary roots in this study. This could easily be tested in future
studies of porcine pulmonary valve conduits decellularised with and without PAA
sterilisation. Sterilisation of the decellularised scaffold is a prerequisite for any future
in vivo studies and clinical translation and hence, if loss of basement membrane
collagen IV does affect endothelialisation it will be necessary to investigate alternative
sterilisation methods in future studies. Alternative methods that could be investigated
include alternative chemical sterilising agents such as hydrogen peroxide and ethanol, -
irradiation, ethylene oxide or electron-beam sterilisation. Gorschewsky et al. (2005)
reported that acid or solvent sterilisation caused ECM damage. -irradiation is known to
induce free radical formation and this may alter the mechanical properties of the ECM
through cross-linking of collagens (Rosatio et al., 2008; Freytes et al., 2008; Sun &
Liung, 2008; Grouk et al., 2008). There is also a possibility that scaffolds could become
cytotoxic after sterilisation treatment (Moreau et al., 2000). Ethylene oxide sterilisation
is only effective in the absence of water and would require the tissue to be freeze dried
prior to treatment, which may affect the integrity of the scaffold. A future direction
could be to investigate the use of low dose -irradiation or electron-beam sterilisation on
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the integrity and biomechanical properties of the acellular pulmonary heart valve
conduit.
Immunohistochemistry was also used to detect the presence of the xenoantigen, the α-
gal epitope in the decellularised scaffolds. The presence of α-gal in the xenogeneic 
scaffold could cause inflammation following implantation in Man. The failure of the
first acellular porcine heart valve implanted in patients, the SynergraftTM , with
disasterous consequences was reportedly due to the presence of residual cells expressing
α-gal (Simon et al., 2003). For the acellular porcine pulmonary heart valve conduit
produced in this study, there was no evidence of residual -gal throughout the tissue. A
limitation of this part of the study was that the determination of the presence of α-gal by 
immunohistochemistry was only qualitative. It is possible to quantify the levels of α-gal 
in tissues using an anti--gal antibody absorption assay followed by an ELISA to detect
unbound antibodies (Stapleton et al., 2008). Although this was not carried out during
the present study, this analysis will be important to perform in future studies.
In addition, the potential presence of porcine endogenous retrovirus (PERV) is another
important concern in the use of tissues derived from pigs. There is a possibility that
PERV introduced into patients through implantation of tissues of porcine origin could
recombine with a latent human virus with serious consequences (Hammer, 2003;
Boneva & Folks, 2004). Given the lack of detectable functional DNA in the acellular
porcine pulmonary valve conduits it is unlikely that any functional retroviral DNA
would be present in the tissues, however, it will be important to confirm this through
use of PCR using PERV specific primers
In vitro biocompatibility studies were carried out to determine whether the
decellularised porcine pulmonary heart valve conduit contained any residual reagents
that were cytotoxic to cells. The acellular leaflet tissue was shown to be biocompatible
using contact cytotoxicity tests with 3T3 and L929 fibroblasts. An extract cytotoxicity
assay was used to assess the in vitro biocompatibility of the decellularised pulmonary
arteries. The experiments showed that extracts from 3 out of 6 replicate acellular arterial
tissues had a significant effect on the growth of 3T3 cells but not L929 cells. This
revealed that the wash procedure used in the final stages of the decellularisation process
was not consistently removing all of the residual chemicals from the thicker pulmonary
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artery tissue and that increased washes would be required to ensure a reproducibly
biocompatible acellular pulmonary heart valve conduit.
Biomechanical testing provided information on any changes in the stress-strain
behaviour of the pulmonary valve leaflet and artery tissues following decellularisation.
Biomechanical testing also provided an indirect assessment of the integrity of the major
structural components of the ECM (elastin and collagen). The stress-strain behaviour of
both fresh and decellularised leaflet and pulmonary artery tissues demonstrated typical
quasi-linear trends, which were in agreement with the previous studies of the
biomechanical properties of cardiac valve tissues (Jennings, 2001; Stradins et al., 2004;
Seebacher et al., 2007). The pulmonary leaflet and artery tissues showed reduced
extensibility and increased strength when tested in uniaxial tensile tests in the
circumferential direction compared to the radial direction. This finding supported the
anisotropy of the valvular tissue indicated by the directionality of the ECM. The
anisotropy in the pulmonary leaflets was more apparent than that in the pulmonary
artery. No significant difference was observed for any of the mechanical parameters
between the fresh and decellularised leaflets, or the fresh and decellularised pulmonary
arteries, with the exception of the elastin phase slope of the pulmonary artery in both
directions which showed a significant decrease in the decellularised tissue. This finding
indicated that decellularisation resulted in a more compliant tissue in the elastin phase
within the physiological range. The results indicated that the strength of the pulmonary
leaflets and arteries were not compromised following decellularisation. The results
obtained in the present study were in general agreement with the results reported by
Korossis (2002), who tested the mechanical properties of porcine aortic root tissues
which had been decellularised using a very similar method based on 0.1 % (w/v) SDS.
Pulsatile flow testing at physiological pulmonary pressures was carried out to
investigate the hydrodynamic function of the decellularised porcine pulmonary roots in
comparison to the fresh tissue. No significant difference was observed in the EOA for
any of the test conditions between decellularised and fresh pulmonary roots. The QRMS
of the decellularised pulmonary roots showed no significant difference compared to the
fresh group except for flow condition 2 (72 bpm/70 ml), during which a significant
decrease was observed in the pulmonary roots following decellularisation. Interestingly,
the lower QRMS indicated better performance of the roots following decellularisation
treatment. The data obtained was in very good agreement with the previously reported
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studies for porcine pulmonary roots (Nagy et al., 2000). The leaflet kinematics was
assessed by recording the leaflet motion during a test run in the pulsatile flow testing.
The results demonstrated a circular configuration when the valves were fully open, and
no visible leakage orifices or coaptation flaws were observed in all decellularised valves.
There was no significant difference in the phase durations of opening, fully open,
closing and fully closed phases for the decellularised and the fresh valves, and the
results were in very good agreement with the previous study reported by Korossis et al.
(2005). No significant difference was observed in the minimum bending radius of the
fresh and decellularised pulmonary leaflets. No damage to the hydrodynamic function
and leaflet kinematics of the porcine pulmonary roots following decellularisation was
observed.
Overall the biological, biomechanical and hydrodynamic characterisation of the
acellular porcine pulmonary heart valve conduits indicated that the decellularisation
process had produced minimum changes to the properties of the tissues. This indicated
that the acellular porcine pulmonary cardiac valve conduits were suitable for further
studies of their regenerative capacity in vitro and in vivo. In order to progress to studies
of the in vitro regeneration of the acellular scaffolds, it was necessary to develop
appropriate physiological physically interactive culture conditions. This led to
preliminary studies using a novel “in house” heart valve bioreactor. Fresh porcine
pulmonary roots were cultured in the heart valve bioreactor for one week in an attempt
to determine whether the physically interactive culture conditions in the bioreactor
could maintain tissue viability and function in comparison to fresh tissue and tissue
cultured statically. The cell density and parenchymal cell distribution in the porcine
pulmonary roots cultured in the bioreactor for 7 days were maintained as compared to
the fresh tissue and the ECM histoarchitecture showed no overt changes as determined
by H&E and Hoechst staining.
Qualitatively the levels and distribution of fibronectin and collagen IV remained the
same in both dynamic and static cultured pulmonary roots when compared to the fresh
tissue. Interestingly, however, there was a qualitative reduction in the levels of vimentin
and desmin in the myocardium of the statically cultured tissue but no difference
between the fresh and dynamically cultured tissues. This suggested that dynamic flow
and stress conditions provided during leaflet opening and closing could be important to
the function of the cardiac muscle cells. The levels and distribution of α-SMA in the 
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dynamically cultured porcine pulmonary roots was no different to the fresh tissue. There
was however, a lack of α-SMA expression in the ventricularis of the leaflets in the
statically cultured pulmonary roots. It has been reported that the ventricularis in the
semilunar valve leaflets contains smooth muscle-like cells because this layer faces the
blood flow and bears the most pressure during leaflet function (DellaRocca et al., 2000;
Bertiplaglia et al., 2003). This interesting result therefore led to the hypothesis that
pressure due to flow on the ventricularis during leaflet opening and closing might play
an important role in the distribution of smooth-muscle-like cells in the ventricularis in
the pulmonary leaflets. Unfortunately, a lack of von Willebrand factor expression on the
surfaces of the pulmonary leaflets or pulmonary artery in either the dynamically or
statically cultured roots indicated a loss of endothelial cells. This finding was also
supported by the live/dead cell staining of the leaflets. Further investigation indicated
that the Cambridge antibiotic solution which was used for surface disinfection of the
pulmonary roots was responsible for the loss of endothelial cells. Therefore, in order to
maintain the presence and viability of the endothelial cells in the pulmonary roots
during tissue culture, it will be essential to develop an alternative disinfection solution.
Unfortunately, neither the dynamically or statically cultured tissue retained viability at
the level of the fresh tissue control. Hence, the conclusion was that the conditions
within the heart valve bioreactor did not promote tissue viability in comparison to static
culture. The loss of tissue viability was not due to the treatment with Cambridge
antibiotics. It is possible that the thickness of the tissue in the pulmonary artery wall
was too great to allow adequate nutrient diffusion, even under dynamic culture
conditions. Studies have shown that oxygen diffusion into heart valve leaflet tissue is
limited to a depth of 300-500 microns (Wang et al., 2008; Wang et al., 2009). If cells
were dying in the thickness of the arterial wall, this could have had an effect on the
viability of the cells in the leaflets. In future studies of the behaviour of the fresh
pulmonary valve conduits in the bioreactor it may be necessary to reduce the thickness
of the artery wall in order to maintain tissue viability to study the effects of dynamic
culture on leaflet viability and function.
Acellular biological scaffolds for cardiac valve replacement may be used either pre-
seeded with the patient’s own autologous cells prior to implantation or implanted
directly with a view to the patient’s own endogenous cells repopulating the scaffolds
and regenerating the tissues in vivo. When this project commenced, both strategies were
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considered as options for the future clinical translation of the scaffolds. Some
researchers believe that pre-seeding of acellular xenografts with autologous endothelial
cells is necessary for clinical success (Dohmen et al., 2002). However, harvesting of
cells from patients and pre-seeding of scaffolds is a time consuming and risky procedure.
In addition, this approach would not be possible for the majority of patients requiring a
cardiac valve replacement.
It would be desirable if acellular cardiac valve scaffolds remodelled and regenerated in
vivo following implantation. This approach has the advantage of an “off the shelf”
solution for the majority of patients. Interestingly, the clinical use of acellular allogeneic
and xenogeneic heart valves in cardiac valve replacement surgery heart has advanced
considerably since the start of this project. Currently, commercially available acellular
pulmonary valve grafts include the SynerGraft™ pulmonary homograft (Cyrolife Inc,
USA) and the Matrix P™ porcine pulmonary valve (AutoTissue, Germany).
The early results for the SynerGraft™ pulmonary homograft appear to be good,
demonstrating that this approach is safe. The implanted acellular allogeneic scaffolds
have been shown to have comparable hemodynamic performance, and have been shown
to be as competent as cryopreserved homografts according to current experience
(Brown et al., 2010; Brown et al., 2011), although further long term follow up will be
needed to evaluate the long term success of the SynerGraft™ pulmonary homografts.
To date, however, there are no apparent clinical advantages to the use of the
SynerGraft™ pulmonary homograft over traditional cryopreserved homografts. The real
test will be the comparative performance at 8-12 years, when the cryopreserved
homografts begin to fail due to calcification and degeneration. It is important to
recognise that, if, as anticipated, the SynerGraft™ pulmonary homograft cardiac valve
shows advantages over cryopreserved homografts in the longer term, there will still be
limitations of availability since the tissue is derived from human donors.
The use of xenogeneic tissue, as with the Matrix P™ porcine pulmonary grafts has the
advantage of unlimited availability in a range of different sizes. However, a number of
studies have reported inflammatory responses to the Matrix P™ porcine pulmonary
grafts associated with predominantly peripheral conduit narrowing (Bayrak et al., 2010;
Ruffer et al., 2010; Mahler & Butcher, 2011). It is interesting to speculate whether the
decellularisation process used in the production of the Matrix P™ porcine pulmonary
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graft is adequately quality controlled, especially in light of the Cryolife experience with
the SynerGraft™ technology applied to porcine pulmonary cardiac valves (Simon et al.,
2003).
There have been other reports that have demonstrated the successful repopulation of
decellularised heart valve scaffolds either in animal studies or clinical use (Kim et al.,
2004; da Costa et al., 2007). In particular, da Costa et al. (2009; 2010) reported on the
successful clinical use of non-pre-seeded decellularised allogeneic pulmonary and aortic
roots produced using the process based on 0.1 % (w/v) SDS developed by Booth et al.
(2002) and Wilcox et al. (2005). The acellular pulmonary homografts were used in the
Ross procedure for right ventricular outflow tract reconstruction and demonstrated
stable structural integrity, low rate of calcification, and adequate hemodynamics in early
and midterm clinical results (da Costa et al., 2009). Although the acellular allogeneic
grafts used by da Costa et al. (2009; 2010) would suffer from limited availability, the
clinical studies have shown promising results for the use of 0.1 % (w/v) SDS
decellularisation in the production of acellular homografts. The application of a similar
decellularisation process to porcine tissue in this study may offer a solution to achieve
similar promising clinical results while solving the problem associated with the limited
availability of homografts.
In this study, a decellularisation method for porcine pulmonary roots was developed
based on the use of 0.1 % (w/v) SDS. Cell removal was achieved with the majority of
ECM biological characteristics well retained. The scaffold demonstrated excellent
biomechanical and hydrodynamic performance. The decellularised pulmonary leaflets
showed similar leaflet kinematics and deformation compared to the fresh tissue. Minor
modifications to the decellularisation process are still needed in order to produce a
reproducibly biocompatible scaffold with the basement membrane retained. Further
assessment of the decellularised porcine pulmonary root scaffold is required, in
particular quantitative determination of α-gal. Overall the decellularised porcine 
pulmonary roots have excellent potential for development of a tissue engineered
solution for right ventricular outflow tract reconstruction during the Ross procedure.
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Appendix 1
Coding sequences for Sus scrofa Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), Swine leukocyte
antigen (SLA), beta 2-microglobulin (β 2-
microglobulin) and beta actin (β actin) 
1. Sus scrofa glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA,
complete cds
CTCTCTGCTCCCTCCCCGTTCCACAGACAGCCGTGTGTTCCGTGCATTGCCAGGTAAAGCCTGGCGGAGT
GGAGCCACAAGGTTCGAGGACTGGTCCAAAGGGACCGGGGGCCGTGCGCGGTCTGGGAGTGTGGGTGCGG
GCCCGGCTGGGGGCCGGAGTTGTGCTGCGCCGGCCGGGCCCCTGCATTGCGGGTTGAGGGGGAGGAAGGA
CGTGCAGAAGAGCAGAGCGAGGATGGAGGCCACTGGGGGAGGGGCGGGGAGGGCACCGTCGGGCTCCAGC
CGCTTTGCCCCGCGATCTAATGTTCTCTTTCCTCTGCCGGCAGCCGCGTCCCTGAGACACGATGGTGAAG
GTCGGAGTGAACGGATTTGGCCGCATCGGGCGCCTGGTCACCAGGGCTGCTTTTAACTCTGGCAAAGTGG
ACATTGTCGCCATCAATGACCCCTTCATTGACCTCCACTACATGGTCTACATGTTCCAGTATGATTCTAC
CCATGGCAAATTCCACGGCACAGTCAAGGCTGAGAATGGGAAGCTTGTCATCAATGGAAATCCCATCACC
ATCTTCCAGGAGCGAGATCCCGCCAAAATCAAATGGGGCGATGCTGGTGCTGAGTATGTCGTGGAGTCCA
CTGGTGTCTTCACGACCATGGAGAAGGCTGGGGCTCACTTGAAGGGGGGAGCCAAAAGGGTCATCATCTC
TGCCCCTTCTGCTGATGCCCCCATGTTTGTGATGGGCATGAACCATGAGAAGTATGACAACAGCCTCAAG
ATCATCAGCAATGCCTCCTGTACCACCAACTGCTTGGCACCCCTGGCCAAGGTCATCCATGACAACTTCG
GCATCGTGGAAGGACTCATGACCACAGTCCATGCCATCACTGCCACCCAGAAGACTGTGGATGGCCCCTC
TGGGAAACTGTGGCGTGATGGCCGAGGGGCTCTCCAGAACATCATCCCTGCTTCTACTGGTGCTGCCAAG
GCTGTGGGCAAGGTCATCCCTGAGCTCAACGGGAAGCTCACTGGCATGGCCTTCCGTGTCCCTACTGCCA
ACGTGTCGGTTGTGGACCTGACCTGCCGTCTGGAGAAACCTGCCAAATATGATGACATCAAGAAGGTGGT
GAAGCAGGCGTCCGAGGGCCCCCTCAAGGGCATCCTGGGCTACACTGAGCACCAGGTTGTGTCCTCTGAC
TTTAACAGTGACACTCACTCTTCTACCTTTGATGCTGGGGCTGGCATTGCCCTCAACGACCACTTTGTCA
AGCTCATTTCCTCGTACGACAATGAATTTGGCTACAGCAACAGGGTGGTGGACCTCATGGTCCACATGGC
CTCCAAGGAGTAAGAGCCCCTGGACCACCAACCCCAGCAAGAGCACGCGAGGAGGAGAGAGGCCCTCAGT
CGTCGGGGATGCACAGCCC
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2. Sus scrofa SLA-2 mRNA for MHC class I antigen, complete cds, allele: SLA-2-
TPK (1119bp)
AGATGCGGGTCAGGGGCCCTCAAGCCATCCTCATTCCGCTGTCGGGGGCCCTGGCCCTGACCGGGACCCA
GGCGGGTTCCCACTCCCTGAGCTATTTCTACACCGCCGTGTCCCGGCCCGACCGCGGGGACTCCCGCTTC
CTCACCGTCGGGTACGTGGACGACACGCAGTTCGTGCGGTTCGACAGCGACGCCCCGAATCCGAGGGAGG
AGCCGCGGGTGCCGTGGATACAGCAGGAGGGGCAGGACTATTGGGATAGGAACACGCAGATTTACAAGGA
AACCGCACAGATTTACAGAGTGGGCCTGAACAACCTGCGCGGCTACTACAACCAGAGCGAGGCCGGGTCT
CACACCTTCCAGAGCATGTACGGCTGCGACGTGGGACCAGACGGGCTCTTCCTCCGCGGGTACAGTCAGG
ACGCCTACGACGGCGCCGATTACGTCGCCCTGAACGAGGACCTGCGCTCCTGGACCGCGGCGGACACGGC
GGCTCAGATCACCAAGCGCAAGAGGGAGGCGGCCGATGCGGCGGAGCAGTGGAGGAGCTACCTGCGGGGC
ACGTGTATGGAGGGGCTCCGCAGATACCTGGAGATGGGGAAGGACACGCTGCAGCGCGCAGAGCCTCCAA
AGACACATGTGACCCGCCACCCCAGCTCTGACCTGGGGGTCACCTTGAGGTGCTGGGCCCTGGGCTTCTA
CCCTAAGGAGATCTCCCTGACCTGGCAGCGCGAGGGCCAGGACCAGAGCCAGGACATGGAGCTGGTGGAG
ACCAGGCCCTCAGGGGATGGGACCTTCCAGAAGTGGGCGGCCCTGGTGGTGCCTCCTGGAGAGGAGCAGA
GCTACACCTGCCATGTGCAGCACGAGGGCCTGCAGGAGCCCCTCACCCTGAGATGGGACCCTCCTCAGCC
CCCCGTCCCCATCGTGGGCATCATTGTTGGCCTGGTTCTGGTCCTGGTCACTGGAGCCGTGGTGACTGGA
GTTGTGATCTGGAGAAAGAAGCGCTCAGGTGAAAAAGGAGGGAGCTACACTCAGGCTGCAGGCAGTGACA
GTGCCCAGGGCTCCGATGTGTCCCTTACCAAGGATCCTAGAGTGTGAGACAGCTGCCTTGTGGGGACTG
3. Sus scrofa beta 2-microglobulin mRNA, complete cds (543bp)
AAGGGTCTTAAAACTTTTTAAATCAAGTCAACCACTTTTCACACCGCTCCAGTAGCGATGGCTCCCCTCG
TGGCCTTGGTCCTGCTCGGGCTGCTCTCACTGTCTGGCCTGGATGCGGTCGCGCGTCCCCCGAAGGTTCA
GGTTTACTCACGCCACCCAGCGGAAAACGGAAAGCCAAATTACCTGAACTGCTATGTATCTGGGTTCCAT
CCGCCCCAGATTGAAATTGATTTGCTGAAAAACGGGGAGAAGATGAACGCGGAGCAGTCAGACCTGTCTT
TCAGCAAGGACTGGTCTTTCTACCTTCTGGTCCACACTGAGTTCACTCCTAACGCTGTGGATCAGTATAG
CTGCCGCGTGAAGCACGTGACTCTCGATAAGCCCAAGATAGTTAAGTGGGATCGAGACCACTAACCGGCA
TCACAGAGATTATGAAGATGCTGCATCTGGGTTGGATGAATCCAAATTCTGATTTGTTGCTTTTTAATAC
TGATAAGCTTTTATACTTTATGCACATAAATCAGAAATCGTATTGATGTTACC
4. Sus scrofa beta actin mRNA, partial cds (706bp)
ATGTTTGAGACCTTCAACACGCCGGCCATGTACGTGGCCATCCAGGCTGTGCTGTCCCTGTACGCCTCTG
GCCGCACCACTGGCATTGTCATGGACTCTGGGGATGGGGTCACCCACACGGTGCCCATCTACGAGGGGTA
CGCCCTGCCCCACGCCATCCTGCGTCTGGACCTGGCTGGCCGGGACCTGACCGACTACCTCATGAAGATC
CTCACGGAGCGGGGCTACAGCTTCACCACCACGGCCGAGCGGGAGATCGTGCGGGACATCAAGGAGAAGC
TCTGCTACGTCGCCCTGGACTTCGAGCAGGAGATGGCCACGGCCGCCTCCTCCTCCTCCCTGGAGAAGAG
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CTACGAGCTGCCCGACGGGCAGGTCATCACCATCGGCAACGAGCGCTTCCGGTGTCCAGAGGCGCTCTTC
CAGCCCTCCTTCCTGGGCATGGAGTCCTGCGGCATCCACGAGACCACCTTCAACTCGATCATGAAGTGCG
ACGTGGACATCAGGAAGGACCTCTACGCCAACACGGTGCTGTCTGGCGGGACCACCATGTACCCCGGCAT
CGCCGACAGGATGCAGAAGGAGATCACGGCCCTGGCGCCCAGCACCATGAAGATCAAGATCATCGCCCCT
CCCGAGCGCAAGTACTCCGTGTGGATCGGGGGCTCCATCCTGGCCTCGCTGTCCACCTTCCAGCAGATGT
GGATCA
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Appendix 2
Determination of leaflet average curvature
The mathematical rationale for the determination of the leaflet average curvature has
been described by Courden et al. (1995a, 1995b). The cubic spline, s(x), was fitted to
the transformed data (Xα,trans, Yα,trans), using a standard numerical routine integrated
into the Origin programme (Version 8.0). The spline was represented in its B-spline
form as: CkNk
Where Nk(x) is the normalised 3rd degree B-spline, and ck are the spline coefficients
estimated by the routine. A further numerical routine was used to evaluate the spline at
90 equally spaced points (Xi, Yi) along the curve.
The curvature Ki at each point along the spline was calculated according to [Gere &
Timoshenko (1984)]:
Where the derivatives were evaluated at each point using the central difference
expressions, given by:
and
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Since any leaflet has a finite thickness when viewed using the image analysis system it
was possible to introduce false local curvatures when defining the leaflet using a
polyline. This concept is illustrated in Figure B.1. In order to eliminate the effect of
these false curvatures that may have contaminated the data, an average value of
curvature was calculated according to the formula:
The value of n was chosen to satisfy the following condition:
Where t is the thickness of the leaflet, n is an odd integer and ln is parameter defining a
length of leaflet over which the average curvature is calculated. The ensured a sufficient
aspect ratio between ln and t to allow the use of thin shell bending theory to calculate the
bending stresses in the leaflet (t/ ln < 0.1). The fresh left pulmonary leaflets had an
average thickness of 0.348 mm, and the decellularised left pulmonary leaflets had an
average thickness of 0.262 mm. The value n of 13 was used.
Figure B.1 Schematic of possible false curvature.
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Ji Luo, John Fisher, Zhongmin Jin, Eileen Ingham, and Sotirios Korossis (2009)
Biomechanical and Histological Characterisation of Low Concentration SDS
Decellularised Porcine Pulmonary Valvular Scaffold. 11th Annual White Rose Work
in Progress Meeting, York. Poster presentation.
Ji Luo, Sotirios Korossis, Zhongmin Jin, John Fisher, Eileen Ingham (2009)
Biomechanical testing of low concentration SDS decellularised porcine pulmonary
valves. The Society of Heart Valve Diseases 5th Biennial meeting, Berlin. Poster
presentation.
Ji Luo, John Fisher, Zhongmin Jin, Eileen Ingham, and Sotirios Korossis (2009)
Biomechanical and Histological Characterisation of Low Concentration SDS
Decellularised Porcine Pulmonary Valvular Scaffold. Tissue Engineering and
Regenetive Medicine International Society (TERMIS) World Congress, Seoul. Poster
presentation.
J Luo, John Fisher, Zhongmin Jin, Eileen Ingham, Sotirios Korossis (2010)
Biomechanical Testing of Low-Concentration SDS Decellularised Porcine
Pulmonary Valves. Tissue and Cell Engineering Society meeting, Manchester. Poster
presentation.
Ji Luo, John Fisher, Zhongmin Jin, Daniel Thomas, Sotirios Korossis and Eileen
Ingham (2010) Biomechanical and Histological Characterisation of Trypsin and
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